US20090204128A1 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions - Google Patents

Devices, systems and methods for treating benign prostatic hyperplasia and other conditions Download PDF

Info

Publication number
US20090204128A1
US20090204128A1 US11/838,058 US83805807A US2009204128A1 US 20090204128 A1 US20090204128 A1 US 20090204128A1 US 83805807 A US83805807 A US 83805807A US 2009204128 A1 US2009204128 A1 US 2009204128A1
Authority
US
United States
Prior art keywords
anchor
distal
prostate gland
lumen
proximal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/838,058
Other versions
US8343187B2 (en
Inventor
Theodore Charles Lamson
Joshua Makower
Joseph Catanese, III
Jacqueline Nerney Welch
Amrish Jayprakash Walke
Claude Vidal
Russell J. Redmond
Michael Collinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teleflex Life Sciences LLC
Original Assignee
Neotract Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/838,058 priority Critical patent/US8343187B2/en
Application filed by Neotract Inc filed Critical Neotract Inc
Publication of US20090204128A1 publication Critical patent/US20090204128A1/en
Application granted granted Critical
Publication of US8343187B2 publication Critical patent/US8343187B2/en
Assigned to Neotract, Inc reassignment Neotract, Inc ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MAKOWER, JOSHUA, COLLINSON, MICHAEL, REDMOND, RUSSELL J, VIDAL, CLAUDE, CATANESE, JOSEPH, III, LAMSON, THEODORE C, NERNEY WELCH, JACQUELINE, WALKE, AMRISH JAYPRAKASH
Assigned to Neotract, Inc reassignment Neotract, Inc CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MAKOWER, JOSHUA, COLLINSON, MICHAEL, REDMOND, RUSSELL J, VIDAL, CLAUDE, CATANESE, JOSEPH, III, LAMSON, THEODORE C, NERNEY WELCH, JACQUELINE, WALKE, AMRISH JAYPRAKASH
Assigned to CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P. reassignment CAPITAL ROYALTY PARTNERS II L.P. SHORT-FORM PATENT SECURITY AGREEMENT Assignors: NEOTRACT, INC.
Assigned to EXPLORAMED NC2, INC. reassignment EXPLORAMED NC2, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 032212 FRAME: 0047. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Assignors: MAKOWER, JOSHUA, COLLINSON, MICHAEL, REDMOND, RUSSELL J., VIDAL, CLAUDE, CATANESE, JOSEPH, III, LAMSON, THEODORE CHARLES, WALKE, AMRISH JAYPRAKASH, WELCH, JACQUELINE NERNEY
Assigned to NEOTRACT, INC. reassignment NEOTRACT, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED AT REEL: 032264 FRAME: 0028. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Assignors: EXPLORAMED NC2, INC.
Assigned to NEOTRACT, INC. reassignment NEOTRACT, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., CAPITAL ROYALTY PARTNERS II L.P., PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Assigned to JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT reassignment JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEOTRACT, INC.
Assigned to TELEFLEX LIFE SCIENCES LIMITED reassignment TELEFLEX LIFE SCIENCES LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEOTRACT, INC.
Assigned to TELEFLEX LIFE SCIENCES LIMITED reassignment TELEFLEX LIFE SCIENCES LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEOTRACT, INC.
Assigned to TELEFLEX LIFE SCIENCES III LLC reassignment TELEFLEX LIFE SCIENCES III LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TELEFLEX LIFE SCIENCES LIMITED
Assigned to Teleflex Life Sciences Llc reassignment Teleflex Life Sciences Llc MERGER (SEE DOCUMENT FOR DETAILS). Assignors: TELEFLEX LIFE SCIENCES III LLC
Assigned to TELEFLEX LIFE SCIENCES III LLC reassignment TELEFLEX LIFE SCIENCES III LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TELEFLEX LIFE SCIENCES LIMITED
Assigned to Teleflex Life Sciences Llc reassignment Teleflex Life Sciences Llc MERGER Assignors: TELEFLEX LIFE SCIENCES III LLC
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0482Needle or suture guides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0487Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B17/06109Big needles, either gripped by hand or connectable to a handle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B17/0218Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0467Instruments for cutting sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3468Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/34Trocars; Puncturing needles
    • A61B17/3478Endoscopic needles, e.g. for infusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00274Prostate operation, e.g. prostatectomy, turp, bhp treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00792Plastic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00796Breast surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00805Treatment of female stress urinary incontinence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0404Buttons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0409Instruments for applying suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0417T-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0419H-fasteners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0448Additional elements on or within the anchor
    • A61B2017/0451Cams or wedges holding the suture by friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0454Means for attaching and blocking the suture in the suture anchor the anchor being crimped or clamped on the suture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0456Surface features on the anchor, e.g. ribs increasing friction between the suture and the anchor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0458Longitudinal through hole, e.g. suture blocked by a distal suture knot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0446Means for attaching and blocking the suture in the suture anchor
    • A61B2017/0461Means for attaching and blocking the suture in the suture anchor with features cooperating with special features on the suture, e.g. protrusions on the suture
    • A61B2017/0462One way system, i.e. also tensioning the suture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • A61B2017/0464Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0487Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
    • A61B2017/0488Instruments for applying suture clamps, clips or locks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B2017/06052Needle-suture combinations in which a suture is extending inside a hollow tubular needle, e.g. over the entire length of the needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • A61B2017/06176Sutures with protrusions, e.g. barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00505Urinary tract
    • A61B2018/00517Urinary bladder or urethra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00547Prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00589Coagulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00601Cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1425Needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/144Wire
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/041Bile ducts

Definitions

  • the present invention relates generally to medical devices and methods and more particularly to devices, systems and methods for treating conditions wherein a tissue (e.g., the prostate gland) has a) become enlarged and/or b) undergone a change in form, position, structure, rigidity or force exertion with respect to another anatomical structure and/or c) has begun to impinge upon or compress an adjacent anatomical structure (e.g., the urethra).
  • a tissue e.g., the prostate gland
  • an adjacent anatomical structure e.g., the urethra
  • a tissue e.g., a gland, tumor, cyst, muscle, fascia, skin, adipose, mucous membrane, etc.
  • a tissue e.g., a gland, tumor, cyst, muscle, fascia, skin, adipose, mucous membrane, etc.
  • anatomical structure e.g., the urethra
  • tissue relaxation or collapse loose skin, fat or muscle folds, vaginal, rectal, or bladder prolapse, incontinence, etc.
  • tissue remodeling scar formation, bladder stiffness secondary to chronic overexertion, infiltrative lung disease
  • traumatic injury i.e. removal of supportive tissues, removal of tumors, reattachment of ligaments, etc.
  • tissue growth or enlargement i.e.
  • luminal obstruction or occlusion coronary artery disease, peripheral vascular disease, stroke, non-communicating hydrocephalus, infertility secondary to non-patent fallopian tubes, urinary tract obstruction, etc.
  • tissue impingement slipped spinal disks, degenerative joint disease, etc.
  • ptosis ptosis
  • Benign Prostatic Hyperplasia is one of the most common medical conditions that affect men, especially elderly men. It has been reported that, in the United Sates, more than half of all men have histopathologic evidence of BPH by age 60 and, by age 85, approximately 9 out of 10 men suffer from the condition. Moreover, the incidence and prevalence of BPH are expected to increase as the average age of the population in developed countries increases.
  • the prostate gland enlarges throughout a man's life.
  • the prostatic capsule around the prostate gland may prevent the prostate gland from enlarging further. This causes the inner region of the prostate gland to squeeze the urethra. This compression of the urethra increases resistance to urine flow through the region of the urethra enclosed by the prostate.
  • the urinary bladder has to exert more pressure to force urine through the increased resistance of the urethra.
  • Chronic over-exertion causes the muscular walls of the urinary bladder to remodel and become stiffer.
  • This combination of increased urethral resistance to urine flow and stiffness and hypertrophy of urinary bladder walls leads to a variety of lower urinary tract symptoms (LUTS) that may severely reduce the patient's quality of life.
  • LUTS lower urinary tract symptoms
  • LUTS may also be present in patients with prostate cancer, prostate infections, and chronic use of certain medications (e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine etc.) that cause urinary retention especially in men with prostate enlargement.
  • certain medications e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine etc.
  • BPH is rarely life threatening, it can lead to numerous clinical conditions including urinary retention, renal insufficiency, recurrent urinary tract infection, incontinence, hematuria, and bladder stones.
  • Medications for treating BPH symptoms include phytotherapy and prescription medications.
  • plant products such as Saw Palmetto, African Pygeum, Serenoa repens (sago palm) and South African star grass are administered to the patient.
  • Prescription medications are prescribed as first line therapy in patients with symptoms that are interfering with their daily activities.
  • Two main classes of prescription medications are alpha-1a-adrenergic receptors blockers and 5-alpha-reductase inhibitors.
  • Alpha-1a-adrenergic receptors blockers block that activity of alpha-1a-adrenergic receptors that are responsible for causing constriction of smooth muscle cells in the prostate. Thus, blocking the activity of alpha-1a-adrenergic receptors causes prostatic smooth muscle relaxation.
  • 5-alpha-reductase inhibitors block the conversion of testosterone to dihydrotestosterone.
  • Dihydrotestosterone causes growth of epithelial cells in the prostate gland.
  • 5-alpha-reductase inhibitors cause regression of epithelial cells in the prostate gland and hence reduce the volume of the prostate gland which in turn reduces the severity of the symptoms.
  • Surgical procedures for treating BPH symptoms include Transurethal Resection of Prostate (TURP), Transurethral Electrovaporization of Prostate (TVP), Transurethral Incision of the Prostate (TUIP), Laser Prostatectomy and Open Prostatectomy.
  • TURP Transurethal Resection of Prostate
  • TVP Transurethral Electrovaporization of Prostate
  • TUIP Transurethral Incision of the Prostate
  • Laser Prostatectomy Open Prostatectomy.
  • Transurethal Resection of Prostate is the most commonly practiced surgical procedure implemented for the treatment of BPH.
  • prostatic urethral obstruction is reduced by removing most of the prostatic urethra and a sizeable volume of the surrounding prostate gland. This is carried out under general or spinal anesthesia.
  • a urologist visualizes the urethra by inserting a resectoscope, that houses an optical lens in communication with a video camera, into the urethra such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland.
  • the distal region of the resectoscope consists of an electric cutting loop that can cut prostatic tissue when an electric current is applied to the device.
  • An electric return pad is placed on the patient to close the cutting circuit.
  • the electric cutting loop is used to scrape away tissue from the inside of the prostate gland.
  • the tissue that is scraped away is flushed out of the urinary system using an irrigation fluid.
  • the loop is also used to cauterize transected vessels during the operation.
  • TVP Transurethral Electrovaporization of the Prostate
  • a part of prostatic tissue squeezing the urethra is desiccated or vaporized. This is carried out under general or spinal anesthesia.
  • a resectoscope is inserted transurethrally such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland.
  • the distal region of the resectoscope consists of a rollerball or a grooved roller electrode.
  • a controlled amount of electric current is passed through the electrode.
  • the surrounding tissue is rapidly heated up and vaporized to create a vaporized space.
  • the region of urethra that is blocked by the surrounding prostate gland is opened up.
  • TUIP Transurethral Incision of the Prostate
  • the resistance to urine flow is reduced by making one or more incisions in the prostrate gland in the region where the urethra meets the urinary bladder.
  • This procedure is performed under general or spinal anesthesia.
  • one or more incisions are made in the muscle of the bladder neck, which is the region where the urethra meets the urinary bladder.
  • the incisions are in most cases are deep enough to cut the surrounding prostate gland tissue including the prostatic capsule. This releases any compression on the bladder neck and causes the bladder neck to spring apart.
  • the incisions can be made using a resectoscope, laser beam etc.
  • VLAP Visual Laser Ablation of the Prostate
  • HoLEP Holmium Laser Resection/Enucleation of the Prostate
  • VLAP a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser is used to ablate tissue by causing coagulation necrosis. The procedure is performed under visual guidance.
  • a holmium: Yttrium-aluminum-garnet laser is used for direct contact ablation of tissue. Both these techniques are used to remove tissue obstructing the urethral passage to reduce the severity of BPH symptoms.
  • PVP Photoselective Vaporization of the Prostate
  • laser energy is used to vaporize prostatic tissue to relieve obstruction to urine flow in the urethra.
  • the type of laser used is the Potassium-Titanyl-Phosphate (KTP) laser.
  • KTP Potassium-Titanyl-Phosphate
  • the wavelength of this laser is highly absorbed by oxyhemoglobin. This laser vaporizes cellular water and hence is used to remove tissue that is obstructing the urethra.
  • Open Prostatectomy Another example of a surgical procedure for treating BPH symptoms is Open Prostatectomy.
  • the prostate gland is surgically removed by an open surgery. This is done under general anesthesia.
  • the prostate gland is removed through an incision in the lower abdomen or the perineum.
  • the procedure is used mostly in patients that have a large (greater than approximately 100 grams) prostate gland.
  • Minimally invasive procedures for treating BPH symptoms include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
  • TUMT Transurethral Microwave Thermotherapy
  • TUNA Transurethral Needle Ablation
  • ILC Interstitial Laser Coagulation
  • Prostatic Stents include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
  • microwave energy is used to generate heat that destroys hyperplastic prostate tissue.
  • This procedure is performed under local anesthesia.
  • a microwave antenna is inserted in the urethra.
  • a rectal thermosensing unit is inserted into the rectum to measure rectal temperature. Rectal temperature measurements are used to prevent overheating of the anatomical region.
  • the microwave antenna is then used to deliver microwaves to lateral lobes of the prostate gland. The microwaves are absorbed as they pass through prostate tissue. This generates heat which in turn destroys the prostate tissue.
  • the destruction of prostate tissue reduces the degree of squeezing of the urethra by the prostate gland thus reducing the severity of BPH symptoms.
  • TUNA Transurethral Needle Ablation
  • heat induced coagulation necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using local anesthetic and intravenous or oral sedation.
  • a delivery catheter is inserted into the urethra.
  • the delivery catheter comprises two radiofrequency needles that emerge at an angle of 90 degrees from the delivery catheter.
  • the two radiofrequency needles are aligned are at an angle of 40 degrees to each other so that they penetrate the lateral lobes of the prostate.
  • a radiofrequency current is delivered through the radiofrequency needles to heat the tissue of the lateral lobes to 70-100 degree Celsius at a radiofrequency power of approximately 456 KHz for approximately 4 minutes per lesion. This creates coagulation defects in the lateral lobes. The coagulation defects cause shrinkage of prostatic tissue which in turn reduces the degree of squeezing of the urethra by the prostate gland thus reducing the severity of BPH symptoms.
  • ILC Interstitial Laser Coagulation
  • laser induced necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using regional anesthesia, spinal or epidural anesthesia or local anesthesia (periprostatic block).
  • a cystoscope sheath is inserted into the urethra and the region of the urethra surrounded by the prostate gland is inspected.
  • a laser fiber is inserted into the urethra.
  • the laser fiber has a sharp distal tip to facilitate the penetration of the laser scope into prostatic tissue.
  • the distal tip of the laser fiber has a distal-diffusing region that distributes laser energy 3600 along the terminal 3 mm of the laser fiber.
  • the distal tip is inserted into the middle lobe of the prostate gland and laser energy is delivered through the distal tip for a desired time. This heats the middle lobe and causes laser induced necrosis of the tissue around the distal tip. Thereafter, the distal tip is withdrawn from the middle lobe. The same procedure of inserting the distal tip into a lobe and delivering laser energy is repeated with the lateral lobes. This causes tissue necrosis in several regions of the prostate gland which in turn causes the prostate gland to shrink. Shrinkage of the prostate gland reduces the degree of squeezing of the urethra by the prostate thus reducing the severity of BPH symptoms.
  • Prostatic Stents Another example of a minimally invasive procedure for treating BPH symptoms is implanting Prostatic Stents.
  • the region of urethra surrounded by the prostate is mechanically supported to reduce the constriction caused by an enlarged prostate.
  • Prostatic stents are flexible devices that are expanded after their insertion in the urethra. They mechanically support the urethra by pushing the obstructing prostatic tissue away from the urethra. This reduces the constriction of the urethra and improves urine flow past the prostate gland thereby reducing the severity of BPH symptoms.
  • Surgical treatments of BPH carry a risk of complications including erectile dysfunction; retrograde ejaculation; urinary incontinence; complications related to anesthesia; damage to the penis or urethra, need for a repeat surgery etc.
  • TURP which is the gold standard in treatment of BPH, carries a high risk of complications.
  • Adverse events associated with this procedure are reported to include retrograde ejaculation (65% of patients), post-operative irritation (15%), erectile dysfunction (10%), need for transfusion (8%), bladder neck constriction (7%), infection (6%), significant hematuria (6%), acute urinary retention (5%), need for secondary procedure (5%), and incontinence (3%)
  • Typical recovery from TURP involves several days of inpatient hospital treatment with an indwelling urethral catheter, followed by several weeks in which obstructive symptoms are relieved but there is pain or discomfort during micturition.
  • the reduction in the symptom score after minimally invasive procedures is not as large as the reduction in symptom score after TURP. Up to 25% of patients who receive these minimally invasive procedures ultimately undergo a TURP within 2 years.
  • the improvement in the symptom score generally does not occur immediately after the procedure. For example, it takes an average of one month for a patient to notice improvement in symptoms after TUMT and 1.5 months to notice improvement after ILC. In fact, symptoms are typically worse for these therapies that heat or cook tissue, because of the swelling and necrosis that occurs in the initial weeks following the procedures. Prostatic stents often offer more immediate relief from obstruction but are now rarely used because of high adverse effect rates.
  • Stents have the risk of migration from the original implant site (up to 12.5% of patients), encrustation (up to 27.5%), incontinence (up to 3%), and recurrent pain and discomfort. In published studies, these adverse effects necessitated 8% to 47% of stents to be explanted. Overgrowth of tissue through the stent and complex stent geometries have made their removal quite difficult and invasive.
  • catheterization is indicated because the therapy actually causes obstruction during a period of time post operatively, and in other cases it is indicated because of post-operative bleeding and potentially occlusive clot formation.
  • drug therapies are easy to administer, the results are suboptimal, take significant time to take effect, and often entail undesired side effects.
  • the present invention provides devices, systems and methods for compressing, cutting, incising, reconfiguring, remodeling, attaching, repositioning, supporting, dislocating or altering the composition of tissues or anatomical structures to alter their positional or force relationship to other tissues or anatomical structures.
  • the invention may be used to improve patency or fluid flow through a body lumen or cavity.
  • Examples of body lumens through which flow may be facilitated using the present invention include the urethra, ureter, trachea, bronchus, bronchiole, other respiratory passageway, stomach, duodenum, small intestine, jejunum, illium, colon, cystic duct, hepatic duct, common bile duct, pancreatic duct, the alimentary canal, an endocrine passageway, a lymphatic, etc.
  • the implantable devices useable for this purpose generally comprising anchoring elements and tensioning elements that extend between the anchoring elements.
  • the anchoring elements are implanted at selected locations and the tensioning elements then draw or pull the anchoring elements toward one another, thereby compressing tissue between the anchoring elements.
  • anchoring and tensioning element(s) are implanted and tensioned to compress or reposition prostatic tissue thereby lessening prostate induced constriction of the urethra.
  • this invention may be used to treat prostatic enlargement without causing substantial damage to the urethra (e.g., forming an opening in the urethra no larger than about 2 mm in its greatest cross-dimension).
  • compress includes not only actual compression of the tissue but also any application of pressure or force upon the tissue that causes the intended therapeutic effect by reconfiguring, remodeling, repositioning or altering the tissue.
  • one or more working devices may be inserted into the body and used to incise the capsule of an encapsulated organ, tumor, mass or other structure, thereby relieving the capsule's constraint of the encapsulated organ, tumor, mass or other structure and allowing the encapsulated organ, tumor, mass or other structure to expand, herniate, evulse, splay, spread apart, reconfigure or move in a way that results in decreased pressure on, or decreased interference with, the adjacent anatomical structure.
  • a cutting device may be anchoring and tensioning element(s) are implanted and tensioned to compress or reposition prostatic tissue thereby lessening prostate induced constriction of the urethra.
  • FIG. 1A is a sagittal sectional view of a male human body through the lower abdomen showing the male urinary tract.
  • FIG. 1B is a coronal sectional view through the lower abdomen of a human male showing a region of the male urogenital system.
  • FIG. 2A is a coronal sectional view through the prostate gland and adjacent structures showing a first trans-urethral approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2B is a coronal sectional view through the prostate gland and adjacent structures showing a second trans-urethral approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2C is a coronal sectional view through the prostate gland and adjacent structures showing a third trans-urethral approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2D is a coronal sectional view through the prostate gland and adjacent structures showing a transperineal approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2E is a coronal sectional view through the prostate gland and adjacent structures showing a percutaneous approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2F is a coronal sectional view through the prostate gland and adjacent structures showing a percutaneous trans-osseus approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2G is a coronal sectional view through the prostate gland and adjacent structures showing a percutaneous suprapubic approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2H is a sagittal sectional view through the prostate gland and adjacent structures showing a percutaneous infrapubic approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIG. 2I is a sagittal sectional view through the prostate gland and adjacent structures showing a trans-rectal approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • tissue compression devices e.g., clips, compression elements, anchoring elements, etc.
  • FIGS. 3A to 3H show various components of a system for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIG. 3A shows the perspective view of an introducer device.
  • FIG. 3B shows a perspective view of an injecting needle that may be used for injecting one or more diagnostic or therapeutic agents in the anatomy.
  • FIG. 3C shows a perspective view of an introducing sheath.
  • FIG. 3D shows a perspective view of a trocar.
  • FIG. 3E shows a perspective view of an anchor delivery device.
  • FIG. 3F shows an enlarged view of the distal region of the device in FIG. 3E .
  • FIG. 3G shows a perspective view of deployed anchors showing radially expanded splayable arms of proximal anchor and distal anchor.
  • FIG. 3H shows a perspective view from the proximal direction of a particular embodiment of the attachment mechanism of FIG. 99E .
  • FIGS. 4A through 4H show a coronal section through the prostate gland showing the various steps of a method of treating prostate gland disorders by compressing a region of the prostate gland using the kit shown in FIGS. 3A through 3H .
  • FIGS. 4 G′ through 4 H′ show the final steps of an embodiment of method of treating prostate gland disorders by deploying a proximal anchor in the urethra.
  • FIG. 4 H′′ shows a coronal section through the prostate gland showing a final deployed configuration of an embodiment of bone anchoring devices for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIGS. 4I and 4J is a crossectional view through the prostatic urethra (i.e., the portion of the urethra that passes through the prostate gland) showing the appearance of the urethral lumen before and after performing the method shown in FIGS. 4A through 4H .
  • FIGS. 5A through 5I show perspective views of some designs of the tension elements that can be used in the embodiments disclosed elsewhere in this patent application.
  • FIG. 5A shows a perspective view of a tension element comprising a single strand of an untwisted material.
  • FIG. 5B shows a perspective view of a tension element comprising one or more serrations or notches.
  • FIG. 5C shows a perspective view of a tension element comprising multiple filaments of a material twisted together.
  • FIG. 5D shows a perspective view of a tension element comprising a flexible, elastic, spiral or spring element.
  • FIG. 5E shows a perspective view of a tension element comprising a screw threading on the outer surface of tension element.
  • FIG. 5F shows a perspective view of a tension element comprising a hollow shaft comprising one or more collapsible regions.
  • FIG. 5G shows a perspective view of an anchoring device 522 comprising a tension element and two anchors.
  • FIG. 5H shows a perspective view of a tensioning element device comprising a detachable region.
  • FIG. 5I shows a perspective view of a tensioning element comprising telescoping tubes.
  • FIGS. 6A through 11B show various examples of anchor designs and/or anchoring device designs.
  • FIGS. 6A and 6B show perspective views of two states of a crumpling anchor.
  • FIGS. 7A and 7B show sectional views of an undeployed configuration and a deployed configuration respectively of a deployable anchor.
  • FIGS. 8A and 8B show sectional views of an undeployed configuration and a deployed configuration respectively of a “T” shaped deployable anchor.
  • FIGS. 9A through 9D show various alternate configurations of the anchoring arms in FIGS. 7A and 7B .
  • FIGS. 10 A and 10 A′ show a distal view and a perspective view respectively of an anchor comprising a spiral element having a three dimensional shape.
  • FIGS. 10 B and 10 B′ show a distal view and a side view respectively of an anchor comprising a spiral element having a two dimensional shape.
  • FIGS. 10 C and 10 C′ show a distal view and a perspective view respectively of an anchor comprising one or more circular elements.
  • FIG. 10D shows a perspective view of an embodiment of an anchoring device comprising an outer ring.
  • FIG. 10E shows a partial perspective view of an anchoring device comprising a hemostatic element.
  • FIG. 11A shows a perspective view of a device having a set of anchors comprising a curved sheet.
  • FIGS. 12A through 171 show further examples of anchor designs and/or anchoring device designs.
  • FIG. 12A shows a perspective view of an anchor comprising an arrowhead.
  • FIG. 12B shows a crossectional view of an anchor comprising a cup-shaped element that encloses a cavity.
  • FIG. 12C shows a perspective view of an anchor comprising a screw.
  • FIGS. 13A and 13B show perspective views of an uncollapsed state and a collapsed state respectively of an anchor comprising a collapsible region.
  • FIGS. 13C and 13D show perspective views of an undeployed state and a deployed state respectively of an anchor comprising radially spreading arms.
  • FIG. 13E shows perspective views of an alternate embodiment of an undeployed state of an anchor comprising radially spreading arms.
  • FIGS. 14A and 14B show perspective views of anchoring devices comprising an adhesive delivering element.
  • FIGS. 15A and 15B show two configurations of an anchoring device comprising a ratcheted tension element.
  • FIG. 16 shows a perspective view of an anchor comprising a trocar lumen.
  • FIG. 17A shows a perspective view in the undeployed state of an anchor comprising a rigid or partially flexible T element and a crumpling element.
  • FIGS. 17B and 17C show various steps of a method to deploy the anchoring device shown in FIG. 17A .
  • FIGS. 17D and 17E show perspective views of an undeployed and deployed configuration of an anchor comprising a rigid or partially flexible T element with one or more openings or perforations.
  • FIGS. 17F and 17G show perspective views of an undeployed and deployed configuration of an anchor comprising a stent.
  • FIGS. 17H and 17I show perspective views of an undeployed and deployed configuration of an anchor comprising a spring.
  • FIGS. 18A through 22E show various embodiments of mechanisms to deploy one or more anchors.
  • FIGS. 18A and 18B show a crossection of an anchor deploying mechanism comprising a screw system.
  • FIGS. 19A and 19B show a crossectional view of an anchor deploying system comprising an electrolytic detachment element.
  • FIG. 20 shows a perspective view of an anchor deploying system comprising a looped ribbon.
  • FIG. 21A shows a crossectional view of an anchor deploying system comprising a locked ball.
  • FIGS. 21B and 21C show a method of deploying an anchor comprising a locked ball.
  • FIGS. 22A through 22C show various views of an anchor deploying system comprising two interlocking cylinders.
  • FIGS. 22D and 22E show the steps of a method of unlocking the two interlocking cylinders from the anchor deploying systems of FIGS. 22A through 22C .
  • FIG. 23A shows a perspective view of a distal end of an anchoring device that has an imaging modality.
  • FIGS. 23B through 23G show various steps of a method for compressing an anatomical region using the anchoring device of FIG. 23A .
  • FIGS. 24 A through 24 C′ show the device and various steps of a method of compressing an anatomical region using a device with deploying arms deployed through a trocar.
  • FIG. 24D shows a crossection through the deployed anchoring device of FIG. 24A .
  • FIG. 25A shows a perspective view of a spring clip that can be used to spread the anatomy.
  • FIGS. 25B through 25F show various steps of a method of spreading an anatomical region or regions using the spring clip of FIG. 25A .
  • FIGS. 26A and 26B show a crossectional view and a perspective view respectively of a mechanism of cinching a tension element or tether to an anchor.
  • FIGS. 26C and 26D show a partial section through a cinching mechanism comprising a cam element.
  • FIG. 26E shows a sectional view of an embodiment of a cinching mechanism comprising a locking ball.
  • FIG. 26F shows a side view of an embodiment of a cinching mechanism comprising multiple locking flanges.
  • FIG. 26G shows an end view of body of FIG. 26F .
  • FIG. 26H shows a side view of an embodiment of a cinching mechanism comprising a single locking flange.
  • FIG. 26I shows an end view of body of FIG. 26H .
  • FIG. 26J shows an end view of a cinching mechanism comprising a crimping lumen.
  • FIGS. 26K and 26L show crossections of an embodiment of a cinching mechanism comprising a crimping anchor in the undeployed and deployed configurations respectively.
  • FIG. 26M shows a perspective view of an embodiment of a cinching mechanism comprising an element providing a tortuous path to a tension element.
  • FIG. 26N shows a crossectional view of an embodiment of a locking mechanism comprising a space occupying anchor securely attached to a tension element.
  • FIGS. 26O and 26P shows a partial sectional view and a perspective view of an embodiment of a cinching mechanism comprising a punched disk.
  • FIGS. 26Q and 26R show a perspective view of a first embodiment of a cutting device before and after cutting an elongate element.
  • FIG. 26S show a crossectional view of a second embodiment of a cutting device for cutting an elongate element.
  • FIGS. 27A through 27D show axial sections through the prostate gland showing various configurations of anchoring devices comprising distal anchors and a tension element.
  • FIGS. 28 and 28A show perspective views of an embodiment of an anchoring device comprising an elongate element comprising multiple barbs or anchors.
  • FIGS. 28B through 28E show a coronal section through the prostate gland showing various steps of a method of treating the prostate gland using the device of FIG. 28 .
  • FIG. 29A shows an axial section of the prostate gland showing a pair of implanted magnetic anchors.
  • FIGS. 29B through 29D show a coronal section through the prostate gland showing the steps of a method of implanting magnetic anchors of FIG. 29A .
  • FIG. 30A is a coronal sectional view of a portion of the male urogenital system showing a transurethral approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 30B is a coronal sectional view of a portion of the male urogenital system showing another transurethral approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 30C is a coronal sectional view of a portion of the male urogenital system showing a transurethral/transvesicular approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 30D is a coronal sectional view of a portion of the male urogenital system showing another transurethral approach that may be used to perform a prostate cutting procedure of the present invention, wherein a device advances from the urethra, through the prostate gland, and thereafter accesses the prostate capsule from its outer surface.
  • FIG. 31 is a coronal sectional view of a portion of the male urogenital system showing a percutaneous/infrapubic approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 32 is a coronal sectional view of a portion of the male urogenital system showing a percutaneous/transvesicular approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIGS. 33A-33E shows perspective views of various devices that may be included in a system for performing a prostate cutting procedure in accordance with the present invention.
  • FIG. 33A shows a perspective view of an introducer device comprising a first tubular element having a working device lumen.
  • FIG. 33B shows a perspective view of an injecting needle that may be used for injecting one or more diagnostic or therapeutic substances.
  • FIG. 33C shows a perspective view of a guiding device comprising an elongate body comprising a sharp distal tip.
  • FIG. 33D shows a perspective view of a RF cutting device
  • FIG. 33E shows a perspective view of an embodiment of a plugging device to plug an opening created during a procedure.
  • FIGS. 33F through 33N show various alternate embodiments of the electrosurgical cutting device in FIG. 33D .
  • FIGS. 33F and 33G show perspective views of the distal region of a first alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively.
  • FIGS. 33H and 33I show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively.
  • FIGS. 33J through 33L show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device.
  • FIGS. 33M through 33N show perspective views of the distal region of a third alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device.
  • FIG. 34 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting blades.
  • FIG. 35 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting wires.
  • FIGS. 36A and 36B series show perspective views of an undeployed state and a deployed state respectively of a tissue displacement device.
  • FIGS. 36C and 36D show a coronal view and a lateral view respectively of a pair of deployed tissue displacement devices of FIGS. 36A and 36B implanted in the prostate gland.
  • FIGS. 36E through 36H show an axial section through a prostate gland showing the various steps of a method of cutting or puncturing the prostate gland and lining or plugging the cut or puncture.
  • FIGS. 37A through 37K show an embodiment of a method of treating prostate gland disorders by cutting a region of the prostate gland using the devices described in FIG. 33A through 33E .
  • FIGS. 38A to 38D show various components of a kit for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIG. 38A shows the perspective view of an introducer device.
  • FIG. 38B shows a perspective view of a bridge device
  • FIG. 38C shows a perspective view of a distal anchor deployment device
  • FIG. 38D shows the proximal anchor delivery tool
  • FIG. 38E shows a close-up perspective view of proximal anchor 3833 mounted on proximal anchor delivery tool of FIG. 38D .
  • FIG. 1A shows a sagittal section of a male human body through the lower abdomen showing the male urinary tract.
  • the male urinary tract comprises a pair of tubular organs called ureters (UR) that conduct urine produced by the kidneys.
  • the ureters empty into the urinary bladder.
  • the urinary bladder is a hollow muscular organ that temporarily stores urine. It is situated posterior to the pubic bone.
  • the inferior region of the urinary bladder has a narrow muscular opening called the bladder neck which opens into a soft, flexible, tubular organ called the urethra.
  • the muscles around the bladder neck are called the internal urethral sphincter.
  • the internal urethral sphincter is normally contracted to prevent urine leakage.
  • the urinary bladder gradually fills with urine until full capacity is reached, at which point the sphincter relaxes. This causes the bladder neck to open, thereby releasing the urine stored in the urinary bladder into the urethra.
  • the urethra begins at the bladder neck, terminates at the end of the penis, and allows for urine to exit the body.
  • the region of the urethra just inferior to the urinary bladder is completely surrounded by the prostate gland.
  • the prostate gland is part of the male reproductive system and is usually walnut shaped.
  • the prostate is divided into lobes.
  • the lateral lobes are located lateral to the urethra; the middle lobe is located on the dorsal aspect of the urethra, near the bladder neck.
  • the lateral lobes become enlarged and act like curtains to close the urethral conduit.
  • the middle lobe grows in size and becomes problematic. Because of its superior location near the bladder neck with respect to the urethra, an enlarged middle lobe acts like a ball valve and occludes fluid passage.
  • FIG. 1B shows a coronal section through the lower abdomen of a human male showing a region of the male urinary system.
  • the prostate gland (PG) is located around the urethra at the union of the urethra and the urinary bladder.
  • FIGS. 2A through 2H show various alternate approaches to deploy implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIGS. 2A through 2H show various alternate approaches to deploy implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • Specific examples of implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) useable in this invention are shown in other figures of this patent application and are described more fully herebelow.
  • FIG. 2A shows a first trans-urethral approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 200 is introduced in the urethra through the urethral opening of the penis.
  • Introducing device 200 comprises an elongate body 202 comprising a lumen that terminates distally in a distal opening 204 .
  • One or more working device(s) 206 is/are then introduced through distal opening 204 into the urethra.
  • the working device(s) 206 penetrate the urethral wall and thereafter one or more lobes of the prostate gland. In some applications of the method, working device(s) 206 may further penetrate the prostate capsule and enters the pelvic cavity.
  • Working device(s) 206 are also used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2B shows a second trans-urethral approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 210 is introduced in the urethra through the urethral opening UO of the penis.
  • Introducing device 210 comprises an elongate body 212 comprising a lumen that terminates distally in a distal opening 214 .
  • One or more working device(s) 216 is/are insertable through distal opening 214 into the urethra.
  • Working device(s) 216 penetrate(s) the urethral wall inferior to the prostate gland and enters the pelvic cavity.
  • working device(s) 216 penetrate(s) the prostate capsule CP and thereafter one or more lobes of the prostate gland. In some applications of the method the working device(s) 216 may further penetrate the urethral wall enclosed by the prostate gland EG and enters the urethral lumen. Working device(s) 216 may then be used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2C shows a third trans-urethral approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 220 is introduced in the urethra through the urethral opening UO of the penis.
  • Introducing device 220 comprises an elongate body 222 comprising a lumen that terminates distally in a distal opening 224 .
  • Introducing device 220 is positioned such that distal opening 224 is located in the urinary bladder UB.
  • a one or more working device(s) 226 is/are introduced through distal opening 224 into the urinary bladder UB.
  • Working device(s) 226 penetrate(s) the wall of the urinary bladder UB and thereafter penetrate(s) one or more lobes of the prostate gland PG. In some applications of the method, the working device(s) 226 may further penetrate the prostate capsule and enter the pelvic cavity. Working device(s) 226 may then be used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2D shows a transperineal approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 230 is introduced in the pelvic cavity percutaneously through the perineum.
  • Introducing device 230 comprises an elongate body 232 comprising a lumen that terminates distally in a distal opening 234 .
  • Introducing device 230 is positioned such that distal opening 234 is located in the pelvic cavity adjacent to prostate gland.
  • one or more working device(s) 236 is/are introduced through distal opening 234 into the prostate gland PG.
  • Working device(s) 236 penetrate(s) the prostate capsule CP and thereafter penetrate(s) one or more lobes of the prostate gland PG.
  • the working device(s) 236 may further penetrate the urethral wall surrounded by the prostate gland PG and enter the urethral lumen.
  • Working device 236 may then be used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2E shows a percutaneous/transvesicular approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 240 is introduced percutaneously through the abdominal wall.
  • Introducing device 240 comprises an elongate body 242 comprising a lumen that terminates distally in a distal opening 244 .
  • introducing device 240 is advanced through the wall of the urinary bladder UB such that distal opening 244 is located in the urinary bladder UB.
  • one or more working device(s) 246 is/are introduced through distal opening 244 into the urinary bladder UB.
  • One or more working device(s) 246 are advanced through the wall of the urinary bladder UB and into the prostate gland PG. In some applications of the method, working device(s) 246 may further penetrate through the prostate gland capsule and enter the pelvic cavity. Working device(s) 246 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2F shows a percutaneous trans-osseus approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 250 is introduced percutaneously through the abdominal wall.
  • Introducing device 250 comprises an elongate body 252 comprising a lumen that terminates distally in a distal opening 254 .
  • Introducing device 250 is used to penetrate a pelvic bone (e.g. the pubic bone PB). Thereafter, introducing device 250 is positioned such that distal opening 254 is located adjacent to the prostate gland PG.
  • one or more working device(s) 256 is/are introduced through distal opening 254 into the prostate gland PG.
  • Working device(s) 256 penetrate the prostate capsule and thereafter penetrate one or more lobes of the prostate gland PG. In some applications of the method, working device(s) 256 may further penetrate the urethral wall surrounded by the prostate gland and enter the urethral lumen. Working device(s) 256 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2G shows a percutaneous suprapubic approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 260 is introduced in the pelvic cavity percutaneously in a trajectory that passes superior to the pubis bone.
  • Introducing device 260 comprises an elongate body 262 comprising a lumen that terminates distally in a distal opening 264 .
  • Introducing device 260 is then positioned such that distal opening 264 is located in the pelvic cavity adjacent to prostate gland.
  • one or more working device(s) 266 is/are introduced through distal opening 264 into the prostate gland PG.
  • Working device(s) 266 penetrate the prostate capsule CP and thereafter penetrate one or more lobes of the prostate gland PG. In some applications of the method, working device(s) 266 may further penetrate the urethral wall surrounded by the prostate gland and enter the urethral lumen. Working device(s) 266 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2H shows a percutaneous infrapubic approach that may be used to implant tissue compression devices(s) to compress the prostate gland. In FIG.
  • an introducing device 270 is introduced in the pelvic cavity percutaneously in a trajectory that passes inferior to the pubis bone.
  • Introducing device 270 comprises an elongate body 272 comprising a lumen that terminates distally in a distal opening 274 .
  • Introducing device 270 is introduced percutaneously in the pelvic cavity in a trajectory that passes inferior to the pubic bone.
  • Introducing device 270 is then positioned such that distal opening 274 is located in the pelvic cavity adjacent to prostate gland.
  • one or more working device(s) 276 is/are introduced through distal opening 274 into the prostate gland PG.
  • Working device(s) 276 penetrate the prostate capsule CP and thereafter penetrate one or more lobes of the prostate gland PG.
  • working device(s) 276 may further penetrate the urethral wall surrounded by the prostate gland PG and enter the urethral lumen.
  • Working device(s) 276 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIG. 2I shows a trans-rectal approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG.
  • an introducing device 280 is introduced in the rectum.
  • Introducing device 280 comprises an elongate body 282 comprising a lumen that terminates distally in a distal opening 284 .
  • Introducing device is then advanced such that it penetrates the rectal wall and enters the pelvic cavity.
  • Introducing device 280 is then positioned such that distal opening 284 is located in the pelvic cavity adjacent to prostate gland.
  • one or more working device(s) 286 is/are introduced through distal opening 284 into the prostate gland PG.
  • Working device(s) 286 penetrate the prostate capsule CP and thereafter penetrate one or more lobes of the prostate gland. In some applications of the method, working device(s) 286 may further penetrate the urethral wall surrounded by the prostate gland and enter the urethral lumen. Working device(s) 286 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • implantable tissue compression device(s) e.g., one or more clips, anchoring elements, tensioning members, etc.
  • FIGS. 3A to 3F show various examples of devices and systems that are useable to treat conditions where the prostate gland PG is compressing a region of the urethra such that the urethra does not expand normally during micturition and urine outflow is impeded.
  • FIG. 3A shows the perspective view of an introducer device 300 .
  • Introducer device 300 comprises an outer body 301 constructed from suitable biocompatible materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP, EPTFE etc.
  • Body 301 comprises a working device lumen 302 .
  • Distal end of working device lumen 302 emerges out of the distal end of body 301 .
  • distal end of working device lumen 302 has a bent or curved region.
  • Proximal end of working device lumen 302 emerges out of a first flexible tube 304 .
  • first flexible tube 304 comprises a stasis valve 306 .
  • Body 301 further comprises a cystoscope lumen 308 .
  • Distal end of cystoscope lumen 308 emerges out of the distal end of body 301 .
  • Proximal end of cystoscope lumen 308 emerges out of a second flexible tube 310 .
  • the proximal end of second flexible tube 310 comprises a stasis valve 312 .
  • Cystoscope lumen 308 may comprise one or more side ports e.g. a first side port 318 for the introduction or removal of one or more fluids.
  • Working device lumen 302 may comprise one or more side ports e.g. a second side port 320 for the introduction or removal of one or more fluids.
  • FIG. 3B shows a perspective view of an injecting needle.
  • Injecting needle 330 is used for injecting one or more diagnostic or therapeutic substances.
  • the injecting needle 330 may be used to inject local anesthetic in the urethra, prostate gland and/or tissues near the prostate gland.
  • target areas for injecting local anesthetics are the neurovascular bundles, the genitourinary diaphragm, the region between the rectal wall and prostate, etc.
  • Examples of local anesthetics that can be injected by injecting needle 330 are anesthetic solutions e.g. 1% lidocaine solution; anesthetic gels e.g. lidocaine gels; combination of anesthetic agents e.g.
  • Injecting needle 330 comprises a hollow shaft 332 made of suitable biocompatible materials including, but not limited to stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.
  • the distal end of hollow shaft 332 comprises a sharp tip 334 .
  • the proximal end of hollow shaft 332 has a needle hub 336 made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.; polymers e.g.
  • needle hub 336 comprises a luer lock.
  • FIG. 3C shows an example of an introducing device or introducing sheath 340 .
  • Introducing sheath 340 comprises a hollow, tubular body 342 made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc.
  • Tubular body 342 further comprises two marker bands: a proximal marker band 344 and a distal marker band 346 . The marker bands can be seen by a cystoscope.
  • proximal marker band 344 and distal marker band 346 are radiopaque.
  • the position of proximal marker band 344 and distal marker band 346 is such that after introducing sheath 340 is placed in an optimum location in the anatomy, proximal marker band 344 is located in the urethra where it can be seen by a cystoscope and distal marker band 346 is located in the prostrate gland or in the wall of the urethra where it cannot be seen by a cystoscope.
  • Tubular body 342 further comprises a series of distance markers 348 on the outer surface of tubular body 342 .
  • the proximal end of tubular body 342 further comprises a hub 350 made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc.
  • hub 350 comprises a luer lock.
  • FIG. 3D shows a perspective view of a trocar.
  • Trocar 360 comprises a tubular trocar body 362 .
  • the proximal end of trocar body 362 comprises a hub 364 .
  • Trocar body 362 and hub can be constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc.
  • Distal end of trocar body 362 ends in a sharp trocar tip 366 .
  • FIG. 3E shows a perspective view of an anchor delivery device.
  • Anchor delivery device 370 comprises a body 372 having a distal opening 373 . A section of the distal region of body 372 has been removed to show a view of the anchor assembly.
  • Body 372 encloses a distal anchor 374 and a proximal anchor 376 .
  • Proximal anchor 376 and distal anchor 374 can have a variety of designs including, but not limited to the designs disclosed elsewhere in this patent application.
  • Proximal anchor 376 and distal anchor 374 can be constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g.
  • proximal anchor 9976 and distal anchor 9974 comprise splayable elements that expand in a radially outward direction when a radial compression force, as enacted by body lumen 9972 , on proximal anchor 9976 and distal anchor 9974 is removed.
  • the splayable elements can be made of suitable super-elastic materials such as Nickel-Titanium alloys etc.
  • Tension element 9978 can be made of suitable elastic or non-elastic materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, suture materials, titanium etc. or polymers such as silicone, nylon, polyamide, polyglycolic acid, polypropylene, Pebax, PTFE, ePTFE, silk, gut, or any other braided or mono-filament material.
  • Tension element 9978 can have a variety of designs including the designs shown in FIGS. 5A through 5F . As shown in FIG.
  • proximal end of proximal anchor 9976 is connected by an attachment mechanism 9980 to a torquable shaft 9982 .
  • the proximal end of torquable shaft 9982 is attached to a control button 9984 .
  • Control button 9984 can be used to deploy proximal anchor 9976 by sliding control button 9984 along groove 9985 in the distal direction.
  • Control button 9984 is then used to deploy distal anchor 9974 by turning control button 9984 in the circumferential direction along groove 9985 .
  • FIG. 3H shows a perspective view from the proximal direction of a particular embodiment of the attachment mechanism of FIG. 3E .
  • Attachment mechanism 380 comprises a circular plate 386 made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Polycarbonate, PVC, Pebax, Polyimide, Polyurethane, Nylon, Hytrel, HDPE, PEEK, PTFE, PFA, FEP etc.
  • the proximal face of circular plate 386 is connected to torquable shaft 382 .
  • Circular plate 386 further comprises a semicircular groove 388 .
  • One end of semicircular groove 388 comprises an enlarged region 390 .
  • a knob 392 located on the proximal portion of proximal anchor 376 slides on semicircular groove 388 .
  • the size of knob 322 is larger than the size of semicircular groove 388 but smaller than size of enlarged region 390 .
  • control button 384 is turned in the circumferential direction along groove 385 , torquable shaft 382 is turned. This turns circular plate 386 causing knob 392 to slide on the groove 388 .
  • knob 392 reaches enlarged region 390 . This releases knob 392 from circular plate 386 thereby releasing proximal anchor 376 from anchor delivery device 370 .
  • FIGS. 4A through 4H show a coronal section through the prostate gland showing the various steps of a method of treating prostate gland disorders by compressing a region of the prostate gland using the kit shown in FIGS. 3A through 3F .
  • introducer device 300 is introduced in the urethra through the urethral opening at the tip if the penis.
  • a cystoscope is inserted in introducer device 300 through cystoscope lumen 308 such that the lens of the cystoscope is located in the distal opening of cystoscope lumen.
  • the cystoscope is used to navigate introducer device 300 through the urethra such that the distal region of introducer device 300 is located in a target region in the prostatic urethra.
  • injecting needle 330 is advanced through working device lumen 302 such that the distal tip of injecting needle 330 penetrates into a region of the urethral wall or the prostate gland. Injecting needle 330 is then used to inject one or more diagnostic or therapeutic agents into the urethral wall or the prostate gland. This step may be repeated one or more times to inject one or more diagnostic or therapeutic agents in one or more regions of the urethral wall and/or the prostate gland. In one method embodiment, injecting needle 330 is used to inject an anesthetic in one or more regions of the urethral wall and/or the prostate gland. In another embodiment, injecting needle 330 is used to deliver energy in the form of radiofrequency energy, resistive heating, laser energy, microwave energy etc.
  • injecting needle 330 is used to deliver alpha antagonist agents, such as phenoxybenzamine, prazosin, doxazosin, terazosin, tamsulosin, alfuzosin etc.
  • injecting needle 330 is used to deliver anti-androgen, such as flutamide or 5-alpha reductase inhibitors, such as finasteride, dutasteride, 3-oxosteroid compounds, 4-aza-3-oxosteroid derivatives of testosterone etc.
  • injecting needle 330 is used to deliver anti-inflammatory agents, such as rapamycin, paclitaxel, ABT-578, everolimus, taxol etc.
  • injecting needle 330 is used to deliver ablative agents such as methyl alcohol etc.
  • injecting needle 330 is used to deliver energy in the form of radiofrequency energy, resistive heating, laser energy, microwave energy etc.
  • injecting needle 330 is used to deliver alpha antagonist agents, such as phenoxybenzamine, prazosin, doxazosin, terazosin, tamsulosin, alfuzosin etc.
  • injecting needle 330 is used to deliver anti-androgen, such as flutamide or 5-alpha reductase inhibitors, such as finasteride, dutasteride, 3-oxosteroid compounds, 4-aza-3-oxosteroid derivatives of testosterone etc.
  • injecting needle 330 is used to deliver anti-inflammatory agents, such as rapamycin, paclitaxel, ABT-578, everolimus, taxol etc. In another embodiment, injecting needle 330 is used to deliver ablative agents such as methyl alcohol etc.
  • step 4 C injecting needle 330 is withdrawn from introducer device 300 .
  • introducer sheath 340 and trocar 360 are advanced through working device lumen 302 .
  • introducer sheath 340 and trocar 360 are advanced till the distal tip of trocar 360 penetrates the capsule of the prostate gland and the distal end of introducer sheath 340 is located outside the prostate gland in the pelvic cavity.
  • trocar 360 is withdrawn from working device lumen 302 leaving introducer sheath 340 in place.
  • anchor delivery device 370 is introduced through the lumen of introducer sheath 340 till the distal end of body 372 protrudes through the distal tip of introducer sheath 340 .
  • distal anchor 374 is deployed. It should be noted that the anchor may be carried to the site and deployed from within an introducer, on the outside of an introducer, or it may be the distal tip of the introducer itself. Thereafter, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 so that distal anchor 374 is anchored on the outer surface of the prostate capsule. This step may be used to create tension in the tension element 378 . In one method embodiment, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 such that the distal end of anchor delivery device 370 is located in the prostate gland.
  • anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 till the distal end of anchor delivery device 370 is located in the urethral wall or the urethral lumen.
  • proximal anchor 376 is deployed. Proximal anchor 376 may be deployed in the prostate gland, in the urethral wall or in the urethral lumen. Proximal anchor 376 is still attached by attachment mechanism 380 to anchor delivery device 370 . The proximal anchor may be pre-loaded on the tension element, or may subsequently be loaded by the operator on the tension element.
  • FIGS. 4G through 4H show the steps of deploying proximal anchor 376 in the prostate gland. In FIG.
  • proximal anchor 376 is separated from anchor delivery device 370 . This separation may be achieved via numerous means including cutting, melting, un-locking a link, or breaking the tensioning element at a desired location. Ideally this residual end of the tensioning element will not protrude substantially into the lumen of the urethra. Thus proximal anchor 376 and distal anchor 374 are anchored in the anatomy. Thereafter, anchor delivery device 370 and introducer sheath 340 are both pulled in the proximal direction and are withdrawn into introducer device 300 . Thereafter, introducer device 300 is pulled in the proximal direction to pull it out of the urethra. In FIG. 4H , the steps from FIG. 4A through 4G are repeated in a second region of the prostate gland if desired to implant two or more sets of anchoring devices.
  • FIGS. 4 G′ through 4 H′ show the steps of deploying proximal anchor 376 in the urethra.
  • proximal anchor 376 is separated from anchor delivery device 370 in the urethra.
  • proximal anchor 376 and distal anchor 374 are anchored in the urethra and the prostate capsule respectively.
  • anchor delivery device 370 and introducer sheath 340 are both pulled in the proximal direction and are withdrawn into introducer device 300 .
  • introducer device 300 is pulled in the proximal direction to pull it out of the urethra.
  • FIG. 4 H′ the steps from FIG.
  • 4 A through 4 G′ are repeated optionally in a second region of the prostate gland to implant two or more sets of anchoring devices. It should be understood that this method and devices may be applied to any lobe (middle or lateral lobes) of the prostate and further more may be used multiple times in the same lobe to achieve the desired effect.
  • FIG. 4 H′′ shows a coronal section through the prostate gland showing the final deployed configuration of an embodiment of bone anchoring devices for treating prostate gland disorders by compressing a region of the prostate gland.
  • introducer sheath 340 and trocar 360 are advanced till the distal tip of trocar 360 penetrates a bone in the abdomen (e.g. the pelvic bone, etc.) and the distal end of introducer sheath 340 is located outside the bone.
  • trocar 360 is withdrawn from working device lumen 302 leaving introducer sheath 340 in place.
  • anchor delivery device 370 is introduced through the lumen of introducer sheath 340 until the distal end of body 372 touches the bone through the distal tip of introducer sheath 340 .
  • distal anchor 374 is implanted in the bone.
  • Distal anchor 374 may comprise a variety of designs including, but not limited to designs of distal tips of Kirschner wires. Examples of such Kirschner wire distal tips are spiral drill tips, lancer tips, threaded trocar tips, lengthwise knurled tips, 3-sided trocar tips, 4-sided trocar tips,
  • anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 . This step creates tension in the tension element 378 .
  • anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 till the distal end of anchor delivery device 370 is located in the urethral wall or the urethral lumen.
  • the remaining method steps are similar to steps 4 F through 4 H.
  • One or more anchors disclosed in this patent application may be implanted in anatomical locations that include, but are not limited to:
  • FIGS. 4I and 4J show a crossection of the urethra through the prostate gland PG showing the appearance of the urethral lumen before and after performing the method shown in FIGS. 4A through 4H .
  • FIG. 4I shows a crossection of the urethra through the prostate gland showing the appearance of the urethral lumen in a patient with BPH.
  • FIG. 4J shows a crossection of the urethra through the prostate gland PG showing the appearance of the urethral lumen after performing the procedure shown in FIGS. 4A through 4H .
  • the urethral lumen shown in FIG. 4I is larger than the urethral lumen in FIG. 4J .
  • FIGS. 5A through 5F show perspective views of some designs of the tension elements that can be used in the embodiments disclosed elsewhere in this patent application.
  • FIG. 5A shows a perspective view of a tension element 500 comprising a single strand of an untwisted material.
  • materials that can be used to manufacture tension element 500 include but are not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • FIG. 1 shows a perspective view of a tension element 500 comprising a single strand of an untwisted material.
  • synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.
  • metals e.g. various grades of stainless steel,
  • FIG. 5B shows a perspective view of a tension element 502 comprising one or more serrations 504 or notches. Serrations 504 may be aligned in a particular direction to allow relatively easy movement of an outer body along tension element 502 in one direction and offer significant resistance to movement of the outer body along the tension element in the other direction.
  • FIG. 5C shows a perspective view of a tension element 506 comprising multiple filaments 507 of a material twisted together. Examples of materials that can be used include to manufacture multiple filaments 507 include but are not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g.
  • FIG. 5D shows a perspective view of a tension element 509 comprising a flexible, elastic, spiral or spring element.
  • tension element 509 examples include but are not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.
  • FIG. 5E shows a perspective view of a tension element 510 comprising a screw threading 511 on the outer surface of tension element 510 . Screw threading 511 enables tension element 510 to be screwed through an outer element to advance or withdraw tension element through the outer element.
  • FIG. 5F shows a perspective view of a tension element 512 comprising a hollow shaft 514 comprising one or more collapsible regions 516 .
  • a collapsible region 516 comprises one or more windows 518 .
  • Windows 518 are cut in hollow shaft 514 in such a way that several thin, collapsible struts 520 are created between adjacent windows 518 .
  • tension element 512 is compresses along its length, collapsible struts 520 are deformed in the radially outward direction to create one or more anchoring regions.
  • FIG. 5G shows a perspective view of an anchoring device 522 comprising a tension element and two anchors. Distal end of a tension element 524 is attached to a distal anchor 526 . Proximal end of tension element 524 is attached to a proximal anchor 528 .
  • FIG. 5H shows a perspective view of a tensioning element device comprising a detachable region.
  • Anchoring device 530 comprises a first anchor 532 and a second anchor 534 .
  • First anchor 532 and second anchor 534 may comprise a variety of anchor designs disclosed elsewhere in this patent application.
  • one or both of first anchor 532 and second anchor 534 comprise a substantially flat plate.
  • the substantially flat plate may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g.
  • First anchor 532 and second anchor 534 are connected to a tensioning element.
  • the tensioning element comprises two flexible members: a first tensioning member 536 and a second tensioning member 538 .
  • the distal end of first tensioning member 536 is connected to first anchor 532 and the proximal end of second tensioning member 538 is connected to second anchor 534 .
  • Proximal end of first tensioning member 536 and distal end of second tensioning member 538 are connected to a releasable member 540 .
  • Releasable member 540 can be releasably connected to a deploying device.
  • first anchor 532 is deployed out of an anatomical tissue (e.g. the prostate gland) into a first anatomical cavity (e.g. the pelvic cavity).
  • second anchor 534 is deployed into a second anatomical cavity (e.g. the urethral lumen).
  • releasable member 540 is released from the deploying device to deliver anchoring device 530 in a target region.
  • FIG. 5I shows a perspective view of a tensioning element comprising telescoping tubes.
  • Tensioning element 544 may comprise two or more telescoping tubes.
  • tensioning element 544 comprises three telescoping tubes: a first telescoping tube 546 , a second telescoping tube 548 and a third telescoping tube 550 .
  • Second telescoping tube 548 slidably fits into a lumen of first telescoping tube 546 .
  • third telescoping tube 550 slidably fits into a lumen of second telescoping tube 548 .
  • the telescoping tubes have a locking mechanism to prevent a telescoping tube from completely disengaging from another telescoping tube.
  • the telescoping tubes may be made from a variety of biocompatible materials including, but not limited to plastics, metals etc.
  • All the components of the systems disclosed herein may be coated or embedded with therapeutic or diagnostic substances (e.g., drugs or therapeutic agents) or such therapeutic or diagnostic substances may be introduced into or near the prostate or adjacent tissue through a catheter, cannula needles, etc.
  • therapeutic or diagnostic substances e.g., drugs or therapeutic agents
  • therapeutic and diagnostic substances include but are not limited to: hemostatic agents; antimicrobial agents (antibacterials, antibiotics, antifungals, antiprotozoals; antivirals; antimicrobial metals (e.g., silver, gold, etc.); hemostatic and/or vasoconstricting agents (e.g., pseudoephedrine, xylometazoline, oxymetazoline, phenylephrine, epinephrine, cocaine, etc.); local anesthetic agents (lidocaine, cocaine, bupivacaine,); hormones; anti-inflammatory agents (steroidal and non-steroidal); hormonally active agents; agents to enhance potency; substances to dissolve, degrade, cut, break, weaken, soften, modify or remodel connective tissue or other tissues; (e.g., enzymes or other agents such as collagenase (CGN), trypsin, trypsin/EDTA, hyaluronidase, and tosylly
  • CGN collagenase
  • antitumor agents e.g., cancer chemotherapeutic agents, biological response modifiers, vascularization inhibitors, hormone receptor blockers, cryotherapeutic agents or other agents that destroy or inhibit neoplasia or tumorigenesis
  • alkylating agents or other agents which directly kill cancer cells by attacking their DNA e.g., cyclophosphamide, isophosphamide
  • nitrosoureas or other agents which kill cancer cells by inhibiting changes necessary for cellular DNA repair e.g., carmustine (BCNU) and lomustine (CCNU)
  • antimetabolites and other agents that block cancer cell growth by interfering with certain cell functions usually DNA synthesis (e.g., 6 mercaptopurine and 5-fluorouracil (5FU), antitumor antibiotics and other compounds that act by binding or intercalating DNA and preventing RNA synthesis (e.g., doxorubicin, daunorubi
  • biological response modifiers e.g., interferon, bacillus calmette-guerin (BCG), monoclonal antibodies, interluken 2, granulocyte colony stimulating factor (GCSF), etc.
  • PGDF receptor antagonists herceptin, asparaginase, busulphan, carboplatin, cisplatin, carmustine, cchlorambucil, cytarabine, dacarbazine, etoposide, flucarbazone, fluorouracil, gemcitabine, hydroxyurea, ifosphamide, irinotecan, lomustine, melphalan, mercaptopurine, methotrexate, thioguanine, thiotepa, tomudex, topotecan, treosulfan, vinblastine, vincristine, mitoazitrone, oxaliplatin
  • the substances delivered in this invention may include cells (mucosal cells, fibroblasts, stem cells or genetically engineered cells) as well as genes and gene delivery vehicles like plasmids, adenoviral vectors or naked DNA, mRNA, etc. injected with genes that code for anti-inflammatory substances, etc., and, as mentioned above, macrophages or giant cells that modify or soften tissue when so desired, cells that participate in or effect the growth of tissue.
  • FIGS. 6A through 11A show various examples of anchor designs and/or anchoring device designs.
  • FIGS. 6A and 6B show examples of a crumpling anchor 600 .
  • crumpling anchor 600 comprises a substantially flattened body 602 .
  • Body 602 can be made of a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • any or all of the anchors, the tensioning element(s) and any other components may be coated, impregnated, embedded or otherwise provided with substance(s) (e.g., drugs, biologics, cells, etc.) to reduce the likelihood of infection, inflammation, treat the prostatic adenoma directly or enhance the likelihood of endothelialization, deter adhesion formation, promote healing or otherwise improve the likelihood or degree of success of the procedure.
  • substance(s) e.g., drugs, biologics, cells, etc.
  • Such substance(s) may be released primarily at the time of delivery or may be released over a sustained period. Examples of such substances are listed above and include but are not limited to certain metals with bacteriostatic action (i.e.
  • Body 602 may be non-woven or woven. Body 602 may have a variety of shapes including, but not limited to square, rectangular, triangular, other regular polygonal, irregular polygonal, circular etc. Body 602 may have a substantially one dimensional, two dimensional or three dimensional shape. The material chosen for this device may have hemostatic properties to reduce bleeding from the implantation tract or site.
  • Body 602 further comprises one or more attachment means 606 .
  • Attachment means are used to create a channel in the body 602 through which tension element 604 passes.
  • Crumpling anchor 600 is introduced through a region of tissue (e.g. through prostate gland tissue) into a cavity or lumen e.g. pelvic cavity, urethral lumen etc.
  • FIG. 6B tension element 604 is pulled in the proximal direction.
  • FIGS. 7A and 7B show an example of a deployable anchor 700 in an undeployed configuration and a deployed configuration, respectively.
  • This deployable anchor 700 comprises one or more anchoring arms 702 .
  • Anchoring arms 702 may be made from a variety of elastic, super-elastic or shape memory materials etc. Typical examples of such materials include but are not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.
  • Anchoring arms 702 are connected to a central hub 704 . Central hub in turn is connected to the distal end of a tension element 706 .
  • FIG. 7A anchoring arms 702 are folded inside a hollow deploying sheath 708 .
  • FIG. 7B deploying sheath 708 is pulled in the proximal direction. This releases anchoring arms 702 from the distal end of deploying sheath 702 . This causes anchoring arms 702 to open in the radially outward direction. Anchor 700 can then anchor to tissue and resist movement of tension element 706 in the proximal direction.
  • FIGS. 8A and 8B show sectional views of an undeployed configuration and a deployed configuration respectively of a “T” shaped deployable anchor.
  • Anchor 8110 comprises an elongate region 802 .
  • Elongate region 802 may be made from a variety of elastic, super-elastic or shape memory materials etc. Typical examples of such materials include but are not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc.
  • Middle section of elongate region 802 is connected to the distal end of a tension element 804 to form a “T” shaped anchor.
  • middle section of elongate region 802 is connected to the distal end of a tension element 804 by a hinge.
  • elongate region 802 is folded inside a hollow deploying sheath 806 . This reduces the undeployed diameter of the distal region of anchor 8110 and also prevents unwanted anchoring of elongate region 802 to tissue.
  • deploying sheath 806 is pulled in the proximal direction. This releases elongate region 802 from the distal end of deploying sheath 806 . This in turn causes elongate region 802 to twist and orient itself perpendicular to the distal end of a tension element 804 .
  • Anchor 800 can then anchor to tissue and resist movement of tension element 804 in the proximal direction.
  • Anchoring arms 702 in FIGS. 7A and 7B can have a variety of configurations including, but not limited to configurations shown in FIGS. 9A through 9D .
  • FIG. 9A shows a distal end view of an embodiment of an anchor comprising two triangular arms.
  • Anchor 900 comprises two anchor arms 902 .
  • Anchor arms 902 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc.
  • Anchor arms 902 are connected to a tension element 904 .
  • anchor arms 902 are connected to a central hub, which in turn is connected to tension element 904 .
  • the arms in each of these devices may be folded or contained prior to deployment through the use of a sheath or grasping or mounting device.
  • FIG. 9B shows a distal end view of an embodiment of an anchor comprising four rectangular arms.
  • Anchor 906 comprises four anchor arms 908 .
  • Anchor arms 908 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc.
  • Anchor arms 908 are connected to a tension element 910 .
  • anchor arms 908 are connected to a central hub, which in turn is connected to tension element 910 .
  • FIG. 9C shows a distal end view of an embodiment of an anchor comprising a mesh or a woven material.
  • Anchor 912 comprises four anchor arms 914 .
  • Anchor arms 914 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc.
  • Anchor arms 914 are connected to a tension element 916 .
  • anchor arms 914 are connected to a central hub, which in turn is connected to tension element 916 .
  • Porous material 918 comprises a plurality of pores that allow for tissue ingrowth. Porous material 918 may also help to distribute the pressure on anchor arms 914 over a wider area.
  • Porous material 918 can be made of variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Porous material 918 may be non-woven or woven.
  • FIG. 9D shows a distal end view of an embodiment of an anchor comprising four curved arms.
  • Anchor 920 comprises four curved anchor arms 922 .
  • Curved anchor arms 922 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc.
  • Curved anchor arms 922 are connected to a tension element 924 .
  • curved anchor arms 922 are connected to a central hub which in turn is connected to tension element 924 .
  • FIG. 10A shows a distal end view of an anchor comprising a spiral element having a three dimensional shape.
  • Anchor 1000 comprises a three dimensional spiral element 1002 .
  • Diameter of spiral element 1002 may be substantially constant or may substantially vary along the length of spiral element 1002 .
  • Spiral element 1002 may be made of an elastic, super-elastic or shape memory materials.
  • Spiral element 1002 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g.
  • FIG. 10 A′ shows a side view of the anchor in FIG. 10A .
  • FIG. 10 A′ shows anchor 1000 comprising spiral element 1002 connected to central hub 1004 which in turn is connected to a tension element 1006 .
  • FIG. 10B shows a distal end view of an anchor comprising a spiral element having a two dimensional shape.
  • Anchor 1000 comprises a two dimensional spiral element 1010 .
  • Spiral element 1010 may be made of an elastic, super-elastic or shape memory materials.
  • Spiral element 1010 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • Spiral element 1010 is connected to a central hub 1012 which in turn is connected to a tension element.
  • spiral element 1010 is directly connected to a tension element without using central hub 1012 .
  • FIG. 10 B′ shows a side view of the anchor in FIG. 10B .
  • FIG. 10 B′ shows anchor 1008 comprising spiral element 1010 connected to central hub 1012 which in turn is connected to a tension element 1014 .
  • FIG. 10C shows a distal end view of an anchor comprising one or more circular elements.
  • anchor 1016 comprises an inner circular element 1018 and an outer circular element 1020 .
  • a series of radial arms or struts 1022 connect inner circular element 1018 to outer circular element 1020 and to a central hub 1024 .
  • Central hub 1024 may have a lumen 1026 .
  • Anchor 1016 may be substantially two dimensional or three dimensional.
  • FIG. 10 C′ shows a perspective view of the anchor in FIG. 10C .
  • FIG. 10 C′ shows an anchor 1016 comprising an inner circular element 1018 , an outer circular element 1020 and series of radial arms or struts 1022 connecting inner circular element 1018 to outer circular element 1020 and to a central hub 1024 .
  • Central hub 1024 is connected to a tension element.
  • FIG. 10D shows a perspective view of an embodiment of an anchoring device comprising an outer ring.
  • Anchor 1040 comprises a central hub 1042 and an outer ring 1044 .
  • central hub 1042 acts as a plug to plug an opening in the anatomy to reduce or prevent bleeding or leakage of fluids.
  • Central hub 1042 is connected to outer ring 1044 by one or more bars or struts 1046 .
  • central hub 1042 is connected to an inner ring 1048 which in turn is connected to outer ring 1044 by one or more bars or struts 1046 .
  • Central hub 1042 further comprises a locking element 1050 .
  • Locking element 1050 comprises a lumen 1052 through which a tension element can slide.
  • Anchor 1040 may be made from a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.
  • metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.
  • natural fibers e.g. cotton, silk etc.
  • rubber materials e.g. various grades of silicone rubber etc.
  • FIG. 10E shows a partial perspective view of an anchoring device comprising a hemostatic element.
  • Anchor 1060 comprises a central hub 1062 .
  • central hub 1062 acts as a plug to plug an opening in the anatomy to reduce or prevent bleeding or leakage of fluids.
  • Central hub 1062 comprises a cinching mechanism to allow central hub 1062 to cinch on to a tension element 1064 passing through central hub 1062 .
  • the free end 1066 of tension element 1064 is severed to minimize the presence of tension element 1064 in the anatomy.
  • Anchor 1060 further comprises an outer ring 1068 .
  • Central hub 1062 is connected to outer ring 1068 by one or more struts 1070 .
  • Anchor 1060 further comprises a mesh or porous element 1072 between outer ring 1068 and struts 1070 .
  • the mesh or porous element 1072 may be concave shaped as shown in FIG. 10E .
  • Mesh or porous element 1072 allows for tissue ingrowth over a period of time thus providing additional securing of anchor 1060 to tissue.
  • FIG. 11A shows a perspective view of a device having a set of anchors comprising a curved sheet.
  • Anchoring device 1100 may comprise one or more anchors comprising a curved sheet.
  • anchoring device 1100 comprises a first anchor 1102 and a second anchor 1104 .
  • First anchor 1102 and second anchor 1104 may comprise elastic, super elastic or shape memory materials.
  • First anchor 1102 and second anchor 1104 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g.
  • first anchor 1102 is deployed out of an anatomical tissue (e.g. the prostate gland) into a first anatomical cavity (e.g. the pelvic cavity). Thereafter, second anchor 1104 is deployed into a second anatomical cavity (e.g. the urethral lumen).
  • anatomical tissue e.g. the prostate gland
  • first anatomical cavity e.g. the pelvic cavity
  • second anchor 1104 is deployed into a second anatomical cavity (e.g. the urethral lumen).
  • This method embodiment has the advantage of using the natural curvature of first anchor 1102 and second anchor 1104 to distribute pressure on first anchor 1102 and second anchor 1104 over a large area.
  • FIGS. 12A through 17I show further examples of anchor designs and/or anchoring device designs.
  • FIG. 12A shows a perspective view of an anchor comprising an arrowhead.
  • Anchor 1200 comprises an arrowhead 1202 .
  • Arrowhead 1202 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc.
  • Arrowhead 1202 may comprise a sharp distal tip.
  • Arrowhead 1202 may have a three dimensional or a substantially two dimensional design.
  • FIG. 12B shows a crossectional view of an anchor comprising a cup-shaped element that encloses a cavity.
  • Anchor 1208 comprises a cup-shaped element 1210 .
  • Proximal, concave surface of cup-shaped element 1210 encloses a cavity.
  • Cup-shaped element 1210 may be made from various materials including, but not limited to metals e.g.
  • FIG. 12C shows a perspective view of an anchor comprising a screw.
  • Anchor 1216 comprises a screw 1218 .
  • Screw 1218 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.
  • Screw 1218 may comprise a sharp distal tip. Proximal region of screw 1218 may be wider that the distal region of screw 1218 to resist motion of screw 1218 along the proximal direction after it is deployed in a tissue. Screw 1218 comprises a thread rolled thread including, but not limited to wood screw style thread, double lead thread, tapping style thread, tapered wood thread etc. Proximal region of arrowhead 1202 is connected to a tension element 1204 .
  • FIGS. 13A and 13B show perspective views of an uncollapsed state and a collapsed state respectively of an anchor comprising a collapsible region.
  • anchor element 1300 is in an uncollapsed state.
  • Anchor element 1300 comprises a hollow shaft 1302 comprising one or more collapsible regions.
  • a collapsible region comprises one or more windows 1304 .
  • Windows 1304 are cut in hollow shaft 1302 in such a way that several thin, collapsible struts 1306 are created between adjacent windows 1304 .
  • anchor element 1300 is in a collapsed state. When anchor element 1300 is compresses along its length, collapsible struts 1306 are deformed in the radially outward direction to create one or more anchoring regions.
  • FIGS. 13C and 13D show perspective views of an undeployed state and a deployed state respectively of an anchor comprising radially spreading arms.
  • anchor 1312 comprises a hollow tube 1314 .
  • Hollow tube 1314 is made from suitable elastic, super-elastic or shape memory materials such as metals including, but not limited to titanium, stainless steel, Nitinol etc.; suitable elastic polymers etc.
  • U-shaped slots 1316 are cut in hollow tube 1314 in such a way that arms 1318 are created within U-shaped slots 1316 .
  • U-shaped slots are substantially parallel to the axis of hollow tube 1314 . In absence of an external force, arms 1318 tend to spread in a radially outward direction.
  • Anchor 1312 is kept in an undeployed state by enclosing anchor 1312 in a sheath. Anchor 1312 is deployed by removing the sheath to allow arms 1318 to spread in a radially outward direction as shown in FIG. 13D .
  • Hollow tube 1314 may comprise one or more cinching elements. Cinching elements may be located on the proximal region, distal region or a middle region of hollow tube 1314 .
  • the cinching element or elements may comprise cinching mechanisms including, but not limited to cinching mechanisms disclosed in FIGS. 26A through 29P .
  • FIG. 13E shows perspective views of an alternate embodiment of an undeployed state of an anchor comprising radially spreading arms.
  • anchor 1320 comprises a hollow tube 1322 .
  • Hollow tube 1322 is made from suitable elastic, super-elastic or shape memory materials such as metals including, but not limited to titanium, stainless steel, Nitinol etc.; suitable elastic polymers etc.
  • U-shaped slots 1324 are cut in hollow tube 1322 in such a way that arms 1326 are created within U-shaped slots 1324 . In this embodiment, U-shaped slots are at an angle to the axis of hollow tube 1322 as shown in FIG. 13E .
  • FIGS. 14A and 14B show perspective views of anchoring devices comprising an adhesive delivering element.
  • FIG. 14A shows a perspective view of an anchoring device 1400 comprising a hollow shaft 1402 with a shaft lumen.
  • Hollow shaft 1402 can be made of suitable biocompatible materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • Distal end of shaft lumen ends in a delivery opening 1404 . When an adhesive is injected through the shaft lumen, it emerges out of anchoring device 1400 through delivery opening 1404 .
  • Hollow shaft 1402 may also comprise an attachment element 1406 such as a porous woven or non-woven circular sleeve securely attached to hollow shaft 1402 .
  • the circular sleeve may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • FIG. 14B shows a perspective view of an anchoring device 1408 comprising a hollow shaft 1410 with a shaft lumen.
  • Hollow shaft 1410 can be made of suitable biocompatible materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • Distal end of shaft lumen ends in a delivery opening 1412 . When an adhesive is injected through the shaft lumen, it emerges out of anchoring device 1408 through delivery opening 1412 .
  • Hollow shaft 1410 may also comprise an attachment element 1414 such as porous foam securely attached to hollow shaft 1410 .
  • the porous foam may be made of a variety of materials including, but not limited to polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; rubber materials e.g. various grades of silicone rubber etc.
  • the adhesive flowing out through delivery opening comes into contact with attachment element 1414 and securely attaches attachment element 1414 to surrounding tissue.
  • Typical examples of adhesives that can be used with anchoring device 1400 and anchoring device 1408 include but are not limited to cyanoacrylates, marine adhesive proteins, fibrin-based sealants etc.
  • FIGS. 15A and 15B show two configurations of an anchoring device comprising a ratcheted tension element.
  • Anchoring device 1500 comprises a distal anchor.
  • Distal anchor may comprise a design selected from the variety of designs disclosed elsewhere in this document.
  • distal anchor comprises a series of radial arms 1502 connected to a central hub 1504 .
  • the proximal end of central hub is attached to a ratcheted tension element 1506 .
  • a proximal anchor is located on ratcheted tension element 1506 proximal to the distal anchor.
  • Proximal anchor may comprise a design selected from the variety designs disclosed elsewhere in this document.
  • distal anchor comprises a series of radial arms 1508 connected to a central hub 1510 .
  • Central hub 8368 has a central lumen through which ratcheted tension element 1506 can slide.
  • Ratcheted tension element 1506 has ratchets arranged such that proximal anchor can slide easily over ratcheted tension element 1506 in the distal direction but cannot slide easily in the proximal direction.
  • proximal anchor slides over ratcheted tension element 1506 in the distal direction. This causes a compression of tissue between distal anchor and proximal anchor. The compression of tissue can be maintained since proximal anchor cannot slide easily in the proximal direction.
  • distal anchor is introduced via an anatomical lumen (e.g.
  • Anchoring device 1500 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.
  • FIG. 16 shows a perspective view of an anchor comprising a trocar lumen.
  • Anchor 1600 comprises a hollow shaft 1602 comprising a lumen.
  • a trocar 1604 or a penetrating device can pass through hollow shaft 1602 such that the distal tip of trocar 1604 emerges out through the distal end of hollow shaft 1602 .
  • Distal end of hollow shaft 1602 comprises a tapering region 1606 with a smaller distal diameter and a larger proximal diameter.
  • Tapering region 1606 further comprises a series of sharp projections 1608 located on the proximal end of tapering region 1606 . Projections 1608 may be projecting in the proximal direction, radially outward direction etc.
  • Anchor 1600 may also comprise a sleeve 1610 located proximal to tapering region 1606 .
  • Sleeve 1610 is made of a porous material that has a plurality of pores that allow for tissue ingrowth thus anchoring sleeve 1610 firmly in tissue.
  • Sleeve 1610 may also help to distribute the pressure on tapering region 1606 over a wider area.
  • Sleeve 1610 may be non-woven or woven.
  • Sleeve 1610 can be made of variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • FIG. 17A shows a perspective view in the undeployed state of an anchor comprising a rigid or partially flexible T element and a crumpling element.
  • anchoring device 1700 comprises a distal, T element 1702 .
  • the T element 1702 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. Further it may be a composite material or have cut out sections to allow it to be flexible in certain dimensions but rigid in other dimensions.
  • T element 1702 is in the form of a hollow cylinder.
  • the proximal end of T element 1702 is in contact with the distal end of a delivery rod 1704 .
  • Delivery rod 1704 is hollow and is used to deliver T element 8266 in a target anatomical region.
  • a trocar 1705 can pass through delivery rod 1704 and through T element 1702 such that the distal tip of trocar emerges through the distal end of rigid element 1702 .
  • the T-element could also be contained within a lumen of the trocar or may be the trocar itself. of the T element 1702 is connected to the distal end of a flexible tension element 1706 .
  • tension element 1706 being tied or crimped to the T element, or passing through a loop in the T element, or being adhered by adhesive or weld, or by being made of a continuous material which becomes the T element.
  • T element is shown as a T, any shape which is larger in at least one dimension compared to its other dimensions could appropriately be released and cause to change it's orientation to produce an anchoring effect.
  • materials that can be used to manufacture tension element 1706 include but are not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g.
  • a substantially flattened body 1708 is located on the distal region of tension element 1706 .
  • Tension element 1706 is threaded through body 1708 in such a way that tension element 1706 can slide through body 1708 .
  • Body 1708 may be non-woven or woven.
  • Body 1708 can be made of a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g.
  • FIGS. 17B and 17C show various steps of a method to deploy the anchoring device shown in FIG. 17A .
  • anchoring device 1700 is introduced in an anatomical cavity (e.g. the pelvic cavity) through a tissue (e.g. the prostate gland).
  • trocar 1705 is withdrawn by pulling trocar 1705 in the proximal direction.
  • delivery rod 1704 is withdrawn by pulling delivery rod 1704 in the proximal direction.
  • tension element 1706 is pulled in the proximal direction.
  • Tension element 1706 in turn pulls T element 1702 in the proximal direction.
  • rigid element 1702 is pulled against a wall of the tissue (e.g. the prostate gland) but is unable to penetrate the tissue because of its size. This causes body 1708 to crumple because of compression of body 1708 between the wall of the tissue and rigid element 1702 . Crumpled body 1708 may be designed to cause tissue ingrowth or epithelialization in body 1708 as well as healing, hemostasis or a more even force distribution.
  • FIGS. 17D and 17E show perspective views of an undeployed and deployed configuration of an anchor comprising a rigid or partially flexible T element with one or more openings or perforations.
  • FIG. 17D shows a perspective view of an anchoring device 1720 comprising an anchor 1722 .
  • Anchor 1722 comprises a tubular body.
  • the tubular body may comprise one or more openings or perforations 1724 in the tubular body. Openings or perforations 1724 increase the flexibility of anchor 1722 . This makes it easier to navigate anchoring device 1720 through the anatomy before reaching its target location. Further it enables anchoring device 1720 to be passed through a tight bend in the anatomy or through a delivery device.
  • trocar tip 1727 Within tubular body of anchor 1722 is trocar tip 1727 that is fixedly attached to tensioning element 1728 .
  • anchor 1722 comprises a lumen.
  • a length of the distal end of deployment element 1726 passes through the proximal end of the lumen and abuts trocar tip 1727 that enables anchor 1722 to puncture tissue.
  • trocar tip is fixedly attached to elongate deployment element 1726 and is retracted fully into element 1729 upon anchor deployment.
  • distal tip of deployment device 1726 is not exposed through the distal end of anchor 1722 .
  • Distal end of anchor 1722 comprises a sharp tip to enable anchor 1722 to puncture tissue.
  • Anchoring element 1720 further comprises a tension element 1728 attached to tubular body 1722 .
  • Anchor 1722 is deployed by pushing in a distal direction one elongate deployment element 1726 , that runs within lumen of anchor 1722 abutting trocar tip 1727 distally, in tandem with another elongate deployment element 1729 that abuts the proximal end of anchor 1722 .
  • Anchoring device 1720 punctures tissue to transport anchor 1722 through a first anatomical location (e.g. a prostate gland) to a second anatomical location (e.g. the pelvic cavity, urethra etc.).
  • Anchoring device 1720 can be made from a variety of materials including, but not limited to metals such as synthetic fibers e.g.
  • Tension element 1728 may then be connected to any one of the other anchoring elements such as anchor 10 D.
  • FIGS. 17F and 17G show perspective views of an undeployed and deployed configuration of an anchor comprising a stent.
  • Anchor 1730 comprises a self-expanding stent 1732 and a tension element 1734 .
  • Distal end of tension element 1734 is attached to stent 1732 .
  • distal end of tension element 1734 is attached on the mid section of stent 1732 .
  • Stent 1732 may comprise various designs including, but not limited to metallic tube designs, polymeric tube designs, spiral designs, chain-linked designs, rolled sheet designs, single wire designs etc.
  • Stent 1732 may have an open celled or closed celled structure.
  • a variety of fabrication methods can be used for fabricating stent 1732 including but not limited to laser cutting a metal or polymer element, welding metal elements etc.
  • a variety of materials can be used for fabricating stent 1732 including but not limited to metals, polymers, foam type materials, super elastic materials etc.
  • a variety of features can be added to stent 1732 including but not limited to radiopaque coatings, drug elution mechanisms etc.
  • Anchor 1730 is introduced through a sheath 1736 into a target anatomy. Thereafter, sheath 1736 is withdrawn. This causes stent 1732 to revert to its natural shape as shown in FIG. 17G and act as an anchor.
  • FIGS. 17H and 17I show perspective views of an undeployed and deployed configuration of an anchor comprising a spring.
  • Anchor 1740 comprises an elastic spring 1742 and a tension element 1744 . Distal end of tension element 1744 is attached to spring 1742 . In one embodiment, distal end of tension element 1744 is attached on the mid section of spring 1742 .
  • a variety of materials can be used for fabricating spring 1742 including but not limited to metals, polymers, foam type materials, super elastic materials etc.
  • a variety of features can be added to spring 1742 including but not limited to radiopaque coatings, drug elution mechanisms etc.
  • Anchor 1740 is introduced through a sheath 1746 into a target anatomy to reduce the profile of spring 1742 . Thereafter, sheath 1746 is withdrawn. This causes spring 1742 to revert to its natural shape as shown in FIG. 17I and act as an anchor.
  • FIGS. 18A through 22E show various embodiments of mechanisms to deploy one or more anchors.
  • FIG. 18A shows a crossection of an anchor deploying mechanism comprising a screw system.
  • FIG. 18A shows an anchor deploying mechanism comprising an anchor 1800 comprising an anchor body 1802 and anchoring elements 1804 attached to anchor body 1802 .
  • Anchor body 1802 comprises an inner lumen.
  • Inner lumen of anchor body 1802 comprises screw threading.
  • Anchoring elements 1804 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document.
  • Anchor body 1802 and anchoring elements 1804 may be made of a variety of materials including, but not limited to metals e.g.
  • the anchor deploying mechanism further comprises a deploying shaft 1806 .
  • Distal region of deploying shaft 1806 comprises a screw threading such that deploying shaft 1806 can be screwed into anchor body 1802 .
  • FIG. 18B shows the method of deploying an anchor comprising a screw mechanism. Deploying shaft 1806 is rotated to release the distal region of deploying shaft 1806 from anchor body 1802 after positioning anchor 1800 in a desired location. Such a mechanism can be used to deploy one or more anchors.
  • more than one anchors are located on deploying shaft 1806 .
  • the anchors can be sequentially deployed by rotating deploying shaft 1806 .
  • Deploying shaft 1806 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.
  • the anchor deploying mechanism is located inside an outer sheath.
  • FIGS. 19A and 19B show a crossectional view of an anchor deploying system comprising an electrolytic detachment element.
  • FIG. 19A shows a crossection of an anchor deploying mechanism comprising a deployable anchor 1900 .
  • Deployable anchor 1900 comprises an anchor body 1902 and anchoring elements 1904 attached to anchor body 1902 .
  • Anchoring elements 1904 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document.
  • Anchor body 8402 and anchoring elements 8404 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g.
  • Proximal region of deployable anchor 1900 further comprises an electrolyzable element 1906 .
  • Electrolyzable element 1906 is made of a length of metallic wire e.g. steel wire.
  • Proximal region of electrolyzable element 1906 is electrically connected to a deploying shaft 1908 .
  • Proximal region of deploying shaft 1908 is further connected to a first electrode.
  • the anchor deploying system further comprises a second electrode 1910 connected to a bodily region of the patient to be treated. In FIG. 19B , the first electrode is connected to a positive terminal of a power supply and the second electrode is connected to the negative terminal of the power supply to form an electrical circuit. Electrical current flowing between electrolyzable element 1906 and second electrode 1910 causes metallic ions from electrolyzable element 1906 to dissolve into surrounding anatomy. This causes electrolyzable element 1906 to detach from deploying shaft 1908 .
  • FIG. 20 shows a perspective view of an anchor deploying system comprising a looped ribbon.
  • the anchor deploying system comprises a deployable anchor 2000 .
  • Deployable anchor 2000 comprises an anchor body 2002 and anchoring elements 2004 attached to anchor body 2002 .
  • Anchoring elements 2004 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document.
  • Anchor body 2002 and anchoring elements 2004 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc.
  • Proximal region of deployable anchor 2000 further comprises a looping lumen 2006 .
  • a looped ribbon 2008 is looped through looping lumen 2006 .
  • Looped ribbon 2008 may be made of a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • looped ribbon 2008 extends to a proximal region where it can be cut by a user.
  • looped ribbon 2008 In a method of deploying deployable anchor 2000 , a single cut is made in looped ribbon 2008 at a proximal region. This turns looped ribbon 2008 into a straight ribbon. The straight ribbon can then be pulled in the proximal direction to remove it from deployable anchor 2000 . Looped ribbon 2008 may also be in the form of a looped monofilament or multifilament wire or suture.
  • FIG. 21A shows a crossectional view of an anchor deploying system comprising a locked ball.
  • the anchor deploying system comprises a deployable anchor 2100 .
  • Deployable anchor 2100 comprises an anchor body 2102 .
  • Deployable anchor 2100 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document.
  • Proximal end of anchor body 2102 is connected to a thin shaft 2104 .
  • Proximal end of thin shaft 2104 comprises a locking ball 2106 .
  • Anchor body 8428 , thin shaft 2104 and locking ball 2106 may be made of a variety of materials including, but not limited to metals e.g.
  • the anchor deploying system further comprises an outer locking sheath 2108 .
  • Distal end of locking sheath 2108 comprises an opening 2110 .
  • Diameter of opening 2110 is greater than the diameter of thin shaft 2104 but greater than diameter of locking ball 2106 .
  • the anchor deploying system further comprises a deploying shaft 2112 located within locking sheath 2108 .
  • Deploying shaft 2112 can be pushed in the distal direction within locking sheath 2108 by a user.
  • Locking sheath 2108 and deploying shaft 2112 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.
  • distal region of locking sheath 2108 comprises one or more longitudinal grooves or windows to allow distal region of locking sheath 2108 to expand easily in the radial direction.
  • FIGS. 21B and 21C show a method of deploying an anchor comprising a locked ball. In FIG.
  • deploying shaft 2112 is pushed in the distal direction by a user. This causes distal end of deploying shaft 2112 to push locking ball 2106 in the distal direction. This in turn causes locking ball 2106 to exert a force on the distal end of locking sheath 2108 . This force causes opening 2110 to enlarge and release locking ball 2106 .
  • FIG. 21C locking ball 2106 is released by locking sheath 2108 thus releasing deployable anchor 2100 .
  • FIGS. 22A through 22C show various views of an anchor deploying system comprising two interlocking cylinders.
  • the anchor deploying system comprises a proximal interlocking cylinder and a distal interlocking cylinder.
  • the distal interlocking cylinder is located on an anchor to be deployed.
  • FIG. 22A shows a perspective view of a proximal interlocking cylinder 2200 comprising a locking element 2202 located on the distal end of proximal interlocking cylinder 2200 .
  • locking element 2202 comprises a solid cylinder with a ninety degree bend.
  • Proximal interlocking cylinder 2200 and locking element 2202 may be made of a variety of materials including, but not limited to metals e.g.
  • FIG. 22B shows a crossectional view of the anchor deploying system comprising proximal interlocking cylinder 2200 interlocked with a distal interlocking cylinder 2204 .
  • Distal interlocking cylinder 2204 comprises a groove 2206 which locks locking element 2202 .
  • Locking element 2202 can be unlocked from distal interlocking cylinder 2204 by turning proximal interlocking cylinder 2200 .
  • distal interlocking cylinder 2204 may be made of a variety of materials including, but not limited to metals e.g.
  • FIG. 22C shows a crossectional view through plane A-A in FIG. 22B .
  • FIG. 22C shows distal interlocking cylinder comprising groove 2206 .
  • locking element 2202 located in groove 2206 .
  • Turning proximal interlocking cylinder 2200 turns locking element 2202 .
  • distal region of locking element 2202 can pass easily through groove 2206 unlocking proximal interlocking cylinder 2200 from distal interlocking cylinder 2204 .
  • FIGS. 22D and 22E show the steps of a method of unlocking the two interlocking cylinders from the anchor deploying systems of FIGS. 22A through 22C .
  • locking element 2202 of proximal interlocking cylinder 2200 is locked in groove 2206 of distal interlocking cylinder 2204 .
  • proximal interlocking cylinder 2200 is turned in a clockwise or counterclockwise direction to unlock locking element 2202 from groove 2206 . Thereafter, proximal interlocking cylinder 2200 is pulled in the proximal direction to separate proximal interlocking cylinder 2200 from distal interlocking cylinder 2204 .
  • FIG. 23A shows a perspective view of a distal end of an anchoring device that has an imaging modality.
  • Anchoring device 2300 comprises an elongate shaft 2302 comprising a lumen.
  • Elongate shaft 2302 can be made of suitable biocompatible materials such as metals, polymers etc.
  • the lumen of shaft 2302 terminates in a window 2304 located on the distal region of shaft 2302 .
  • Anchoring device further comprises an imaging modality such as a cystoscope, an ultrasound imaging system etc.
  • the imaging modality is a cystoscope 2306 .
  • Distal end of cystoscope 2306 is located in window 2304 to allow visualization of the anatomy adjacent to window 2304 .
  • cystoscope 2306 is permanently fixed to anchoring device 2300 .
  • cystoscope 2306 can be introduced through the proximal region of anchoring device 2300 .
  • Anchoring device 2300 further comprises a puncturing device 2308 .
  • Puncturing device 2308 comprises a sharp distal tip and a lumen that holds an anchor.
  • Anchoring device 2300 further comprises an anchor deployment device 2310 . Distal end of anchor deployment device 2310 is detachably attached to the anchor.
  • FIGS. 23B through 23G show various steps of a method for compressing an anatomical region using the anchoring device of FIG. 23A .
  • Anchoring device 2300 is introduced in an anatomical region such that distal end of anchoring device 2300 is located adjacent to a target anatomical region to be treated.
  • anchoring device 2300 is introduced transurethrally into the prostatic urethra.
  • puncturing device 2308 is advanced to puncture the anatomical region.
  • puncturing device 2308 punctures the prostate gland PG such that distal end of puncturing device 2308 is located in the pelvic cavity. Puncturing device comprises an anchor located in the lumen of puncturing device 2308 .
  • the anchor comprises a distal anchor 2312 , a tension element 2314 connected at one end to distal anchor 2312 and a proximal anchor 2316 that can slide over tension element 2314 .
  • Puncturing device 2308 comprises a groove at the distal end such that tension element exits puncturing device 2308 through the groove. Puncturing device 2308 further comprises a pusher 2318 that can push distal anchor 2312 out of puncturing device 2308 .
  • Proximal anchor 2316 is detachably attached to the distal region of anchor deployment device 2310 .
  • Proximal anchor 2312 , distal anchor 2316 and tension element 2314 may comprise designs including, but not limited to the designs disclosed elsewhere in this patent application.
  • the imaging modality may be used to verify the accurate placement and working of anchoring device 2300 .
  • pusher 2318 is pushed in the distal direction to push distal anchor 2312 out of puncturing device 2308 .
  • Distal anchor 2312 is thus deployed in the anatomy e.g. in the pelvic cavity surrounding the prostate gland PG.
  • Puncturing device 2308 is withdrawn by pulling it in the proximal direction.
  • tension element 2314 is pulled in the proximal direction through anchor deployment device 2310 .
  • tension element 2314 is pulled further in the proximal direction such that the anatomical region between proximal anchor 2316 and distal anchor 2312 is compressed.
  • proximal anchor 2316 is securely locked on to tension element 2314 .
  • proximal anchor 2316 is detached from anchor deployment device 2310 .
  • the detachment can be performed by a variety of mechanisms including, but not limited to the anchor detachment mechanisms disclosed elsewhere in this patent application.
  • excess length of tension element 2314 is removed. This removal can be done using a variety of methods including, but not limited to the methods disclosed elsewhere in this patent application such as cutting, delinking, melting, and breaking.
  • anchoring device 2300 is withdrawn from the anatomy. It should be understood that these deployment steps may be repeated in the same, opposing or neighboring tissues to essentially tack up the encroaching tissue (i.e.
  • both anchors become completely embedded within the tissue and covered to prevent encrustation, clotting or other tissue or body-fluid interaction—this may be facilitated by the processes, therapeutic agents and coatings described elsewhere in the application.
  • these anchors are shown on either side of the tissue, it may be possible to deploy either or both of them within the body of the tissue itself to help bury them and eliminate the possibility that they may interact with other parts of the body. It should further be noted that in the case of application to the prostate, that this technique may be used on any of the lateral or middle lobes to compress or hold the prostate gland PG away from the lumen of the urethra.
  • FIGS. 24 A through 24 C′ show various steps of a method of compressing an anatomical region using a device with deploying arms deployed through a trocar.
  • an anchoring device 2400 is introduced in an anatomical region.
  • Anchoring device 2400 comprising a distal anchor 2402 is introduced in the anatomy.
  • Distal anchor 2402 comprises a hollow shaft.
  • Distal end of distal anchor 2402 comprises one or more outwardly curling or spreading arms 2404 .
  • Curling or spreading arms 2404 are made of an elastic, springy, super-elastic or shape memory material such that they tend to curl or spread in a radially outward direction in absence of an external force.
  • Anchoring device 2400 further comprises a proximal anchor comprising a variety of designs including, but not limited to the designs disclosed elsewhere in this patent application.
  • proximal anchor is designed similar to anchor 1040 in FIG. 10D .
  • Anchor 1040 can slide along proximal region of distal anchor 2402 .
  • Anchor 1040 can also be attached to distal anchor 2402 after a desired positioning between anchor 1040 and distal anchor 2402 is achieved.
  • Anchoring device 2400 is delivered through a trocar 2406 .
  • Trocar 2406 comprises a sharp distal tip 2408 that can penetrate through tissue.
  • the proximal region of distal tip 2408 comprises one or more grooves or notches such that distal ends of curling or spreading arms 2404 can be temporarily held together by distal tip 2408 to allow for easy introduction into a target anatomy.
  • Anchoring device 2400 is introduced into a target tissue to be compressed such that curling or spreading arms 2404 are distal to the target tissue and anchor 1040 is proximal to the target tissue.
  • FIG. 24 A′ shows the distal end view of the anchoring device 2400 .
  • trocar 2406 is pushed in the distal direction relative to proximal anchor 2402 . This releases the distal ends of curling or spreading arms 2404 causing them to curl or spread outwards.
  • FIG. 24B trocar 2406 is pushed in the distal direction relative to proximal anchor 2402 . This releases the distal ends of curling or spreading arms 2404 causing them to curl or spread outwards.
  • 24 A′ shows the distal end view of the anchoring device 2400 with released curling or spreading arms 2404 .
  • anchor 1040 is pushed in the distal direction over distal anchor 2402 to compress tissue between anchor 1040 and distal anchor 2402 .
  • anchor 1040 is attached to the hollow shaft of distal anchor 2402 .
  • trocar 2406 is withdrawn from the anatomy.
  • the tethering function is performed by the shaft of the distal anchor, and the force is created by the curling arms. This tension may be pre-set into the arms through heat forming.
  • any mechanism capable of expanding from within a tubular shape and capable of applying retrograde forces on the tissue are within the scope of this invention such as expandable flanges, balloons, cages, molly-bolt-like structures, stent-like structures and springs.
  • FIG. 24D shows a crossection through the deployed anchoring device 2400 of FIG. 24A .
  • anchoring device 2400 comprises a distal anchor such as the distal anchor described in FIG. 17A instead of distal anchor 2412 .
  • FIG. 25A shows a perspective view of a spring clip that can be used to spread the anatomy.
  • Clip 2500 comprises two or more spreading arms 2502 .
  • Spreading arms 2502 may be curved or straight.
  • Distal ends of spreading arms 2502 may comprise a flattened region.
  • the proximal ends or curved arms 2502 are connected to each other by a heel region 2504 .
  • Heel region 2504 may be made from the same material as curved arms 2502 .
  • spreading arms 2502 are held close to each other.
  • spreading arms 2502 tend to expand away from each other thus spreading the anatomical region or regions between spreading arms 2502 .
  • Clip 2500 can be made of suitable elastic, super-elastic or shape memory biocompatible materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, etc.
  • synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.
  • metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, etc.
  • FIGS. 25B through 25F show various steps of a method of spreading an anatomical region or regions using the spring clip of FIG. 25A .
  • a delivery tool 2506 comprising a clip 2500 is introduced in the anatomy and positioned near the target anatomy to be spread.
  • Delivery tool 2506 comprises an elongate hollow body 2508 comprising a lumen.
  • Distal end of body 2508 may comprise a blunt, atraumatic end.
  • Distal region of body 2508 comprises a slot 2510 that is in fluid communication with the lumen of body 2508 .
  • Delivery tool may further comprise an outer sheath 2512 and an imaging modality 2514 .
  • Imaging modality 2514 may be permanently attached to delivery tool 2506 or may be introduced into delivery tool 2506 by a user.
  • imaging modality 2514 is a cystoscope.
  • clip 2500 is introduced into the anatomy by pushing clip 2500 out of slot 2510 such that the distal ends of spreading arms 2502 emerge first. Slot 2510 is designed such that spreading arms 2504 are biased towards each other as they emerge out of slot 2510 .
  • clip 2500 is further advanced such that distal tips of spreading arms 2502 penetrate into the tissue to be spread.
  • clip 2500 is advanced further such that the biasing forces on spreading arms 2502 are removed. Spreading arms 2502 tend to spread away from each other thus spreading the tissue between them.
  • Clip 2500 is detachably attached to delivery tool 2506 by a detaching mechanism 2516 including, but not limited to the several detaching mechanisms disclosed elsewhere in this patent application.
  • detaching mechanism 2516 is used to detach clip 2500 from delivery tool 2506 or deploy clip 2500 in the target anatomy.
  • distal region of delivery tool 2506 is inserted transurethrally into the prostatic urethra.
  • Clip 2500 is then delivered into the anterior commissure to spread the two lateral lobes of the prostate gland PG apart.
  • an opening in the commissure is made prior to the method of FIGS. 25B through 25G .
  • the spreading force exerted by spreading arms 2502 cause cutting of the anterior commissure.
  • Clip 2500 may be placed completely sub-urethrally or a small amount of heel region 2504 remains in the urethra.
  • the embodiments of anchoring devices wherein a sliding anchor is slid over a tension element may comprise one or more cinching elements. These cinching elements may be present on the sliding anchors, on the tension elements etc.
  • a cinching element may be a separate device that cinches to a tension element. In doing so, it increases the effective diameter of that region of the tension element and prevents the tension element from sliding through a sliding anchor. Cinching elements may allow only unidirectional motion of the sliding anchor over the tension element or may prevent any substantial motion of the sliding anchor over the tension element. Typical examples of such cinching mechanisms include, but are not limited to mechanisms described in the FIG. 26 series. For example, FIGS.
  • cinching mechanism 2600 comprises an outer base 2602 .
  • Outer base 2602 comprises one or more grooves created by the presence of two or more leaflets 2604 .
  • Leaflets 2604 are biased along a first axial direction as shown in FIG. 26A .
  • cinching mechanism 2600 allows motion of tension element 2606 only along the first axial direction and prevents substantial movement of tension element 2606 in the opposite direction.
  • FIGS. 26C and 26D show a partial section through a cinching mechanism comprising a cam element.
  • cinching mechanism 2610 comprises an outer body 2612 made of suitable biocompatible metals, polymers etc.
  • Body 2162 comprises a cam 2614 located on a pivot 2616 .
  • Cam 2614 may comprise a series of teeth to grip a tension element 2618 passing through body 2612 .
  • body 2162 comprises an opening 2620 located proximal to cam 2614 . Proximal region of tension element 2618 passes out of body 2612 through opening 2620 .
  • Cinching mechanism 2610 allows movement of body 2162 over tension element 2618 in the proximal direction.
  • FIG. 26C cinching mechanism 2610 comprises an outer body 2612 made of suitable biocompatible metals, polymers etc.
  • Body 2162 comprises a cam 2614 located on a pivot 2616 .
  • Cam 2614 may comprise a series of teeth to grip a tension element 2618 passing through body 2612 .
  • body 2162
  • FIG. 26E shows a sectional view of an embodiment of a cinching mechanism comprising a locking ball.
  • Cinching mechanism 2630 comprises an outer body 2632 comprising a lumen.
  • a tension element 2634 passes through the lumen of outer body 2632 .
  • the lumen of outer body gradually reduces in the proximal direction as shown in FIG. 26E .
  • a locking ball 2636 is present in the lumen. Motion of outer body 2632 over tension element 2634 in the distal direction pushes locking ball 2636 in the proximal region of outer body 2632 .
  • a proximal end region 2638 of a small diameter prevents locking ball 2636 from falling out of outer body 2632 .
  • the large lumen diameter in the proximal region of outer body 2632 allows free motion of locking ball 2636 .
  • presence of locking ball 2636 does not hinder the motion of outer body 2632 over tension element 2634 in the proximal direction.
  • locking ball 2636 is pushed in the distal region of outer body 2632 .
  • the small lumen diameter in the proximal region of outer body 2632 constricts motion of locking ball 2636 . This causes a region of tension element 2634 to be pinched between anchoring ball 2636 and outer body 2632 . This in turn prevents further motion of outer body 2632 over tension element 2634 in the proximal direction. This mechanism thus allows unidirectional motion of outer body 2632 is over tension element.
  • FIG. 26F shows a side view of an embodiment of a cinching mechanism comprising multiple locking flanges.
  • cinching mechanism 2644 comprises a body 2646 comprising a lumen lined by a first locking flange 2648 and a second locking flange 2650 .
  • First locking flange 2648 and second locking flange 2650 are biased in the proximal direction as shown.
  • a tension element 2652 passes through the lumen of body 2646 .
  • First locking flange 2648 and second locking flange 2650 together allow the movement of body 2646 over tension element 2652 in the distal direction, but prevent movement of body 2646 over tension element 2652 in the proximal direction.
  • Similar cinching mechanisms may be designed comprising more than two locking flanges.
  • FIG. 26G shows an end view of body 2646 comprising a lumen lined by first locking flange 2648 and second locking flange 2650 .
  • Body 2646 may be made of suitable biocompatible metals, polymers
  • FIG. 26H shows a side view of an embodiment of a cinching mechanism comprising a single locking flange.
  • cinching mechanism 2656 comprises a body 2658 comprising a lumen lined by a locking flange 2660 .
  • Locking flange 2660 is biased in the proximal direction as shown.
  • a tension element 2662 passes through the lumen of body 2658 .
  • Locking flange 2660 allows the movement of body 2658 over tension element 2662 in the distal direction, but prevents movement of body 2658 over tension element 2662 in the proximal direction.
  • FIG. 26I shows an end view of body 2658 comprising a lumen 2662 lined by locking flange 2660 .
  • Body 2658 may be made of suitable biocompatible metals, polymers etc.
  • FIG. 26J shows an end view of a cinching mechanism comprising a crimping lumen.
  • Cinching mechanism 2670 comprises a body 2672 comprising a crimping lumen 2674 .
  • Crimping lumen 2674 is in the form of an arc with a gradually reducing size as shown in FIG. 26J .
  • a tension element 2676 passes through crimping lumen 2674 .
  • tension element 2676 is locked in a region of crimping lumen 2674 of a diameter smaller than the diameter of tension element 2676 .
  • Tension element 2676 can be unlocked from crimping lumen 2674 by rotating body 2672 in the anti-clockwise direction. Similarly, rotating body 2672 in the clockwise direction causes an unlocked tension element 2676 to be locked into crimping lumen 2674 .
  • cinching mechanism comprises a disk shaped body comprising a central lumen. Central lumen is large enough to allow a tension element to slide easily through the central lumen. One or more radially oriented slits emerge from the central lumen. The radially oriented slits have a diameter that is of the same size or is slightly smaller than the diameter of the tension element. To lock cinching mechanism to the tension element, the tension element is forced through one of the radially oriented slits. The friction between the disk shaped body and the tension element prevents or resists sliding of tension element through the disk shaped body. To unlock cinching mechanism from the tension element, the tension element is moved back to the central lumen.
  • cinching mechanism comprises a disk shaped body comprising a small central lumen.
  • the central region of the body comprises three or more triangular flaps biased together out of the plane of the body.
  • the ends of the triangular flaps together form the central lumen that is of the same size or is slightly smaller than the diameter of the tension element.
  • Tension element can pass easily through the central lumen in the direction of the bias of the triangular flaps. But, tension element cannot pass or encounters substantial resistance when the tension element is pulled through the central lumen in the opposite direction.
  • FIGS. 26K and 26L show crossections of an embodiment of a cinching mechanism comprising a crimping anchor in the undeployed and deployed configurations respectively.
  • Cinching mechanism 2680 comprises a crimping anchor 2680 comprising a lumen.
  • Crimping anchor 2680 can be made of a variety of biocompatible materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc., polymers, etc.
  • a tension element 2684 passes through the lumen of crimping anchor 2680 .
  • the lumen of an undeployed crimping anchor 2680 is larger than the diameter of tension element 2684 .
  • Crimping anchor 2680 is deployed by compressing the middle section of crimping anchor 2680 such that crimping anchor 2680 compresses tension element 2684 . Friction between crimping anchor 2680 and tension element 2684 prevents relative motion between crimping anchor 2680 and tension element 2684 .
  • Crimping anchor 2680 may be a component of a sliding anchor or may be a stand-alone device used to prevent or restrict motion of a sliding anchor over a tension element.
  • FIG. 26M shows a perspective view of an embodiment of a cinching mechanism comprising an element providing a tortuous path to a tension element.
  • cinching mechanism 2686 comprises a spring 2688 .
  • a tension element 2690 is passed through spring 2688 such that the path of tension element 2690 through spring 2688 is tortuous.
  • spring 2688 is moved over tension element, motion of tension element 2690 through the tortuous path generates high frictional forces that prevent or reduce motion of spring 2688 over tension element 2690 .
  • the frictional forces are strong enough to resist motion of spring 2688 over tension element 2690 after deploying cinching mechanism 2686 in the anatomy.
  • a user can move spring 2688 over tension element 2690 by applying a force that overcomes the resistive frictional forces that prevent movement of spring 2688 over tension element 2690 .
  • other cinching mechanisms comprising a tortuous path can be used instead of spring 2688 .
  • examples of such mechanisms are solid elements comprising tortuous lumens, elements comprising multiple struts or bars that provide a tortuous path etc.
  • the cinching mechanism comprises a knot on one or more tensioning element. Said knot can be advanced fully tightened or can be loose when advanced and tightened in situ.
  • FIG. 26N shows a crossectional view of an embodiment of a locking mechanism comprising a space occupying anchor securely attached to a tension element.
  • Locking mechanism 2692 comprises a hollow element 2694 comprising a lumen.
  • Hollow element 2694 is a component of a sliding anchor that slides over tension element 2696 .
  • Tension element 2696 comprises a space occupying anchor 2698 comprising a tapering distal end 2699 .
  • Anchor 2698 is securely attached to tension element 2696 .
  • Diameter of anchor 2698 is larger than the diameter of the lumen of hollow element. Due to this, anchor 2698 cannot pass through hollow element 2694 effectively locking the position of tension element 2696 with respect to the position of hollow element 2694 .
  • FIGS. 26O and 26P shows a partial sectional view and a perspective view of an embodiment of a cinching mechanism comprising a punched disk.
  • Cinching mechanism 2602 ′ comprises a disk 2604 ′ comprising a punched hole 2606 ′.
  • Punched hole 2606 ′ is made by punching disk 2604 ′ along the proximal direction such that the punching action leaves an edge that is biased along the proximal direction as shown in FIG. 26O .
  • Disk 2604 ′ can slide over a tension element 2608 ′ along the distal direction. However, motion of disk 2604 ′ over tension element 2608 ′ along the proximal direction is substantially resisted by the proximally biased edges of punched hole 2606 ′.
  • FIGS. 26Q and 26 R show a perspective view of a first embodiment of a cutting device before and after cutting an elongate element.
  • cutting device 2610 ′ comprises an outer sheath 2612 ′ comprising a sharp distal edge 2614 ′.
  • Outer sheath 2612 ′ encloses an inner sheath 2616 ′.
  • Inner diameter of outer sheath 2612 ′ is slightly larger than outer diameter of inner sheath 2616 ′ such that inner sheath 2616 ′ can slide easily through outer sheath 2612 ′.
  • Inner sheath 2616 ′ comprises a lumen that terminates distally in an opening 2618 ′.
  • An elongate severable device passes through the lumen and emerges out of opening 2618 ′.
  • An example of an elongate severable device is a tension element 2620 ′.
  • the desired area of tension element 2620 ′ to be cut or severed is positioned near opening 2618 ′ by advancing or withdrawing cutting device 2610 ′ over tension element 2620 ′.
  • outer sheath 2612 ′ is advanced over inner sheath 2616 ′ to cut tension element 2620 ′ between sharp distal edge 2614 ′ and an edge of opening 2618 ′.
  • Inner sheath 2616 ′ and outer sheath 2612 ′ may be substantially rigid or flexible. They may be made of suitable materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • FIG. 26S show a crossectional view of a second embodiment of a cutting device for cutting an elongate element.
  • Cutting device 2622 ′ comprises an outer sheath 2624 ′ comprising a lumen that opens in an opening 2626 ′ in outer sheath 2624 ′.
  • Outer sheath 2624 ′ encloses an inner sheath 2628 ′ that comprises a lumen and a sharp distal edge 2630 ′.
  • Inner diameter of outer sheath 2624 ′ is slightly larger than outer diameter of inner sheath 2628 ′ such that inner sheath 2628 ′ can slide easily through outer sheath 2624 ′.
  • An elongate severable device passes through the lumen of inner sheath 2628 ′ and emerges out of distal end of inner sheath 2628 ′ and out of outer sheath 2624 ′ through opening 2626 ′.
  • An example of an elongate severable device is a tension element 2632 ′.
  • the desired area of tension element 2632 ′ to be cut or severed is positioned near opening 2626 ′ by advancing or withdrawing cutting device 2622 ′ over tension element 2632 ′.
  • inner sheath 2628 ′ is advanced through outer sheath 2624 ′ to cut tension element 2632 ′ between sharp distal edge 2630 ′ and an edge of opening 2626 ′.
  • Inner sheath 2628 ′ and outer sheath 2624 may be substantially rigid or flexible. They may be made of suitable materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • the cutting device comprises an outer hollow sheath.
  • Outer hollow sheath has a distal end plate comprising a window.
  • An elongate severable device passes through the window.
  • An example of an elongate severable device is a tension element.
  • An inner shaft can slide and rotate within outer hollow sheath. Distal end of inner shaft comprises a blade that is usually located away from the window and adjacent to the distal end plate of the outer hollow sheath.
  • the desired area of the elongate severable device to be cut or severed is positioned near the window.
  • Inner shaft and outer hollow sheath may be substantially rigid or flexible. They may be made of suitable materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • the end plate and the blade are preferentially rigid. They may be made of suitable materials including, but not limited to metals like stainless steel, polymers like Polycarbonate, Polyimide, PVC, Hytrel, HDPE, PEEK and fluoropolymers like PTFE, PFA, FEP etc.
  • FIGS. 27A through 27D show axial sections through the prostate gland PG showing various configurations of anchoring devices comprising distal anchors 2700 and a tension element 2702 that is anchored at a suitable location such that a sufficient tension exists in tension element 2702 .
  • FIGS. 28 and 28A show perspective views of an embodiment of an anchoring device comprising an elongate element comprising multiple barbs or anchors.
  • FIG. 28 shows a perspective view of anchoring device 2800 comprising an elongate element 2802 .
  • Elongate element 2802 can be made of several biocompatible materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • Elongate element 2802 may comprise natural or artificial suture materials.
  • materials include but are not limited to Polyamide (Nylon), Polypropylene, Polyglycolic Acid (PGA), polylactic acid (PLA) and copolymers of polylactic acid, polyglycolic acid and copolymers of polyglycolic acid, copolymers of PLA and PGA, Silk, Polyester, silicone, collagen, Polymers of Glycolide and Lactide.
  • a particular example of a suture is the Nordstrom suture which is a highly elastic silicone suture.
  • the suture material is bioabsorbable.
  • Elongate element 2802 comprises two sets of projections such as barbs, anchors or hooks.
  • elongate element 2802 comprises a set of distal barbs 2804 and a set of proximal barbs 2806 .
  • Distal barbs 2804 are oriented in the proximal direction and proximal barbs 2806 are oriented in the distal direction as shown in FIG. 25 .
  • FIG. 28A shows a magnified view of the region 28 A of anchoring device 2800 showing proximal barbs 2806 .
  • FIGS. 28B through 28E show a coronal section through the prostate gland PG showing various steps of a method of treating the prostate gland PG using the device of FIG. 28 .
  • introducer device 300 of FIG. 3A comprising a working device lumen and a cystoscope lumen 308 is introduced into the urethra such that the distal end of introducer device 300 is located in the prostatic urethra.
  • a hollow puncturing device 2808 is inserted in the working device lumen of introducer device. Puncturing device 2808 is advanced such that distal end of puncturing device 2808 penetrates the prostate gland PG.
  • anchoring device 2800 is introduced through puncturing device 2808 into the prostate gland PG.
  • puncturing device 2808 is pulled in the proximal direction.
  • anchoring device 2800 is pulled in the proximal direction to anchor distal barbs 2804 in the anatomy.
  • puncturing device 2808 is pulled further in the proximal direction to expose the entire anchoring device 2800 .
  • the proximal end of anchoring device 2800 is detached to deploy anchoring device 2800 in the anatomy.
  • tissue between distal barbs 2804 and proximal barbs 2806 is anchored to anchoring device 2800 .
  • FIG. 29A shows an axial section of the prostate gland PG showing a pair of implanted magnetic anchors.
  • a first magnetic anchor 2900 and a second magnetic anchor 2902 are implanted in the prostate gland PG on either side of the urethra.
  • Like poles of first magnetic anchor 2900 and second magnetic anchor 2902 face each other such that there is magnetic repulsion between first magnetic anchor 2900 and second magnetic anchor 2902 . This causes the urethral lumen to widen potentially reducing the severity of BPH symptoms.
  • FIGS. 29B through 29D show a coronal section through the prostate gland PG showing the steps of a method of implanting magnetic anchors of FIG. 29A .
  • a deployment device 2904 is advanced trans-urethrally.
  • Deployment device 2904 comprises a sharp distal tip 2906 and first magnetic anchor 2900 .
  • Distal tip 2906 of deployment device 2904 penetrates prostatic tissue and implants first magnetic anchor 2900 in the prostate gland PG.
  • another deployment device 2908 comprising a sharp distal tip 2920 is used to implant second magnetic anchor 2902 in the prostate gland PG.
  • First magnetic anchor 2900 and second magnetic anchor 2902 are implanted on opposite sides of the urethra such that like poles of first magnetic anchor 2900 and second magnetic anchor 2902 face each other. This causes magnetic repulsion between first magnetic anchor 2900 and second magnetic anchor 2902 . This causes the urethral lumen to widen potentially reducing the severity of BPH symptoms.
  • deployment device 2904 can be used to deploy multiple magnetic anchors.
  • FIG. 30A shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device inserted into the prostate gland PG from the urethra.
  • Cutting device 3000 comprises an outer body 3002 comprising a side port 3004 .
  • Outer body 3002 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Cutting device 3000 further comprises an access device 3006 that can be deployed out of side port 3004 . Access device 3006 can be retracted back into side port 3004 .
  • Typical examples of elements that can be used as access device 3006 are needles, trocars etc.
  • Access device 3006 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Access device 3006 penetrates the walls of the urethra and enters the prostate gland PG by creating an access channel in the prostate gland PG.
  • Cutting device 3000 further comprises a cutting element 3008 that is introduced into the prostate gland PG through the access channel in the prostate gland PG. In one embodiment, cutting element 3008 enters the prostate gland PG through access device 3006 .
  • Cutting element 3008 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc.
  • Cutting element 3008 may be moved through prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3008 ; one or more articulating elements located on cutting element 3008 ; motion of cutting device 3000 along the urethra etc.
  • Cutting element 3008 is used to cut one or more regions of the prostate gland PG including peripheral zone, transition zone, central zone or prostatic capsule. After the desired region or regions of the prostate gland PG are cut, cutting element 3008 and access device 3006 are withdrawn into cutting device 3000 . Thereafter, cutting device 3000 is withdrawn from the urethra.
  • cutting device 3000 comprises an endoscope or means for inserting an endoscope.
  • FIG. 30B shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device that accesses outer surface of the prostate gland PG by passing through the walls of the urethra distal to the prostate gland PG.
  • Cutting device 3020 comprises an outer body 3022 comprising a side port 3024 .
  • Outer body 3022 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Cutting device 3020 is advanced into the urethra such that side port 3024 is located distal to the prostate gland PG.
  • Cutting device 3020 further comprises an access device 3026 that can be deployed out of side port 3024 .
  • Access device 3026 can be retracted back into side port 3024 .
  • Typical examples of elements that can be used as access device 3026 are needles, trocars etc.
  • Access device 3026 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Access device 3026 is deployed from side port 3024 in a desired orientation such that access device 3026 penetrates the wall of the urethra. Access device 3026 is advanced further such that distal end of access device 3026 is located near the prostate gland PG.
  • a cutting element 3028 is introduced through access device 3026 to the outer surface of the prostate gland PG.
  • Cutting element 3028 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc.
  • Cutting element 3028 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone.
  • Cutting element 3028 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3028 ; motion of cutting element 3028 along access device 3026 etc. In one method embodiment, cutting element 3028 cuts prostatic capsule while being withdrawn into access device 3026 .
  • cutting device 3020 After the desired region or regions of the prostate gland PG are cut, cutting element 3028 and access device 3026 are withdrawn into cutting device 3020 . Thereafter, cutting device 3020 is withdrawn from the urethra. In one device embodiment, cutting device 3020 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 30C shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device that accesses outer surface of the prostate gland PG by passing through the wall of the urinary bladder.
  • Cutting device 3040 comprises an outer body 3042 comprising a side port 3044 .
  • Outer body 3042 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Cutting device 3040 is advanced into the urethra such that side port 3044 is located inside the urinary bladder.
  • Cutting device 3040 further comprises an access device 3046 that can be deployed out of side port 3044 .
  • Access device 3046 can be retracted back into side port 3044 .
  • Typical examples of elements that can be used as access device 3046 are needles, trocars etc.
  • Access device 3046 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Access device 3046 is deployed from side port 3044 in a desired orientation such that access device 3046 penetrates the wall of the urinary bladder.
  • Access device 3046 is advanced further such that distal end of access device 3046 is located near the prostate gland PG. Thereafter, a cutting element 3048 is introduced through access device 3046 to the outer surface of the prostate gland PG.
  • Cutting element 3048 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc.
  • Cutting element 3048 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone.
  • Cutting element 3048 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3048 ; motion of cutting element 3048 along access device 3046 etc.
  • cutting element 3048 cuts prostatic capsule while being withdrawn into access device 3046 .
  • cutting element 3048 and access device 3046 are withdrawn into cutting device 3040 .
  • cutting device 3040 is withdrawn from the urethra.
  • cutting device 3040 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 30D shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device that accesses outer surface of the prostate gland PG by passing through the walls of the urethra enclosed to the prostate gland PG.
  • Cutting device 3060 comprises an outer body 3062 comprising a side port 3064 .
  • Outer body 3062 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Cutting device 3060 is advanced into the urethra such that side port 3064 is located in the region of the urethra enclosed by the prostate gland PG.
  • Cutting device 3060 further comprises an access device 3066 that can be deployed out of side port 3064 .
  • Access device 3066 can be retracted back into side port 3064 .
  • Typical examples of elements that can be used as access device 3066 are needles, trocars etc.
  • Access device 3066 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc.
  • Access device 3066 is deployed from side port 3064 in a desired orientation such that access device 3066 penetrates the prostate. Thereafter, a cutting element 3068 is introduced through access device 3066 such that the distal region of cutting element can access the outer surface of the prostate gland PG.
  • Cutting element 3068 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc.
  • Cutting element 3068 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone.
  • Cutting element 3068 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3068 ; motion of cutting element 3068 along access device 3066 etc.
  • cutting element 3068 cuts prostatic capsule while being withdrawn into access device 3066 .
  • cutting element 3068 and access device 3066 are withdrawn into cutting device 3060 .
  • cutting device 3060 is withdrawn from the urethra.
  • cutting device 3060 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 31 shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue by a percutaneous device that accesses the prostate gland PG through an incision in the abdomen.
  • a cannula 3100 is introduced percutaneously into the lower abdomen.
  • Cannula 3100 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers etc.
  • Cannula 3100 is advanced into the abdomen such that it passes below the pubic bone. The distal end of cannula 3100 is positioned near the prostate gland PG.
  • a cutting device 3102 is advanced through distal end of cannula 3100 to the outer surface of the prostate gland PG.
  • Cutting device 3102 can be retracted back into cannula 3100 .
  • Cutting device 3102 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc.
  • Cutting device 3102 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone.
  • Cutting device 3102 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting device 3102 ; motion of cutting device 3102 along cannula 3100 etc. In one method embodiment, cutting device 3102 cuts prostatic capsule while being withdrawn into cannula 3100 .
  • cannula 3100 is withdrawn from the urethra.
  • cannula 3100 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 32 shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue by a percutaneous device that penetrates the urinary bladder and accesses the outer surface of the prostate gland PG through an incision in the urinary bladder.
  • a cannula 3200 is introduced percutaneously into the lower abdomen.
  • Cannula 3200 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers etc.
  • Cannula 3200 is advanced into the abdomen such that it passes above the pubic bone. The distal end of cannula 3200 enters the urinary bladder.
  • an access device 3202 is advanced through cannula 3200 such that access device 3202 penetrates the urinary bladder wall as shown in FIG. 4 .
  • a cutting device 3204 is advanced through distal end of access device 3202 to the outer surface of the prostate gland PG.
  • Cutting device 3202 can be retracted back into access device 3202 .
  • Cutting device 3202 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc.
  • Cutting device 3202 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone.
  • Cutting device 3202 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting device 3202 or access device 3202 ; motion of cutting device 3202 along access device 3202 etc.
  • cutting device 3202 cuts prostatic capsule while being withdrawn into access device 3202 . After the desired region or regions of the prostate gland PG are cut, cutting device 3202 is withdrawn into access device 3202 . Access device 3202 is then withdrawn into cannula 3200 . Thereafter, cannula 3200 is withdrawn from the urinary bladder.
  • cannula 3200 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 33 series shows a perspective view of a prostate treatment kit to cut prostate tissue.
  • FIG. 33A shows a perspective view of an introducer device.
  • Introducer device 3300 comprises a first tubular element 3302 enclosing a working device lumen 3304 .
  • First tubular element 3302 can be made of suitable biocompatible materials such as Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • the proximal end of working device lumen 3304 comprises a first stasis valve 3306 .
  • the distal end of working device lumen 3304 comprises a deflection mechanism.
  • the deflection mechanism is used to bend the distal region of working device lumen 3304 .
  • deflection mechanism is a pull wire and a deflection dial 3310 to adjust the magnitude and/or the direction of deflection caused by the pull wire.
  • other deflection mechanisms can be used in the introducer device instead of a pull wire.
  • Introducer device 3300 further comprises a second tubular element 3312 which encloses a cystoscope lumen 3314 .
  • a cystoscope can be introduced through cystoscope lumen 3314 into the urethra.
  • cystoscopes that can be used with introducer device are those manufactured by Olympus, Pentax, Storz, Wolf, Circon-ACMI, etc.
  • the proximal end of cystoscope lumen 3314 comprises a second stasis valve 3316 .
  • the cystoscope is inserted through the proximal end of cystoscope lumen 3314 and emerges out into the urethra from the distal end of cystoscope lumen 3314 .
  • the cystoscope can then be used to visualize the anatomy and various instruments during a procedure.
  • Working device lumen 3314 may comprise one or more side ports e.g. a first side port 3318 for the introduction or removal of one or more fluids.
  • Cystoscope lumen 3314 may comprise one or more side ports e.g. a second side port 3320 for the introduction or removal of one or more fluids.
  • FIG. 33B shows a perspective view of an injecting needle.
  • Injecting needle 3330 is used for injecting one or more diagnostic or therapeutic agents in the anatomy.
  • injecting needle 3330 is used to inject local anesthetic in the urethra and/or prostate gland PG.
  • target areas for injecting local anesthetics are the neurovascular bundles, the genitourinary diaphragm, the region between the rectal wall and prostate, etc.
  • Examples of local anesthetics that can be injected by injecting needle 3330 are anesthetic solutions e.g. 1% lidocaine solution; anesthetic gels e.g. lidocaine gels; combination of anesthetic agents e.g.
  • Injecting needle 3330 comprises a hollow shaft 3332 made of suitable biocompatible materials including, but not limited to stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.
  • the length of hollow shaft 3332 can range from to centimeters.
  • the distal end of hollow shaft 3332 comprises a sharp tip 3334 .
  • the proximal end of hollow shaft 3332 has a needle hub 3336 made of suitable biocompatible materials including, but not limited to metals e.g. like stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.; polymers e.g. polypropylene etc.
  • needle hub 3336 comprises a luer lock.
  • FIG. 33C shows a perspective view of a guiding device.
  • Guiding device 3338 comprises an elongate body 3340 comprising a sharp distal tip 3342 .
  • guiding device 3338 is a guidewire.
  • Distal end of elongate body 3340 may comprise an anchoring element to reversibly anchor guiding device 3338 into tissue.
  • suitable anchoring elements are barbs, multipronged arrowheads, balloons, other mechanically actuable members (e.g. bendable struts), screw tips, shape memory elements, or other suitable anchor designs disclosed elsewhere in this patent application.
  • FIG. 33D shows a perspective view of a RF cutting device.
  • Cutting device 3343 comprises an inner sheath 3344 and an outer sheath 3346 .
  • Inner sheath 3344 comprises a lumen of a suitable dimension such that cutting device 3343 can be advanced over guiding device 538 .
  • Outer sheath 3346 can slide on inner sheath 3344 .
  • Outer sheath 3346 also comprises two marker bands: a proximal marker band 3348 and a distal marker band 3350 .
  • the marker bands can be seen by a cystoscope.
  • proximal marker band 3348 and distal marker band 3350 are radiopaque.
  • proximal marker band 3348 and distal marker band 3350 are such that after cutting device 3343 is placed in an optimum location in the anatomy, proximal marker band 3348 is located in the urethra where it can be seen by a cystoscope and distal marker band 3350 is located in the prostrate gland PG or in the wall of the urethra where it cannot be seen by the cystoscope.
  • Cutting device 3343 further comprises a cutting wire 3352 that is capable of delivering electrical energy to the surrounding tissue.
  • the distal end of cutting wire 3352 is fixed to the distal region of outer sheath 3344 .
  • the proximal end of cutting wire 3352 is connected to a distal region of outer sheath 3346 and is further connected to a source of electrical energy.
  • FIG. 33D cutting wire 3352 is in an undeployed configuration.
  • FIG. 33 D′ shows the distal region of cutting device 3343 when cutting wire 3352 is in a deployed configuration.
  • inner sheath 3344 is moved in the proximal direction with respect to outer sheath 546 . This causes cutting wire 3352 to bend axially outward thus deploying cutting wire 3352 in the surrounding anatomy.
  • FIG. 33E shows a perspective view of an embodiment of a plugging device to plug an opening created during a procedure.
  • Plugging device 3354 comprises a tubular shaft 3356 comprising a distal opening 3358 .
  • Distal opening 3358 is used to deliver one or more plugging materials 3360 in the adjacent anatomy.
  • Plugging material 3360 may comprise a porous or non-porous matrix formed of a biodegradable or non-biodegradable material such as a flexible or rigid polymer foam, cotton wadding, gauze, hydrogels, etc.
  • plugging material 3360 comprises biocompatible sealants including but not limited to fibrin sealants, combination of natural proteins (e.g. collagen, albumin etc.) with aldehyde cross-linking agents (e.g.
  • Plugging device 3354 may be introduced in the anatomy by various approaches including the approaches disclosed elsewhere in this patent application. Plugging device 3354 may be introduced in the anatomy through a cannula, over a guiding device such as a guidewire etc. In the embodiment shown in FIG. 33E , plugging material 3360 is preloaded in plugging device 3354 . Plugging material 3360 is introduced through distal opening 3358 by pushing plunger 3362 in the distal direction. In another embodiment, plugging device 3354 comprises a lumen that extends from the proximal end to distal opening 3358 . Plugging material 3360 may be injected through the proximal end of the lumen such that it emerges out through distal opening 3358 .
  • FIGS. 33F through 33N show various alternate embodiments of the electrosurgical cutting device in FIG. 33D .
  • FIGS. 33F and 33G show perspective views of the distal region of a first alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively.
  • FIG. 33F show an electrosurgical cutting device 570 comprising an elongate shaft 3372 .
  • Shaft 3372 is made of an electrically insulating material.
  • Electrosurgical cutting device 3370 further comprises an electrosurgical cutting wire 3374 .
  • Electrosurgical cutting wire 3374 can be made of a variety of materials including, but not limited to tungsten, stainless steel, etc. Distal end of cutting wire 3374 is attached to distal region of shaft 3372 .
  • the proximal region of cutting wire 3374 can be pulled in the proximal direction by an operator.
  • electrosurgical cutting device 3370 is introduced in the target anatomy through a sheath 3376 .
  • FIG. 33F electrosurgical cutting device 3370 is deployed by pulling cutting wire 3374 in the proximal direction. This causes distal region of shaft 3372 to bend. Thereafter, electrical energy is delivered through cutting wire 3374 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3370 along the proximal or distal direction.
  • FIGS. 33H and 33I show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively.
  • Electrosurgical cutting device 3380 comprises an elongate sheath 3382 comprising a lumen. Distal region of sheath 3382 has a window 3384 .
  • Electrosurgical cutting device 3380 further comprises an electrosurgical cutting wire 3386 located in the lumen. Distal end of cutting wire 3386 is fixed to the distal end of sheath 3384 . Proximal end of cutting wire 3386 can be pushed in the distal direction by a user. In FIG. 331 , cutting wire 3386 is deployed by pushing cutting wire 3386 in the distal direction.
  • FIGS. 33J through 33L show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device.
  • Electrosurgical cutting device 3390 comprises an elongate sheath 3391 comprising a lumen 3392 .
  • an electrosurgical cutting wire 3394 is introduced through lumen 3392 such that it emerges out through the distal opening of lumen 3392 .
  • cutting wire 3394 is further advanced in the distal direction.
  • Distal end of cutting wire 3394 has a curved region so that cutting wire 3394 starts to bend as it emerges out of lumen 3392 .
  • cutting wire 3394 is further advanced in the distal direction to fully deploy cutting wire 3394 .
  • electrical energy is delivered through cutting wire 3394 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3390 along the proximal or distal direction.
  • FIGS. 33M through 33N show perspective views of the distal region of a third alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device.
  • Electrosurgical cutting device 3395 comprises an elongate sheath 3396 comprising a lumen.
  • Cutting device 3395 further comprises a cutting wire 3398 located in the lumen of elongate sheath 3396 .
  • the proximal end of cutting wire 3398 is connected to a source of electrical energy.
  • Distal end of cutting wire 3398 is connected to the inner surface of the distal region of elongate sheath 3396 .
  • Cutting wire 3398 may be made from suitable elastic, super-elastic or shape memory materials including but not limited to Nitinol, titanium, stainless steel etc.
  • Electrosurgical cutting device 3395 is deployed by pushing the proximal region of cutting wire 3398 in the distal direction. This causes a distal region of cutting wire 3398 to emerge from the distal end of elongate sheath 3396 as a loop. Thereafter, electrical energy is delivered through cutting wire 3398 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3395 along the proximal or distal direction. Electrosurgical cutting device 3395 can be used to cut multiple planes of tissue by withdrawing cutting wire 3398 in elongate sheath 3396 , rotating elongate sheath 3396 to a new orientation, redeploying cutting wire 3398 and delivering electrical energy through cutting wire 3398 .
  • the devices 33 H through 33 N may be introduced by one or more access devices such as guidewires, sheaths etc.
  • FIG. 34 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting blades.
  • Balloon catheter 3400 can be introduced into a lumen or in the tissue of an organ to be treated using one or more of the introducing methods disclosed elsewhere in this patent application.
  • Balloon catheter 3400 comprises a shaft 3402 .
  • Shaft 3402 may comprise a lumen to allow balloon catheter 3400 to be introduced over a guidewire.
  • shaft 3402 is torquable.
  • Shaft 3402 comprises a balloon 3404 located on the distal end of shaft 3402 .
  • Balloon 3404 can be fabricated from materials including, but not limited to polyethylene terephthalate, Nylon, polyurethane, polyvinyl chloride, crosslinked polyethylene, polyolefins, HPTFE, HPE, HDPE, LDPE, EPTFE, block copolymers, latex and silicone. Balloon 3404 further comprises one or more cutter blades 3406 . Balloon catheter 3400 is advanced with balloon 3404 deflated, into a natural or surgically created passageway and positioned adjacent to tissue or matter that is to be cut, dilated, or expanded. Thereafter, balloon 3404 is inflated to cause cutter blades 3406 to make one or more cuts in the adjacent tissue or matter.
  • Balloon catheter 3400 may comprise one or more navigation markers including, but not limited to radio-opaque markers, ultrasound markers, light source that can be detected visually etc.
  • FIG. 35 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting wires.
  • Balloon catheter 3500 can be introduced into a lumen or in the tissue of an organ to be treated using one or more of the introducing methods disclosed elsewhere in this patent application.
  • Balloon catheter 3500 comprises a shaft 3502 .
  • Shaft 3502 may comprise a lumen to allow balloon catheter 3500 to be introduced over a guidewire.
  • shaft 3502 is torquable.
  • Shaft 3502 comprises a balloon 3504 located on the distal end of shaft 3502 .
  • Balloon 3504 can be fabricated from materials including, but not limited to polyethylene terephthalate, Nylon, polyurethane, polyvinyl chloride, crosslinked polyethylene, polyolefins, HPTFE, HPE, HDPE, LDPE, EPTFE, block copolymers, latex and silicone. Balloon 3504 further comprises one or more radiofrequency wires 3506 . Balloon catheter 3500 is advanced with balloon 3504 deflated, into a natural or surgically created passageway and positioned adjacent to tissue or matter that is to be cut, dilated, or expanded. Thereafter, balloon 3504 is inflated and an electrical current is delivered through radiofrequency wires 3506 to make one or more cuts in the adjacent tissue or matter.
  • Balloon catheter 3500 may comprise one or more navigation markers including, but not limited to radio-opaque markers, ultrasound markers, light source that can be detected visually etc.
  • FIGS. 36A and 36B series show perspective views of an undeployed state and a deployed state respectively of a tissue displacement device.
  • FIG. 36A shows a tissue anchoring device 3600 in the undeployed state.
  • Anchoring device 3600 comprises an elongate body having a proximal end 3602 and a distal end 3604 .
  • Anchoring device 3600 may be made of a variety of elastic or super-elastic materials including, but not limited to Nitinol, stainless steel, titanium etc.
  • Anchoring device 3600 is substantially straight in the undeployed state and has a tendency to become substantially curved in the deployed state.
  • Anchoring device 3600 is maintained in the undeployed state by a variety of means including, but not limited to enclosing anchoring device 3600 in a cannula or sheath, etc.
  • FIG. 36B shows tissue anchoring device 3600 in the deployed state.
  • Anchoring device 3600 comprises a curved region.
  • Anchoring device 3600 changes from an undeployed state to a deployed state, the anatomical tissue adjacent to the central region of anchoring device 3600 is displaced along the direction of motion of the central region.
  • Anchoring device 3600 can be deployed by a variety of methods including, but not limited to removing anchoring device 3600 from a sheath or cannula, etc.
  • anchoring device 3600 is made from a shape memory material such as Nitinol.
  • anchoring device 3600 is maintained in the undeployed state by maintaining anchor device 3600 in a temperature lower than the transition temperature of the super-elastic material.
  • Anchoring device 3600 is converted to the deployed state by implanting anchoring device 3600 in a patient such that the device is warmed to the body temperature which is above the transition temperature of the super-elastic material.
  • FIGS. 36C and 36D show a coronal view and a lateral view respectively of a pair of deployed tissue displacement devices of FIGS. 36A and 36B implanted in the prostate gland PG.
  • two anchoring devices are implanted in the prostate gland PG near the prostatic urethra in a patient with BPH.
  • a first anchoring device 3600 is introduced on a first side of the urethra and is deployed there as shown.
  • a second anchoring device 3606 comprising a proximal end 3608 and a distal end 3610 is introduced on the other side of the urethra and is deployed there as shown.
  • First anchoring device 3600 and second anchoring device 3606 change into the deployed curved configuration.
  • FIG. 36D shows a lateral view of the urethra enclosed by the prostate gland PG showing deployed first anchoring device 3600 and second anchoring device 3606 .
  • FIGS. 36E through 36H show an axial section through a prostate gland showing the various steps of a method of cutting or puncturing the prostate gland and lining or plugging the cut or puncture.
  • FIG. 36E shows a section of the prostate gland showing the urethra, the lateral lobes and the middle lobe surrounded by the prostatic pseudocapsule.
  • FIG. 36F one or more cuts are made in a region of the prostatic pseudocapsule.
  • one or more cuts may be made in a region of between two lobes of the prostate gland.
  • a plugging material 3619 is introduced in the one or more regions of the prostate gland that are cut or punctured.
  • Plugging material 3619 may be delivered through one or more delivery devices including, but not limited to the device disclosed in FIG. 33E .
  • Plugging material 3619 may comprises a material such as plugging material 3360 .
  • FIG. 36H shows an axial section through a prostate gland showing a clip for spreading open a cut or punctured region of the prostate gland.
  • Spreading device 3620 comprises a body having a central region and two distal arms.
  • Spreading device 3620 may be made of a variety of elastic or super-elastic materials including, but not limited to Nitinol, stainless steel, titanium etc.
  • Spreading device 3620 has a reduced profile in the undeployed state by maintaining distal arms close to each other.
  • Spreading device 5000 is maintained in the undeployed state by a variety of means including, but not limited to enclosing spreading device 3620 in a cannula or sheath, etc.
  • spreading device 3620 changes from an undeployed state to a deployed state, the distance between the two distal arms increases. This causes any anatomical tissue between two distal arms to spread along the straight line between two distal arms
  • Spreading device 3620 can be deployed by a variety of methods including, but not limited to removing spreading device 3620 from a sheath or cannula, etc.
  • spreading device 3620 is made from a shape memory material such as Nitinol.
  • spreading device 3620 is maintained in the undeployed state by maintaining anchor device 3620 in a temperature lower than the transition temperature of the super-elastic material.
  • Spreading device 3620 is converted to the deployed state by implanting spreading device 3620 in a patient such that the device is warmed to the body temperature which is above the transition temperature of the super-elastic material.
  • Stretching of prostate gland tissue can be used to eliminate or reduce the compression of the urethra by an enlarged prostate gland or to prevent cut edges of a cut from rejoining.
  • More than one spreading device 3620 may be used to treat the effects of an enlarged prostate or to eliminate or reduce the compression of the urethra by an enlarged prostate gland or to prevent cut edges of a cut from rejoining.
  • FIGS. 37A through 37K show an embodiment of a method of treating prostate gland disorders by cutting a region of the prostate gland using the devices described in FIG. 33A through 33E .
  • introducer device 3300 is introduced in the urethra. It is advanced through the urethra such that the distal tip of introducer device 3300 is located in the prostatic urethra.
  • injecting needle 3330 is introduced through introducer device 3300 .
  • the distal tip of injecting needle 3330 is advanced such that injecting needle 3330 penetrates the prostate gland.
  • injecting needle 3330 is then used to inject a substance such as an anesthetic in the prostate gland.
  • injecting needle 3330 is withdrawn from the anatomy.
  • first tubular element 3302 is bent or deflected with a bending or deflecting mechanism such as the bending mechanism in FIGS. 37 C′′ and 37 C′′′ to align the distal region of first tubular element 3302 along a desired trajectory of puncturing the prostate gland.
  • FIG. 37 C′ shows the proximal region of introducer device 3300 .
  • a cystoscope 3700 is introduced through second stasis valve 3316 such that the distal end of cystoscope 3700 emerges through the distal end of introducer device 3300 . Cystoscope 3700 is then used to visualize the anatomy to facilitate the method of treating prostate gland disorders.
  • FIG. 37 C′′ shows a perspective view of the distal region of an embodiment of introducer device 3300 comprising a bending or deflecting mechanism.
  • first tubular element 3302 comprises a spiral cut distal end and a pull wire.
  • the pull wire is pulled by deflection dial 3310 . This deflects the distal tip of first tubular element 3302 as shown.
  • guiding device 3338 is introduced through first tubular element 3302 .
  • Guiding device 3338 is advanced through first tubular element 3302 such that the distal tip of guiding device 3338 penetrates into the prostate gland.
  • guiding device 3338 is further advanced such that the distal tip of guiding device 3338 penetrates through the prostate gland and enters the urinary bladder.
  • distal region of guiding device 3338 comprises an anchoring element 3702 .
  • Anchoring element 3702 is deployed as shown in FIG. 37E . Thereafter, guiding device 3338 is pulled in the proximal direction till anchoring element 3702 is snug against the wall of the urinary bladder.
  • Cystoscope 3700 can be used to visualize the steps of penetrating the prostate gland by guiding device 3338 and deploying anchoring element 3702 . If guiding device 3338 is not positioned in a satisfactory position, guiding device 3338 is pulled back in introducer device 3300 . The deflection angle of distal end of first tubular lumen 3302 is changed and guiding device 3338 is re-advanced into the urinary bladder.
  • FIG. 37 E′ shows a perspective view of an embodiment of anchoring element 3702 .
  • Anchoring element comprises a hollow sheath 3704 . Distal region of hollow sheath 3704 is attached to distal region of guiding device 3338 .
  • a number of windows are cut in the distal region of hollow sheath 3704 such that several thin, splayable strips are formed between adjacent windows.
  • Pushing hollow sheath 3704 in the distal direction causes splayable strips to splay in the radially outward direction to form an anchoring element.
  • cutting device 3343 is advanced over guiding device 3338 into the prostate gland.
  • cutting device 3343 is positioned in the prostate gland such that proximal marker band 3348 can be seen by cystoscope 3700 but distal marker band 3350 cannot be seen.
  • relative motion between outer sheath 3343 and inner sheath 3344 causes cutting wire 3352 to deploy outward in the axial direction.
  • this step is carried out by moving outer sheath 3343 in the distal direction while the inner sheath 3344 is stationary. In another embodiment, this step is carried out by moving inner sheath 3344 in the proximal direction while outer sheath 3343 is kept stationary.
  • electrical energy is delivered through cutting wire 3352 to cut tissue.
  • cutting device 3343 is pulled in the proximal direction such that the deployed cutting wire 3352 slices through tissue. Thereafter, cutting wire 3352 is withdrawn again in cutting device 3343 . Cutting device 3343 is then removed from the anatomy.
  • plugging device 3354 is introduced over guiding device 3338 through the puncture or opening in the prostate gland. Thereafter, in FIG. 37K , anchoring element 3702 is undeployed and guiding device 3343 is withdrawn from the anatomy. Thereafter, plugging device 3354 is used to deliver one or more plugging materials in the adjacent anatomy. The plugging materials can be used to plug or line some or all of the cuts or punctures created during the method.
  • FIGS. 38A to 38D show various components of a kit for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIG. 38A shows the perspective view of an introducer device 3800 .
  • Introducer device 3800 comprises an outer body 3801 constructed from suitable biocompatible materials including, but not limited to metals like stainless steel, Nichol plated brass, polymers like Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK and fluoropolymers like PTFE, PFA, FEP, EPTFE etc.
  • Body 3801 comprises a working device lumen 3802 . Distal end of working device lumen 3802 emerges out of the distal end of body 3801 .
  • Proximal end of working device lumen 3802 incorporates lock thread 3803 such that introducer device may join with other devices.
  • Device lumen 3802 may comprise one or more side ports e.g. a first side port 3804 and a second side port 3805 for the introduction or removal of one or more fluids.
  • FIG. 38B shows a perspective view of a bridge device 3806 constructed from suitable biocompatible materials including, but not limited to metals like stainless steel, Nichol plated brass, polymers like Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK and fluoropolymers like PTFE, PFA, FEP, EPTFE etc.
  • Bridge device may insert into introducer lumen 3802 and lock into place by threadably mating thread lock 3807 with thread 3803 .
  • Bridge may incorporate port 3808 for cystoscope with locking means 3809 that joins to cystoscope when inserted.
  • Bridge device may incorporate one or more working lumens.
  • Working lumen 3810 emerges out of the distal end of body 3806 .
  • distal end of working device lumen 3810 has a bent or curved region.
  • Proximal end of lumen 3810 emerges from port 3811 that may incorporate fluid stasis valve 3812 and a luer lock.
  • Working lumen 3813 emerges distally in straight fashion through blunt obturator 3814 at distal end of body 3806 and emerges proximally through second port that may incorporate fluid stasis valve and luer lock.
  • FIG. 38C shows a perspective view of a distal anchor deployment device 3815 constructed from suitable biocompatible materials including, but not limited to polymers like Polycarbonate, PVC, Pebax, Polyimide, Braided Pebax, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel, Nichol plated brass, and fluoropolymers like PTFE, PFA, FEP, EPTFE etc.
  • Deployment device 3815 comprises handle 3816 , which incorporates movable thumb ring pusher 3817 and anchor deployment latch 3818 ; and distal shaft 3819 which has trocar point 3820 at distal end. Mounted on distal shaft 3819 is distal anchor 3821 that incorporates tether 3822 .
  • Tether 3822 can be made of suitable elastic or non-elastic materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, suture materials, titanium etc. or polymers such as silicone, nylon, polyamide, polyglycolic acid, polypropylene, Pebax, PTFE, ePTFE, silk, gut, or any other monofilament or any braided or mono-filament material.
  • Proximal end of tether 3822 may incorporate hypotube 3823 .
  • Distal anchor 3821 is constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g.
  • Deployment device 3815 is inserted into bridge working lumen 3810 .
  • Advancement of thumb ring 3817 extends distal shaft 3819 through distal end of working lumen 3810 , preferably into tissue for deployment of distal anchor 3821 .
  • Depth of distal shaft deployment can be monitored on cystoscope by visualizing depth markers 3824 .
  • anchor deployment latch 3818 is rotated to release distal anchor 3821 .
  • Retraction of thumb ring 3817 then retracts distal shaft 3819 while leaving distal anchor 3821 in tissue.
  • Bridge 3806 is then disconnected from introducer device 3800 and removed.
  • FIG. 38D shows the proximal anchor delivery tool 3825 constructed from suitable biocompatible materials including, but not limited to polymers like Polycarbonate, PVC, Pebax, Polyimide, Braided Pebax, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel, Nichol plated brass, and fluoropolymers like PTFE, PFA, FEP, EPTFE etc.
  • Proximal anchor delivery tool 3825 comprises handle 3826 , which incorporates anchor deployment switch 3827 in slot 3828 and tether cut switch 3829 ; and distal shaft 3830 which houses hypotube 3831 . Lumen of hypotube 3831 emerges proximally at port 3832 which may incorporate a luer lock.
  • Proximal anchor 3833 is constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Braided Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE or biodegradable polymers e.g.
  • metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.
  • polymers e.g. Pebax, Braided Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE or biodegradable polymers e.g.
  • FIG. 38E shows a close-up perspective view of proximal anchor 3833 mounted on hypotube 3831 and distal shaft 3830 of proximal anchor delivery tool 3825 .
  • Hypotube 3831 biases open the cinching lock 3835 of cinching hub 3834 .
  • hypotube 3823 is loaded into hypotube 3831 until it exits proximal port 3832 .
  • Hypotube 3823 is then stabilized while proximal anchor delivery tool 3825 is advanced into introducer device lumen 3802 and advanced to tissue target.
  • hypotube 3831 biases open cinching lock 3835 , the proximal anchor delivery tool travels freely along tether 3822 .
  • anchor deployment switch 3827 is retracted.
  • hypotube 3831 is retracted proximal to cinching hub 3834 and tether 3822 is tightened.
  • switch 3827 is fully retracted or desired tension is accomplished, tether 3822 is cut within cinching hub 3834 by advancing cutting switch 3829 .
  • Any of the anchoring devices disclosed herein may comprise one or more sharp distal tips, barbs, hooks etc. to attach to tissue.
  • endoscopes can be used in conjunction with the devices disclosed herein such as flexible scopes that are thin, flexible, fibre-optic endoscopes and rigid scopes that are thin, solid, straight endoscopes.
  • the scopes may have one or more side channels for insertion of various instruments. Further they may be used with in conjunction with standard and modified sheaths intended for endoscopic and transurethral use.
  • Local or general anesthesia may be used while performing the procedures disclosed herein.
  • local anesthetics that can be used are anesthetic gels e.g. lidocaine gels in the urethra; combination of anesthetic agents e.g. combination of lidocaine and bupivacaine in the urethra; spinal anesthetics e.g. ropivacaine, fentanyl etc.; injectable anesthetics e.g. 1% lidocaine solution injected into the neurovascular bundles, the genitourinary diaphragm, and between the rectal wall and prostate; etc.
  • anesthetic gels e.g. lidocaine gels in the urethra
  • combination of anesthetic agents e.g. combination of lidocaine and bupivacaine in the urethra
  • spinal anesthetics e.g. ropivacaine, fentanyl etc.
  • An optional trans-rectal ultrasound exam may be performed before and/or during the procedures disclosed herein.
  • a device called ultrasound transducer is inserted into the rectum.
  • the ultrasound transducer is then used to image the prostate gland PG using ultrasound waves.
  • the devices may be modified so that they are more visible under ultrasound such as etched surfaces.
  • Other imaging devices may also be optionally used such as MRI, RF, electromagnetic and fluoroscopic or X-ray guidance.
  • the anchoring devices or delivery devices may contain sensors or transmitters so that certain elements may be tracked and located within the body.
  • the tethering devices may be used as cables to temporarily transmit energy to the distal and/or proximal anchors during deployment.

Abstract

Devices, systems and methods for compressing, cutting, incising, reconfiguring, remodeling, attaching, repositioning, supporting, dislocating or altering the composition of tissues or anatomical structures to alter their positional or force relationship to other tissues or anatomical structures. In some applications, the invention may be used to used to improve patency or fluid flow through a body lumen or cavity (e.g., to limit constriction of the urethra by an enlarged prostate gland).

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to medical devices and methods and more particularly to devices, systems and methods for treating conditions wherein a tissue (e.g., the prostate gland) has a) become enlarged and/or b) undergone a change in form, position, structure, rigidity or force exertion with respect to another anatomical structure and/or c) has begun to impinge upon or compress an adjacent anatomical structure (e.g., the urethra).
  • BACKGROUND OF THE INVENTION
  • There are numerous pathological and nonpathological conditions in which a tissue (e.g., a gland, tumor, cyst, muscle, fascia, skin, adipose, mucous membrane, etc.) becomes enlarged, changed form or position and/or causes unwanted impingement, obstruction, occlusion, stretching, sagging, caving, expulsion and/or collapse of an adjacent body lumen or anatomical structure (e.g., the urethra). Examples of specific conditions which illustrate these medical problems include tissue relaxation or collapse (loose skin, fat or muscle folds, vaginal, rectal, or bladder prolapse, incontinence, etc.), tissue remodeling (scar formation, bladder stiffness secondary to chronic overexertion, infiltrative lung disease), traumatic injury, surgical manipulation (i.e. removal of supportive tissues, removal of tumors, reattachment of ligaments, etc.), tissue growth or enlargement (i.e. benign growths, cancers, angiomas, bone spurs, etc.), luminal obstruction or occlusion (coronary artery disease, peripheral vascular disease, stroke, non-communicating hydrocephalus, infertility secondary to non-patent fallopian tubes, urinary tract obstruction, etc.), tissue impingement (slipped spinal disks, degenerative joint disease, etc.), and ptosis.
  • In particular, Benign Prostatic Hyperplasia (BPH) is one of the most common medical conditions that affect men, especially elderly men. It has been reported that, in the United Sates, more than half of all men have histopathologic evidence of BPH by age 60 and, by age 85, approximately 9 out of 10 men suffer from the condition. Moreover, the incidence and prevalence of BPH are expected to increase as the average age of the population in developed countries increases.
  • The prostate gland enlarges throughout a man's life. In some men, the prostatic capsule around the prostate gland may prevent the prostate gland from enlarging further. This causes the inner region of the prostate gland to squeeze the urethra. This compression of the urethra increases resistance to urine flow through the region of the urethra enclosed by the prostate. Thus the urinary bladder has to exert more pressure to force urine through the increased resistance of the urethra. Chronic over-exertion causes the muscular walls of the urinary bladder to remodel and become stiffer. This combination of increased urethral resistance to urine flow and stiffness and hypertrophy of urinary bladder walls leads to a variety of lower urinary tract symptoms (LUTS) that may severely reduce the patient's quality of life. These symptoms include weak or intermittent urine flow while urinating, straining when urinating, hesitation before urine flow starts, feeling that the bladder has not emptied completely even after urination, dribbling at the end of urination or leakage afterward, increased frequency of urination particularly at night, urgent need to urinate etc.
  • In addition to patients with BPH, LUTS may also be present in patients with prostate cancer, prostate infections, and chronic use of certain medications (e.g. ephedrine, pseudoephedrine, phenylpropanolamine, antihistamines such as diphenhydramine, chlorpheniramine etc.) that cause urinary retention especially in men with prostate enlargement.
  • Although BPH is rarely life threatening, it can lead to numerous clinical conditions including urinary retention, renal insufficiency, recurrent urinary tract infection, incontinence, hematuria, and bladder stones.
  • In developed countries, a large percentage of the patient population undergoes treatment for BPH symptoms. It has been estimated that by the age of 80 years, approximately 25% of the male population of the United States will have undergone some form of BPH treatment. At present, the available treatment options for BPH include watchful waiting, medications (phytotherapy and prescription medications), surgery and minimally invasive procedures.
  • For patients who choose the watchful waiting option, no immediate treatment is provided to the patient, but the patient undergoes regular exams to monitor progression of the disease. This is usually done on patients that have minimal symptoms that are not especially bothersome.
  • Medications for treating BPH symptoms include phytotherapy and prescription medications. In phytotherapy, plant products such as Saw Palmetto, African Pygeum, Serenoa repens (sago palm) and South African star grass are administered to the patient. Prescription medications are prescribed as first line therapy in patients with symptoms that are interfering with their daily activities. Two main classes of prescription medications are alpha-1a-adrenergic receptors blockers and 5-alpha-reductase inhibitors. Alpha-1a-adrenergic receptors blockers block that activity of alpha-1a-adrenergic receptors that are responsible for causing constriction of smooth muscle cells in the prostate. Thus, blocking the activity of alpha-1a-adrenergic receptors causes prostatic smooth muscle relaxation. This in turn reduces urethral resistance thereby reducing the severity of the symptoms. 5-alpha-reductase inhibitors block the conversion of testosterone to dihydrotestosterone. Dihydrotestosterone causes growth of epithelial cells in the prostate gland. Thus 5-alpha-reductase inhibitors cause regression of epithelial cells in the prostate gland and hence reduce the volume of the prostate gland which in turn reduces the severity of the symptoms.
  • Surgical procedures for treating BPH symptoms include Transurethal Resection of Prostate (TURP), Transurethral Electrovaporization of Prostate (TVP), Transurethral Incision of the Prostate (TUIP), Laser Prostatectomy and Open Prostatectomy.
  • Transurethal Resection of Prostate (TURP) is the most commonly practiced surgical procedure implemented for the treatment of BPH. In this procedure, prostatic urethral obstruction is reduced by removing most of the prostatic urethra and a sizeable volume of the surrounding prostate gland. This is carried out under general or spinal anesthesia. In this procedure, a urologist visualizes the urethra by inserting a resectoscope, that houses an optical lens in communication with a video camera, into the urethra such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland. The distal region of the resectoscope consists of an electric cutting loop that can cut prostatic tissue when an electric current is applied to the device. An electric return pad is placed on the patient to close the cutting circuit. The electric cutting loop is used to scrape away tissue from the inside of the prostate gland. The tissue that is scraped away is flushed out of the urinary system using an irrigation fluid. Using a coagulation energy setting, the loop is also used to cauterize transected vessels during the operation.
  • Another example of a surgical procedure for treating BPH symptoms is Transurethral Electrovaporization of the Prostate (TVP). In this procedure, a part of prostatic tissue squeezing the urethra is desiccated or vaporized. This is carried out under general or spinal anesthesia. In this procedure, a resectoscope is inserted transurethrally such that the distal region of the resectoscope is in the region of the urethra surrounded by the prostate gland. The distal region of the resectoscope consists of a rollerball or a grooved roller electrode. A controlled amount of electric current is passed through the electrode. The surrounding tissue is rapidly heated up and vaporized to create a vaporized space. Thus the region of urethra that is blocked by the surrounding prostate gland is opened up.
  • Another example of a surgical procedure for treating BPH symptoms is Transurethral Incision of the Prostate (TUIP). In this procedure, the resistance to urine flow is reduced by making one or more incisions in the prostrate gland in the region where the urethra meets the urinary bladder. This procedure is performed under general or spinal anesthesia. In this procedure, one or more incisions are made in the muscle of the bladder neck, which is the region where the urethra meets the urinary bladder. The incisions are in most cases are deep enough to cut the surrounding prostate gland tissue including the prostatic capsule. This releases any compression on the bladder neck and causes the bladder neck to spring apart. The incisions can be made using a resectoscope, laser beam etc.
  • Another example of a surgical procedure for treating BPH symptoms is Laser Prostatectomy. Two common techniques used for Laser Prostatectomy are Visual Laser Ablation of the Prostate (VLAP) and the Holmium Laser Resection/Enucleation of the Prostate (HoLEP). In VLAP, a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser is used to ablate tissue by causing coagulation necrosis. The procedure is performed under visual guidance. In HoLEP, a holmium: Yttrium-aluminum-garnet laser is used for direct contact ablation of tissue. Both these techniques are used to remove tissue obstructing the urethral passage to reduce the severity of BPH symptoms.
  • Another example of a surgical procedure for treating BPH symptoms is Photoselective Vaporization of the Prostate (PVP). In this procedure, laser energy is used to vaporize prostatic tissue to relieve obstruction to urine flow in the urethra. The type of laser used is the Potassium-Titanyl-Phosphate (KTP) laser. The wavelength of this laser is highly absorbed by oxyhemoglobin. This laser vaporizes cellular water and hence is used to remove tissue that is obstructing the urethra.
  • Another example of a surgical procedure for treating BPH symptoms is Open Prostatectomy. In this procedure, the prostate gland is surgically removed by an open surgery. This is done under general anesthesia. The prostate gland is removed through an incision in the lower abdomen or the perineum. The procedure is used mostly in patients that have a large (greater than approximately 100 grams) prostate gland.
  • Minimally invasive procedures for treating BPH symptoms include Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation (TUNA), Interstitial Laser Coagulation (ILC), and Prostatic Stents.
  • In Transurethral Microwave Thermotherapy (TUMT), microwave energy is used to generate heat that destroys hyperplastic prostate tissue. This procedure is performed under local anesthesia. In this procedure, a microwave antenna is inserted in the urethra. A rectal thermosensing unit is inserted into the rectum to measure rectal temperature. Rectal temperature measurements are used to prevent overheating of the anatomical region. The microwave antenna is then used to deliver microwaves to lateral lobes of the prostate gland. The microwaves are absorbed as they pass through prostate tissue. This generates heat which in turn destroys the prostate tissue. The destruction of prostate tissue reduces the degree of squeezing of the urethra by the prostate gland thus reducing the severity of BPH symptoms.
  • Another example of a minimally invasive procedure for treating BPH symptoms is Transurethral Needle Ablation (TUNA). In this procedure, heat induced coagulation necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using local anesthetic and intravenous or oral sedation. In this procedure, a delivery catheter is inserted into the urethra. The delivery catheter comprises two radiofrequency needles that emerge at an angle of 90 degrees from the delivery catheter. The two radiofrequency needles are aligned are at an angle of 40 degrees to each other so that they penetrate the lateral lobes of the prostate. A radiofrequency current is delivered through the radiofrequency needles to heat the tissue of the lateral lobes to 70-100 degree Celsius at a radiofrequency power of approximately 456 KHz for approximately 4 minutes per lesion. This creates coagulation defects in the lateral lobes. The coagulation defects cause shrinkage of prostatic tissue which in turn reduces the degree of squeezing of the urethra by the prostate gland thus reducing the severity of BPH symptoms.
  • Another example of a minimally invasive procedure for treating BPH symptoms is Interstitial Laser Coagulation (ILC). In this procedure, laser induced necrosis of prostate tissue regions causes the prostate gland to shrink. It is performed using regional anesthesia, spinal or epidural anesthesia or local anesthesia (periprostatic block). In this procedure, a cystoscope sheath is inserted into the urethra and the region of the urethra surrounded by the prostate gland is inspected. A laser fiber is inserted into the urethra. The laser fiber has a sharp distal tip to facilitate the penetration of the laser scope into prostatic tissue. The distal tip of the laser fiber has a distal-diffusing region that distributes laser energy 3600 along the terminal 3 mm of the laser fiber. The distal tip is inserted into the middle lobe of the prostate gland and laser energy is delivered through the distal tip for a desired time. This heats the middle lobe and causes laser induced necrosis of the tissue around the distal tip. Thereafter, the distal tip is withdrawn from the middle lobe. The same procedure of inserting the distal tip into a lobe and delivering laser energy is repeated with the lateral lobes. This causes tissue necrosis in several regions of the prostate gland which in turn causes the prostate gland to shrink. Shrinkage of the prostate gland reduces the degree of squeezing of the urethra by the prostate thus reducing the severity of BPH symptoms.
  • Another example of a minimally invasive procedure for treating BPH symptoms is implanting Prostatic Stents. In this procedure, the region of urethra surrounded by the prostate is mechanically supported to reduce the constriction caused by an enlarged prostate. Prostatic stents are flexible devices that are expanded after their insertion in the urethra. They mechanically support the urethra by pushing the obstructing prostatic tissue away from the urethra. This reduces the constriction of the urethra and improves urine flow past the prostate gland thereby reducing the severity of BPH symptoms.
  • Although existing treatments provide some relief to the patient from symptoms of BPH, they have significant disadvantages. Alpha-1a-adrenergic receptors blockers have side effects such as dizziness, postural hypotension, lightheadedness, asthenia and nasal stuffiness. Retrograde ejaculation can also occur. 5-alpha-reductase inhibitors have minimal side effects, but only a modest effect on BPH symptoms and the flow rate of urine. In addition, anti-androgens, such as 5-alpha-reductase, require months of therapy before LUTS improvements are observed. Surgical treatments of BPH carry a risk of complications including erectile dysfunction; retrograde ejaculation; urinary incontinence; complications related to anesthesia; damage to the penis or urethra, need for a repeat surgery etc. Even TURP, which is the gold standard in treatment of BPH, carries a high risk of complications. Adverse events associated with this procedure are reported to include retrograde ejaculation (65% of patients), post-operative irritation (15%), erectile dysfunction (10%), need for transfusion (8%), bladder neck constriction (7%), infection (6%), significant hematuria (6%), acute urinary retention (5%), need for secondary procedure (5%), and incontinence (3%) Typical recovery from TURP involves several days of inpatient hospital treatment with an indwelling urethral catheter, followed by several weeks in which obstructive symptoms are relieved but there is pain or discomfort during micturition.
  • The reduction in the symptom score after minimally invasive procedures is not as large as the reduction in symptom score after TURP. Up to 25% of patients who receive these minimally invasive procedures ultimately undergo a TURP within 2 years. The improvement in the symptom score generally does not occur immediately after the procedure. For example, it takes an average of one month for a patient to notice improvement in symptoms after TUMT and 1.5 months to notice improvement after ILC. In fact, symptoms are typically worse for these therapies that heat or cook tissue, because of the swelling and necrosis that occurs in the initial weeks following the procedures. Prostatic stents often offer more immediate relief from obstruction but are now rarely used because of high adverse effect rates. Stents have the risk of migration from the original implant site (up to 12.5% of patients), encrustation (up to 27.5%), incontinence (up to 3%), and recurrent pain and discomfort. In published studies, these adverse effects necessitated 8% to 47% of stents to be explanted. Overgrowth of tissue through the stent and complex stent geometries have made their removal quite difficult and invasive.
  • Thus the most effective current methods of treating BPH carry a high risk of adverse effects. These methods and devices either require general or spinal anesthesia or have potential adverse effects that dictate that the procedures be performed in a surgical operating room, followed by a hospital stay for the patient. The methods of treating BPH that carry a lower risk of adverse effects are also associated with a lower reduction in the symptom score. While several of these procedures can be conducted with local analgesia in an office setting, the patient does not experience immediate relief and in fact often experiences worse symptoms for weeks after the procedure until the body begins to heal. Additionally all device approaches require a urethral catheter placed in the bladder, in some cases for weeks. In some cases catheterization is indicated because the therapy actually causes obstruction during a period of time post operatively, and in other cases it is indicated because of post-operative bleeding and potentially occlusive clot formation. While drug therapies are easy to administer, the results are suboptimal, take significant time to take effect, and often entail undesired side effects.
  • Thus there remains a need for the development of new devices, systems and methods for treating BPH as well as other conditions in which one tissue or anatomical structure impinges upon or compresses another tissue or anatomical structure.
  • SUMMARY OF THE INVENTION
  • The present invention provides devices, systems and methods for compressing, cutting, incising, reconfiguring, remodeling, attaching, repositioning, supporting, dislocating or altering the composition of tissues or anatomical structures to alter their positional or force relationship to other tissues or anatomical structures. In some applications, the invention may be used to improve patency or fluid flow through a body lumen or cavity. Examples of body lumens through which flow may be facilitated using the present invention include the urethra, ureter, trachea, bronchus, bronchiole, other respiratory passageway, stomach, duodenum, small intestine, jejunum, illium, colon, cystic duct, hepatic duct, common bile duct, pancreatic duct, the alimentary canal, an endocrine passageway, a lymphatic, etc. Examples of tissues and anatomical structures that may be compressed, cut, incised, reconfigured, remodeled, attached, repositioned, supported, dislocated or compositionally altered by the present invention include the prostate gland, other glands and organs, neoplasms, benign growths, cancerous growths, tumors, cysts, other masses, congenital deformities, structures that have become enlarged due to hypertrophy, hyperplasia, edema, fluid build up, fluid retention, excess fluid production, impeded fluid outflow, etc.
  • In accordance with the invention there are provided devices, systems and methods for implanting devices within the body to compress tissue in a manner that relieves pressure exerted on or interference with an adjacent anatomical structure. The implantable devices useable for this purpose generally comprising anchoring elements and tensioning elements that extend between the anchoring elements. The anchoring elements are implanted at selected locations and the tensioning elements then draw or pull the anchoring elements toward one another, thereby compressing tissue between the anchoring elements. In applications where these devices are implanted to treat prostatic enlargement, anchoring and tensioning element(s) are implanted and tensioned to compress or reposition prostatic tissue thereby lessening prostate induced constriction of the urethra. In at least some applications, this invention may be used to treat prostatic enlargement without causing substantial damage to the urethra (e.g., forming an opening in the urethra no larger than about 2 mm in its greatest cross-dimension). As used herein, the term “compress” includes not only actual compression of the tissue but also any application of pressure or force upon the tissue that causes the intended therapeutic effect by reconfiguring, remodeling, repositioning or altering the tissue.
  • Still further in accordance with the invention there are provided devices, systems and methods for cutting tissue(s) of the body in a manner that relieves pressure exerted on or interference with an adjacent anatomical structure. In some applications of the invention, one or more working devices may be inserted into the body and used to incise the capsule of an encapsulated organ, tumor, mass or other structure, thereby relieving the capsule's constraint of the encapsulated organ, tumor, mass or other structure and allowing the encapsulated organ, tumor, mass or other structure to expand, herniate, evulse, splay, spread apart, reconfigure or move in a way that results in decreased pressure on, or decreased interference with, the adjacent anatomical structure. In applications where the invention is used to treat prostatic enlargement, a cutting device may be anchoring and tensioning element(s) are implanted and tensioned to compress or reposition prostatic tissue thereby lessening prostate induced constriction of the urethra.
  • Additional and more specific aspects, elements, steps, applications, embodiments and examples of the invention will be understood by those of skill in the art upon reading of the detailed description and claims set forth herebelow.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a sagittal sectional view of a male human body through the lower abdomen showing the male urinary tract.
  • FIG. 1B is a coronal sectional view through the lower abdomen of a human male showing a region of the male urogenital system.
  • FIG. 2A is a coronal sectional view through the prostate gland and adjacent structures showing a first trans-urethral approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2B is a coronal sectional view through the prostate gland and adjacent structures showing a second trans-urethral approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2C is a coronal sectional view through the prostate gland and adjacent structures showing a third trans-urethral approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2D is a coronal sectional view through the prostate gland and adjacent structures showing a transperineal approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2E is a coronal sectional view through the prostate gland and adjacent structures showing a percutaneous approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2F is a coronal sectional view through the prostate gland and adjacent structures showing a percutaneous trans-osseus approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2G is a coronal sectional view through the prostate gland and adjacent structures showing a percutaneous suprapubic approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2H is a sagittal sectional view through the prostate gland and adjacent structures showing a percutaneous infrapubic approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIG. 2I is a sagittal sectional view through the prostate gland and adjacent structures showing a trans-rectal approach that may be used to implant tissue compression devices(s) (e.g., clips, compression elements, anchoring elements, etc.) to compress or modify the shape of the prostate gland.
  • FIGS. 3A to 3H show various components of a system for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIG. 3A shows the perspective view of an introducer device.
  • FIG. 3B shows a perspective view of an injecting needle that may be used for injecting one or more diagnostic or therapeutic agents in the anatomy.
  • FIG. 3C shows a perspective view of an introducing sheath.
  • FIG. 3D shows a perspective view of a trocar.
  • FIG. 3E shows a perspective view of an anchor delivery device.
  • FIG. 3F shows an enlarged view of the distal region of the device in FIG. 3E.
  • FIG. 3G shows a perspective view of deployed anchors showing radially expanded splayable arms of proximal anchor and distal anchor.
  • FIG. 3H shows a perspective view from the proximal direction of a particular embodiment of the attachment mechanism of FIG. 99E.
  • FIGS. 4A through 4H show a coronal section through the prostate gland showing the various steps of a method of treating prostate gland disorders by compressing a region of the prostate gland using the kit shown in FIGS. 3A through 3H.
  • FIGS. 4G′ through 4H′ show the final steps of an embodiment of method of treating prostate gland disorders by deploying a proximal anchor in the urethra.
  • FIG. 4H″ shows a coronal section through the prostate gland showing a final deployed configuration of an embodiment of bone anchoring devices for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIGS. 4I and 4J is a crossectional view through the prostatic urethra (i.e., the portion of the urethra that passes through the prostate gland) showing the appearance of the urethral lumen before and after performing the method shown in FIGS. 4A through 4H.
  • FIGS. 5A through 5I show perspective views of some designs of the tension elements that can be used in the embodiments disclosed elsewhere in this patent application.
  • FIG. 5A shows a perspective view of a tension element comprising a single strand of an untwisted material.
  • FIG. 5B shows a perspective view of a tension element comprising one or more serrations or notches.
  • FIG. 5C shows a perspective view of a tension element comprising multiple filaments of a material twisted together.
  • FIG. 5D shows a perspective view of a tension element comprising a flexible, elastic, spiral or spring element.
  • FIG. 5E shows a perspective view of a tension element comprising a screw threading on the outer surface of tension element.
  • FIG. 5F shows a perspective view of a tension element comprising a hollow shaft comprising one or more collapsible regions.
  • FIG. 5G shows a perspective view of an anchoring device 522 comprising a tension element and two anchors.
  • FIG. 5H shows a perspective view of a tensioning element device comprising a detachable region.
  • FIG. 5I shows a perspective view of a tensioning element comprising telescoping tubes.
  • FIGS. 6A through 11B show various examples of anchor designs and/or anchoring device designs.
  • FIGS. 6A and 6B show perspective views of two states of a crumpling anchor.
  • FIGS. 7A and 7B show sectional views of an undeployed configuration and a deployed configuration respectively of a deployable anchor.
  • FIGS. 8A and 8B show sectional views of an undeployed configuration and a deployed configuration respectively of a “T” shaped deployable anchor.
  • FIGS. 9A through 9D show various alternate configurations of the anchoring arms in FIGS. 7A and 7B.
  • FIGS. 10A and 10A′ show a distal view and a perspective view respectively of an anchor comprising a spiral element having a three dimensional shape.
  • FIGS. 10B and 10B′ show a distal view and a side view respectively of an anchor comprising a spiral element having a two dimensional shape.
  • FIGS. 10C and 10C′ show a distal view and a perspective view respectively of an anchor comprising one or more circular elements.
  • FIG. 10D shows a perspective view of an embodiment of an anchoring device comprising an outer ring.
  • FIG. 10E shows a partial perspective view of an anchoring device comprising a hemostatic element.
  • FIG. 11A shows a perspective view of a device having a set of anchors comprising a curved sheet.
  • FIGS. 12A through 171 show further examples of anchor designs and/or anchoring device designs. FIG. 12A shows a perspective view of an anchor comprising an arrowhead.
  • FIG. 12B shows a crossectional view of an anchor comprising a cup-shaped element that encloses a cavity.
  • FIG. 12C shows a perspective view of an anchor comprising a screw.
  • FIGS. 13A and 13B show perspective views of an uncollapsed state and a collapsed state respectively of an anchor comprising a collapsible region.
  • FIGS. 13C and 13D show perspective views of an undeployed state and a deployed state respectively of an anchor comprising radially spreading arms.
  • FIG. 13E shows perspective views of an alternate embodiment of an undeployed state of an anchor comprising radially spreading arms.
  • FIGS. 14A and 14B show perspective views of anchoring devices comprising an adhesive delivering element.
  • FIGS. 15A and 15B show two configurations of an anchoring device comprising a ratcheted tension element.
  • FIG. 16 shows a perspective view of an anchor comprising a trocar lumen.
  • FIG. 17A shows a perspective view in the undeployed state of an anchor comprising a rigid or partially flexible T element and a crumpling element.
  • FIGS. 17B and 17C show various steps of a method to deploy the anchoring device shown in FIG. 17A.
  • FIGS. 17D and 17E show perspective views of an undeployed and deployed configuration of an anchor comprising a rigid or partially flexible T element with one or more openings or perforations.
  • FIGS. 17F and 17G show perspective views of an undeployed and deployed configuration of an anchor comprising a stent.
  • FIGS. 17H and 17I show perspective views of an undeployed and deployed configuration of an anchor comprising a spring.
  • FIGS. 18A through 22E show various embodiments of mechanisms to deploy one or more anchors. FIGS. 18A and 18B show a crossection of an anchor deploying mechanism comprising a screw system.
  • FIGS. 19A and 19B show a crossectional view of an anchor deploying system comprising an electrolytic detachment element.
  • FIG. 20 shows a perspective view of an anchor deploying system comprising a looped ribbon.
  • FIG. 21A shows a crossectional view of an anchor deploying system comprising a locked ball.
  • FIGS. 21B and 21C show a method of deploying an anchor comprising a locked ball.
  • FIGS. 22A through 22C show various views of an anchor deploying system comprising two interlocking cylinders.
  • FIGS. 22D and 22E show the steps of a method of unlocking the two interlocking cylinders from the anchor deploying systems of FIGS. 22A through 22C.
  • FIG. 23A shows a perspective view of a distal end of an anchoring device that has an imaging modality.
  • FIGS. 23B through 23G show various steps of a method for compressing an anatomical region using the anchoring device of FIG. 23A.
  • FIGS. 24A through 24C′ show the device and various steps of a method of compressing an anatomical region using a device with deploying arms deployed through a trocar.
  • FIG. 24D shows a crossection through the deployed anchoring device of FIG. 24A.
  • FIG. 25A shows a perspective view of a spring clip that can be used to spread the anatomy.
  • FIGS. 25B through 25F show various steps of a method of spreading an anatomical region or regions using the spring clip of FIG. 25A.
  • FIGS. 26A and 26B show a crossectional view and a perspective view respectively of a mechanism of cinching a tension element or tether to an anchor.
  • FIGS. 26C and 26D show a partial section through a cinching mechanism comprising a cam element.
  • FIG. 26E shows a sectional view of an embodiment of a cinching mechanism comprising a locking ball.
  • FIG. 26F shows a side view of an embodiment of a cinching mechanism comprising multiple locking flanges.
  • FIG. 26G shows an end view of body of FIG. 26F.
  • FIG. 26H shows a side view of an embodiment of a cinching mechanism comprising a single locking flange.
  • FIG. 26I shows an end view of body of FIG. 26H.
  • FIG. 26J shows an end view of a cinching mechanism comprising a crimping lumen.
  • FIGS. 26K and 26L show crossections of an embodiment of a cinching mechanism comprising a crimping anchor in the undeployed and deployed configurations respectively.
  • FIG. 26M shows a perspective view of an embodiment of a cinching mechanism comprising an element providing a tortuous path to a tension element.
  • FIG. 26N shows a crossectional view of an embodiment of a locking mechanism comprising a space occupying anchor securely attached to a tension element.
  • FIGS. 26O and 26P shows a partial sectional view and a perspective view of an embodiment of a cinching mechanism comprising a punched disk.
  • FIGS. 26Q and 26R show a perspective view of a first embodiment of a cutting device before and after cutting an elongate element.
  • FIG. 26S show a crossectional view of a second embodiment of a cutting device for cutting an elongate element.
  • FIGS. 27A through 27D show axial sections through the prostate gland showing various configurations of anchoring devices comprising distal anchors and a tension element.
  • FIGS. 28 and 28A show perspective views of an embodiment of an anchoring device comprising an elongate element comprising multiple barbs or anchors.
  • FIGS. 28B through 28E show a coronal section through the prostate gland showing various steps of a method of treating the prostate gland using the device of FIG. 28.
  • FIG. 29A shows an axial section of the prostate gland showing a pair of implanted magnetic anchors.
  • FIGS. 29B through 29D show a coronal section through the prostate gland showing the steps of a method of implanting magnetic anchors of FIG. 29A.
  • FIG. 30A is a coronal sectional view of a portion of the male urogenital system showing a transurethral approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 30B is a coronal sectional view of a portion of the male urogenital system showing another transurethral approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 30C is a coronal sectional view of a portion of the male urogenital system showing a transurethral/transvesicular approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 30D is a coronal sectional view of a portion of the male urogenital system showing another transurethral approach that may be used to perform a prostate cutting procedure of the present invention, wherein a device advances from the urethra, through the prostate gland, and thereafter accesses the prostate capsule from its outer surface.
  • FIG. 31 is a coronal sectional view of a portion of the male urogenital system showing a percutaneous/infrapubic approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIG. 32 is a coronal sectional view of a portion of the male urogenital system showing a percutaneous/transvesicular approach that may be used to perform a prostate cutting procedure of the present invention.
  • FIGS. 33A-33E shows perspective views of various devices that may be included in a system for performing a prostate cutting procedure in accordance with the present invention.
  • FIG. 33A shows a perspective view of an introducer device comprising a first tubular element having a working device lumen.
  • FIG. 33B shows a perspective view of an injecting needle that may be used for injecting one or more diagnostic or therapeutic substances.
  • FIG. 33C shows a perspective view of a guiding device comprising an elongate body comprising a sharp distal tip.
  • FIG. 33D shows a perspective view of a RF cutting device
  • FIG. 33E shows a perspective view of an embodiment of a plugging device to plug an opening created during a procedure.
  • FIGS. 33F through 33N show various alternate embodiments of the electrosurgical cutting device in FIG. 33D.
  • FIGS. 33F and 33G show perspective views of the distal region of a first alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively.
  • FIGS. 33H and 33I show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively.
  • FIGS. 33J through 33L show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device.
  • FIGS. 33M through 33N show perspective views of the distal region of a third alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device.
  • FIG. 34 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting blades.
  • FIG. 35 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting wires.
  • FIGS. 36A and 36B series show perspective views of an undeployed state and a deployed state respectively of a tissue displacement device.
  • FIGS. 36C and 36D show a coronal view and a lateral view respectively of a pair of deployed tissue displacement devices of FIGS. 36A and 36B implanted in the prostate gland.
  • FIGS. 36E through 36H show an axial section through a prostate gland showing the various steps of a method of cutting or puncturing the prostate gland and lining or plugging the cut or puncture.
  • FIGS. 37A through 37K show an embodiment of a method of treating prostate gland disorders by cutting a region of the prostate gland using the devices described in FIG. 33A through 33E.
  • FIGS. 38A to 38D show various components of a kit for treating prostate gland disorders by compressing a region of the prostate gland.
  • FIG. 38A shows the perspective view of an introducer device.
  • FIG. 38B shows a perspective view of a bridge device
  • FIG. 38C shows a perspective view of a distal anchor deployment device
  • FIG. 38D shows the proximal anchor delivery tool
  • FIG. 38E shows a close-up perspective view of proximal anchor 3833 mounted on proximal anchor delivery tool of FIG. 38D.
  • DETAILED DESCRIPTION
  • The following detailed description and the accompanying drawings are intended to describe some, but not necessarily all, examples or embodiments of the invention only and does not limit the scope of the invention in any way.
  • The following detailed description and the accompanying drawings are intended to describe some, but not necessarily all, examples or embodiments of the invention only and does not limit the scope of the invention in any way.
  • A number of the drawings in this patent application show anatomical structures of the male reproductive and/or urinary system. In general, these anatomical structures are labeled with the following reference letters:
  • Urethra UT
    Urethral Lumen UL
    Urethral Opening UO
    Urinary Bladder UB
    Ureters UR
    Prostate Gland PG
    Capsule of Prostate Gland CP
    Testis TS
    Vas Deferens VD
  • FIG. 1A shows a sagittal section of a male human body through the lower abdomen showing the male urinary tract. The male urinary tract comprises a pair of tubular organs called ureters (UR) that conduct urine produced by the kidneys. The ureters empty into the urinary bladder. The urinary bladder is a hollow muscular organ that temporarily stores urine. It is situated posterior to the pubic bone. The inferior region of the urinary bladder has a narrow muscular opening called the bladder neck which opens into a soft, flexible, tubular organ called the urethra. The muscles around the bladder neck are called the internal urethral sphincter. The internal urethral sphincter is normally contracted to prevent urine leakage. The urinary bladder gradually fills with urine until full capacity is reached, at which point the sphincter relaxes. This causes the bladder neck to open, thereby releasing the urine stored in the urinary bladder into the urethra. The urethra begins at the bladder neck, terminates at the end of the penis, and allows for urine to exit the body.
  • The region of the urethra just inferior to the urinary bladder is completely surrounded by the prostate gland. The prostate gland is part of the male reproductive system and is usually walnut shaped. Clinically, the prostate is divided into lobes. The lateral lobes are located lateral to the urethra; the middle lobe is located on the dorsal aspect of the urethra, near the bladder neck. Most commonly in BPH, the lateral lobes become enlarged and act like curtains to close the urethral conduit. Less commonly, the middle lobe grows in size and becomes problematic. Because of its superior location near the bladder neck with respect to the urethra, an enlarged middle lobe acts like a ball valve and occludes fluid passage.
  • FIG. 1B shows a coronal section through the lower abdomen of a human male showing a region of the male urinary system. The prostate gland (PG) is located around the urethra at the union of the urethra and the urinary bladder.
  • FIGS. 2A through 2H show various alternate approaches to deploy implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra. Specific examples of implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) useable in this invention are shown in other figures of this patent application and are described more fully herebelow.
  • FIG. 2A shows a first trans-urethral approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2A, an introducing device 200 is introduced in the urethra through the urethral opening of the penis. Introducing device 200 comprises an elongate body 202 comprising a lumen that terminates distally in a distal opening 204. One or more working device(s) 206 is/are then introduced through distal opening 204 into the urethra. The working device(s) 206 penetrate the urethral wall and thereafter one or more lobes of the prostate gland. In some applications of the method, working device(s) 206 may further penetrate the prostate capsule and enters the pelvic cavity. Working device(s) 206 are also used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2B shows a second trans-urethral approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2B, an introducing device 210 is introduced in the urethra through the urethral opening UO of the penis. Introducing device 210 comprises an elongate body 212 comprising a lumen that terminates distally in a distal opening 214. One or more working device(s) 216 is/are insertable through distal opening 214 into the urethra. Working device(s) 216 penetrate(s) the urethral wall inferior to the prostate gland and enters the pelvic cavity. Thereafter, working device(s) 216 penetrate(s) the prostate capsule CP and thereafter one or more lobes of the prostate gland. In some applications of the method the working device(s) 216 may further penetrate the urethral wall enclosed by the prostate gland EG and enters the urethral lumen. Working device(s) 216 may then be used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2C shows a third trans-urethral approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2C, an introducing device 220 is introduced in the urethra through the urethral opening UO of the penis. Introducing device 220 comprises an elongate body 222 comprising a lumen that terminates distally in a distal opening 224. Introducing device 220 is positioned such that distal opening 224 is located in the urinary bladder UB. Thereafter, a one or more working device(s) 226 is/are introduced through distal opening 224 into the urinary bladder UB. Working device(s) 226 penetrate(s) the wall of the urinary bladder UB and thereafter penetrate(s) one or more lobes of the prostate gland PG. In some applications of the method, the working device(s) 226 may further penetrate the prostate capsule and enter the pelvic cavity. Working device(s) 226 may then be used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2D shows a transperineal approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2D, an introducing device 230 is introduced in the pelvic cavity percutaneously through the perineum. Introducing device 230 comprises an elongate body 232 comprising a lumen that terminates distally in a distal opening 234. Introducing device 230 is positioned such that distal opening 234 is located in the pelvic cavity adjacent to prostate gland. Thereafter, one or more working device(s) 236 is/are introduced through distal opening 234 into the prostate gland PG. Working device(s) 236 penetrate(s) the prostate capsule CP and thereafter penetrate(s) one or more lobes of the prostate gland PG. In some applications of the method, the working device(s) 236 may further penetrate the urethral wall surrounded by the prostate gland PG and enter the urethral lumen. Working device 236 may then be used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2E shows a percutaneous/transvesicular approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2E, an introducing device 240 is introduced percutaneously through the abdominal wall. Introducing device 240 comprises an elongate body 242 comprising a lumen that terminates distally in a distal opening 244. After passing through the abdominal wall, introducing device 240 is advanced through the wall of the urinary bladder UB such that distal opening 244 is located in the urinary bladder UB. Thereafter, one or more working device(s) 246 is/are introduced through distal opening 244 into the urinary bladder UB. One or more working device(s) 246 are advanced through the wall of the urinary bladder UB and into the prostate gland PG. In some applications of the method, working device(s) 246 may further penetrate through the prostate gland capsule and enter the pelvic cavity. Working device(s) 246 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2F shows a percutaneous trans-osseus approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2F, an introducing device 250 is introduced percutaneously through the abdominal wall. Introducing device 250 comprises an elongate body 252 comprising a lumen that terminates distally in a distal opening 254. Introducing device 250 is used to penetrate a pelvic bone (e.g. the pubic bone PB). Thereafter, introducing device 250 is positioned such that distal opening 254 is located adjacent to the prostate gland PG. Thereafter, one or more working device(s) 256 is/are introduced through distal opening 254 into the prostate gland PG. Working device(s) 256 penetrate the prostate capsule and thereafter penetrate one or more lobes of the prostate gland PG. In some applications of the method, working device(s) 256 may further penetrate the urethral wall surrounded by the prostate gland and enter the urethral lumen. Working device(s) 256 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2G shows a percutaneous suprapubic approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2G, an introducing device 260 is introduced in the pelvic cavity percutaneously in a trajectory that passes superior to the pubis bone. Introducing device 260 comprises an elongate body 262 comprising a lumen that terminates distally in a distal opening 264. Introducing device 260 is then positioned such that distal opening 264 is located in the pelvic cavity adjacent to prostate gland. Thereafter, one or more working device(s) 266 is/are introduced through distal opening 264 into the prostate gland PG. Working device(s) 266 penetrate the prostate capsule CP and thereafter penetrate one or more lobes of the prostate gland PG. In some applications of the method, working device(s) 266 may further penetrate the urethral wall surrounded by the prostate gland and enter the urethral lumen. Working device(s) 266 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra. FIG. 2H shows a percutaneous infrapubic approach that may be used to implant tissue compression devices(s) to compress the prostate gland. In FIG. 2H, an introducing device 270 is introduced in the pelvic cavity percutaneously in a trajectory that passes inferior to the pubis bone. Introducing device 270 comprises an elongate body 272 comprising a lumen that terminates distally in a distal opening 274. Introducing device 270 is introduced percutaneously in the pelvic cavity in a trajectory that passes inferior to the pubic bone. Introducing device 270 is then positioned such that distal opening 274 is located in the pelvic cavity adjacent to prostate gland. Thereafter, one or more working device(s) 276 is/are introduced through distal opening 274 into the prostate gland PG. Working device(s) 276 penetrate the prostate capsule CP and thereafter penetrate one or more lobes of the prostate gland PG. In some applications of the method, working device(s) 276 may further penetrate the urethral wall surrounded by the prostate gland PG and enter the urethral lumen. Working device(s) 276 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIG. 2I shows a trans-rectal approach that may be used to implant tissue compression devices(s) to compress the prostate gland PG. In FIG. 2I, an introducing device 280 is introduced in the rectum. Introducing device 280 comprises an elongate body 282 comprising a lumen that terminates distally in a distal opening 284. Introducing device is then advanced such that it penetrates the rectal wall and enters the pelvic cavity. Introducing device 280 is then positioned such that distal opening 284 is located in the pelvic cavity adjacent to prostate gland. Thereafter, one or more working device(s) 286 is/are introduced through distal opening 284 into the prostate gland PG. Working device(s) 286 penetrate the prostate capsule CP and thereafter penetrate one or more lobes of the prostate gland. In some applications of the method, working device(s) 286 may further penetrate the urethral wall surrounded by the prostate gland and enter the urethral lumen. Working device(s) 286 is/are then used to deploy and implant implantable tissue compression device(s) (e.g., one or more clips, anchoring elements, tensioning members, etc.) to compress the prostate gland PG, thereby relieving constriction of the urethra.
  • FIGS. 3A to 3F show various examples of devices and systems that are useable to treat conditions where the prostate gland PG is compressing a region of the urethra such that the urethra does not expand normally during micturition and urine outflow is impeded.
  • FIG. 3A shows the perspective view of an introducer device 300. Introducer device 300 comprises an outer body 301 constructed from suitable biocompatible materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP, EPTFE etc. Body 301 comprises a working device lumen 302. Distal end of working device lumen 302 emerges out of the distal end of body 301. In one embodiment, distal end of working device lumen 302 has a bent or curved region. Proximal end of working device lumen 302 emerges out of a first flexible tube 304. The proximal end of first flexible tube 304 comprises a stasis valve 306. Body 301 further comprises a cystoscope lumen 308. Distal end of cystoscope lumen 308 emerges out of the distal end of body 301. Proximal end of cystoscope lumen 308 emerges out of a second flexible tube 310. The proximal end of second flexible tube 310 comprises a stasis valve 312. Cystoscope lumen 308 may comprise one or more side ports e.g. a first side port 318 for the introduction or removal of one or more fluids. Working device lumen 302 may comprise one or more side ports e.g. a second side port 320 for the introduction or removal of one or more fluids.
  • FIG. 3B shows a perspective view of an injecting needle. Injecting needle 330 is used for injecting one or more diagnostic or therapeutic substances. In some applications of the invention, the injecting needle 330 may be used to inject local anesthetic in the urethra, prostate gland and/or tissues near the prostate gland. Specific examples of target areas for injecting local anesthetics are the neurovascular bundles, the genitourinary diaphragm, the region between the rectal wall and prostate, etc. Examples of local anesthetics that can be injected by injecting needle 330 are anesthetic solutions e.g. 1% lidocaine solution; anesthetic gels e.g. lidocaine gels; combination of anesthetic agents e.g. combination of lidocaine and bupivacaine; etc. Injecting needle 330 comprises a hollow shaft 332 made of suitable biocompatible materials including, but not limited to stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. In this example, the distal end of hollow shaft 332 comprises a sharp tip 334. The proximal end of hollow shaft 332 has a needle hub 336 made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.; polymers e.g. polypropylene, Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc. In one embodiment, needle hub 336 comprises a luer lock.
  • FIG. 3C shows an example of an introducing device or introducing sheath 340. Introducing sheath 340 comprises a hollow, tubular body 342 made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc. Tubular body 342 further comprises two marker bands: a proximal marker band 344 and a distal marker band 346. The marker bands can be seen by a cystoscope. In one embodiment, proximal marker band 344 and distal marker band 346 are radiopaque. The position of proximal marker band 344 and distal marker band 346 is such that after introducing sheath 340 is placed in an optimum location in the anatomy, proximal marker band 344 is located in the urethra where it can be seen by a cystoscope and distal marker band 346 is located in the prostrate gland or in the wall of the urethra where it cannot be seen by a cystoscope. Tubular body 342 further comprises a series of distance markers 348 on the outer surface of tubular body 342. The proximal end of tubular body 342 further comprises a hub 350 made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc. In one embodiment, hub 350 comprises a luer lock.
  • FIG. 3D shows a perspective view of a trocar. Trocar 360 comprises a tubular trocar body 362. The proximal end of trocar body 362 comprises a hub 364. Trocar body 362 and hub can be constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc. Distal end of trocar body 362 ends in a sharp trocar tip 366.
  • FIG. 3E shows a perspective view of an anchor delivery device. Anchor delivery device 370 comprises a body 372 having a distal opening 373. A section of the distal region of body 372 has been removed to show a view of the anchor assembly. Body 372 encloses a distal anchor 374 and a proximal anchor 376. Proximal anchor 376 and distal anchor 374 can have a variety of designs including, but not limited to the designs disclosed elsewhere in this patent application. Proximal anchor 376 and distal anchor 374 can be constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc. In one embodiment, shown in FIGS. 3F and 3G, proximal anchor 9976 and distal anchor 9974 comprise splayable elements that expand in a radially outward direction when a radial compression force, as enacted by body lumen 9972, on proximal anchor 9976 and distal anchor 9974 is removed. The splayable elements can be made of suitable super-elastic materials such as Nickel-Titanium alloys etc. Proximal anchor 9976 and distal anchor 9974 are connected to each other by a tension element 9978. Tension element 9978 can be made of suitable elastic or non-elastic materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, suture materials, titanium etc. or polymers such as silicone, nylon, polyamide, polyglycolic acid, polypropylene, Pebax, PTFE, ePTFE, silk, gut, or any other braided or mono-filament material. Tension element 9978 can have a variety of designs including the designs shown in FIGS. 5A through 5F. As shown in FIG. 3E, the proximal end of proximal anchor 9976 is connected by an attachment mechanism 9980 to a torquable shaft 9982. The proximal end of torquable shaft 9982 is attached to a control button 9984. Control button 9984 can be used to deploy proximal anchor 9976 by sliding control button 9984 along groove 9985 in the distal direction. Control button 9984 is then used to deploy distal anchor 9974 by turning control button 9984 in the circumferential direction along groove 9985.
  • FIG. 3H shows a perspective view from the proximal direction of a particular embodiment of the attachment mechanism of FIG. 3E. Attachment mechanism 380 comprises a circular plate 386 made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Polycarbonate, PVC, Pebax, Polyimide, Polyurethane, Nylon, Hytrel, HDPE, PEEK, PTFE, PFA, FEP etc. The proximal face of circular plate 386 is connected to torquable shaft 382. Circular plate 386 further comprises a semicircular groove 388. One end of semicircular groove 388 comprises an enlarged region 390. A knob 392 located on the proximal portion of proximal anchor 376 slides on semicircular groove 388. The size of knob 322 is larger than the size of semicircular groove 388 but smaller than size of enlarged region 390. This keeps proximal anchor 376 attached to circular plate 386. When control button 384 is turned in the circumferential direction along groove 385, torquable shaft 382 is turned. This turns circular plate 386 causing knob 392 to slide on the groove 388. Ultimately, knob 392 reaches enlarged region 390. This releases knob 392 from circular plate 386 thereby releasing proximal anchor 376 from anchor delivery device 370.
  • FIGS. 4A through 4H show a coronal section through the prostate gland showing the various steps of a method of treating prostate gland disorders by compressing a region of the prostate gland using the kit shown in FIGS. 3A through 3F. In FIG. 4A, introducer device 300 is introduced in the urethra through the urethral opening at the tip if the penis. A cystoscope is inserted in introducer device 300 through cystoscope lumen 308 such that the lens of the cystoscope is located in the distal opening of cystoscope lumen. The cystoscope is used to navigate introducer device 300 through the urethra such that the distal region of introducer device 300 is located in a target region in the prostatic urethra. Thereafter in FIG. 4B, injecting needle 330 is advanced through working device lumen 302 such that the distal tip of injecting needle 330 penetrates into a region of the urethral wall or the prostate gland. Injecting needle 330 is then used to inject one or more diagnostic or therapeutic agents into the urethral wall or the prostate gland. This step may be repeated one or more times to inject one or more diagnostic or therapeutic agents in one or more regions of the urethral wall and/or the prostate gland. In one method embodiment, injecting needle 330 is used to inject an anesthetic in one or more regions of the urethral wall and/or the prostate gland. In another embodiment, injecting needle 330 is used to deliver energy in the form of radiofrequency energy, resistive heating, laser energy, microwave energy etc. In another embodiment, injecting needle 330 is used to deliver alpha antagonist agents, such as phenoxybenzamine, prazosin, doxazosin, terazosin, tamsulosin, alfuzosin etc. In another embodiment, injecting needle 330 is used to deliver anti-androgen, such as flutamide or 5-alpha reductase inhibitors, such as finasteride, dutasteride, 3-oxosteroid compounds, 4-aza-3-oxosteroid derivatives of testosterone etc. In another embodiment, injecting needle 330 is used to deliver anti-inflammatory agents, such as rapamycin, paclitaxel, ABT-578, everolimus, taxol etc. In another embodiment, injecting needle 330 is used to deliver ablative agents such as methyl alcohol etc.
  • In another embodiment, injecting needle 330 is used to deliver energy in the form of radiofrequency energy, resistive heating, laser energy, microwave energy etc. In another embodiment, injecting needle 330 is used to deliver alpha antagonist agents, such as phenoxybenzamine, prazosin, doxazosin, terazosin, tamsulosin, alfuzosin etc. In another embodiment, injecting needle 330 is used to deliver anti-androgen, such as flutamide or 5-alpha reductase inhibitors, such as finasteride, dutasteride, 3-oxosteroid compounds, 4-aza-3-oxosteroid derivatives of testosterone etc. In another embodiment, injecting needle 330 is used to deliver anti-inflammatory agents, such as rapamycin, paclitaxel, ABT-578, everolimus, taxol etc. In another embodiment, injecting needle 330 is used to deliver ablative agents such as methyl alcohol etc.
  • In step 4C, injecting needle 330 is withdrawn from introducer device 300. Thereafter, introducer sheath 340 and trocar 360 are advanced through working device lumen 302. In the example shown, introducer sheath 340 and trocar 360 are advanced till the distal tip of trocar 360 penetrates the capsule of the prostate gland and the distal end of introducer sheath 340 is located outside the prostate gland in the pelvic cavity. Thereafter, trocar 360 is withdrawn from working device lumen 302 leaving introducer sheath 340 in place. In FIG. 4D, anchor delivery device 370 is introduced through the lumen of introducer sheath 340 till the distal end of body 372 protrudes through the distal tip of introducer sheath 340. In step 4E, distal anchor 374 is deployed. It should be noted that the anchor may be carried to the site and deployed from within an introducer, on the outside of an introducer, or it may be the distal tip of the introducer itself. Thereafter, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 so that distal anchor 374 is anchored on the outer surface of the prostate capsule. This step may be used to create tension in the tension element 378. In one method embodiment, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 such that the distal end of anchor delivery device 370 is located in the prostate gland. In another method embodiment, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 till the distal end of anchor delivery device 370 is located in the urethral wall or the urethral lumen. In step 4F, proximal anchor 376 is deployed. Proximal anchor 376 may be deployed in the prostate gland, in the urethral wall or in the urethral lumen. Proximal anchor 376 is still attached by attachment mechanism 380 to anchor delivery device 370. The proximal anchor may be pre-loaded on the tension element, or may subsequently be loaded by the operator on the tension element. FIGS. 4G through 4H show the steps of deploying proximal anchor 376 in the prostate gland. In FIG. 4G, proximal anchor 376 is separated from anchor delivery device 370. This separation may be achieved via numerous means including cutting, melting, un-locking a link, or breaking the tensioning element at a desired location. Ideally this residual end of the tensioning element will not protrude substantially into the lumen of the urethra. Thus proximal anchor 376 and distal anchor 374 are anchored in the anatomy. Thereafter, anchor delivery device 370 and introducer sheath 340 are both pulled in the proximal direction and are withdrawn into introducer device 300. Thereafter, introducer device 300 is pulled in the proximal direction to pull it out of the urethra. In FIG. 4H, the steps from FIG. 4A through 4G are repeated in a second region of the prostate gland if desired to implant two or more sets of anchoring devices.
  • Alternatively, FIGS. 4G′ through 4H′ show the steps of deploying proximal anchor 376 in the urethra. After the step in FIG. 4F, in FIG. 4G′, proximal anchor 376 is separated from anchor delivery device 370 in the urethra. Thus proximal anchor 376 and distal anchor 374 are anchored in the urethra and the prostate capsule respectively. Thereafter, anchor delivery device 370 and introducer sheath 340 are both pulled in the proximal direction and are withdrawn into introducer device 300. Thereafter, introducer device 300 is pulled in the proximal direction to pull it out of the urethra. In FIG. 4H′, the steps from FIG. 4A through 4G′ are repeated optionally in a second region of the prostate gland to implant two or more sets of anchoring devices. It should be understood that this method and devices may be applied to any lobe (middle or lateral lobes) of the prostate and further more may be used multiple times in the same lobe to achieve the desired effect.
  • FIG. 4H″ shows a coronal section through the prostate gland showing the final deployed configuration of an embodiment of bone anchoring devices for treating prostate gland disorders by compressing a region of the prostate gland. In the method of deploying this device, introducer sheath 340 and trocar 360 are advanced till the distal tip of trocar 360 penetrates a bone in the abdomen (e.g. the pelvic bone, etc.) and the distal end of introducer sheath 340 is located outside the bone. Thereafter, trocar 360 is withdrawn from working device lumen 302 leaving introducer sheath 340 in place. Thereafter, anchor delivery device 370 is introduced through the lumen of introducer sheath 340 until the distal end of body 372 touches the bone through the distal tip of introducer sheath 340. Thereafter, distal anchor 374 is implanted in the bone. Distal anchor 374 may comprise a variety of designs including, but not limited to designs of distal tips of Kirschner wires. Examples of such Kirschner wire distal tips are spiral drill tips, lancer tips, threaded trocar tips, lengthwise knurled tips, 3-sided trocar tips, 4-sided trocar tips, Thereafter, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340. This step creates tension in the tension element 378. In another method embodiment, anchor deliver device 370 is pulled in the proximal direction along with introducer sheath 340 till the distal end of anchor delivery device 370 is located in the urethral wall or the urethral lumen. The remaining method steps are similar to steps 4F through 4H.
  • One or more anchors disclosed in this patent application may be implanted in anatomical locations that include, but are not limited to:
      • a location within prostatic lobe;
      • a location within peripheral zone of prostate;
      • a location within prostatic capsule;
      • a location between prostatic capsule and pubic fascia;
      • a location within the pubic fascia;
      • a location within the levator ani muscle a location within the obturator internus muscle;
      • a location within the pelvic bone;
      • a location within the periostium of pelvic bone;
      • a location within the pubic bone;
      • a location within the periostium of pubic bone;
      • a location within the symphysis pubica;
      • a location within the urinary bladder wall;
      • a location within the ischiorectal fossa;
      • a location within the urogenital diaphragm; and
      • a location within the abdominal fascia.
  • FIGS. 4I and 4J show a crossection of the urethra through the prostate gland PG showing the appearance of the urethral lumen before and after performing the method shown in FIGS. 4A through 4H. FIG. 4I shows a crossection of the urethra through the prostate gland showing the appearance of the urethral lumen in a patient with BPH. FIG. 4J shows a crossection of the urethra through the prostate gland PG showing the appearance of the urethral lumen after performing the procedure shown in FIGS. 4A through 4H. The urethral lumen shown in FIG. 4I is larger than the urethral lumen in FIG. 4J.
  • FIGS. 5A through 5F show perspective views of some designs of the tension elements that can be used in the embodiments disclosed elsewhere in this patent application. FIG. 5A shows a perspective view of a tension element 500 comprising a single strand of an untwisted material. Examples of materials that can be used to manufacture tension element 500 include but are not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. FIG. 5B shows a perspective view of a tension element 502 comprising one or more serrations 504 or notches. Serrations 504 may be aligned in a particular direction to allow relatively easy movement of an outer body along tension element 502 in one direction and offer significant resistance to movement of the outer body along the tension element in the other direction. FIG. 5C shows a perspective view of a tension element 506 comprising multiple filaments 507 of a material twisted together. Examples of materials that can be used include to manufacture multiple filaments 507 include but are not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. multiple filaments 507 may be coated with a coating 508 including, but not limited to a lubricious coating, antibiotic coating, etc. It is also possible for the tension element to comprise a composite braided structure in a plastic/metal or plastic/plastic configuration to reduce profile and increase strength. Such materials could have preset levels of elasticity and non-elasticity. FIG. 5D shows a perspective view of a tension element 509 comprising a flexible, elastic, spiral or spring element. Examples of materials that can be used include to manufacture tension element 509 include but are not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc. FIG. 5E shows a perspective view of a tension element 510 comprising a screw threading 511 on the outer surface of tension element 510. Screw threading 511 enables tension element 510 to be screwed through an outer element to advance or withdraw tension element through the outer element. FIG. 5F shows a perspective view of a tension element 512 comprising a hollow shaft 514 comprising one or more collapsible regions 516. A collapsible region 516 comprises one or more windows 518. Windows 518 are cut in hollow shaft 514 in such a way that several thin, collapsible struts 520 are created between adjacent windows 518. When tension element 512 is compresses along its length, collapsible struts 520 are deformed in the radially outward direction to create one or more anchoring regions.
  • FIG. 5G shows a perspective view of an anchoring device 522 comprising a tension element and two anchors. Distal end of a tension element 524 is attached to a distal anchor 526. Proximal end of tension element 524 is attached to a proximal anchor 528.
  • FIG. 5H shows a perspective view of a tensioning element device comprising a detachable region. Anchoring device 530 comprises a first anchor 532 and a second anchor 534. First anchor 532 and second anchor 534 may comprise a variety of anchor designs disclosed elsewhere in this patent application. In one embodiment, one or both of first anchor 532 and second anchor 534 comprise a substantially flat plate. The substantially flat plate may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. First anchor 532 and second anchor 534 are connected to a tensioning element. The tensioning element comprises two flexible members: a first tensioning member 536 and a second tensioning member 538. The distal end of first tensioning member 536 is connected to first anchor 532 and the proximal end of second tensioning member 538 is connected to second anchor 534. Proximal end of first tensioning member 536 and distal end of second tensioning member 538 are connected to a releasable member 540. Releasable member 540 can be releasably connected to a deploying device. In one embodiment of a method using anchoring device 530, first anchor 532 is deployed out of an anatomical tissue (e.g. the prostate gland) into a first anatomical cavity (e.g. the pelvic cavity). Thereafter, second anchor 534 is deployed into a second anatomical cavity (e.g. the urethral lumen). Thereafter, releasable member 540 is released from the deploying device to deliver anchoring device 530 in a target region.
  • FIG. 5I shows a perspective view of a tensioning element comprising telescoping tubes. Tensioning element 544 may comprise two or more telescoping tubes. In this example, tensioning element 544 comprises three telescoping tubes: a first telescoping tube 546, a second telescoping tube 548 and a third telescoping tube 550. Second telescoping tube 548 slidably fits into a lumen of first telescoping tube 546. Similarly third telescoping tube 550 slidably fits into a lumen of second telescoping tube 548. The telescoping tubes have a locking mechanism to prevent a telescoping tube from completely disengaging from another telescoping tube. The telescoping tubes may be made from a variety of biocompatible materials including, but not limited to plastics, metals etc.
  • All the components of the systems disclosed herein (including but not limited to the tensioning elements, inner and outer anchor members) may be coated or embedded with therapeutic or diagnostic substances (e.g., drugs or therapeutic agents) or such therapeutic or diagnostic substances may be introduced into or near the prostate or adjacent tissue through a catheter, cannula needles, etc. Examples of therapeutic and diagnostic substances that may be introduced or eluted include but are not limited to: hemostatic agents; antimicrobial agents (antibacterials, antibiotics, antifungals, antiprotozoals; antivirals; antimicrobial metals (e.g., silver, gold, etc.); hemostatic and/or vasoconstricting agents (e.g., pseudoephedrine, xylometazoline, oxymetazoline, phenylephrine, epinephrine, cocaine, etc.); local anesthetic agents (lidocaine, cocaine, bupivacaine,); hormones; anti-inflammatory agents (steroidal and non-steroidal); hormonally active agents; agents to enhance potency; substances to dissolve, degrade, cut, break, weaken, soften, modify or remodel connective tissue or other tissues; (e.g., enzymes or other agents such as collagenase (CGN), trypsin, trypsin/EDTA, hyaluronidase, and tosyllysylchloromethane (TLCM)); chemotherapeutic or antineoplastic agents; substances that prevent adhesion formation (e.g., hyaluronic acid gel); substances that promote desired tissue ingrowth into an anchoring device or other implanted device; substances that promote or facilitate epithelialization of the urethra or other areas; substances that create a coagulative lesion which is subsequently resorbed causing the tissue to shrink; substances that cause the prostate to decrease in size; phytochemicals that cause the prostate to decrease in size; alpha-1a-adrenergic receptor blocking agents; 5-alpha-reductase inhibitors; smooth muscle relaxants; agents that inhibit the conversion of testosterone to dihydrotestosterone, etc. Specific examples of antitumor agents (e.g., cancer chemotherapeutic agents, biological response modifiers, vascularization inhibitors, hormone receptor blockers, cryotherapeutic agents or other agents that destroy or inhibit neoplasia or tumorigenesis) that may be delivered in accordance with the present invention include but are not limited to; alkylating agents or other agents which directly kill cancer cells by attacking their DNA (e.g., cyclophosphamide, isophosphamide), nitrosoureas or other agents which kill cancer cells by inhibiting changes necessary for cellular DNA repair (e.g., carmustine (BCNU) and lomustine (CCNU)), antimetabolites and other agents that block cancer cell growth by interfering with certain cell functions, usually DNA synthesis (e.g., 6 mercaptopurine and 5-fluorouracil (5FU), antitumor antibiotics and other compounds that act by binding or intercalating DNA and preventing RNA synthesis (e.g., doxorubicin, daunorubicin, epirubicin, idarubicin, mitomycin-C and bleomycin) plant (vinca) alkaloids and other anti-tumor agents derived from plants (e.g., vincristine and vinblastine), steroid hormones, hormone inhibitors, hormone receptor antagonists and other agents which affect the growth of hormone-responsive cancers (e.g., tamoxifen, herceptin, aromatase inhibitors such as aminoglutethimide and formestane, triazole inhibitors such as letrozole and anastrozole, steroidal inhibitors such as exemestane), antiangiogenic proteins, small molecules, gene therapies and/or other agents that inhibit angiogenesis or vascularization of tumors (e.g., meth-1, meth-2, thalidomide), bevacizumab (Avastin), squalamine, endostatin, angiostatin, Angiozyme, AE-941 (Neovastat), CC-5013 (Revimid), medi-522 (Vitaxin), 2-methoxyestradiol (2ME2, Panzem), carboxyamidotriazole (CAI), combretastatin A4 prodrug (CA4P), SU6668, SU11248, BMS-275291, COL-3, EMD 121974, IMC-1C11, IM862, TNP-470, celecoxib (Celebrex), rofecoxib (Vioxx), interferon alpha, interleukin-12 (IL-12) or any of the compounds identified in Science Vol. 289, Pages 1197-1201 (Aug. 17, 2000) which is expressly incorporated herein by reference, biological response modifiers (e.g., interferon, bacillus calmette-guerin (BCG), monoclonal antibodies, interluken 2, granulocyte colony stimulating factor (GCSF), etc.), PGDF receptor antagonists, herceptin, asparaginase, busulphan, carboplatin, cisplatin, carmustine, cchlorambucil, cytarabine, dacarbazine, etoposide, flucarbazone, fluorouracil, gemcitabine, hydroxyurea, ifosphamide, irinotecan, lomustine, melphalan, mercaptopurine, methotrexate, thioguanine, thiotepa, tomudex, topotecan, treosulfan, vinblastine, vincristine, mitoazitrone, oxaliplatin, procarbazine, stereopticon, taxol, taxotere, analogs/congeners and derivatives of such compounds as well as other antitumor agents not listed here.
  • Additionally or alternatively, in some applications such as those where it is desired to grow new cells or to modify existing cells, the substances delivered in this invention may include cells (mucosal cells, fibroblasts, stem cells or genetically engineered cells) as well as genes and gene delivery vehicles like plasmids, adenoviral vectors or naked DNA, mRNA, etc. injected with genes that code for anti-inflammatory substances, etc., and, as mentioned above, macrophages or giant cells that modify or soften tissue when so desired, cells that participate in or effect the growth of tissue.
  • FIGS. 6A through 11A show various examples of anchor designs and/or anchoring device designs. FIGS. 6A and 6B show examples of a crumpling anchor 600. In FIG. 6A, crumpling anchor 600 comprises a substantially flattened body 602. Body 602 can be made of a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Further, in any of the implantable tissue compression devices, any or all of the anchors, the tensioning element(s) and any other components may be coated, impregnated, embedded or otherwise provided with substance(s) (e.g., drugs, biologics, cells, etc.) to reduce the likelihood of infection, inflammation, treat the prostatic adenoma directly or enhance the likelihood of endothelialization, deter adhesion formation, promote healing or otherwise improve the likelihood or degree of success of the procedure. Such substance(s) may be released primarily at the time of delivery or may be released over a sustained period. Examples of such substances are listed above and include but are not limited to certain metals with bacteriostatic action (i.e. silver, gold, etc.), antibiotics, antifungals, hemostatic agents (i.e. collagen, hyaluronic acid, gelfoam, cyano-acrylate, etc.), anti-inflammatory agents (steroidal and non-steroidal), hormonally active agents, stem cells, endothelial cells, genes, vectors containing genes, etc. Body 602 may be non-woven or woven. Body 602 may have a variety of shapes including, but not limited to square, rectangular, triangular, other regular polygonal, irregular polygonal, circular etc. Body 602 may have a substantially one dimensional, two dimensional or three dimensional shape. The material chosen for this device may have hemostatic properties to reduce bleeding from the implantation tract or site. Distal end of body 602 is connected to the distal end of tension element 604. Body 602 further comprises one or more attachment means 606. Attachment means are used to create a channel in the body 602 through which tension element 604 passes. Crumpling anchor 600 is introduced through a region of tissue (e.g. through prostate gland tissue) into a cavity or lumen e.g. pelvic cavity, urethral lumen etc. In FIG. 6B, tension element 604 is pulled in the proximal direction. The causes crumpling (e.g., collapsing) of the crumpling anchor 600 between the tissue and the distal end of tension element 604. This process prevents tension element 604 in the tissue and prevents further movement of tension element 604 in the proximal direction.
  • FIGS. 7A and 7B show an example of a deployable anchor 700 in an undeployed configuration and a deployed configuration, respectively. This deployable anchor 700 comprises one or more anchoring arms 702. Anchoring arms 702 may be made from a variety of elastic, super-elastic or shape memory materials etc. Typical examples of such materials include but are not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc. Anchoring arms 702 are connected to a central hub 704. Central hub in turn is connected to the distal end of a tension element 706. In FIG. 7A, anchoring arms 702 are folded inside a hollow deploying sheath 708. This reduces the undeployed diameter of anchoring arms 702 and also prevents unwanted anchoring of anchoring arms 702. In FIG. 7B, deploying sheath 708 is pulled in the proximal direction. This releases anchoring arms 702 from the distal end of deploying sheath 702. This causes anchoring arms 702 to open in the radially outward direction. Anchor 700 can then anchor to tissue and resist movement of tension element 706 in the proximal direction.
  • FIGS. 8A and 8B show sectional views of an undeployed configuration and a deployed configuration respectively of a “T” shaped deployable anchor. Anchor 8110 comprises an elongate region 802. Elongate region 802 may be made from a variety of elastic, super-elastic or shape memory materials etc. Typical examples of such materials include but are not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc. Middle section of elongate region 802 is connected to the distal end of a tension element 804 to form a “T” shaped anchor. In one embodiment, middle section of elongate region 802 is connected to the distal end of a tension element 804 by a hinge. In FIG. 8A, elongate region 802 is folded inside a hollow deploying sheath 806. This reduces the undeployed diameter of the distal region of anchor 8110 and also prevents unwanted anchoring of elongate region 802 to tissue. In FIG. 8B, deploying sheath 806 is pulled in the proximal direction. This releases elongate region 802 from the distal end of deploying sheath 806. This in turn causes elongate region 802 to twist and orient itself perpendicular to the distal end of a tension element 804. Anchor 800 can then anchor to tissue and resist movement of tension element 804 in the proximal direction.
  • Anchoring arms 702 in FIGS. 7A and 7B can have a variety of configurations including, but not limited to configurations shown in FIGS. 9A through 9D. FIG. 9A shows a distal end view of an embodiment of an anchor comprising two triangular arms. Anchor 900 comprises two anchor arms 902. Anchor arms 902 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc. Anchor arms 902 are connected to a tension element 904. In one embodiment, anchor arms 902 are connected to a central hub, which in turn is connected to tension element 904. The arms in each of these devices may be folded or contained prior to deployment through the use of a sheath or grasping or mounting device. FIG. 9B shows a distal end view of an embodiment of an anchor comprising four rectangular arms. Anchor 906 comprises four anchor arms 908. Anchor arms 908 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc. Anchor arms 908 are connected to a tension element 910. In one embodiment, anchor arms 908 are connected to a central hub, which in turn is connected to tension element 910. FIG. 9C shows a distal end view of an embodiment of an anchor comprising a mesh or a woven material. Anchor 912 comprises four anchor arms 914. Anchor arms 914 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc. Anchor arms 914 are connected to a tension element 916. In one embodiment, anchor arms 914 are connected to a central hub, which in turn is connected to tension element 916. A layer of porous material 918 is located between anchor arms 914. Porous material 918 comprises a plurality of pores that allow for tissue ingrowth. Porous material 918 may also help to distribute the pressure on anchor arms 914 over a wider area. Porous material 918 can be made of variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Porous material 918 may be non-woven or woven. Any of the arms or struts in one or more anchoring devices may comprise bent or curved regions. For example, FIG. 9D shows a distal end view of an embodiment of an anchor comprising four curved arms. Anchor 920 comprises four curved anchor arms 922. Curved anchor arms 922 can be made of a variety of materials including, but not limited to metals e.g. stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc; polymers e.g. polypropylene, Teflon etc. Curved anchor arms 922 are connected to a tension element 924. In one embodiment, curved anchor arms 922 are connected to a central hub which in turn is connected to tension element 924.
  • FIG. 10A shows a distal end view of an anchor comprising a spiral element having a three dimensional shape. Anchor 1000 comprises a three dimensional spiral element 1002. Diameter of spiral element 1002 may be substantially constant or may substantially vary along the length of spiral element 1002. Spiral element 1002 may be made of an elastic, super-elastic or shape memory materials. Spiral element 1002 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Spiral element 1002 is connected to a central hub 1004, which in turn is connected to a tension element. In one embodiment, spiral element 1002 is directly connected to a tension element without using central hub 1004. FIG. 10A′ shows a side view of the anchor in FIG. 10A. FIG. 10A′ shows anchor 1000 comprising spiral element 1002 connected to central hub 1004 which in turn is connected to a tension element 1006. FIG. 10B shows a distal end view of an anchor comprising a spiral element having a two dimensional shape. Anchor 1000 comprises a two dimensional spiral element 1010. Spiral element 1010 may be made of an elastic, super-elastic or shape memory materials. Spiral element 1010 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Spiral element 1010 is connected to a central hub 1012 which in turn is connected to a tension element. In one embodiment, spiral element 1010 is directly connected to a tension element without using central hub 1012. FIG. 10B′ shows a side view of the anchor in FIG. 10B. FIG. 10B′ shows anchor 1008 comprising spiral element 1010 connected to central hub 1012 which in turn is connected to a tension element 1014. FIG. 10C shows a distal end view of an anchor comprising one or more circular elements. In FIG. 10C, anchor 1016 comprises an inner circular element 1018 and an outer circular element 1020. A series of radial arms or struts 1022 connect inner circular element 1018 to outer circular element 1020 and to a central hub 1024. Central hub 1024 may have a lumen 1026. Anchor 1016 may be substantially two dimensional or three dimensional. FIG. 10C′ shows a perspective view of the anchor in FIG. 10C. FIG. 10C′ shows an anchor 1016 comprising an inner circular element 1018, an outer circular element 1020 and series of radial arms or struts 1022 connecting inner circular element 1018 to outer circular element 1020 and to a central hub 1024. Central hub 1024 is connected to a tension element.
  • FIG. 10D shows a perspective view of an embodiment of an anchoring device comprising an outer ring. Anchor 1040 comprises a central hub 1042 and an outer ring 1044. In one embodiment, central hub 1042 acts as a plug to plug an opening in the anatomy to reduce or prevent bleeding or leakage of fluids. Central hub 1042 is connected to outer ring 1044 by one or more bars or struts 1046. In one embodiment, central hub 1042 is connected to an inner ring 1048 which in turn is connected to outer ring 1044 by one or more bars or struts 1046. Central hub 1042 further comprises a locking element 1050. Locking element 1050 comprises a lumen 1052 through which a tension element can slide. After positioning anchor 1040 in a desired position with respect to the tension element, locking element 1050 is used to securely attach anchor 1040 on the tension element. Locking element 1050 may comprise a design disclosed including various locking designs disclosed elsewhere in this patent application. Anchor 1040 may be made from a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • FIG. 10E shows a partial perspective view of an anchoring device comprising a hemostatic element. Anchor 1060 comprises a central hub 1062. In one embodiment, central hub 1062 acts as a plug to plug an opening in the anatomy to reduce or prevent bleeding or leakage of fluids. Central hub 1062 comprises a cinching mechanism to allow central hub 1062 to cinch on to a tension element 1064 passing through central hub 1062. The free end 1066 of tension element 1064 is severed to minimize the presence of tension element 1064 in the anatomy. Anchor 1060 further comprises an outer ring 1068. Central hub 1062 is connected to outer ring 1068 by one or more struts 1070. Anchor 1060 further comprises a mesh or porous element 1072 between outer ring 1068 and struts 1070. The mesh or porous element 1072 may be concave shaped as shown in FIG. 10E. Mesh or porous element 1072 allows for tissue ingrowth over a period of time thus providing additional securing of anchor 1060 to tissue.
  • FIG. 11A shows a perspective view of a device having a set of anchors comprising a curved sheet. Anchoring device 1100 may comprise one or more anchors comprising a curved sheet. In this example, anchoring device 1100 comprises a first anchor 1102 and a second anchor 1104. First anchor 1102 and second anchor 1104 may comprise elastic, super elastic or shape memory materials. First anchor 1102 and second anchor 1104 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. The concave surface of first anchor 1102 is connected to a first end of a tension element 1106. Second end of tension element 1106 is connected to the convex surface of second anchor 1104. In one embodiment of a method to deploy anchoring device 1106, first anchor 1102 is deployed out of an anatomical tissue (e.g. the prostate gland) into a first anatomical cavity (e.g. the pelvic cavity). Thereafter, second anchor 1104 is deployed into a second anatomical cavity (e.g. the urethral lumen). This method embodiment has the advantage of using the natural curvature of first anchor 1102 and second anchor 1104 to distribute pressure on first anchor 1102 and second anchor 1104 over a large area.
  • FIGS. 12A through 17I show further examples of anchor designs and/or anchoring device designs. FIG. 12A shows a perspective view of an anchor comprising an arrowhead. Anchor 1200 comprises an arrowhead 1202. Arrowhead 1202 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. Arrowhead 1202 may comprise a sharp distal tip. Arrowhead 1202 may have a three dimensional or a substantially two dimensional design. Proximal region of arrowhead 1202 is wider that the distal region of arrowhead 1202 to resist motion of arrowhead 1202 along the proximal direction after it is deployed in a tissue. Proximal region of arrowhead 1202 is connected to a tension element 1204. FIG. 12B shows a crossectional view of an anchor comprising a cup-shaped element that encloses a cavity. Anchor 1208 comprises a cup-shaped element 1210. Proximal, concave surface of cup-shaped element 1210 encloses a cavity. Cup-shaped element 1210 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. Proximal region of cup-shaped element 1210 is connected to a tension element 1212. FIG. 12C shows a perspective view of an anchor comprising a screw. Anchor 1216 comprises a screw 1218. Screw 1218 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc. Screw 1218 may comprise a sharp distal tip. Proximal region of screw 1218 may be wider that the distal region of screw 1218 to resist motion of screw 1218 along the proximal direction after it is deployed in a tissue. Screw 1218 comprises a thread rolled thread including, but not limited to wood screw style thread, double lead thread, tapping style thread, tapered wood thread etc. Proximal region of arrowhead 1202 is connected to a tension element 1204.
  • FIGS. 13A and 13B show perspective views of an uncollapsed state and a collapsed state respectively of an anchor comprising a collapsible region. In FIG. 13A, anchor element 1300 is in an uncollapsed state. Anchor element 1300 comprises a hollow shaft 1302 comprising one or more collapsible regions. A collapsible region comprises one or more windows 1304. Windows 1304 are cut in hollow shaft 1302 in such a way that several thin, collapsible struts 1306 are created between adjacent windows 1304. In FIG. 13B, anchor element 1300 is in a collapsed state. When anchor element 1300 is compresses along its length, collapsible struts 1306 are deformed in the radially outward direction to create one or more anchoring regions.
  • FIGS. 13C and 13D show perspective views of an undeployed state and a deployed state respectively of an anchor comprising radially spreading arms. In FIG. 13C, anchor 1312 comprises a hollow tube 1314. Hollow tube 1314 is made from suitable elastic, super-elastic or shape memory materials such as metals including, but not limited to titanium, stainless steel, Nitinol etc.; suitable elastic polymers etc. U-shaped slots 1316 are cut in hollow tube 1314 in such a way that arms 1318 are created within U-shaped slots 1316. In this embodiment, U-shaped slots are substantially parallel to the axis of hollow tube 1314. In absence of an external force, arms 1318 tend to spread in a radially outward direction. Anchor 1312 is kept in an undeployed state by enclosing anchor 1312 in a sheath. Anchor 1312 is deployed by removing the sheath to allow arms 1318 to spread in a radially outward direction as shown in FIG. 13D.
  • Hollow tube 1314 may comprise one or more cinching elements. Cinching elements may be located on the proximal region, distal region or a middle region of hollow tube 1314. The cinching element or elements may comprise cinching mechanisms including, but not limited to cinching mechanisms disclosed in FIGS. 26A through 29P.
  • FIG. 13E shows perspective views of an alternate embodiment of an undeployed state of an anchor comprising radially spreading arms. In FIG. 13C, anchor 1320 comprises a hollow tube 1322. Hollow tube 1322 is made from suitable elastic, super-elastic or shape memory materials such as metals including, but not limited to titanium, stainless steel, Nitinol etc.; suitable elastic polymers etc. U-shaped slots 1324 are cut in hollow tube 1322 in such a way that arms 1326 are created within U-shaped slots 1324. In this embodiment, U-shaped slots are at an angle to the axis of hollow tube 1322 as shown in FIG. 13E.
  • FIGS. 14A and 14B show perspective views of anchoring devices comprising an adhesive delivering element. FIG. 14A shows a perspective view of an anchoring device 1400 comprising a hollow shaft 1402 with a shaft lumen. Hollow shaft 1402 can be made of suitable biocompatible materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc. Distal end of shaft lumen ends in a delivery opening 1404. When an adhesive is injected through the shaft lumen, it emerges out of anchoring device 1400 through delivery opening 1404. Hollow shaft 1402 may also comprise an attachment element 1406 such as a porous woven or non-woven circular sleeve securely attached to hollow shaft 1402. The circular sleeve may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. The adhesive flowing out through delivery opening comes into contact with attachment element 1406 and securely attaches attachment element 1406 to surrounding tissue. FIG. 14B shows a perspective view of an anchoring device 1408 comprising a hollow shaft 1410 with a shaft lumen. Hollow shaft 1410 can be made of suitable biocompatible materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc. Distal end of shaft lumen ends in a delivery opening 1412. When an adhesive is injected through the shaft lumen, it emerges out of anchoring device 1408 through delivery opening 1412. Hollow shaft 1410 may also comprise an attachment element 1414 such as porous foam securely attached to hollow shaft 1410. The porous foam may be made of a variety of materials including, but not limited to polymers e.g. polypropylene, Teflon etc.; synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; rubber materials e.g. various grades of silicone rubber etc. The adhesive flowing out through delivery opening comes into contact with attachment element 1414 and securely attaches attachment element 1414 to surrounding tissue. Typical examples of adhesives that can be used with anchoring device 1400 and anchoring device 1408 include but are not limited to cyanoacrylates, marine adhesive proteins, fibrin-based sealants etc.
  • FIGS. 15A and 15B show two configurations of an anchoring device comprising a ratcheted tension element. Anchoring device 1500 comprises a distal anchor. Distal anchor may comprise a design selected from the variety of designs disclosed elsewhere in this document. In this particular example, distal anchor comprises a series of radial arms 1502 connected to a central hub 1504. The proximal end of central hub is attached to a ratcheted tension element 1506. A proximal anchor is located on ratcheted tension element 1506 proximal to the distal anchor. Proximal anchor may comprise a design selected from the variety designs disclosed elsewhere in this document. In this particular example, distal anchor comprises a series of radial arms 1508 connected to a central hub 1510. Central hub 8368 has a central lumen through which ratcheted tension element 1506 can slide. Ratcheted tension element 1506 has ratchets arranged such that proximal anchor can slide easily over ratcheted tension element 1506 in the distal direction but cannot slide easily in the proximal direction. In FIG. 15B, proximal anchor slides over ratcheted tension element 1506 in the distal direction. This causes a compression of tissue between distal anchor and proximal anchor. The compression of tissue can be maintained since proximal anchor cannot slide easily in the proximal direction. In one embodiment of a method using anchoring device 1500, distal anchor is introduced via an anatomical lumen (e.g. the urethral lumen) and through a tissue (e.g. the prostate gland) into an anatomical cavity (e.g. the pelvic cavity). Thereafter, proximal anchor is advanced along ratcheted tension element 1506 till it encounters a wall (e.g. the urethral wall) of the anatomical lumen. Anchoring device 1500 may be made from various materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.
  • FIG. 16 shows a perspective view of an anchor comprising a trocar lumen. Anchor 1600 comprises a hollow shaft 1602 comprising a lumen. A trocar 1604 or a penetrating device can pass through hollow shaft 1602 such that the distal tip of trocar 1604 emerges out through the distal end of hollow shaft 1602. Distal end of hollow shaft 1602 comprises a tapering region 1606 with a smaller distal diameter and a larger proximal diameter. Tapering region 1606 further comprises a series of sharp projections 1608 located on the proximal end of tapering region 1606. Projections 1608 may be projecting in the proximal direction, radially outward direction etc. Projections 1608 prevent the movement of anchor 1600 in the proximal direction after it has penetrated through a tissue. Anchor 1600 may also comprise a sleeve 1610 located proximal to tapering region 1606. Sleeve 1610 is made of a porous material that has a plurality of pores that allow for tissue ingrowth thus anchoring sleeve 1610 firmly in tissue. Sleeve 1610 may also help to distribute the pressure on tapering region 1606 over a wider area. Sleeve 1610 may be non-woven or woven. Sleeve 1610 can be made of variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc.
  • FIG. 17A shows a perspective view in the undeployed state of an anchor comprising a rigid or partially flexible T element and a crumpling element. In FIG. 17A, anchoring device 1700 comprises a distal, T element 1702. The T element 1702 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. Further it may be a composite material or have cut out sections to allow it to be flexible in certain dimensions but rigid in other dimensions. In this example, T element 1702 is in the form of a hollow cylinder. The proximal end of T element 1702 is in contact with the distal end of a delivery rod 1704. Delivery rod 1704 is hollow and is used to deliver T element 8266 in a target anatomical region. A trocar 1705 can pass through delivery rod 1704 and through T element 1702 such that the distal tip of trocar emerges through the distal end of rigid element 1702. The T-element could also be contained within a lumen of the trocar or may be the trocar itself. of the T element 1702 is connected to the distal end of a flexible tension element 1706. Various connection means are possible such as the tension element being tied or crimped to the T element, or passing through a loop in the T element, or being adhered by adhesive or weld, or by being made of a continuous material which becomes the T element. Although the T element is shown as a T, any shape which is larger in at least one dimension compared to its other dimensions could appropriately be released and cause to change it's orientation to produce an anchoring effect. Examples of materials that can be used to manufacture tension element 1706 include but are not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. A substantially flattened body 1708 is located on the distal region of tension element 1706. Tension element 1706 is threaded through body 1708 in such a way that tension element 1706 can slide through body 1708. Body 1708 may be non-woven or woven. Body 1708 can be made of a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Body 1708 may have a variety of shapes including, but not limited to square, rectangular, triangular, other regular polygonal, irregular polygonal, circular etc. Body 1708 may have a substantially one dimensional, two dimensional or three dimensional shape. FIGS. 17B and 17C show various steps of a method to deploy the anchoring device shown in FIG. 17A. In FIG. 17B, anchoring device 1700 is introduced in an anatomical cavity (e.g. the pelvic cavity) through a tissue (e.g. the prostate gland). Thereafter, trocar 1705 is withdrawn by pulling trocar 1705 in the proximal direction. Thereafter, delivery rod 1704 is withdrawn by pulling delivery rod 1704 in the proximal direction. Thereafter, tension element 1706 is pulled in the proximal direction. Tension element 1706 in turn pulls T element 1702 in the proximal direction. In FIG. 17C, rigid element 1702 is pulled against a wall of the tissue (e.g. the prostate gland) but is unable to penetrate the tissue because of its size. This causes body 1708 to crumple because of compression of body 1708 between the wall of the tissue and rigid element 1702. Crumpled body 1708 may be designed to cause tissue ingrowth or epithelialization in body 1708 as well as healing, hemostasis or a more even force distribution.
  • FIGS. 17D and 17E show perspective views of an undeployed and deployed configuration of an anchor comprising a rigid or partially flexible T element with one or more openings or perforations. FIG. 17D shows a perspective view of an anchoring device 1720 comprising an anchor 1722. Anchor 1722 comprises a tubular body. The tubular body may comprise one or more openings or perforations 1724 in the tubular body. Openings or perforations 1724 increase the flexibility of anchor 1722. This makes it easier to navigate anchoring device 1720 through the anatomy before reaching its target location. Further it enables anchoring device 1720 to be passed through a tight bend in the anatomy or through a delivery device. Within tubular body of anchor 1722 is trocar tip 1727 that is fixedly attached to tensioning element 1728. In the embodiment shown in FIG. 17D, anchor 1722 comprises a lumen. A length of the distal end of deployment element 1726 passes through the proximal end of the lumen and abuts trocar tip 1727 that enables anchor 1722 to puncture tissue. In an alternate embodiment trocar tip is fixedly attached to elongate deployment element 1726 and is retracted fully into element 1729 upon anchor deployment. In an alternate embodiment, distal tip of deployment device 1726 is not exposed through the distal end of anchor 1722. Distal end of anchor 1722 comprises a sharp tip to enable anchor 1722 to puncture tissue. Anchoring element 1720 further comprises a tension element 1728 attached to tubular body 1722. In this embodiment, distal end of tension element 1728 attached to the inner surface of the trocar tip 1727. Proximal region of tension element 1728 passes through deployment element 1726. Anchor 1722 is deployed by pushing in a distal direction one elongate deployment element 1726, that runs within lumen of anchor 1722 abutting trocar tip 1727 distally, in tandem with another elongate deployment element 1729 that abuts the proximal end of anchor 1722. Anchoring device 1720 punctures tissue to transport anchor 1722 through a first anatomical location (e.g. a prostate gland) to a second anatomical location (e.g. the pelvic cavity, urethra etc.). Thereafter, deployment element 1726 is withdrawn by pulling deployment element 1726 in the proximal direction. Thereafter, tension element 1728 is pulled in the proximal direction. This causes anchor 1722 to anchor in tissue as shown in FIG. 17E. Proximal portion of tension element 1728 emerges out of anchor 1722 through a lengthwise groove in anchor 1722 to create a T shaped anchor as shown in FIG. 17E. Tension on tensioning element 1728 causes trocar tip 1727 to retract into lumen 1722. In the example shown, the first anatomical location is the prostate gland PG and the second anatomical location is the pelvic cavity. Anchoring device 1720 can be made from a variety of materials including, but not limited to metals such as synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Tension element 1728 may then be connected to any one of the other anchoring elements such as anchor 10D.
  • FIGS. 17F and 17G show perspective views of an undeployed and deployed configuration of an anchor comprising a stent. Anchor 1730 comprises a self-expanding stent 1732 and a tension element 1734. Distal end of tension element 1734 is attached to stent 1732. In one embodiment, distal end of tension element 1734 is attached on the mid section of stent 1732. Stent 1732 may comprise various designs including, but not limited to metallic tube designs, polymeric tube designs, spiral designs, chain-linked designs, rolled sheet designs, single wire designs etc. Stent 1732 may have an open celled or closed celled structure. A variety of fabrication methods can be used for fabricating stent 1732 including but not limited to laser cutting a metal or polymer element, welding metal elements etc. A variety of materials can be used for fabricating stent 1732 including but not limited to metals, polymers, foam type materials, super elastic materials etc. A variety of features can be added to stent 1732 including but not limited to radiopaque coatings, drug elution mechanisms etc. Anchor 1730 is introduced through a sheath 1736 into a target anatomy. Thereafter, sheath 1736 is withdrawn. This causes stent 1732 to revert to its natural shape as shown in FIG. 17G and act as an anchor.
  • FIGS. 17H and 17I show perspective views of an undeployed and deployed configuration of an anchor comprising a spring. Anchor 1740 comprises an elastic spring 1742 and a tension element 1744. Distal end of tension element 1744 is attached to spring 1742. In one embodiment, distal end of tension element 1744 is attached on the mid section of spring 1742. A variety of materials can be used for fabricating spring 1742 including but not limited to metals, polymers, foam type materials, super elastic materials etc. A variety of features can be added to spring 1742 including but not limited to radiopaque coatings, drug elution mechanisms etc. Anchor 1740 is introduced through a sheath 1746 into a target anatomy to reduce the profile of spring 1742. Thereafter, sheath 1746 is withdrawn. This causes spring 1742 to revert to its natural shape as shown in FIG. 17I and act as an anchor.
  • FIGS. 18A through 22E show various embodiments of mechanisms to deploy one or more anchors. FIG. 18A shows a crossection of an anchor deploying mechanism comprising a screw system. FIG. 18A shows an anchor deploying mechanism comprising an anchor 1800 comprising an anchor body 1802 and anchoring elements 1804 attached to anchor body 1802. Anchor body 1802 comprises an inner lumen. Inner lumen of anchor body 1802 comprises screw threading. Anchoring elements 1804 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document. Anchor body 1802 and anchoring elements 1804 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. The anchor deploying mechanism further comprises a deploying shaft 1806. Distal region of deploying shaft 1806 comprises a screw threading such that deploying shaft 1806 can be screwed into anchor body 1802. FIG. 18B shows the method of deploying an anchor comprising a screw mechanism. Deploying shaft 1806 is rotated to release the distal region of deploying shaft 1806 from anchor body 1802 after positioning anchor 1800 in a desired location. Such a mechanism can be used to deploy one or more anchors. In one embodiment, more than one anchors are located on deploying shaft 1806. The anchors can be sequentially deployed by rotating deploying shaft 1806. Deploying shaft 1806 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc. In one embodiment, the anchor deploying mechanism is located inside an outer sheath.
  • FIGS. 19A and 19B show a crossectional view of an anchor deploying system comprising an electrolytic detachment element. FIG. 19A shows a crossection of an anchor deploying mechanism comprising a deployable anchor 1900. Deployable anchor 1900 comprises an anchor body 1902 and anchoring elements 1904 attached to anchor body 1902. Anchoring elements 1904 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document. Anchor body 8402 and anchoring elements 8404 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. Proximal region of deployable anchor 1900 further comprises an electrolyzable element 1906. Electrolyzable element 1906 is made of a length of metallic wire e.g. steel wire. Proximal region of electrolyzable element 1906 is electrically connected to a deploying shaft 1908. Proximal region of deploying shaft 1908 is further connected to a first electrode. The anchor deploying system further comprises a second electrode 1910 connected to a bodily region of the patient to be treated. In FIG. 19B, the first electrode is connected to a positive terminal of a power supply and the second electrode is connected to the negative terminal of the power supply to form an electrical circuit. Electrical current flowing between electrolyzable element 1906 and second electrode 1910 causes metallic ions from electrolyzable element 1906 to dissolve into surrounding anatomy. This causes electrolyzable element 1906 to detach from deploying shaft 1908.
  • FIG. 20 shows a perspective view of an anchor deploying system comprising a looped ribbon. The anchor deploying system comprises a deployable anchor 2000. Deployable anchor 2000 comprises an anchor body 2002 and anchoring elements 2004 attached to anchor body 2002. Anchoring elements 2004 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document. Anchor body 2002 and anchoring elements 2004 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. Proximal region of deployable anchor 2000 further comprises a looping lumen 2006. A looped ribbon 2008 is looped through looping lumen 2006. Looped ribbon 2008 may be made of a variety of materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. looped ribbon 2008 extends to a proximal region where it can be cut by a user. In a method of deploying deployable anchor 2000, a single cut is made in looped ribbon 2008 at a proximal region. This turns looped ribbon 2008 into a straight ribbon. The straight ribbon can then be pulled in the proximal direction to remove it from deployable anchor 2000. Looped ribbon 2008 may also be in the form of a looped monofilament or multifilament wire or suture.
  • FIG. 21A shows a crossectional view of an anchor deploying system comprising a locked ball. The anchor deploying system comprises a deployable anchor 2100. Deployable anchor 2100 comprises an anchor body 2102. Deployable anchor 2100 may have various designs including, but not limited to anchor designs disclosed elsewhere in this document. Proximal end of anchor body 2102 is connected to a thin shaft 2104. Proximal end of thin shaft 2104 comprises a locking ball 2106. Anchor body 8428, thin shaft 2104 and locking ball 2106 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. The anchor deploying system further comprises an outer locking sheath 2108. Distal end of locking sheath 2108 comprises an opening 2110. Diameter of opening 2110 is greater than the diameter of thin shaft 2104 but greater than diameter of locking ball 2106. Thus, locking ball 2106 is locked in locking sheath 2108. The anchor deploying system further comprises a deploying shaft 2112 located within locking sheath 2108. Deploying shaft 2112 can be pushed in the distal direction within locking sheath 2108 by a user. Locking sheath 2108 and deploying shaft 2112 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc. In one embodiment, distal region of locking sheath 2108 comprises one or more longitudinal grooves or windows to allow distal region of locking sheath 2108 to expand easily in the radial direction. FIGS. 21B and 21C show a method of deploying an anchor comprising a locked ball. In FIG. 21B, deploying shaft 2112 is pushed in the distal direction by a user. This causes distal end of deploying shaft 2112 to push locking ball 2106 in the distal direction. This in turn causes locking ball 2106 to exert a force on the distal end of locking sheath 2108. This force causes opening 2110 to enlarge and release locking ball 2106. In FIG. 21C, locking ball 2106 is released by locking sheath 2108 thus releasing deployable anchor 2100.
  • FIGS. 22A through 22C show various views of an anchor deploying system comprising two interlocking cylinders. The anchor deploying system comprises a proximal interlocking cylinder and a distal interlocking cylinder. The distal interlocking cylinder is located on an anchor to be deployed. FIG. 22A shows a perspective view of a proximal interlocking cylinder 2200 comprising a locking element 2202 located on the distal end of proximal interlocking cylinder 2200. In this example, locking element 2202 comprises a solid cylinder with a ninety degree bend. Proximal interlocking cylinder 2200 and locking element 2202 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc. FIG. 22B shows a crossectional view of the anchor deploying system comprising proximal interlocking cylinder 2200 interlocked with a distal interlocking cylinder 2204. Distal interlocking cylinder 2204 comprises a groove 2206 which locks locking element 2202. Locking element 2202 can be unlocked from distal interlocking cylinder 2204 by turning proximal interlocking cylinder 2200. distal interlocking cylinder 2204 may be made of a variety of materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; polymers e.g. polypropylene, Teflon etc.; rubber materials e.g. various grades of silicone rubber etc. FIG. 22C shows a crossectional view through plane A-A in FIG. 22B. FIG. 22C shows distal interlocking cylinder comprising groove 2206. Also shown is locking element 2202 located in groove 2206. Turning proximal interlocking cylinder 2200 turns locking element 2202. At a particular orientation, distal region of locking element 2202 can pass easily through groove 2206 unlocking proximal interlocking cylinder 2200 from distal interlocking cylinder 2204.
  • FIGS. 22D and 22E show the steps of a method of unlocking the two interlocking cylinders from the anchor deploying systems of FIGS. 22A through 22C. In FIG. 22D, locking element 2202 of proximal interlocking cylinder 2200 is locked in groove 2206 of distal interlocking cylinder 2204. In FIG. 22E, proximal interlocking cylinder 2200 is turned in a clockwise or counterclockwise direction to unlock locking element 2202 from groove 2206. Thereafter, proximal interlocking cylinder 2200 is pulled in the proximal direction to separate proximal interlocking cylinder 2200 from distal interlocking cylinder 2204.
  • FIG. 23A shows a perspective view of a distal end of an anchoring device that has an imaging modality. Anchoring device 2300 comprises an elongate shaft 2302 comprising a lumen. Elongate shaft 2302 can be made of suitable biocompatible materials such as metals, polymers etc. The lumen of shaft 2302 terminates in a window 2304 located on the distal region of shaft 2302. Anchoring device further comprises an imaging modality such as a cystoscope, an ultrasound imaging system etc. In this example, the imaging modality is a cystoscope 2306. Distal end of cystoscope 2306 is located in window 2304 to allow visualization of the anatomy adjacent to window 2304. In one embodiment, cystoscope 2306 is permanently fixed to anchoring device 2300. In another embodiment, cystoscope 2306 can be introduced through the proximal region of anchoring device 2300. Anchoring device 2300 further comprises a puncturing device 2308. Puncturing device 2308 comprises a sharp distal tip and a lumen that holds an anchor. Anchoring device 2300 further comprises an anchor deployment device 2310. Distal end of anchor deployment device 2310 is detachably attached to the anchor.
  • FIGS. 23B through 23G show various steps of a method for compressing an anatomical region using the anchoring device of FIG. 23A. In FIG. 23B, Anchoring device 2300 is introduced in an anatomical region such that distal end of anchoring device 2300 is located adjacent to a target anatomical region to be treated. In one method embodiment, anchoring device 2300 is introduced transurethrally into the prostatic urethra. Thereafter, puncturing device 2308 is advanced to puncture the anatomical region. In this example, puncturing device 2308 punctures the prostate gland PG such that distal end of puncturing device 2308 is located in the pelvic cavity. Puncturing device comprises an anchor located in the lumen of puncturing device 2308. The anchor comprises a distal anchor 2312, a tension element 2314 connected at one end to distal anchor 2312 and a proximal anchor 2316 that can slide over tension element 2314. Puncturing device 2308 comprises a groove at the distal end such that tension element exits puncturing device 2308 through the groove. Puncturing device 2308 further comprises a pusher 2318 that can push distal anchor 2312 out of puncturing device 2308. Proximal anchor 2316 is detachably attached to the distal region of anchor deployment device 2310. Proximal anchor 2312, distal anchor 2316 and tension element 2314 may comprise designs including, but not limited to the designs disclosed elsewhere in this patent application. The imaging modality may be used to verify the accurate placement and working of anchoring device 2300. In FIG. 23C, pusher 2318 is pushed in the distal direction to push distal anchor 2312 out of puncturing device 2308. Distal anchor 2312 is thus deployed in the anatomy e.g. in the pelvic cavity surrounding the prostate gland PG. Thereafter, in step 23D, Puncturing device 2308 is withdrawn by pulling it in the proximal direction. In step 23E, tension element 2314 is pulled in the proximal direction through anchor deployment device 2310. Thereafter, in step 23F, tension element 2314 is pulled further in the proximal direction such that the anatomical region between proximal anchor 2316 and distal anchor 2312 is compressed. Thereafter, in step 23G, proximal anchor 2316 is securely locked on to tension element 2314. Further in step 23G, proximal anchor 2316 is detached from anchor deployment device 2310. The detachment can be performed by a variety of mechanisms including, but not limited to the anchor detachment mechanisms disclosed elsewhere in this patent application. Further in step 23G, excess length of tension element 2314 is removed. This removal can be done using a variety of methods including, but not limited to the methods disclosed elsewhere in this patent application such as cutting, delinking, melting, and breaking. Thereafter, anchoring device 2300 is withdrawn from the anatomy. It should be understood that these deployment steps may be repeated in the same, opposing or neighboring tissues to essentially tack up the encroaching tissue (i.e. prostatic tissue, tumor, relaxed tissue, expanded tissue or growth). It may be desired that over time both anchors become completely embedded within the tissue and covered to prevent encrustation, clotting or other tissue or body-fluid interaction—this may be facilitated by the processes, therapeutic agents and coatings described elsewhere in the application. Although these anchors are shown on either side of the tissue, it may be possible to deploy either or both of them within the body of the tissue itself to help bury them and eliminate the possibility that they may interact with other parts of the body. It should further be noted that in the case of application to the prostate, that this technique may be used on any of the lateral or middle lobes to compress or hold the prostate gland PG away from the lumen of the urethra.
  • If removal of the intra or para luminal anchor is required, it may be possible to resect that region completely, capturing the anchor embedded within the tissue and removing it en-bloc, severing the tether in the process. In the case of prostate applications, such removal may be accomplished with a standard resectoscope system. In other regions, and energized RF or sharp curette or blade may be used to resect the anchor minimally invasively. Alternatively if engagement with the locking mechanism is still achievable, it may be possible to simply unlock the tether, releasing the anchor. Lastly, if applying additional tension at some point after the procedure is required, it may be possible to engage and grasp the tether as it exits the locking device in the anchor and apply additional tension.
  • FIGS. 24A through 24C′ show various steps of a method of compressing an anatomical region using a device with deploying arms deployed through a trocar. In FIG. 24A, an anchoring device 2400 is introduced in an anatomical region. Anchoring device 2400 comprising a distal anchor 2402 is introduced in the anatomy. Distal anchor 2402 comprises a hollow shaft. Distal end of distal anchor 2402 comprises one or more outwardly curling or spreading arms 2404. Curling or spreading arms 2404 are made of an elastic, springy, super-elastic or shape memory material such that they tend to curl or spread in a radially outward direction in absence of an external force. Anchoring device 2400 further comprises a proximal anchor comprising a variety of designs including, but not limited to the designs disclosed elsewhere in this patent application. In this example, proximal anchor is designed similar to anchor 1040 in FIG. 10D. Anchor 1040 can slide along proximal region of distal anchor 2402. Anchor 1040 can also be attached to distal anchor 2402 after a desired positioning between anchor 1040 and distal anchor 2402 is achieved. Anchoring device 2400 is delivered through a trocar 2406. Trocar 2406 comprises a sharp distal tip 2408 that can penetrate through tissue. The proximal region of distal tip 2408 comprises one or more grooves or notches such that distal ends of curling or spreading arms 2404 can be temporarily held together by distal tip 2408 to allow for easy introduction into a target anatomy. Anchoring device 2400 is introduced into a target tissue to be compressed such that curling or spreading arms 2404 are distal to the target tissue and anchor 1040 is proximal to the target tissue. FIG. 24A′ shows the distal end view of the anchoring device 2400. In FIG. 24B, trocar 2406 is pushed in the distal direction relative to proximal anchor 2402. This releases the distal ends of curling or spreading arms 2404 causing them to curl or spread outwards. FIG. 24A′ shows the distal end view of the anchoring device 2400 with released curling or spreading arms 2404. In FIG. 24C, anchor 1040 is pushed in the distal direction over distal anchor 2402 to compress tissue between anchor 1040 and distal anchor 2402. Thereafter, anchor 1040 is attached to the hollow shaft of distal anchor 2402. Thereafter trocar 2406 is withdrawn from the anatomy. In the above embodiment, the tethering function is performed by the shaft of the distal anchor, and the force is created by the curling arms. This tension may be pre-set into the arms through heat forming. It should be noted that any mechanism capable of expanding from within a tubular shape and capable of applying retrograde forces on the tissue are within the scope of this invention such as expandable flanges, balloons, cages, molly-bolt-like structures, stent-like structures and springs.
  • FIG. 24D shows a crossection through the deployed anchoring device 2400 of FIG. 24A.
  • In one anchoring device embodiment, anchoring device 2400 comprises a distal anchor such as the distal anchor described in FIG. 17A instead of distal anchor 2412.
  • FIG. 25A shows a perspective view of a spring clip that can be used to spread the anatomy. Clip 2500 comprises two or more spreading arms 2502. Spreading arms 2502 may be curved or straight. Distal ends of spreading arms 2502 may comprise a flattened region. The proximal ends or curved arms 2502 are connected to each other by a heel region 2504. Heel region 2504 may be made from the same material as curved arms 2502. In an undeployed configuration, spreading arms 2502 are held close to each other. When clip 2500 is deployed, spreading arms 2502 tend to expand away from each other thus spreading the anatomical region or regions between spreading arms 2502. Clip 2500 can be made of suitable elastic, super-elastic or shape memory biocompatible materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, etc.
  • FIGS. 25B through 25F show various steps of a method of spreading an anatomical region or regions using the spring clip of FIG. 25A. In FIG. 25B, a delivery tool 2506 comprising a clip 2500 is introduced in the anatomy and positioned near the target anatomy to be spread. Delivery tool 2506 comprises an elongate hollow body 2508 comprising a lumen. Distal end of body 2508 may comprise a blunt, atraumatic end. Distal region of body 2508 comprises a slot 2510 that is in fluid communication with the lumen of body 2508. Delivery tool may further comprise an outer sheath 2512 and an imaging modality 2514. Imaging modality 2514 may be permanently attached to delivery tool 2506 or may be introduced into delivery tool 2506 by a user. In this example, imaging modality 2514 is a cystoscope. In FIG. 25C, clip 2500 is introduced into the anatomy by pushing clip 2500 out of slot 2510 such that the distal ends of spreading arms 2502 emerge first. Slot 2510 is designed such that spreading arms 2504 are biased towards each other as they emerge out of slot 2510. In FIG. 25D, clip 2500 is further advanced such that distal tips of spreading arms 2502 penetrate into the tissue to be spread. In FIG. 25E, clip 2500 is advanced further such that the biasing forces on spreading arms 2502 are removed. Spreading arms 2502 tend to spread away from each other thus spreading the tissue between them. Clip 2500 is detachably attached to delivery tool 2506 by a detaching mechanism 2516 including, but not limited to the several detaching mechanisms disclosed elsewhere in this patent application. In FIG. 25F, detaching mechanism 2516 is used to detach clip 2500 from delivery tool 2506 or deploy clip 2500 in the target anatomy. In this example, distal region of delivery tool 2506 is inserted transurethrally into the prostatic urethra. Clip 2500 is then delivered into the anterior commissure to spread the two lateral lobes of the prostate gland PG apart. In one method embodiment, an opening in the commissure is made prior to the method of FIGS. 25B through 25G. In another embodiment, the spreading force exerted by spreading arms 2502 cause cutting of the anterior commissure. Clip 2500 may be placed completely sub-urethrally or a small amount of heel region 2504 remains in the urethra.
  • The embodiments of anchoring devices wherein a sliding anchor is slid over a tension element may comprise one or more cinching elements. These cinching elements may be present on the sliding anchors, on the tension elements etc. A cinching element may be a separate device that cinches to a tension element. In doing so, it increases the effective diameter of that region of the tension element and prevents the tension element from sliding through a sliding anchor. Cinching elements may allow only unidirectional motion of the sliding anchor over the tension element or may prevent any substantial motion of the sliding anchor over the tension element. Typical examples of such cinching mechanisms include, but are not limited to mechanisms described in the FIG. 26 series. For example, FIGS. 26A and 26B show a crossectional view and a perspective view respectively of a mechanism of cinching a tension element or tether to an anchor. In FIG. 26A, cinching mechanism 2600 comprises an outer base 2602. Outer base 2602 comprises one or more grooves created by the presence of two or more leaflets 2604. Leaflets 2604 are biased along a first axial direction as shown in FIG. 26A. When a tension element 2606 is located in the one or more grooves, cinching mechanism 2600 allows motion of tension element 2606 only along the first axial direction and prevents substantial movement of tension element 2606 in the opposite direction.
  • FIGS. 26C and 26D show a partial section through a cinching mechanism comprising a cam element. In FIG. 26C, cinching mechanism 2610 comprises an outer body 2612 made of suitable biocompatible metals, polymers etc. Body 2162 comprises a cam 2614 located on a pivot 2616. Cam 2614 may comprise a series of teeth to grip a tension element 2618 passing through body 2612. In one embodiment, body 2162 comprises an opening 2620 located proximal to cam 2614. Proximal region of tension element 2618 passes out of body 2612 through opening 2620. Cinching mechanism 2610 allows movement of body 2162 over tension element 2618 in the proximal direction. In FIG. 26D, body 2162 is moved over tension element 2618 in the distal direction. Motion of tension element 2618 over cam 2614 causes cam 2614 to turn in the anti-clockwise direction. This causes tension element 2618 to be pinched between cam 2614 and body 2612. This in turn prevents further motion of body 2162 over tension element 2618.
  • FIG. 26E shows a sectional view of an embodiment of a cinching mechanism comprising a locking ball. Cinching mechanism 2630 comprises an outer body 2632 comprising a lumen. A tension element 2634 passes through the lumen of outer body 2632. The lumen of outer body gradually reduces in the proximal direction as shown in FIG. 26E. A locking ball 2636 is present in the lumen. Motion of outer body 2632 over tension element 2634 in the distal direction pushes locking ball 2636 in the proximal region of outer body 2632. A proximal end region 2638 of a small diameter prevents locking ball 2636 from falling out of outer body 2632. The large lumen diameter in the proximal region of outer body 2632 allows free motion of locking ball 2636. Thus, presence of locking ball 2636 does not hinder the motion of outer body 2632 over tension element 2634 in the proximal direction. When outer body 2632 is moved over tension element 2634 in the proximal direction, locking ball 2636 is pushed in the distal region of outer body 2632. The small lumen diameter in the proximal region of outer body 2632 constricts motion of locking ball 2636. This causes a region of tension element 2634 to be pinched between anchoring ball 2636 and outer body 2632. This in turn prevents further motion of outer body 2632 over tension element 2634 in the proximal direction. This mechanism thus allows unidirectional motion of outer body 2632 is over tension element.
  • FIG. 26F shows a side view of an embodiment of a cinching mechanism comprising multiple locking flanges. In this embodiment, cinching mechanism 2644 comprises a body 2646 comprising a lumen lined by a first locking flange 2648 and a second locking flange 2650. First locking flange 2648 and second locking flange 2650 are biased in the proximal direction as shown. A tension element 2652 passes through the lumen of body 2646. First locking flange 2648 and second locking flange 2650 together allow the movement of body 2646 over tension element 2652 in the distal direction, but prevent movement of body 2646 over tension element 2652 in the proximal direction. Similar cinching mechanisms may be designed comprising more than two locking flanges. FIG. 26G shows an end view of body 2646 comprising a lumen lined by first locking flange 2648 and second locking flange 2650. Body 2646 may be made of suitable biocompatible metals, polymers etc.
  • FIG. 26H shows a side view of an embodiment of a cinching mechanism comprising a single locking flange. In this embodiment, cinching mechanism 2656 comprises a body 2658 comprising a lumen lined by a locking flange 2660. Locking flange 2660 is biased in the proximal direction as shown. A tension element 2662 passes through the lumen of body 2658. Locking flange 2660 allows the movement of body 2658 over tension element 2662 in the distal direction, but prevents movement of body 2658 over tension element 2662 in the proximal direction. FIG. 26I shows an end view of body 2658 comprising a lumen 2662 lined by locking flange 2660. Body 2658 may be made of suitable biocompatible metals, polymers etc.
  • FIG. 26J shows an end view of a cinching mechanism comprising a crimping lumen. Cinching mechanism 2670 comprises a body 2672 comprising a crimping lumen 2674. Crimping lumen 2674 is in the form of an arc with a gradually reducing size as shown in FIG. 26J. A tension element 2676 passes through crimping lumen 2674. In FIG. 26J, tension element 2676 is locked in a region of crimping lumen 2674 of a diameter smaller than the diameter of tension element 2676. Tension element 2676 can be unlocked from crimping lumen 2674 by rotating body 2672 in the anti-clockwise direction. Similarly, rotating body 2672 in the clockwise direction causes an unlocked tension element 2676 to be locked into crimping lumen 2674.
  • In an alternate embodiment, cinching mechanism comprises a disk shaped body comprising a central lumen. Central lumen is large enough to allow a tension element to slide easily through the central lumen. One or more radially oriented slits emerge from the central lumen. The radially oriented slits have a diameter that is of the same size or is slightly smaller than the diameter of the tension element. To lock cinching mechanism to the tension element, the tension element is forced through one of the radially oriented slits. The friction between the disk shaped body and the tension element prevents or resists sliding of tension element through the disk shaped body. To unlock cinching mechanism from the tension element, the tension element is moved back to the central lumen.
  • In another alternate embodiment, cinching mechanism comprises a disk shaped body comprising a small central lumen. The central region of the body comprises three or more triangular flaps biased together out of the plane of the body. The ends of the triangular flaps together form the central lumen that is of the same size or is slightly smaller than the diameter of the tension element. Tension element can pass easily through the central lumen in the direction of the bias of the triangular flaps. But, tension element cannot pass or encounters substantial resistance when the tension element is pulled through the central lumen in the opposite direction.
  • FIGS. 26K and 26L show crossections of an embodiment of a cinching mechanism comprising a crimping anchor in the undeployed and deployed configurations respectively. Cinching mechanism 2680 comprises a crimping anchor 2680 comprising a lumen. Crimping anchor 2680 can be made of a variety of biocompatible materials including, but not limited to metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc., polymers, etc. A tension element 2684 passes through the lumen of crimping anchor 2680. The lumen of an undeployed crimping anchor 2680 is larger than the diameter of tension element 2684. In FIG. 26L, crimping anchor 2680 is deployed by compressing the middle section of crimping anchor 2680 such that crimping anchor 2680 compresses tension element 2684. Friction between crimping anchor 2680 and tension element 2684 prevents relative motion between crimping anchor 2680 and tension element 2684. Crimping anchor 2680 may be a component of a sliding anchor or may be a stand-alone device used to prevent or restrict motion of a sliding anchor over a tension element.
  • FIG. 26M shows a perspective view of an embodiment of a cinching mechanism comprising an element providing a tortuous path to a tension element. In this example, cinching mechanism 2686 comprises a spring 2688. A tension element 2690 is passed through spring 2688 such that the path of tension element 2690 through spring 2688 is tortuous. When spring 2688 is moved over tension element, motion of tension element 2690 through the tortuous path generates high frictional forces that prevent or reduce motion of spring 2688 over tension element 2690. The frictional forces are strong enough to resist motion of spring 2688 over tension element 2690 after deploying cinching mechanism 2686 in the anatomy. A user can move spring 2688 over tension element 2690 by applying a force that overcomes the resistive frictional forces that prevent movement of spring 2688 over tension element 2690. Similarly, other cinching mechanisms comprising a tortuous path can be used instead of spring 2688. Examples of such mechanisms are solid elements comprising tortuous lumens, elements comprising multiple struts or bars that provide a tortuous path etc. In another embodiment the cinching mechanism comprises a knot on one or more tensioning element. Said knot can be advanced fully tightened or can be loose when advanced and tightened in situ.
  • FIG. 26N shows a crossectional view of an embodiment of a locking mechanism comprising a space occupying anchor securely attached to a tension element. Locking mechanism 2692 comprises a hollow element 2694 comprising a lumen. Hollow element 2694 is a component of a sliding anchor that slides over tension element 2696. Tension element 2696 comprises a space occupying anchor 2698 comprising a tapering distal end 2699. Anchor 2698 is securely attached to tension element 2696. Diameter of anchor 2698 is larger than the diameter of the lumen of hollow element. Due to this, anchor 2698 cannot pass through hollow element 2694 effectively locking the position of tension element 2696 with respect to the position of hollow element 2694.
  • FIGS. 26O and 26P shows a partial sectional view and a perspective view of an embodiment of a cinching mechanism comprising a punched disk. Cinching mechanism 2602′ comprises a disk 2604′ comprising a punched hole 2606′. Punched hole 2606′ is made by punching disk 2604′ along the proximal direction such that the punching action leaves an edge that is biased along the proximal direction as shown in FIG. 26O. Disk 2604′ can slide over a tension element 2608′ along the distal direction. However, motion of disk 2604′ over tension element 2608′ along the proximal direction is substantially resisted by the proximally biased edges of punched hole 2606′.
  • Excess lengths of tension elements or other severable regions of one or more devices disclosed in this patent application may be cut, severed or trimmed using one or more cutting devices. For example, FIGS. 26Q and 26R show a perspective view of a first embodiment of a cutting device before and after cutting an elongate element. In FIG. 26Q, cutting device 2610′ comprises an outer sheath 2612′ comprising a sharp distal edge 2614′. Outer sheath 2612′ encloses an inner sheath 2616′. Inner diameter of outer sheath 2612′ is slightly larger than outer diameter of inner sheath 2616′ such that inner sheath 2616′ can slide easily through outer sheath 2612′. Inner sheath 2616′ comprises a lumen that terminates distally in an opening 2618′. An elongate severable device passes through the lumen and emerges out of opening 2618′. An example of an elongate severable device is a tension element 2620′. In the method of cutting or trimming tension element 2620′ the desired area of tension element 2620′ to be cut or severed is positioned near opening 2618′ by advancing or withdrawing cutting device 2610′ over tension element 2620′. Thereafter, outer sheath 2612′ is advanced over inner sheath 2616′ to cut tension element 2620′ between sharp distal edge 2614′ and an edge of opening 2618′. Inner sheath 2616′ and outer sheath 2612′ may be substantially rigid or flexible. They may be made of suitable materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • FIG. 26S show a crossectional view of a second embodiment of a cutting device for cutting an elongate element. Cutting device 2622′ comprises an outer sheath 2624′ comprising a lumen that opens in an opening 2626′ in outer sheath 2624′. Outer sheath 2624′ encloses an inner sheath 2628′ that comprises a lumen and a sharp distal edge 2630′. Inner diameter of outer sheath 2624′ is slightly larger than outer diameter of inner sheath 2628′ such that inner sheath 2628′ can slide easily through outer sheath 2624′. An elongate severable device passes through the lumen of inner sheath 2628′ and emerges out of distal end of inner sheath 2628′ and out of outer sheath 2624′ through opening 2626′. An example of an elongate severable device is a tension element 2632′. In the method of cutting or trimming tension element 2632′ the desired area of tension element 2632′ to be cut or severed is positioned near opening 2626′ by advancing or withdrawing cutting device 2622′ over tension element 2632′. Thereafter, inner sheath 2628′ is advanced through outer sheath 2624′ to cut tension element 2632′ between sharp distal edge 2630′ and an edge of opening 2626′. Inner sheath 2628′ and outer sheath 2624 may be substantially rigid or flexible. They may be made of suitable materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc.
  • In a third embodiment of a cutting device for cutting an elongate element, the cutting device comprises an outer hollow sheath. Outer hollow sheath has a distal end plate comprising a window. An elongate severable device passes through the window. An example of an elongate severable device is a tension element. An inner shaft can slide and rotate within outer hollow sheath. Distal end of inner shaft comprises a blade that is usually located away from the window and adjacent to the distal end plate of the outer hollow sheath. In the method of cutting or trimming tension element the elongate severable device, the desired area of the elongate severable device to be cut or severed is positioned near the window. This is done by advancing or withdrawing the cutting device over the elongate severable device. Thereafter, the inner shaft is rotated within outer hollow sheath such that the blade cuts the elongate severable device between a sharp edge of the blade and an edge of the window. Inner shaft and outer hollow sheath may be substantially rigid or flexible. They may be made of suitable materials including, but not limited to Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc. The end plate and the blade are preferentially rigid. They may be made of suitable materials including, but not limited to metals like stainless steel, polymers like Polycarbonate, Polyimide, PVC, Hytrel, HDPE, PEEK and fluoropolymers like PTFE, PFA, FEP etc.
  • The anchoring devices disclosed herein may be used in a variety of configurations depending on the location of the disease process, ease of procedure etc. FIGS. 27A through 27D show axial sections through the prostate gland PG showing various configurations of anchoring devices comprising distal anchors 2700 and a tension element 2702 that is anchored at a suitable location such that a sufficient tension exists in tension element 2702.
  • FIGS. 28 and 28A show perspective views of an embodiment of an anchoring device comprising an elongate element comprising multiple barbs or anchors. FIG. 28 shows a perspective view of anchoring device 2800 comprising an elongate element 2802. Elongate element 2802 can be made of several biocompatible materials including, but not limited to synthetic fibers e.g. various grades of Nylon, polyethylene, polypropylene, polyester, Aramid etc.; metals e.g. various grades of stainless steel, titanium, nickel-titanium alloys, cobalt-chromium alloys, tantalum etc.; natural fibers e.g. cotton, silk etc.; rubber materials e.g. various grades of silicone rubber etc. Elongate element 2802 may comprise natural or artificial suture materials. Examples of such materials include but are not limited to Polyamide (Nylon), Polypropylene, Polyglycolic Acid (PGA), polylactic acid (PLA) and copolymers of polylactic acid, polyglycolic acid and copolymers of polyglycolic acid, copolymers of PLA and PGA, Silk, Polyester, silicone, collagen, Polymers of Glycolide and Lactide. A particular example of a suture is the Nordstrom suture which is a highly elastic silicone suture. In one embodiment, the suture material is bioabsorbable. Elongate element 2802 comprises two sets of projections such as barbs, anchors or hooks. In the example shown, elongate element 2802 comprises a set of distal barbs 2804 and a set of proximal barbs 2806. Distal barbs 2804 are oriented in the proximal direction and proximal barbs 2806 are oriented in the distal direction as shown in FIG. 25. FIG. 28A shows a magnified view of the region 28A of anchoring device 2800 showing proximal barbs 2806.
  • FIGS. 28B through 28E show a coronal section through the prostate gland PG showing various steps of a method of treating the prostate gland PG using the device of FIG. 28. In FIG. 28B, introducer device 300 of FIG. 3A comprising a working device lumen and a cystoscope lumen 308 is introduced into the urethra such that the distal end of introducer device 300 is located in the prostatic urethra. Thereafter, a hollow puncturing device 2808 is inserted in the working device lumen of introducer device. Puncturing device 2808 is advanced such that distal end of puncturing device 2808 penetrates the prostate gland PG. In FIG. 28C, anchoring device 2800 is introduced through puncturing device 2808 into the prostate gland PG. Thereafter, puncturing device 2808 is pulled in the proximal direction. Simultaneously, anchoring device 2800 is pulled in the proximal direction to anchor distal barbs 2804 in the anatomy. In FIG. 28D, puncturing device 2808 is pulled further in the proximal direction to expose the entire anchoring device 2800. Thereafter, in step 28E, the proximal end of anchoring device 2800 is detached to deploy anchoring device 2800 in the anatomy. Thus, tissue between distal barbs 2804 and proximal barbs 2806 is anchored to anchoring device 2800.
  • FIG. 29A shows an axial section of the prostate gland PG showing a pair of implanted magnetic anchors. In FIG. 29A, a first magnetic anchor 2900 and a second magnetic anchor 2902 are implanted in the prostate gland PG on either side of the urethra. Like poles of first magnetic anchor 2900 and second magnetic anchor 2902 face each other such that there is magnetic repulsion between first magnetic anchor 2900 and second magnetic anchor 2902. This causes the urethral lumen to widen potentially reducing the severity of BPH symptoms.
  • FIGS. 29B through 29D show a coronal section through the prostate gland PG showing the steps of a method of implanting magnetic anchors of FIG. 29A. In FIG. 29B, a deployment device 2904 is advanced trans-urethrally. Deployment device 2904 comprises a sharp distal tip 2906 and first magnetic anchor 2900. Distal tip 2906 of deployment device 2904 penetrates prostatic tissue and implants first magnetic anchor 2900 in the prostate gland PG. Similarly, another deployment device 2908 comprising a sharp distal tip 2920 is used to implant second magnetic anchor 2902 in the prostate gland PG. First magnetic anchor 2900 and second magnetic anchor 2902 are implanted on opposite sides of the urethra such that like poles of first magnetic anchor 2900 and second magnetic anchor 2902 face each other. This causes magnetic repulsion between first magnetic anchor 2900 and second magnetic anchor 2902. This causes the urethral lumen to widen potentially reducing the severity of BPH symptoms. In one embodiment, deployment device 2904 can be used to deploy multiple magnetic anchors.
  • FIG. 30A shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device inserted into the prostate gland PG from the urethra. Cutting device 3000 comprises an outer body 3002 comprising a side port 3004. Outer body 3002 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Cutting device 3000 further comprises an access device 3006 that can be deployed out of side port 3004. Access device 3006 can be retracted back into side port 3004. Typical examples of elements that can be used as access device 3006 are needles, trocars etc. Access device 3006 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Access device 3006 penetrates the walls of the urethra and enters the prostate gland PG by creating an access channel in the prostate gland PG. Cutting device 3000 further comprises a cutting element 3008 that is introduced into the prostate gland PG through the access channel in the prostate gland PG. In one embodiment, cutting element 3008 enters the prostate gland PG through access device 3006. Cutting element 3008 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc. Cutting element 3008 may be moved through prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3008; one or more articulating elements located on cutting element 3008; motion of cutting device 3000 along the urethra etc. Cutting element 3008 is used to cut one or more regions of the prostate gland PG including peripheral zone, transition zone, central zone or prostatic capsule. After the desired region or regions of the prostate gland PG are cut, cutting element 3008 and access device 3006 are withdrawn into cutting device 3000. Thereafter, cutting device 3000 is withdrawn from the urethra. In one device embodiment, cutting device 3000 comprises an endoscope or means for inserting an endoscope.
  • FIG. 30B shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device that accesses outer surface of the prostate gland PG by passing through the walls of the urethra distal to the prostate gland PG. Cutting device 3020 comprises an outer body 3022 comprising a side port 3024. Outer body 3022 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Cutting device 3020 is advanced into the urethra such that side port 3024 is located distal to the prostate gland PG. Cutting device 3020 further comprises an access device 3026 that can be deployed out of side port 3024. Access device 3026 can be retracted back into side port 3024. Typical examples of elements that can be used as access device 3026 are needles, trocars etc. Access device 3026 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Access device 3026 is deployed from side port 3024 in a desired orientation such that access device 3026 penetrates the wall of the urethra. Access device 3026 is advanced further such that distal end of access device 3026 is located near the prostate gland PG. Thereafter, a cutting element 3028 is introduced through access device 3026 to the outer surface of the prostate gland PG. Cutting element 3028 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc. Cutting element 3028 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone. Cutting element 3028 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3028; motion of cutting element 3028 along access device 3026 etc. In one method embodiment, cutting element 3028 cuts prostatic capsule while being withdrawn into access device 3026. After the desired region or regions of the prostate gland PG are cut, cutting element 3028 and access device 3026 are withdrawn into cutting device 3020. Thereafter, cutting device 3020 is withdrawn from the urethra. In one device embodiment, cutting device 3020 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 30C shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device that accesses outer surface of the prostate gland PG by passing through the wall of the urinary bladder. Cutting device 3040 comprises an outer body 3042 comprising a side port 3044. Outer body 3042 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Cutting device 3040 is advanced into the urethra such that side port 3044 is located inside the urinary bladder. Cutting device 3040 further comprises an access device 3046 that can be deployed out of side port 3044. Access device 3046 can be retracted back into side port 3044. Typical examples of elements that can be used as access device 3046 are needles, trocars etc. Access device 3046 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Access device 3046 is deployed from side port 3044 in a desired orientation such that access device 3046 penetrates the wall of the urinary bladder. Access device 3046 is advanced further such that distal end of access device 3046 is located near the prostate gland PG. Thereafter, a cutting element 3048 is introduced through access device 3046 to the outer surface of the prostate gland PG. Cutting element 3048 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc. Cutting element 3048 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone. Cutting element 3048 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3048; motion of cutting element 3048 along access device 3046 etc. In one method embodiment, cutting element 3048 cuts prostatic capsule while being withdrawn into access device 3046. After the desired region or regions of the prostate gland PG are cut, cutting element 3048 and access device 3046 are withdrawn into cutting device 3040. Thereafter, cutting device 3040 is withdrawn from the urethra. In one device embodiment, cutting device 3040 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 30D shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue using a device that accesses outer surface of the prostate gland PG by passing through the walls of the urethra enclosed to the prostate gland PG. Cutting device 3060 comprises an outer body 3062 comprising a side port 3064. Outer body 3062 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Cutting device 3060 is advanced into the urethra such that side port 3064 is located in the region of the urethra enclosed by the prostate gland PG. Cutting device 3060 further comprises an access device 3066 that can be deployed out of side port 3064. Access device 3066 can be retracted back into side port 3064. Typical examples of elements that can be used as access device 3066 are needles, trocars etc. Access device 3066 may be made from suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers e.g. etc. Access device 3066 is deployed from side port 3064 in a desired orientation such that access device 3066 penetrates the prostate. Thereafter, a cutting element 3068 is introduced through access device 3066 such that the distal region of cutting element can access the outer surface of the prostate gland PG. Cutting element 3068 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc. Cutting element 3068 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone. Cutting element 3068 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting element 3068; motion of cutting element 3068 along access device 3066 etc. In one method embodiment, cutting element 3068 cuts prostatic capsule while being withdrawn into access device 3066. After the desired region or regions of the prostate gland PG are cut, cutting element 3068 and access device 3066 are withdrawn into cutting device 3060. Thereafter, cutting device 3060 is withdrawn from the urethra. In one device embodiment, cutting device 3060 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 31 shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue by a percutaneous device that accesses the prostate gland PG through an incision in the abdomen. In this method, a cannula 3100 is introduced percutaneously into the lower abdomen. Cannula 3100 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers etc. Cannula 3100 is advanced into the abdomen such that it passes below the pubic bone. The distal end of cannula 3100 is positioned near the prostate gland PG. Thereafter, a cutting device 3102 is advanced through distal end of cannula 3100 to the outer surface of the prostate gland PG. Cutting device 3102 can be retracted back into cannula 3100. Cutting device 3102 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc. Cutting device 3102 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone. Cutting device 3102 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting device 3102; motion of cutting device 3102 along cannula 3100 etc. In one method embodiment, cutting device 3102 cuts prostatic capsule while being withdrawn into cannula 3100. After the desired region or regions of the prostate gland PG are cut, cutting device 3102 is withdrawn into cannula 3100. Thereafter, cannula 3100 is withdrawn from the urethra. In one device embodiment, cannula 3100 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 32 shows a coronal section of a region of the male urinary system showing the general working environment of a method of treating prostate disorders by cutting prostrate tissue by a percutaneous device that penetrates the urinary bladder and accesses the outer surface of the prostate gland PG through an incision in the urinary bladder. In this method, a cannula 3200 is introduced percutaneously into the lower abdomen. Cannula 3200 can be made of suitable biocompatible materials including, but not limited to metals e.g. stainless steel, Nickel-Titanium alloys, titanium etc.; polymers etc. Cannula 3200 is advanced into the abdomen such that it passes above the pubic bone. The distal end of cannula 3200 enters the urinary bladder. Thereafter, an access device 3202 is advanced through cannula 3200 such that access device 3202 penetrates the urinary bladder wall as shown in FIG. 4. Thereafter, a cutting device 3204 is advanced through distal end of access device 3202 to the outer surface of the prostate gland PG. Cutting device 3202 can be retracted back into access device 3202. Cutting device 3202 comprises one or more cutting modalities such as electrosurgical cutter, Laser cutter, mechanical cutter e.g. a knife edge etc. Cutting device 3202 is used to cut one or more regions of the prostate gland PG including prostatic capsule, peripheral zone, transition zone or central zone. Cutting device 3202 may be moved relative to prostate tissue by several mechanisms including one or more deflecting or bending elements located on cutting device 3202 or access device 3202; motion of cutting device 3202 along access device 3202 etc. In one method embodiment, cutting device 3202 cuts prostatic capsule while being withdrawn into access device 3202. After the desired region or regions of the prostate gland PG are cut, cutting device 3202 is withdrawn into access device 3202. Access device 3202 is then withdrawn into cannula 3200. Thereafter, cannula 3200 is withdrawn from the urinary bladder. In one device embodiment, cannula 3200 further comprises an endoscope or means for inserting an endoscope.
  • FIG. 33 series shows a perspective view of a prostate treatment kit to cut prostate tissue. FIG. 33A shows a perspective view of an introducer device. Introducer device 3300 comprises a first tubular element 3302 enclosing a working device lumen 3304. First tubular element 3302 can be made of suitable biocompatible materials such as Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel and fluoropolymers like PTFE, PFA, FEP and EPTFE etc. The proximal end of working device lumen 3304 comprises a first stasis valve 3306. The distal end of working device lumen 3304 comprises a deflection mechanism. The deflection mechanism is used to bend the distal region of working device lumen 3304. One example of deflection mechanism is a pull wire and a deflection dial 3310 to adjust the magnitude and/or the direction of deflection caused by the pull wire. Similarly, other deflection mechanisms can be used in the introducer device instead of a pull wire. Introducer device 3300 further comprises a second tubular element 3312 which encloses a cystoscope lumen 3314. A cystoscope can be introduced through cystoscope lumen 3314 into the urethra. Typical examples of cystoscopes that can be used with introducer device are those manufactured by Olympus, Pentax, Storz, Wolf, Circon-ACMI, etc. These may have pre-set angles (i.e. 0, 30, 70, 120 degrees) or may be flexible scopes where in the tip may be deflectable. The proximal end of cystoscope lumen 3314 comprises a second stasis valve 3316. The cystoscope is inserted through the proximal end of cystoscope lumen 3314 and emerges out into the urethra from the distal end of cystoscope lumen 3314. The cystoscope can then be used to visualize the anatomy and various instruments during a procedure. Working device lumen 3314 may comprise one or more side ports e.g. a first side port 3318 for the introduction or removal of one or more fluids. Cystoscope lumen 3314 may comprise one or more side ports e.g. a second side port 3320 for the introduction or removal of one or more fluids.
  • FIG. 33B shows a perspective view of an injecting needle. Injecting needle 3330 is used for injecting one or more diagnostic or therapeutic agents in the anatomy. In one method embodiment, injecting needle 3330 is used to inject local anesthetic in the urethra and/or prostate gland PG. Specific examples of target areas for injecting local anesthetics are the neurovascular bundles, the genitourinary diaphragm, the region between the rectal wall and prostate, etc. Examples of local anesthetics that can be injected by injecting needle 3330 are anesthetic solutions e.g. 1% lidocaine solution; anesthetic gels e.g. lidocaine gels; combination of anesthetic agents e.g. combination of lidocaine and bupivacaine; etc. Injecting needle 3330 comprises a hollow shaft 3332 made of suitable biocompatible materials including, but not limited to stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. The length of hollow shaft 3332 can range from to centimeters. The distal end of hollow shaft 3332 comprises a sharp tip 3334. The proximal end of hollow shaft 3332 has a needle hub 3336 made of suitable biocompatible materials including, but not limited to metals e.g. like stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc.; polymers e.g. polypropylene etc. In one embodiment, needle hub 3336 comprises a luer lock.
  • FIG. 33C shows a perspective view of a guiding device. Guiding device 3338 comprises an elongate body 3340 comprising a sharp distal tip 3342. In one embodiment, guiding device 3338 is a guidewire. Distal end of elongate body 3340 may comprise an anchoring element to reversibly anchor guiding device 3338 into tissue. Examples of suitable anchoring elements are barbs, multipronged arrowheads, balloons, other mechanically actuable members (e.g. bendable struts), screw tips, shape memory elements, or other suitable anchor designs disclosed elsewhere in this patent application.
  • FIG. 33D shows a perspective view of a RF cutting device. Cutting device 3343 comprises an inner sheath 3344 and an outer sheath 3346. Inner sheath 3344 comprises a lumen of a suitable dimension such that cutting device 3343 can be advanced over guiding device 538. Outer sheath 3346 can slide on inner sheath 3344. Outer sheath 3346 also comprises two marker bands: a proximal marker band 3348 and a distal marker band 3350. The marker bands can be seen by a cystoscope. In one embodiment, proximal marker band 3348 and distal marker band 3350 are radiopaque. The position of proximal marker band 3348 and distal marker band 3350 is such that after cutting device 3343 is placed in an optimum location in the anatomy, proximal marker band 3348 is located in the urethra where it can be seen by a cystoscope and distal marker band 3350 is located in the prostrate gland PG or in the wall of the urethra where it cannot be seen by the cystoscope. Cutting device 3343 further comprises a cutting wire 3352 that is capable of delivering electrical energy to the surrounding tissue. The distal end of cutting wire 3352 is fixed to the distal region of outer sheath 3344. The proximal end of cutting wire 3352 is connected to a distal region of outer sheath 3346 and is further connected to a source of electrical energy. In FIG. 33D, cutting wire 3352 is in an undeployed configuration. FIG. 33D′ shows the distal region of cutting device 3343 when cutting wire 3352 is in a deployed configuration. To deploy cutting wire 3352, inner sheath 3344 is moved in the proximal direction with respect to outer sheath 546. This causes cutting wire 3352 to bend axially outward thus deploying cutting wire 3352 in the surrounding anatomy.
  • FIG. 33E shows a perspective view of an embodiment of a plugging device to plug an opening created during a procedure. Plugging device 3354 comprises a tubular shaft 3356 comprising a distal opening 3358. Distal opening 3358 is used to deliver one or more plugging materials 3360 in the adjacent anatomy. Plugging material 3360 may comprise a porous or non-porous matrix formed of a biodegradable or non-biodegradable material such as a flexible or rigid polymer foam, cotton wadding, gauze, hydrogels, etc. Examples of biodegradable polymers that may be foamed or otherwise rendered porous include but are not restricted to polyglycolide, poly-L-lactide, poly-D-lactide, poly(amino acids), polydioxanone, polycaprolactone, polygluconate, polylactic acid-polyethylene oxide copolymers, modified cellulose, collagen, polyorthoesters, polyhydroxybutyrate, polyanhydride, polyphosphoester, poly(alpha-hydroxy acid) and combinations thereof. In one embodiment, plugging material 3360 comprises biocompatible sealants including but not limited to fibrin sealants, combination of natural proteins (e.g. collagen, albumin etc.) with aldehyde cross-linking agents (e.g. glutaraldehyde, formaldehyde) or other polymeric, biological or non-polymeric materials capable of being implanted with the body, etc. Plugging device 3354 may be introduced in the anatomy by various approaches including the approaches disclosed elsewhere in this patent application. Plugging device 3354 may be introduced in the anatomy through a cannula, over a guiding device such as a guidewire etc. In the embodiment shown in FIG. 33E, plugging material 3360 is preloaded in plugging device 3354. Plugging material 3360 is introduced through distal opening 3358 by pushing plunger 3362 in the distal direction. In another embodiment, plugging device 3354 comprises a lumen that extends from the proximal end to distal opening 3358. Plugging material 3360 may be injected through the proximal end of the lumen such that it emerges out through distal opening 3358.
  • FIGS. 33F through 33N show various alternate embodiments of the electrosurgical cutting device in FIG. 33D. FIGS. 33F and 33G show perspective views of the distal region of a first alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively. FIG. 33F show an electrosurgical cutting device 570 comprising an elongate shaft 3372. Shaft 3372 is made of an electrically insulating material. Electrosurgical cutting device 3370 further comprises an electrosurgical cutting wire 3374. Electrosurgical cutting wire 3374 can be made of a variety of materials including, but not limited to tungsten, stainless steel, etc. Distal end of cutting wire 3374 is attached to distal region of shaft 3372. The proximal region of cutting wire 3374 can be pulled in the proximal direction by an operator. In one embodiment, electrosurgical cutting device 3370 is introduced in the target anatomy through a sheath 3376. In FIG. 33F, electrosurgical cutting device 3370 is deployed by pulling cutting wire 3374 in the proximal direction. This causes distal region of shaft 3372 to bend. Thereafter, electrical energy is delivered through cutting wire 3374 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3370 along the proximal or distal direction.
  • FIGS. 33H and 33I show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device in the undeployed and deployed states respectively. Electrosurgical cutting device 3380 comprises an elongate sheath 3382 comprising a lumen. Distal region of sheath 3382 has a window 3384. Electrosurgical cutting device 3380 further comprises an electrosurgical cutting wire 3386 located in the lumen. Distal end of cutting wire 3386 is fixed to the distal end of sheath 3384. Proximal end of cutting wire 3386 can be pushed in the distal direction by a user. In FIG. 331, cutting wire 3386 is deployed by pushing cutting wire 3386 in the distal direction. This causes a region of cutting wire 3386 to bend in the radially outward direction and thus emerge out of window 3384. Thereafter, electrical energy is delivered through cutting wire 3386 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3380 along the proximal or distal direction.
  • FIGS. 33J through 33L show perspective views of the distal region of a second alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device. Electrosurgical cutting device 3390 comprises an elongate sheath 3391 comprising a lumen 3392. In FIG. 33J, an electrosurgical cutting wire 3394 is introduced through lumen 3392 such that it emerges out through the distal opening of lumen 3392. In FIG. 33K, cutting wire 3394 is further advanced in the distal direction. Distal end of cutting wire 3394 has a curved region so that cutting wire 3394 starts to bend as it emerges out of lumen 3392. IN FIG. 33L, cutting wire 3394 is further advanced in the distal direction to fully deploy cutting wire 3394. Thereafter, electrical energy is delivered through cutting wire 3394 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3390 along the proximal or distal direction.
  • FIGS. 33M through 33N show perspective views of the distal region of a third alternate embodiment of an electrosurgical cutting device showing the steps of deploying the electrosurgical cutting device. Electrosurgical cutting device 3395 comprises an elongate sheath 3396 comprising a lumen. Cutting device 3395 further comprises a cutting wire 3398 located in the lumen of elongate sheath 3396. The proximal end of cutting wire 3398 is connected to a source of electrical energy. Distal end of cutting wire 3398 is connected to the inner surface of the distal region of elongate sheath 3396. Cutting wire 3398 may be made from suitable elastic, super-elastic or shape memory materials including but not limited to Nitinol, titanium, stainless steel etc. In FIG. 33N, Electrosurgical cutting device 3395 is deployed by pushing the proximal region of cutting wire 3398 in the distal direction. This causes a distal region of cutting wire 3398 to emerge from the distal end of elongate sheath 3396 as a loop. Thereafter, electrical energy is delivered through cutting wire 3398 to cut tissue. This may be accompanied by motion of electrosurgical cutting device 3395 along the proximal or distal direction. Electrosurgical cutting device 3395 can be used to cut multiple planes of tissue by withdrawing cutting wire 3398 in elongate sheath 3396, rotating elongate sheath 3396 to a new orientation, redeploying cutting wire 3398 and delivering electrical energy through cutting wire 3398. The devices 33H through 33N may be introduced by one or more access devices such as guidewires, sheaths etc.
  • FIG. 34 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting blades. Balloon catheter 3400 can be introduced into a lumen or in the tissue of an organ to be treated using one or more of the introducing methods disclosed elsewhere in this patent application. Balloon catheter 3400 comprises a shaft 3402. Shaft 3402 may comprise a lumen to allow balloon catheter 3400 to be introduced over a guidewire. In one embodiment, shaft 3402 is torquable. Shaft 3402 comprises a balloon 3404 located on the distal end of shaft 3402. Balloon 3404 can be fabricated from materials including, but not limited to polyethylene terephthalate, Nylon, polyurethane, polyvinyl chloride, crosslinked polyethylene, polyolefins, HPTFE, HPE, HDPE, LDPE, EPTFE, block copolymers, latex and silicone. Balloon 3404 further comprises one or more cutter blades 3406. Balloon catheter 3400 is advanced with balloon 3404 deflated, into a natural or surgically created passageway and positioned adjacent to tissue or matter that is to be cut, dilated, or expanded. Thereafter, balloon 3404 is inflated to cause cutter blades 3406 to make one or more cuts in the adjacent tissue or matter. Thereafter balloon 3404 is deflated and balloon catheter 3400 is removed. Cutter blades 3406 may be energized with mono or bi-polar RF energy. Balloon catheter 3400 may comprise one or more navigation markers including, but not limited to radio-opaque markers, ultrasound markers, light source that can be detected visually etc.
  • FIG. 35 shows a perspective view of the distal region of a balloon catheter comprising a balloon with cutting wires. Balloon catheter 3500 can be introduced into a lumen or in the tissue of an organ to be treated using one or more of the introducing methods disclosed elsewhere in this patent application. Balloon catheter 3500 comprises a shaft 3502. Shaft 3502 may comprise a lumen to allow balloon catheter 3500 to be introduced over a guidewire. In one embodiment, shaft 3502 is torquable. Shaft 3502 comprises a balloon 3504 located on the distal end of shaft 3502. Balloon 3504 can be fabricated from materials including, but not limited to polyethylene terephthalate, Nylon, polyurethane, polyvinyl chloride, crosslinked polyethylene, polyolefins, HPTFE, HPE, HDPE, LDPE, EPTFE, block copolymers, latex and silicone. Balloon 3504 further comprises one or more radiofrequency wires 3506. Balloon catheter 3500 is advanced with balloon 3504 deflated, into a natural or surgically created passageway and positioned adjacent to tissue or matter that is to be cut, dilated, or expanded. Thereafter, balloon 3504 is inflated and an electrical current is delivered through radiofrequency wires 3506 to make one or more cuts in the adjacent tissue or matter. Thereafter the electrical current is stopped, balloon 3504 is deflated and balloon catheter 3500 is removed. Radiofrequency wires 3504 may be energized with mono or bi-polar RF energy. Balloon catheter 3500 may comprise one or more navigation markers including, but not limited to radio-opaque markers, ultrasound markers, light source that can be detected visually etc.
  • FIGS. 36A and 36B series show perspective views of an undeployed state and a deployed state respectively of a tissue displacement device. FIG. 36A shows a tissue anchoring device 3600 in the undeployed state. Anchoring device 3600 comprises an elongate body having a proximal end 3602 and a distal end 3604. Anchoring device 3600 may be made of a variety of elastic or super-elastic materials including, but not limited to Nitinol, stainless steel, titanium etc. Anchoring device 3600 is substantially straight in the undeployed state and has a tendency to become substantially curved in the deployed state. Anchoring device 3600 is maintained in the undeployed state by a variety of means including, but not limited to enclosing anchoring device 3600 in a cannula or sheath, etc. FIG. 36B shows tissue anchoring device 3600 in the deployed state. Anchoring device 3600 comprises a curved region. When anchoring device 3600 changes from an undeployed state to a deployed state, the anatomical tissue adjacent to the central region of anchoring device 3600 is displaced along the direction of motion of the central region. Anchoring device 3600 can be deployed by a variety of methods including, but not limited to removing anchoring device 3600 from a sheath or cannula, etc. In one embodiment, anchoring device 3600 is made from a shape memory material such as Nitinol. In this embodiment, anchoring device 3600 is maintained in the undeployed state by maintaining anchor device 3600 in a temperature lower than the transition temperature of the super-elastic material. Anchoring device 3600 is converted to the deployed state by implanting anchoring device 3600 in a patient such that the device is warmed to the body temperature which is above the transition temperature of the super-elastic material.
  • FIGS. 36C and 36D show a coronal view and a lateral view respectively of a pair of deployed tissue displacement devices of FIGS. 36A and 36B implanted in the prostate gland PG. In FIG. 36C, two anchoring devices are implanted in the prostate gland PG near the prostatic urethra in a patient with BPH. A first anchoring device 3600 is introduced on a first side of the urethra and is deployed there as shown. Similarly, a second anchoring device 3606 comprising a proximal end 3608 and a distal end 3610 is introduced on the other side of the urethra and is deployed there as shown. First anchoring device 3600 and second anchoring device 3606 change into the deployed curved configuration. This causes prostate gland PG tissue near the central regions of first anchoring device 3600 and second anchoring device 3606 to be displaced radially away from the urethra. This displacement of prostate gland PG tissue can be used to eliminate or reduce the compression of the urethra by an enlarged prostate gland PG. FIG. 36D shows a lateral view of the urethra enclosed by the prostate gland PG showing deployed first anchoring device 3600 and second anchoring device 3606.
  • The various cuts or punctures made by one or more cutting devices disclosed in this patent application may be plugged or lined by a plugging or space filling substance. FIGS. 36E through 36H show an axial section through a prostate gland showing the various steps of a method of cutting or puncturing the prostate gland and lining or plugging the cut or puncture. FIG. 36E shows a section of the prostate gland showing the urethra, the lateral lobes and the middle lobe surrounded by the prostatic pseudocapsule. In FIG. 36F, one or more cuts are made in a region of the prostatic pseudocapsule. In addition, one or more cuts may be made in a region of between two lobes of the prostate gland. In FIG. 36G, a plugging material 3619 is introduced in the one or more regions of the prostate gland that are cut or punctured. Plugging material 3619 may be delivered through one or more delivery devices including, but not limited to the device disclosed in FIG. 33E. Plugging material 3619 may comprises a material such as plugging material 3360.
  • The various cuts or punctures made by one or more cutting devices disclosed in this patent application may be spread open by a clipping device. For example, FIG. 36H shows an axial section through a prostate gland showing a clip for spreading open a cut or punctured region of the prostate gland. Spreading device 3620 comprises a body having a central region and two distal arms. Spreading device 3620 may be made of a variety of elastic or super-elastic materials including, but not limited to Nitinol, stainless steel, titanium etc. Spreading device 3620 has a reduced profile in the undeployed state by maintaining distal arms close to each other. Spreading device 5000 is maintained in the undeployed state by a variety of means including, but not limited to enclosing spreading device 3620 in a cannula or sheath, etc. When spreading device 3620 changes from an undeployed state to a deployed state, the distance between the two distal arms increases. This causes any anatomical tissue between two distal arms to spread along the straight line between two distal arms Spreading device 3620 can be deployed by a variety of methods including, but not limited to removing spreading device 3620 from a sheath or cannula, etc. In one embodiment, spreading device 3620 is made from a shape memory material such as Nitinol. In this embodiment, spreading device 3620 is maintained in the undeployed state by maintaining anchor device 3620 in a temperature lower than the transition temperature of the super-elastic material. Spreading device 3620 is converted to the deployed state by implanting spreading device 3620 in a patient such that the device is warmed to the body temperature which is above the transition temperature of the super-elastic material. Stretching of prostate gland tissue can be used to eliminate or reduce the compression of the urethra by an enlarged prostate gland or to prevent cut edges of a cut from rejoining.
  • More than one spreading device 3620 may be used to treat the effects of an enlarged prostate or to eliminate or reduce the compression of the urethra by an enlarged prostate gland or to prevent cut edges of a cut from rejoining.
  • FIGS. 37A through 37K show an embodiment of a method of treating prostate gland disorders by cutting a region of the prostate gland using the devices described in FIG. 33A through 33E. In FIG. 37A, introducer device 3300 is introduced in the urethra. It is advanced through the urethra such that the distal tip of introducer device 3300 is located in the prostatic urethra. Thereafter, injecting needle 3330 is introduced through introducer device 3300. The distal tip of injecting needle 3330 is advanced such that injecting needle 3330 penetrates the prostate gland. Injecting needle 3330 is then used to inject a substance such as an anesthetic in the prostate gland. Thereafter, in FIG. 37B, injecting needle 3330 is withdrawn from the anatomy. The distal region of introducer device 3300 is positioned near a region of the prostate gland to be punctured. Thereafter, in FIG. 37C, first tubular element 3302 is bent or deflected with a bending or deflecting mechanism such as the bending mechanism in FIGS. 37C″ and 37C′″ to align the distal region of first tubular element 3302 along a desired trajectory of puncturing the prostate gland.
  • FIG. 37C′ shows the proximal region of introducer device 3300. A cystoscope 3700 is introduced through second stasis valve 3316 such that the distal end of cystoscope 3700 emerges through the distal end of introducer device 3300. Cystoscope 3700 is then used to visualize the anatomy to facilitate the method of treating prostate gland disorders.
  • FIG. 37C″ shows a perspective view of the distal region of an embodiment of introducer device 3300 comprising a bending or deflecting mechanism. In this embodiment, first tubular element 3302 comprises a spiral cut distal end and a pull wire. In FIG. 37C′″, the pull wire is pulled by deflection dial 3310. This deflects the distal tip of first tubular element 3302 as shown.
  • After the step in FIG. 37C, guiding device 3338 is introduced through first tubular element 3302. Guiding device 3338 is advanced through first tubular element 3302 such that the distal tip of guiding device 3338 penetrates into the prostate gland. In one method embodiment, guiding device 3338 is further advanced such that the distal tip of guiding device 3338 penetrates through the prostate gland and enters the urinary bladder. In one embodiment, distal region of guiding device 3338 comprises an anchoring element 3702. Anchoring element 3702 is deployed as shown in FIG. 37E. Thereafter, guiding device 3338 is pulled in the proximal direction till anchoring element 3702 is snug against the wall of the urinary bladder. Cystoscope 3700 can be used to visualize the steps of penetrating the prostate gland by guiding device 3338 and deploying anchoring element 3702. If guiding device 3338 is not positioned in a satisfactory position, guiding device 3338 is pulled back in introducer device 3300. The deflection angle of distal end of first tubular lumen 3302 is changed and guiding device 3338 is re-advanced into the urinary bladder. FIG. 37E′ shows a perspective view of an embodiment of anchoring element 3702. Anchoring element comprises a hollow sheath 3704. Distal region of hollow sheath 3704 is attached to distal region of guiding device 3338. A number of windows are cut in the distal region of hollow sheath 3704 such that several thin, splayable strips are formed between adjacent windows. Pushing hollow sheath 3704 in the distal direction causes splayable strips to splay in the radially outward direction to form an anchoring element. In FIG. 37F, cutting device 3343 is advanced over guiding device 3338 into the prostate gland. In FIG. 37G, cutting device 3343 is positioned in the prostate gland such that proximal marker band 3348 can be seen by cystoscope 3700 but distal marker band 3350 cannot be seen.
  • Thereafter, in FIG. 37H, relative motion between outer sheath 3343 and inner sheath 3344 causes cutting wire 3352 to deploy outward in the axial direction. In one embodiment, this step is carried out by moving outer sheath 3343 in the distal direction while the inner sheath 3344 is stationary. In another embodiment, this step is carried out by moving inner sheath 3344 in the proximal direction while outer sheath 3343 is kept stationary. Also during step, electrical energy is delivered through cutting wire 3352 to cut tissue. In FIG. 37I, cutting device 3343 is pulled in the proximal direction such that the deployed cutting wire 3352 slices through tissue. Thereafter, cutting wire 3352 is withdrawn again in cutting device 3343. Cutting device 3343 is then removed from the anatomy.
  • In FIG. 37J, plugging device 3354 is introduced over guiding device 3338 through the puncture or opening in the prostate gland. Thereafter, in FIG. 37K, anchoring element 3702 is undeployed and guiding device 3343 is withdrawn from the anatomy. Thereafter, plugging device 3354 is used to deliver one or more plugging materials in the adjacent anatomy. The plugging materials can be used to plug or line some or all of the cuts or punctures created during the method.
  • FIGS. 38A to 38D show various components of a kit for treating prostate gland disorders by compressing a region of the prostate gland. FIG. 38A shows the perspective view of an introducer device 3800. Introducer device 3800 comprises an outer body 3801 constructed from suitable biocompatible materials including, but not limited to metals like stainless steel, Nichol plated brass, polymers like Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK and fluoropolymers like PTFE, PFA, FEP, EPTFE etc. Body 3801 comprises a working device lumen 3802. Distal end of working device lumen 3802 emerges out of the distal end of body 3801. Proximal end of working device lumen 3802 incorporates lock thread 3803 such that introducer device may join with other devices. Device lumen 3802 may comprise one or more side ports e.g. a first side port 3804 and a second side port 3805 for the introduction or removal of one or more fluids.
  • FIG. 38B shows a perspective view of a bridge device 3806 constructed from suitable biocompatible materials including, but not limited to metals like stainless steel, Nichol plated brass, polymers like Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK and fluoropolymers like PTFE, PFA, FEP, EPTFE etc. Bridge device may insert into introducer lumen 3802 and lock into place by threadably mating thread lock 3807 with thread 3803. Bridge may incorporate port 3808 for cystoscope with locking means 3809 that joins to cystoscope when inserted. Bridge device may incorporate one or more working lumens. Working lumen 3810 emerges out of the distal end of body 3806. In one embodiment, distal end of working device lumen 3810 has a bent or curved region. Proximal end of lumen 3810 emerges from port 3811 that may incorporate fluid stasis valve 3812 and a luer lock. Working lumen 3813 emerges distally in straight fashion through blunt obturator 3814 at distal end of body 3806 and emerges proximally through second port that may incorporate fluid stasis valve and luer lock.
  • FIG. 38C shows a perspective view of a distal anchor deployment device 3815 constructed from suitable biocompatible materials including, but not limited to polymers like Polycarbonate, PVC, Pebax, Polyimide, Braided Pebax, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel, Nichol plated brass, and fluoropolymers like PTFE, PFA, FEP, EPTFE etc. Deployment device 3815 comprises handle 3816, which incorporates movable thumb ring pusher 3817 and anchor deployment latch 3818; and distal shaft 3819 which has trocar point 3820 at distal end. Mounted on distal shaft 3819 is distal anchor 3821 that incorporates tether 3822. Tether 3822 can be made of suitable elastic or non-elastic materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, suture materials, titanium etc. or polymers such as silicone, nylon, polyamide, polyglycolic acid, polypropylene, Pebax, PTFE, ePTFE, silk, gut, or any other monofilament or any braided or mono-filament material. Proximal end of tether 3822 may incorporate hypotube 3823. Distal anchor 3821 is constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Braided Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE etc. Deployment device 3815 is inserted into bridge working lumen 3810. Advancement of thumb ring 3817 extends distal shaft 3819 through distal end of working lumen 3810, preferably into tissue for deployment of distal anchor 3821. Depth of distal shaft deployment can be monitored on cystoscope by visualizing depth markers 3824. Once distal shaft 3819 is deployed to desired depth, anchor deployment latch 3818 is rotated to release distal anchor 3821. Retraction of thumb ring 3817 then retracts distal shaft 3819 while leaving distal anchor 3821 in tissue. Bridge 3806 is then disconnected from introducer device 3800 and removed.
  • FIG. 38D shows the proximal anchor delivery tool 3825 constructed from suitable biocompatible materials including, but not limited to polymers like Polycarbonate, PVC, Pebax, Polyimide, Braided Pebax, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, metals like stainless steel, Nichol plated brass, and fluoropolymers like PTFE, PFA, FEP, EPTFE etc. Proximal anchor delivery tool 3825 comprises handle 3826, which incorporates anchor deployment switch 3827 in slot 3828 and tether cut switch 3829; and distal shaft 3830 which houses hypotube 3831. Lumen of hypotube 3831 emerges proximally at port 3832 which may incorporate a luer lock. Mounted on the hypotube and distal shaft is the proximal anchor 3833 with cinching hub 3834. Proximal anchor 3833 is constructed from suitable biocompatible materials including, but not limited to metals e.g. stainless steel 304, stainless steel 306, Nickel-Titanium alloys, titanium etc. or polymers e.g. Pebax, Braided Pebax, Polyimide, Braided Polyimide, Polyurethane, Nylon, PVC, Hytrel, HDPE, PEEK, PTFE, PFA, FEP, EPTFE or biodegradable polymers e.g. polyglycolic acid, poly(dioxanone), poly(trimethylene carbonate) copolymers, and poly (ε-caprolactone) homopolymers and copolymers etc. FIG. 38E shows a close-up perspective view of proximal anchor 3833 mounted on hypotube 3831 and distal shaft 3830 of proximal anchor delivery tool 3825. Hypotube 3831 biases open the cinching lock 3835 of cinching hub 3834. In order to deploy proximal anchor 3833, hypotube 3823 is loaded into hypotube 3831 until it exits proximal port 3832. Hypotube 3823 is then stabilized while proximal anchor delivery tool 3825 is advanced into introducer device lumen 3802 and advanced to tissue target. Because hypotube 3831 biases open cinching lock 3835, the proximal anchor delivery tool travels freely along tether 3822. Once proximal anchor 3833 is adequately apposed to urethral wall of prostate, anchor deployment switch 3827 is retracted. During retraction of switch 3827, hypotube 3831 is retracted proximal to cinching hub 3834 and tether 3822 is tightened. When switch 3827 is fully retracted or desired tension is accomplished, tether 3822 is cut within cinching hub 3834 by advancing cutting switch 3829.
  • Any of the anchoring devices disclosed herein may comprise one or more sharp distal tips, barbs, hooks etc. to attach to tissue.
  • Various types of endoscopes can be used in conjunction with the devices disclosed herein such as flexible scopes that are thin, flexible, fibre-optic endoscopes and rigid scopes that are thin, solid, straight endoscopes. The scopes may have one or more side channels for insertion of various instruments. Further they may be used with in conjunction with standard and modified sheaths intended for endoscopic and transurethral use.
  • Local or general anesthesia may be used while performing the procedures disclosed herein. Examples of local anesthetics that can be used are anesthetic gels e.g. lidocaine gels in the urethra; combination of anesthetic agents e.g. combination of lidocaine and bupivacaine in the urethra; spinal anesthetics e.g. ropivacaine, fentanyl etc.; injectable anesthetics e.g. 1% lidocaine solution injected into the neurovascular bundles, the genitourinary diaphragm, and between the rectal wall and prostate; etc.
  • An optional trans-rectal ultrasound exam may be performed before and/or during the procedures disclosed herein. In this exam, a device called ultrasound transducer is inserted into the rectum. The ultrasound transducer is then used to image the prostate gland PG using ultrasound waves. The devices may be modified so that they are more visible under ultrasound such as etched surfaces. Other imaging devices may also be optionally used such as MRI, RF, electromagnetic and fluoroscopic or X-ray guidance. The anchoring devices or delivery devices may contain sensors or transmitters so that certain elements may be tracked and located within the body. The tethering devices may be used as cables to temporarily transmit energy to the distal and/or proximal anchors during deployment.
  • The invention has been described hereabove with reference to certain examples or embodiments of the invention but various additions, deletions, alterations and modifications may be made to those examples and embodiments without departing from the intended spirit and scope of the invention. For example, any element or attribute of one embodiment or example may be incorporated into or used with another embodiment or example, unless to do so would render the embodiment or example unsuitable for its intended use. Also, where the steps of a method or process are described, listed or claimed in a particular order, such steps may be performed in any other order unless to do so would render the embodiment or example un-novel, obvious to a person of ordinary skill in the relevant art or unsuitable for its intended use. All reasonable additions, deletions, modifications and alterations are to be considered equivalents of the described examples and embodiments and are to be included within the scope of the following claims.

Claims (13)

1-153. (canceled)
154. A device for compressing at least one region of the prostate comprising;
a first element configured to communicate force to an anatomical structure outside of the urethra, the first element defining a tubular body having a circumference, a mid-section, an open first end, an open second end, and an opening located near the mid-section extending about at least a half of the circumference;
a second element configured to communicate force to the urethra; and
a tethering element capable of linking the first and second elements;
wherein the tethering element is configured within the tubular body and extends from the first end of the first element and exits an interior of the tubular body at the mid-section of the first element, and the second element is slid over and locked to the tethering element.
155. (canceled)
156. A device for relieving an obstruction of a lumen in the body due to encroachment of a tissue within or outside the lumen comprising:
at least one first element capable of communicating force to an anatomical structure outside of the lumen, the first element defining a tubular body having a circumference, a mid-section, an open first end, an open second end terminating with an narrowed portion, and an opening located near the mid-section extending about at least a half of the circumference the opening providing the tubular body with a longitudinal flexibility;
at least one second element capable of communicating force to the inner surface of the lumen;
a tethering element capable of linking the first and second elements;
wherein the tethering element is configured within the tubular body and extends from the first end of the first element and exits an interior of the tubular body at the mid-section of the first element and the second element is slid over and locked to the tethering element.
157-249. (canceled)
250. The device of claim 154, wherein the second element is sized and shaped to be received within the urethra.
251. The device of claim 154, wherein the first element is sized and shaped to be retained within the prostate.
252. The device of claim 154, wherein the first element is sized and shaped to pass through a prostate and to be placed in a position outside a prostate capsule.
253. The device of claim 154, wherein the device lacks a spring.
254. The device of claim 156, wherein the second element is sized and shaped to be received within an urethra.
255. The device of claim 156, wherein the first element is sized and shaped to be retained within a prostate.
256. The device of claim 156, wherein the first element is sized and shaped to pass through a prostate and to be placed in a position outside a prostate capsule.
257. The device of claim 156, wherein the device lacks a spring.
US11/838,058 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions Active 2026-02-13 US8343187B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/838,058 US8343187B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/134,870 US7758594B2 (en) 2005-05-20 2005-05-20 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,058 US8343187B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/134,870 Division US7758594B2 (en) 2005-05-20 2005-05-20 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

Publications (2)

Publication Number Publication Date
US20090204128A1 true US20090204128A1 (en) 2009-08-13
US8343187B2 US8343187B2 (en) 2013-01-01

Family

ID=37449345

Family Applications (14)

Application Number Title Priority Date Filing Date
US11/134,870 Active 2028-09-10 US7758594B2 (en) 2005-05-20 2005-05-20 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,076 Active 2025-06-05 US8663243B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,058 Active 2026-02-13 US8343187B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,036 Expired - Fee Related US7914542B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,103 Active 2028-02-03 US8715239B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US12/253,821 Abandoned US20090060977A1 (en) 2005-05-20 2008-10-17 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US13/073,763 Active US8734468B2 (en) 2005-05-20 2011-03-28 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US13/844,020 Active US8900252B2 (en) 2005-05-20 2013-03-15 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US14/535,266 Active 2025-10-27 US10105132B2 (en) 2005-05-20 2014-11-06 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US16/107,447 Active 2026-03-31 US11090036B2 (en) 2005-05-20 2018-08-21 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US16/433,018 Active US10575844B2 (en) 2005-05-20 2019-06-06 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US16/798,112 Pending US20200187931A1 (en) 2005-05-20 2020-02-21 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US17/412,402 Active US11471148B2 (en) 2005-05-20 2021-08-26 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US18/181,857 Pending US20230293166A1 (en) 2005-05-20 2023-03-10 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/134,870 Active 2028-09-10 US7758594B2 (en) 2005-05-20 2005-05-20 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,076 Active 2025-06-05 US8663243B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

Family Applications After (11)

Application Number Title Priority Date Filing Date
US11/838,036 Expired - Fee Related US7914542B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11/838,103 Active 2028-02-03 US8715239B2 (en) 2005-05-20 2007-08-13 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US12/253,821 Abandoned US20090060977A1 (en) 2005-05-20 2008-10-17 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US13/073,763 Active US8734468B2 (en) 2005-05-20 2011-03-28 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US13/844,020 Active US8900252B2 (en) 2005-05-20 2013-03-15 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US14/535,266 Active 2025-10-27 US10105132B2 (en) 2005-05-20 2014-11-06 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US16/107,447 Active 2026-03-31 US11090036B2 (en) 2005-05-20 2018-08-21 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US16/433,018 Active US10575844B2 (en) 2005-05-20 2019-06-06 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US16/798,112 Pending US20200187931A1 (en) 2005-05-20 2020-02-21 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US17/412,402 Active US11471148B2 (en) 2005-05-20 2021-08-26 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US18/181,857 Pending US20230293166A1 (en) 2005-05-20 2023-03-10 Devices, systems and methods for treating benign prostatic hyperplasia and other conditions

Country Status (3)

Country Link
US (14) US7758594B2 (en)
EP (1) EP1887976B8 (en)
WO (1) WO2006127431A2 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US20150250998A1 (en) * 2009-04-07 2015-09-10 Boston Scientific Neuromodulation Corporation Anchoring units for implantable electrical stimulation systems and methods of making and using
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US20200022692A1 (en) * 2017-12-23 2020-01-23 Neotract, Inc. Expandable tissue engagement apparatus and method
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US11504149B2 (en) 2005-05-20 2022-11-22 Teleflex Life Sciences Limited Median lobe destruction apparatus and method
US11850140B2 (en) 2013-03-14 2023-12-26 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US11925334B2 (en) 2020-11-30 2024-03-12 Spectranetics Llc Surgical instrument for removing an implanted object

Families Citing this family (673)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662161B2 (en) 1999-09-13 2010-02-16 Rex Medical, L.P Vascular hole closure device
US7879046B2 (en) * 2001-10-01 2011-02-01 Depuy Mitek, Inc. Suturing apparatus and method
EP1605863B1 (en) * 2003-03-14 2016-09-07 Intersect ENT, Inc. Sinus delivery of sustained release therapeutics
US20070084897A1 (en) 2003-05-20 2007-04-19 Shelton Frederick E Iv Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism
US9060770B2 (en) 2003-05-20 2015-06-23 Ethicon Endo-Surgery, Inc. Robotically-driven surgical instrument with E-beam driver
US7846168B2 (en) 2003-10-09 2010-12-07 Sentreheart, Inc. Apparatus and method for the ligation of tissue
US7004965B2 (en) * 2003-12-17 2006-02-28 Yosef Gross Implant and delivery tool therefor
US7608092B1 (en) 2004-02-20 2009-10-27 Biomet Sports Medicince, LLC Method and apparatus for performing meniscus repair
WO2006049725A2 (en) 2004-03-23 2006-05-11 Minimus Surgical Systems Surgical systems and devices to enhance gastric restriction therapies
US20060142790A1 (en) * 2004-03-23 2006-06-29 Michael Gertner Methods and devices to facilitate connections between body lumens
US7255675B2 (en) 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
US7946976B2 (en) 2004-03-23 2011-05-24 Michael Gertner Methods and devices for the surgical creation of satiety and biofeedback pathways
US8215531B2 (en) 2004-07-28 2012-07-10 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having a medical substance dispenser
US11890012B2 (en) 2004-07-28 2024-02-06 Cilag Gmbh International Staple cartridge comprising cartridge body and attached support
US9387010B2 (en) 2004-10-28 2016-07-12 Nico Corporation Surgical access assembly and method of using same
US9186175B2 (en) 2004-10-28 2015-11-17 Nico Corporation Surgical access assembly and method of using same
US8088130B2 (en) 2006-02-03 2012-01-03 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8303604B2 (en) 2004-11-05 2012-11-06 Biomet Sports Medicine, Llc Soft tissue repair device and method
US8128658B2 (en) 2004-11-05 2012-03-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8118836B2 (en) 2004-11-05 2012-02-21 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9017381B2 (en) 2007-04-10 2015-04-28 Biomet Sports Medicine, Llc Adjustable knotless loops
US7905903B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Method for tissue fixation
US7749250B2 (en) 2006-02-03 2010-07-06 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US20060189993A1 (en) 2004-11-09 2006-08-24 Arthrotek, Inc. Soft tissue conduit device
US7658751B2 (en) 2006-09-29 2010-02-09 Biomet Sports Medicine, Llc Method for implanting soft tissue
US8840645B2 (en) 2004-11-05 2014-09-23 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US7905904B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8361113B2 (en) 2006-02-03 2013-01-29 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8298262B2 (en) 2006-02-03 2012-10-30 Biomet Sports Medicine, Llc Method for tissue fixation
US7909851B2 (en) 2006-02-03 2011-03-22 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8137382B2 (en) 2004-11-05 2012-03-20 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US7857830B2 (en) 2006-02-03 2010-12-28 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
US9801708B2 (en) 2004-11-05 2017-10-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8998949B2 (en) 2004-11-09 2015-04-07 Biomet Sports Medicine, Llc Soft tissue conduit device
US8608797B2 (en) 2005-03-17 2013-12-17 Valtech Cardio Ltd. Mitral valve treatment techniques
EP2298318A1 (en) 2005-04-04 2011-03-23 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
AU2006323195A1 (en) * 2005-05-10 2007-06-14 Michael Gertner Obesity treatment systems
US8529584B2 (en) * 2005-05-20 2013-09-10 Neotract, Inc. Median lobe band implant apparatus and method
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8491606B2 (en) * 2005-05-20 2013-07-23 Neotract, Inc. Median lobe retraction apparatus and method
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US8425535B2 (en) 2005-05-20 2013-04-23 Neotract, Inc. Multi-actuating trigger anchor delivery system
AU2006252387B2 (en) * 2005-06-02 2012-03-15 Cardinal Health 529, Llc Patent foramen ovale closure device
US7934630B2 (en) 2005-08-31 2011-05-03 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US10159482B2 (en) 2005-08-31 2018-12-25 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and different staple heights
US11246590B2 (en) 2005-08-31 2022-02-15 Cilag Gmbh International Staple cartridge including staple drivers having different unfired heights
US9237891B2 (en) 2005-08-31 2016-01-19 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US11484312B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US7669746B2 (en) 2005-08-31 2010-03-02 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
WO2007028092A1 (en) 2005-09-01 2007-03-08 Cordis Corporation Patent foramen ovale closure method
US20070106317A1 (en) 2005-11-09 2007-05-10 Shelton Frederick E Iv Hydraulically and electrically actuated articulation joints for surgical instruments
US8708213B2 (en) 2006-01-31 2014-04-29 Ethicon Endo-Surgery, Inc. Surgical instrument having a feedback system
US11793518B2 (en) 2006-01-31 2023-10-24 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US8186555B2 (en) 2006-01-31 2012-05-29 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with mechanical closure system
US8820603B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US7845537B2 (en) 2006-01-31 2010-12-07 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US7753904B2 (en) 2006-01-31 2010-07-13 Ethicon Endo-Surgery, Inc. Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US11224427B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Surgical stapling system including a console and retraction assembly
US20110024477A1 (en) 2009-02-06 2011-02-03 Hall Steven G Driven Surgical Stapler Improvements
US11278279B2 (en) 2006-01-31 2022-03-22 Cilag Gmbh International Surgical instrument assembly
US20120292367A1 (en) 2006-01-31 2012-11-22 Ethicon Endo-Surgery, Inc. Robotically-controlled end effector
US20110290856A1 (en) 2006-01-31 2011-12-01 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical instrument with force-feedback capabilities
US8771352B2 (en) 2011-05-17 2014-07-08 Biomet Sports Medicine, Llc Method and apparatus for tibial fixation of an ACL graft
US8968364B2 (en) 2006-02-03 2015-03-03 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US9149267B2 (en) 2006-02-03 2015-10-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8801783B2 (en) 2006-09-29 2014-08-12 Biomet Sports Medicine, Llc Prosthetic ligament system for knee joint
US9078644B2 (en) 2006-09-29 2015-07-14 Biomet Sports Medicine, Llc Fracture fixation device
US8652171B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US8597327B2 (en) 2006-02-03 2013-12-03 Biomet Manufacturing, Llc Method and apparatus for sternal closure
US8506597B2 (en) 2011-10-25 2013-08-13 Biomet Sports Medicine, Llc Method and apparatus for interosseous membrane reconstruction
US8562645B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9271713B2 (en) 2006-02-03 2016-03-01 Biomet Sports Medicine, Llc Method and apparatus for tensioning a suture
US11311287B2 (en) 2006-02-03 2022-04-26 Biomet Sports Medicine, Llc Method for tissue fixation
US8562647B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for securing soft tissue to bone
US8251998B2 (en) 2006-08-16 2012-08-28 Biomet Sports Medicine, Llc Chondral defect repair
US8574235B2 (en) 2006-02-03 2013-11-05 Biomet Sports Medicine, Llc Method for trochanteric reattachment
US7959650B2 (en) 2006-09-29 2011-06-14 Biomet Sports Medicine, Llc Adjustable knotless loops
US10517587B2 (en) 2006-02-03 2019-12-31 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US8652172B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Flexible anchors for tissue fixation
US11259792B2 (en) 2006-02-03 2022-03-01 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US9468433B2 (en) 2006-02-03 2016-10-18 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9538998B2 (en) 2006-02-03 2017-01-10 Biomet Sports Medicine, Llc Method and apparatus for fracture fixation
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
US7691151B2 (en) * 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8398668B2 (en) 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US20070283969A1 (en) * 2006-06-12 2007-12-13 Medtronic Vascular, Inc. Method of Diagnosing and Treating Erectile Dysfunction
US8322455B2 (en) 2006-06-27 2012-12-04 Ethicon Endo-Surgery, Inc. Manually driven surgical cutting and fastening instrument
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US20100081681A1 (en) * 2006-08-16 2010-04-01 Blagosklonny Mikhail V Methods and compositions for preventing or treating age-related diseases
US7506791B2 (en) 2006-09-29 2009-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with mechanical mechanism for limiting maximum tissue compression
US11259794B2 (en) 2006-09-29 2022-03-01 Biomet Sports Medicine, Llc Method for implanting soft tissue
US8672969B2 (en) 2006-09-29 2014-03-18 Biomet Sports Medicine, Llc Fracture fixation device
US9918826B2 (en) 2006-09-29 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US8500818B2 (en) 2006-09-29 2013-08-06 Biomet Manufacturing, Llc Knee prosthesis assembly with ligament link
US10568652B2 (en) 2006-09-29 2020-02-25 Ethicon Llc Surgical staples having attached drivers of different heights and stapling instruments for deploying the same
US11259924B2 (en) 2006-12-05 2022-03-01 Valtech Cardio Ltd. Implantation of repair devices in the heart
US9883943B2 (en) 2006-12-05 2018-02-06 Valtech Cardio, Ltd. Implantation of repair devices in the heart
WO2008085290A2 (en) 2006-12-28 2008-07-17 Vibrynt, Inc. Devices and methods for treatment of obesity
US11291441B2 (en) 2007-01-10 2022-04-05 Cilag Gmbh International Surgical instrument with wireless communication between control unit and remote sensor
US8684253B2 (en) 2007-01-10 2014-04-01 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US8652120B2 (en) 2007-01-10 2014-02-18 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US7434717B2 (en) 2007-01-11 2008-10-14 Ethicon Endo-Surgery, Inc. Apparatus for closing a curved anvil of a surgical stapling device
US11039836B2 (en) 2007-01-11 2021-06-22 Cilag Gmbh International Staple cartridge for use with a surgical stapling instrument
US11660190B2 (en) 2007-03-13 2023-05-30 Edwards Lifesciences Corporation Tissue anchors, systems and methods, and devices
US20090001130A1 (en) 2007-03-15 2009-01-01 Hess Christopher J Surgical procedure using a cutting and stapling instrument having releasable staple-forming pockets
DK2142107T3 (en) 2007-03-30 2013-04-15 Sentreheart Inc Devices and systems for closing the left ventricular pendant
US8577447B2 (en) * 2007-05-01 2013-11-05 St. Jude Medical, Atrial Fibrillation Division, Inc. Optic-based contact sensing assembly and system
US9855410B2 (en) 2007-05-01 2018-01-02 St. Jude Medical, Atrial Fibrillation Division, Inc. Optic-based contact sensing assembly and system
WO2008142677A2 (en) * 2007-05-18 2008-11-27 Prostaplant, Ltd. Prostate implant and methods for insertion and extraction thereof
US20100130815A1 (en) * 2007-05-18 2010-05-27 Prostaplant Ltd. Intraurethral and extraurethral apparatus
US8931682B2 (en) 2007-06-04 2015-01-13 Ethicon Endo-Surgery, Inc. Robotically-controlled shaft based rotary drive systems for surgical instruments
US11672531B2 (en) 2007-06-04 2023-06-13 Cilag Gmbh International Rotary drive systems for surgical instruments
US7753245B2 (en) 2007-06-22 2010-07-13 Ethicon Endo-Surgery, Inc. Surgical stapling instruments
US11849941B2 (en) 2007-06-29 2023-12-26 Cilag Gmbh International Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis
WO2009011751A1 (en) * 2007-07-13 2009-01-22 Rex Medical, Lp Vascular hole closure device
US20100249855A1 (en) * 2007-07-25 2010-09-30 Nicolas Bless Bone repair eyelet
AU2008298703B2 (en) 2007-09-14 2014-06-26 Arthrocare Corporation Implant system
US8708885B2 (en) * 2007-09-21 2014-04-29 Ams Research Corporation Pelvic floor treatments and related tools and implants
US8197464B2 (en) * 2007-10-19 2012-06-12 Cordis Corporation Deflecting guide catheter for use in a minimally invasive medical procedure for the treatment of mitral valve regurgitation
US20090105815A1 (en) 2007-10-19 2009-04-23 Matthew Krever Push-in retainer system for use in the direct plication annuloplasty treatment of mitral valve regurgitation
AT506095A1 (en) 2007-12-03 2009-06-15 Volopharm Gmbh USE OF PROTEASES
WO2009072131A2 (en) * 2007-12-05 2009-06-11 Aquaduct Ltd - Fortis Prostatic capsulotomy for treatment of conditions
US20110230954A1 (en) * 2009-06-11 2011-09-22 Peter Schneider Stent device having focal elevating elements for minimal surface area contact with lumen walls
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US8128677B2 (en) * 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US7896911B2 (en) * 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
EP2231065B8 (en) 2007-12-18 2021-01-06 Intersect ENT, Inc. Self-expanding devices
EP2240110A4 (en) * 2008-01-29 2015-07-01 Superdimension Ltd Target identification tool for intra body localization
US8573465B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical end effector system with rotary actuated closure systems
US8758391B2 (en) 2008-02-14 2014-06-24 Ethicon Endo-Surgery, Inc. Interchangeable tools for surgical instruments
RU2493788C2 (en) 2008-02-14 2013-09-27 Этикон Эндо-Серджери, Инк. Surgical cutting and fixing instrument, which has radio-frequency electrodes
US7866527B2 (en) 2008-02-14 2011-01-11 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with interlockable firing system
US7819298B2 (en) 2008-02-14 2010-10-26 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with control features operable with one hand
US8636736B2 (en) 2008-02-14 2014-01-28 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument
US9179912B2 (en) 2008-02-14 2015-11-10 Ethicon Endo-Surgery, Inc. Robotically-controlled motorized surgical cutting and fastening instrument
US9585657B2 (en) 2008-02-15 2017-03-07 Ethicon Endo-Surgery, Llc Actuator for releasing a layer of material from a surgical end effector
US20110029013A1 (en) 2008-02-15 2011-02-03 Mcguckin James F Vascular Hole Closure Device
US8920462B2 (en) 2008-02-15 2014-12-30 Rex Medical, L.P. Vascular hole closure device
US8920463B2 (en) 2008-02-15 2014-12-30 Rex Medical, L.P. Vascular hole closure device
US8491629B2 (en) 2008-02-15 2013-07-23 Rex Medical Vascular hole closure delivery device
US9226738B2 (en) 2008-02-15 2016-01-05 Rex Medical, L.P. Vascular hole closure delivery device
US8070772B2 (en) 2008-02-15 2011-12-06 Rex Medical, L.P. Vascular hole closure device
US8998933B2 (en) * 2008-02-28 2015-04-07 Medtronic, Inc. Surgical fastening clips, systems and methods for proximating tissue
US8382829B1 (en) 2008-03-10 2013-02-26 Mitralign, Inc. Method to reduce mitral regurgitation by cinching the commissure of the mitral valve
EP2278925A1 (en) * 2008-04-09 2011-02-02 Paul A. Talmo Devices and methods for deploying medical sutures
US8603123B2 (en) * 2008-04-28 2013-12-10 Urotech, Inc. Benign prostatic hyperplasia surgical system featuring mechanical coring probe with live aspiration
US8272383B2 (en) 2008-05-06 2012-09-25 Nxthera, Inc. Systems and methods for male sterilization
US20100312054A1 (en) * 2008-05-06 2010-12-09 N.M.B. Medical Applications Ltd. Prostatic tissue removal and/or prostatic capsulotomy for treatment of conditions
US8763222B2 (en) 2008-08-01 2014-07-01 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
US9943302B2 (en) * 2008-08-12 2018-04-17 Covidien Lp Medical device for wound closure and method of use
US8192461B2 (en) * 2008-09-11 2012-06-05 Cook Medical Technologies Llc Methods for facilitating closure of a bodily opening using one or more tacking devices
US11648005B2 (en) 2008-09-23 2023-05-16 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US9005230B2 (en) 2008-09-23 2015-04-14 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US9386983B2 (en) 2008-09-23 2016-07-12 Ethicon Endo-Surgery, Llc Robotically-controlled motorized surgical instrument
US8210411B2 (en) 2008-09-23 2012-07-03 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument
US20100094270A1 (en) 2008-10-06 2010-04-15 Sharma Virender K Method and Apparatus for Tissue Ablation
US10695126B2 (en) 2008-10-06 2020-06-30 Santa Anna Tech Llc Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue
US10064697B2 (en) 2008-10-06 2018-09-04 Santa Anna Tech Llc Vapor based ablation system for treating various indications
US9561068B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US9561066B2 (en) 2008-10-06 2017-02-07 Virender K. Sharma Method and apparatus for tissue ablation
US8608045B2 (en) 2008-10-10 2013-12-17 Ethicon Endo-Sugery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
JP2012508069A (en) 2008-11-06 2012-04-05 エヌエックスセラ インコーポレイテッド System and method for treatment of benign prostatic hyperplasia
EP2352452A4 (en) 2008-11-06 2012-07-18 Nxthera Inc Systems and methods for treatment of prostatic tissue
HUE037785T2 (en) 2008-11-06 2018-09-28 Nxthera Inc Systems and methods for treatment of prostatic tissue
MX2011006110A (en) 2008-12-09 2011-06-24 Halozyme Inc Extended soluble ph20 polypeptides and uses thereof.
US10517719B2 (en) 2008-12-22 2019-12-31 Valtech Cardio, Ltd. Implantation of repair devices in the heart
WO2010073246A2 (en) 2008-12-22 2010-07-01 Valtech Cardio, Ltd. Adjustable annuloplasty devices and adjustment mechanisms therefor
US8226684B2 (en) * 2008-12-22 2012-07-24 Ethicon, Inc. Surgical sutures having collapsible tissue anchoring protrusions and methods therefor
US8241351B2 (en) 2008-12-22 2012-08-14 Valtech Cardio, Ltd. Adjustable partial annuloplasty ring and mechanism therefor
US8911494B2 (en) 2009-05-04 2014-12-16 Valtech Cardio, Ltd. Deployment techniques for annuloplasty ring
US8715342B2 (en) 2009-05-07 2014-05-06 Valtech Cardio, Ltd. Annuloplasty ring with intra-ring anchoring
EP2381998B1 (en) * 2008-12-31 2018-04-25 St. Jude Medical, Atrial Fibrillation Division, Inc. Optic-based contact sensing assembly and system
US8388611B2 (en) 2009-01-14 2013-03-05 Nxthera, Inc. Systems and methods for treatment of prostatic tissue
US8517239B2 (en) 2009-02-05 2013-08-27 Ethicon Endo-Surgery, Inc. Surgical stapling instrument comprising a magnetic element driver
RU2525225C2 (en) 2009-02-06 2014-08-10 Этикон Эндо-Серджери, Инк. Improvement of drive surgical suturing instrument
US8353956B2 (en) 2009-02-17 2013-01-15 Valtech Cardio, Ltd. Actively-engageable movement-restriction mechanism for use with an annuloplasty structure
US8292918B2 (en) 2009-02-20 2012-10-23 Boston Scientific Scimed, Inc. Composite plug for arteriotomy closure and method of use
WO2012154284A2 (en) * 2011-02-28 2012-11-15 Virginia Tech Intellectual Properties, Inc. Fiber array for optical imaging and therapeutics
EP2408506B1 (en) 2009-03-20 2020-09-16 Proarc Medical Ltd. Devices for urethral treatment
WO2010115030A1 (en) 2009-04-01 2010-10-07 Sentreheart, Inc. Tissue ligation devices and controls therefor
US9833277B2 (en) 2009-04-27 2017-12-05 Nxthera, Inc. Systems and methods for prostate treatment
US9968452B2 (en) 2009-05-04 2018-05-15 Valtech Cardio, Ltd. Annuloplasty ring delivery cathethers
EP2429624B1 (en) 2009-05-15 2014-04-02 Intersect ENT, Inc. A combination of an expandable device and a delivery device.
US8343227B2 (en) 2009-05-28 2013-01-01 Biomet Manufacturing Corp. Knee prosthesis assembly with ligament link
US9386942B2 (en) * 2009-06-26 2016-07-12 Cianna Medical, Inc. Apparatus, systems, and methods for localizing markers or tissue structures within a body
US8911474B2 (en) 2009-07-16 2014-12-16 Howmedica Osteonics Corp. Suture anchor implantation instrumentation system
US9232954B2 (en) 2009-08-20 2016-01-12 Howmedica Osteonics Corp. Flexible ACL instrumentation, kit and method
WO2011025893A1 (en) 2009-08-28 2011-03-03 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
US8297330B2 (en) 2009-10-01 2012-10-30 Tyco Healthcare Group Lp Welded knot end effector
US9180007B2 (en) 2009-10-29 2015-11-10 Valtech Cardio, Ltd. Apparatus and method for guide-wire based advancement of an adjustable implant
WO2011067770A1 (en) 2009-12-02 2011-06-09 Valtech Cardio, Ltd. Delivery tool for implantation of spool assembly coupled to a helical anchor
US8220688B2 (en) 2009-12-24 2012-07-17 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument with electric actuator directional control assembly
US8851354B2 (en) 2009-12-24 2014-10-07 Ethicon Endo-Surgery, Inc. Surgical cutting instrument that analyzes tissue thickness
US10045842B2 (en) 2009-12-30 2018-08-14 Boston Scientific Scimed, Inc. Systems, implants, tools, and methods for treatments of pelvic conditions
AU2016273873B2 (en) * 2009-12-30 2018-10-04 Boston Scientific Scimed, Inc. Systems, implants, tools, and methods for treatments of pelvic conditions
US8475525B2 (en) 2010-01-22 2013-07-02 4Tech Inc. Tricuspid valve repair using tension
US9307980B2 (en) 2010-01-22 2016-04-12 4Tech Inc. Tricuspid valve repair using tension
US10058323B2 (en) 2010-01-22 2018-08-28 4 Tech Inc. Tricuspid valve repair using tension
BR112012022132A2 (en) 2010-03-25 2016-10-25 Nxthera Inc steam therapy system
JP2013532016A (en) 2010-06-09 2013-08-15 シー・アール・バード・インコーポレーテッド Instrument for delivering a transfascial suture, transfascial suture assembly, and transfascial suture method
WO2012004787A1 (en) * 2010-07-05 2012-01-12 Virtual Ports Ltd. An internal retractor
CN103002815A (en) * 2010-07-16 2013-03-27 伊西康内外科公司 A device for translumenal diversion of bile
US8783543B2 (en) 2010-07-30 2014-07-22 Ethicon Endo-Surgery, Inc. Tissue acquisition arrangements and methods for surgical stapling devices
US20130251633A1 (en) * 2010-08-05 2013-09-26 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for ultrasonic assessment of cancer and response to therapy
US11298125B2 (en) 2010-09-30 2022-04-12 Cilag Gmbh International Tissue stapler having a thickness compensator
US9700317B2 (en) 2010-09-30 2017-07-11 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a releasable tissue thickness compensator
US9629814B2 (en) 2010-09-30 2017-04-25 Ethicon Endo-Surgery, Llc Tissue thickness compensator configured to redistribute compressive forces
US11812965B2 (en) 2010-09-30 2023-11-14 Cilag Gmbh International Layer of material for a surgical end effector
US8857694B2 (en) 2010-09-30 2014-10-14 Ethicon Endo-Surgery, Inc. Staple cartridge loading assembly
US10945731B2 (en) 2010-09-30 2021-03-16 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US11849952B2 (en) 2010-09-30 2023-12-26 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US9839420B2 (en) 2010-09-30 2017-12-12 Ethicon Llc Tissue thickness compensator comprising at least one medicament
US8695866B2 (en) 2010-10-01 2014-04-15 Ethicon Endo-Surgery, Inc. Surgical instrument having a power control circuit
EP2907504B1 (en) 2011-02-08 2017-06-28 Halozyme, Inc. Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
JP2014512867A (en) 2011-02-09 2014-05-29 シー・アール・バード・インコーポレーテッド T-fastener suture feed system
US10035005B2 (en) 2011-03-17 2018-07-31 Proarc Medical Ltd. Devices for urethral treatment
JP2014516286A (en) 2011-03-29 2014-07-10 オキュネティクス・インコーポレーテッド Fasteners, installation systems, and methods for ocular tissue closure and ocular artificial tissue fixation and other uses
US9307985B2 (en) 2011-03-29 2016-04-12 Iridex Corporation Fasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other uses
US9161749B2 (en) 2011-04-14 2015-10-20 Neotract, Inc. Method and apparatus for treating sexual dysfunction
AU2012250197B2 (en) 2011-04-29 2017-08-10 Ethicon Endo-Surgery, Inc. Staple cartridge comprising staples positioned within a compressible portion thereof
KR20140008446A (en) * 2011-05-06 2014-01-21 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 Echogenic sleeve
US11207064B2 (en) 2011-05-27 2021-12-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
US10390977B2 (en) 2011-06-03 2019-08-27 Intact Vascular, Inc. Endovascular implant
US10792152B2 (en) 2011-06-23 2020-10-06 Valtech Cardio, Ltd. Closed band for percutaneous annuloplasty
US9364326B2 (en) 2011-06-29 2016-06-14 Mitralix Ltd. Heart valve repair devices and methods
US9526708B2 (en) * 2011-07-01 2016-12-27 James C. Jensen Methods for prostatectomy
US8998985B2 (en) 2011-07-25 2015-04-07 Rainbow Medical Ltd. Sinus stent
PT2755614T (en) 2011-09-13 2018-01-18 Nxthera Inc Systems for prostate treatment
US9826972B2 (en) 2011-10-24 2017-11-28 C.R. Bard, Inc. Instruments for delivering transfascial sutures, transfascial suture assemblies and methods of transfascial suturing
US9357991B2 (en) 2011-11-03 2016-06-07 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US8858623B2 (en) 2011-11-04 2014-10-14 Valtech Cardio, Ltd. Implant having multiple rotational assemblies
US9924938B2 (en) 2011-11-07 2018-03-27 C.R. Bard, Inc. Instruments for delivering transfascial sutures and methods of transfascial suturing
EP3970627B1 (en) 2011-11-08 2023-12-20 Edwards Lifesciences Innovation (Israel) Ltd. Controlled steering functionality for implant-delivery tool
US9370350B2 (en) 2011-11-10 2016-06-21 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9314241B2 (en) 2011-11-10 2016-04-19 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9381013B2 (en) 2011-11-10 2016-07-05 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9445803B2 (en) 2011-11-23 2016-09-20 Howmedica Osteonics Corp. Filamentary suture anchor
US9017347B2 (en) 2011-12-22 2015-04-28 Edwards Lifesciences Corporation Suture clip deployment devices
US9259217B2 (en) 2012-01-03 2016-02-16 Biomet Manufacturing, Llc Suture Button
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
EP3733134A1 (en) 2012-01-25 2020-11-04 Intact Vascular, Inc. Endoluminal device
US9044230B2 (en) 2012-02-13 2015-06-02 Ethicon Endo-Surgery, Inc. Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
MX350846B (en) 2012-03-28 2017-09-22 Ethicon Endo Surgery Inc Tissue thickness compensator comprising capsules defining a low pressure environment.
CN104379068B (en) 2012-03-28 2017-09-22 伊西康内外科公司 Holding device assembly including tissue thickness compensation part
MX358135B (en) 2012-03-28 2018-08-06 Ethicon Endo Surgery Inc Tissue thickness compensator comprising a plurality of layers.
US10292801B2 (en) * 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10335222B2 (en) 2012-04-03 2019-07-02 Nxthera, Inc. Induction coil vapor generator
US10052092B2 (en) 2012-05-31 2018-08-21 Biomet Sports Medicine, Llc Suture anchor reload
US8961594B2 (en) 2012-05-31 2015-02-24 4Tech Inc. Heart valve repair system
US9101358B2 (en) 2012-06-15 2015-08-11 Ethicon Endo-Surgery, Inc. Articulatable surgical instrument comprising a firing drive
JP6290201B2 (en) 2012-06-28 2018-03-07 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Lockout for empty clip cartridge
US9649111B2 (en) 2012-06-28 2017-05-16 Ethicon Endo-Surgery, Llc Replaceable clip cartridge for a clip applier
US20140005678A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Rotary drive arrangements for surgical instruments
US9289256B2 (en) 2012-06-28 2016-03-22 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
US20140001231A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Firing system lockout arrangements for surgical instruments
US20140005718A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Multi-functional powered surgical device with external dissection features
US11202631B2 (en) 2012-06-28 2021-12-21 Cilag Gmbh International Stapling assembly comprising a firing lockout
BR112014032776B1 (en) 2012-06-28 2021-09-08 Ethicon Endo-Surgery, Inc SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM
US10130353B2 (en) * 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
US10016193B2 (en) 2013-11-18 2018-07-10 Edwards Lifesciences Ag Multiple-firing crimp device and methods for using and manufacturing same
US10624630B2 (en) 2012-07-10 2020-04-21 Edwards Lifesciences Ag Multiple-firing securing device and methods for using and manufacturing same
US9498202B2 (en) * 2012-07-10 2016-11-22 Edwards Lifesciences Corporation Suture securement devices
EP2900150B1 (en) 2012-09-29 2018-04-18 Mitralign, Inc. Plication lock delivery system
WO2014064695A2 (en) 2012-10-23 2014-05-01 Valtech Cardio, Ltd. Percutaneous tissue anchor techniques
US9949828B2 (en) 2012-10-23 2018-04-24 Valtech Cardio, Ltd. Controlled steering functionality for implant-delivery tool
US9730793B2 (en) 2012-12-06 2017-08-15 Valtech Cardio, Ltd. Techniques for guide-wire based advancement of a tool
US20140163371A1 (en) * 2012-12-12 2014-06-12 Olympus Medical Systems Corp. Tumor tissue reductive procedure under ultrasound observation
WO2014108903A1 (en) 2013-01-09 2014-07-17 4Tech Inc. Soft tissue anchors
EP2945556A4 (en) 2013-01-17 2016-08-31 Virender K Sharma Method and apparatus for tissue ablation
US9724084B2 (en) 2013-02-26 2017-08-08 Mitralign, Inc. Devices and methods for percutaneous tricuspid valve repair
JP6382235B2 (en) 2013-03-01 2018-08-29 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Articulatable surgical instrument with a conductive path for signal communication
MX364729B (en) 2013-03-01 2019-05-06 Ethicon Endo Surgery Inc Surgical instrument with a soft stop.
US9757119B2 (en) 2013-03-08 2017-09-12 Biomet Sports Medicine, Llc Visual aid for identifying suture limbs arthroscopically
US9289203B2 (en) 2013-03-11 2016-03-22 Biomet Sports Medicine, Llc Method and apparatus to reload suture anchors
US9629629B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgey, LLC Control systems for surgical instruments
AU2014236729B2 (en) 2013-03-14 2018-11-22 Intersect Ent, Inc. Systems, devices, and method for treating a sinus condition
US9918827B2 (en) 2013-03-14 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
CN105208939A (en) * 2013-03-14 2015-12-30 恩克斯特拉公司 Systems and methods for treating prostate cancer
US9808244B2 (en) 2013-03-14 2017-11-07 Ethicon Llc Sensor arrangements for absolute positioning system for surgical instruments
US10449333B2 (en) 2013-03-14 2019-10-22 Valtech Cardio, Ltd. Guidewire feeder
JP6329570B2 (en) 2013-03-14 2018-05-23 4テック インコーポレイテッド Stent with tether interface
CN105283214B (en) 2013-03-15 2018-10-16 北京泰德制药股份有限公司 Translate conduit, system and its application method
BR112015026109B1 (en) 2013-04-16 2022-02-22 Ethicon Endo-Surgery, Inc surgical instrument
US9826976B2 (en) 2013-04-16 2017-11-28 Ethicon Llc Motor driven surgical instruments with lockable dual drive shafts
WO2014176270A1 (en) 2013-04-22 2014-10-30 Pivot Medical, Inc. Method and apparatus for attaching tissue to bone
CN103263243B (en) * 2013-05-17 2016-02-24 苏新军 Treatment mirror is peeped in a kind of scrotum
US10188383B2 (en) 2013-07-09 2019-01-29 Edwards Lifesciences Corporation Suture clip deployment devices
EP3019091B1 (en) 2013-07-11 2019-10-30 Edwards Lifesciences Corporation Knotless suture fastener installation system
US9510823B2 (en) 2013-08-02 2016-12-06 Covidien Lp Devices, systems, and methods for wound closure
WO2015015475A2 (en) 2013-08-02 2015-02-05 Goldberg Roger P Anchor delivery system and method
MX369362B (en) 2013-08-23 2019-11-06 Ethicon Endo Surgery Llc Firing member retraction devices for powered surgical instruments.
US9808249B2 (en) 2013-08-23 2017-11-07 Ethicon Llc Attachment portions for surgical instrument assemblies
US10070857B2 (en) 2013-08-31 2018-09-11 Mitralign, Inc. Devices and methods for locating and implanting tissue anchors at mitral valve commissure
WO2015059699A2 (en) 2013-10-23 2015-04-30 Valtech Cardio, Ltd. Anchor magazine
US10022114B2 (en) 2013-10-30 2018-07-17 4Tech Inc. Percutaneous tether locking
US10052095B2 (en) 2013-10-30 2018-08-21 4Tech Inc. Multiple anchoring-point tension system
WO2015063580A2 (en) 2013-10-30 2015-05-07 4Tech Inc. Multiple anchoring-point tension system
US9968395B2 (en) 2013-12-10 2018-05-15 Nxthera, Inc. Systems and methods for treating the prostate
CN105813591B (en) 2013-12-10 2018-05-01 恩克斯特拉公司 steam ablation system and method
US10136886B2 (en) 2013-12-20 2018-11-27 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US9610162B2 (en) 2013-12-26 2017-04-04 Valtech Cardio, Ltd. Implantation of flexible implant
US11027106B2 (en) 2014-01-26 2021-06-08 Butterfly Medical Ltd. Dilating device and method for prostatic urethra
US9962161B2 (en) 2014-02-12 2018-05-08 Ethicon Llc Deliverable surgical instrument
US9826977B2 (en) 2014-03-26 2017-11-28 Ethicon Llc Sterilization verification circuit
US20150272557A1 (en) 2014-03-26 2015-10-01 Ethicon Endo-Surgery, Inc. Modular surgical instrument system
BR112016021943B1 (en) 2014-03-26 2022-06-14 Ethicon Endo-Surgery, Llc SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE
US10743909B2 (en) 2014-04-03 2020-08-18 Corbin Clinical Resources, Llc Transperineal prostate biopsy device, systems, and methods of use
US10064681B2 (en) 2014-04-03 2018-09-04 Corbin Clinical Resources, Llc Method, system, and device for planning and performing, guided and free-handed transperineal prostate biopsies
US20150297223A1 (en) 2014-04-16 2015-10-22 Ethicon Endo-Surgery, Inc. Fastener cartridges including extensions having different configurations
JP6612256B2 (en) 2014-04-16 2019-11-27 エシコン エルエルシー Fastener cartridge with non-uniform fastener
BR112016023807B1 (en) 2014-04-16 2022-07-12 Ethicon Endo-Surgery, Llc CARTRIDGE SET OF FASTENERS FOR USE WITH A SURGICAL INSTRUMENT
US9801628B2 (en) 2014-09-26 2017-10-31 Ethicon Llc Surgical staple and driver arrangements for staple cartridges
CN106456176B (en) 2014-04-16 2019-06-28 伊西康内外科有限责任公司 Fastener cartridge including the extension with various configuration
US10542988B2 (en) 2014-04-16 2020-01-28 Ethicon Llc End effector comprising an anvil including projections extending therefrom
US9801651B2 (en) 2014-04-23 2017-10-31 Boston Scientific Scimed, Inc. Tissue extraction devices and related methods
EP3151756B1 (en) 2014-05-30 2019-08-28 Edwards Lifesciences Corporation Systems for securing sutures
US9615822B2 (en) 2014-05-30 2017-04-11 Biomet Sports Medicine, Llc Insertion tools and method for soft anchor
US9700291B2 (en) 2014-06-03 2017-07-11 Biomet Sports Medicine, Llc Capsule retractor
US10610651B2 (en) * 2014-06-09 2020-04-07 Aerami Therapeutics, Inc. Self-puncturing liquid drug cartridges and associated dispenser
DE202015009843U1 (en) * 2014-06-18 2020-08-31 Boston Scientific Scimed, Inc. Bile duct stent
JP6559161B2 (en) 2014-06-19 2019-08-14 4テック インコーポレイテッド Tightening heart tissue
US9700412B2 (en) 2014-06-26 2017-07-11 Mitralix Ltd. Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices
US10555732B2 (en) 2014-07-16 2020-02-11 Edwards Lifesciences Corporation Devices and methods for suturing a cardiac implant
CN106659496B (en) * 2014-08-21 2020-06-16 皇家飞利浦有限公司 Tongue advancer assembly for a tongue manipulation system
US10039543B2 (en) 2014-08-22 2018-08-07 Biomet Sports Medicine, Llc Non-sliding soft anchor
BR112017004361B1 (en) 2014-09-05 2023-04-11 Ethicon Llc ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT
US11311294B2 (en) 2014-09-05 2022-04-26 Cilag Gmbh International Powered medical device including measurement of closure state of jaws
US9724094B2 (en) 2014-09-05 2017-08-08 Ethicon Llc Adjunct with integrated sensors to quantify tissue compression
US10105142B2 (en) 2014-09-18 2018-10-23 Ethicon Llc Surgical stapler with plurality of cutting elements
CN107427300B (en) 2014-09-26 2020-12-04 伊西康有限责任公司 Surgical suture buttress and buttress material
US11523821B2 (en) 2014-09-26 2022-12-13 Cilag Gmbh International Method for creating a flexible staple line
US10076325B2 (en) 2014-10-13 2018-09-18 Ethicon Llc Surgical stapling apparatus comprising a tissue stop
EP3206629B1 (en) 2014-10-14 2021-07-14 Valtech Cardio, Ltd. Apparatus for heart valve leaflet restraining
US9924944B2 (en) 2014-10-16 2018-03-27 Ethicon Llc Staple cartridge comprising an adjunct material
US9986992B2 (en) 2014-10-28 2018-06-05 Stryker Corporation Suture anchor and associated methods of use
US10517594B2 (en) 2014-10-29 2019-12-31 Ethicon Llc Cartridge assemblies for surgical staplers
US11141153B2 (en) 2014-10-29 2021-10-12 Cilag Gmbh International Staple cartridges comprising driver arrangements
US9844376B2 (en) 2014-11-06 2017-12-19 Ethicon Llc Staple cartridge comprising a releasable adjunct material
EP3284412A1 (en) 2014-12-02 2018-02-21 4Tech Inc. Off-center tissue anchors
WO2016089595A1 (en) * 2014-12-03 2016-06-09 Boston Scientific Scimed, Inc. Double barbed suture with needle delivery system
US10736636B2 (en) 2014-12-10 2020-08-11 Ethicon Llc Articulatable surgical instrument system
BR112017012996B1 (en) 2014-12-18 2022-11-08 Ethicon Llc SURGICAL INSTRUMENT WITH AN ANvil WHICH IS SELECTIVELY MOVABLE ABOUT AN IMMOVABLE GEOMETRIC AXIS DIFFERENT FROM A STAPLE CARTRIDGE
US10245027B2 (en) 2014-12-18 2019-04-02 Ethicon Llc Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge
US9987000B2 (en) 2014-12-18 2018-06-05 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US9844375B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Drive arrangements for articulatable surgical instruments
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US10085748B2 (en) 2014-12-18 2018-10-02 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
CN104545783B (en) * 2015-01-28 2016-08-24 凌斌 Deformation comes in and goes out and the targeting visual area regulation and control obturator of vaginal dilation
US9456914B2 (en) 2015-01-29 2016-10-04 Intact Vascular, Inc. Delivery device and method of delivery
US9192500B1 (en) 2015-01-29 2015-11-24 Intact Vascular, Inc. Delivery device and method of delivery
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
JP6757732B2 (en) 2015-01-29 2020-09-23 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Steam cutting system and method
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
KR20170127429A (en) * 2015-01-30 2017-11-21 퓨처매트릭스 인터벤셔널 Ureteral stent
WO2016126699A1 (en) 2015-02-02 2016-08-11 On-X Life Technologies, Inc. Rapid deployment artificial chordae tendinae system
US9955980B2 (en) 2015-02-24 2018-05-01 Biomet Sports Medicine, Llc Anatomic soft tissue repair
US11154301B2 (en) 2015-02-27 2021-10-26 Cilag Gmbh International Modular stapling assembly
EP3264996A4 (en) * 2015-03-04 2018-12-05 Endogear LLC Endoscopic clip
US20160256269A1 (en) 2015-03-05 2016-09-08 Mitralign, Inc. Devices for treating paravalvular leakage and methods use thereof
JP2020121162A (en) 2015-03-06 2020-08-13 エシコン エルエルシーEthicon LLC Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement
US10245033B2 (en) 2015-03-06 2019-04-02 Ethicon Llc Surgical instrument comprising a lockable battery housing
US9924961B2 (en) 2015-03-06 2018-03-27 Ethicon Endo-Surgery, Llc Interactive feedback system for powered surgical instruments
US9993248B2 (en) 2015-03-06 2018-06-12 Ethicon Endo-Surgery, Llc Smart sensors with local signal processing
US9901342B2 (en) 2015-03-06 2018-02-27 Ethicon Endo-Surgery, Llc Signal and power communication system positioned on a rotatable shaft
US10617412B2 (en) 2015-03-06 2020-04-14 Ethicon Llc System for detecting the mis-insertion of a staple cartridge into a surgical stapler
US10687806B2 (en) 2015-03-06 2020-06-23 Ethicon Llc Adaptive tissue compression techniques to adjust closure rates for multiple tissue types
US10052044B2 (en) 2015-03-06 2018-08-21 Ethicon Llc Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US9808246B2 (en) 2015-03-06 2017-11-07 Ethicon Endo-Surgery, Llc Method of operating a powered surgical instrument
US10470759B2 (en) 2015-03-16 2019-11-12 Edwards Lifesciences Corporation Suture securement devices
WO2016154488A2 (en) * 2015-03-24 2016-09-29 Sentreheart, Inc. Tissue ligation devices and methods therefor
US9974534B2 (en) 2015-03-31 2018-05-22 Biomet Sports Medicine, Llc Suture anchor with soft anchor of electrospun fibers
CA2982063A1 (en) 2015-04-30 2016-11-03 Valtech Cardio, Ltd. Annuloplasty technologies
CA2982372A1 (en) 2015-05-13 2016-11-17 Nxthera, Inc. Systems and methods for treating the bladder with condensable vapor
US11344296B2 (en) * 2015-07-07 2022-05-31 Epic M.D Ltd Device and method for suturing
FI3328317T3 (en) * 2015-07-29 2023-01-13 Retracting or/and supporting periurethral tissue
US10631966B2 (en) * 2015-08-12 2020-04-28 Innoventions Ltd System for sphincteric and other tissue regeneration
US11058425B2 (en) 2015-08-17 2021-07-13 Ethicon Llc Implantable layers for a surgical instrument
CN105250054A (en) * 2015-09-15 2016-01-20 浙江科惠医疗器械股份有限公司 Hip joint femoral stem with distributed bearing rivet
US10238386B2 (en) 2015-09-23 2019-03-26 Ethicon Llc Surgical stapler having motor control based on an electrical parameter related to a motor current
US10105139B2 (en) 2015-09-23 2018-10-23 Ethicon Llc Surgical stapler having downstream current-based motor control
US10299878B2 (en) 2015-09-25 2019-05-28 Ethicon Llc Implantable adjunct systems for determining adjunct skew
US10285699B2 (en) 2015-09-30 2019-05-14 Ethicon Llc Compressible adjunct
US10524788B2 (en) 2015-09-30 2020-01-07 Ethicon Llc Compressible adjunct with attachment regions
US11890015B2 (en) 2015-09-30 2024-02-06 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US10980539B2 (en) 2015-09-30 2021-04-20 Ethicon Llc Implantable adjunct comprising bonded layers
CN105232194B (en) * 2015-10-15 2018-06-29 江苏省肿瘤医院 Double J pipe extractor in a kind of males
EP3383281B1 (en) 2015-12-04 2024-01-24 Crossroads Extremity Systems, LLC Devices for anchoring tissue
US10368865B2 (en) 2015-12-30 2019-08-06 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10292704B2 (en) 2015-12-30 2019-05-21 Ethicon Llc Mechanisms for compensating for battery pack failure in powered surgical instruments
WO2017117370A2 (en) 2015-12-30 2017-07-06 Mitralign, Inc. System and method for reducing tricuspid regurgitation
US10265068B2 (en) 2015-12-30 2019-04-23 Ethicon Llc Surgical instruments with separable motors and motor control circuits
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US10588625B2 (en) 2016-02-09 2020-03-17 Ethicon Llc Articulatable surgical instruments with off-axis firing beam arrangements
BR112018016098B1 (en) 2016-02-09 2023-02-23 Ethicon Llc SURGICAL INSTRUMENT
US11213293B2 (en) 2016-02-09 2022-01-04 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US11224426B2 (en) 2016-02-12 2022-01-18 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10448948B2 (en) 2016-02-12 2019-10-22 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10687802B2 (en) 2016-03-02 2020-06-23 Edwards Lifesciences Corporation Systems and method for deploying surgical suture
US10617413B2 (en) 2016-04-01 2020-04-14 Ethicon Llc Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts
US10828028B2 (en) 2016-04-15 2020-11-10 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10357247B2 (en) 2016-04-15 2019-07-23 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10426467B2 (en) 2016-04-15 2019-10-01 Ethicon Llc Surgical instrument with detection sensors
US10456137B2 (en) 2016-04-15 2019-10-29 Ethicon Llc Staple formation detection mechanisms
US11179150B2 (en) 2016-04-15 2021-11-23 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US11607239B2 (en) 2016-04-15 2023-03-21 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10335145B2 (en) 2016-04-15 2019-07-02 Ethicon Llc Modular surgical instrument with configurable operating mode
US10492783B2 (en) 2016-04-15 2019-12-03 Ethicon, Llc Surgical instrument with improved stop/start control during a firing motion
US20170296173A1 (en) 2016-04-18 2017-10-19 Ethicon Endo-Surgery, Llc Method for operating a surgical instrument
US11317917B2 (en) 2016-04-18 2022-05-03 Cilag Gmbh International Surgical stapling system comprising a lockable firing assembly
US10363037B2 (en) 2016-04-18 2019-07-30 Ethicon Llc Surgical instrument system comprising a magnetic lockout
US11331140B2 (en) 2016-05-19 2022-05-17 Aqua Heart, Inc. Heated vapor ablation systems and methods for treating cardiac conditions
US10702274B2 (en) 2016-05-26 2020-07-07 Edwards Lifesciences Corporation Method and system for closing left atrial appendage
WO2017210434A1 (en) 2016-06-01 2017-12-07 On-X Life Technologies, Inc. Pull-through chordae tendineae system
GB201611910D0 (en) 2016-07-08 2016-08-24 Valtech Cardio Ltd Adjustable annuloplasty device with alternating peaks and troughs
US10939905B2 (en) 2016-08-26 2021-03-09 Edwards Lifesciences Corporation Suture clips, deployment devices therefor, and methods of use
US10485543B2 (en) 2016-12-21 2019-11-26 Ethicon Llc Anvil having a knife slot width
US11134942B2 (en) 2016-12-21 2021-10-05 Cilag Gmbh International Surgical stapling instruments and staple-forming anvils
CN110099619B (en) 2016-12-21 2022-07-15 爱惜康有限责任公司 Lockout device for surgical end effector and replaceable tool assembly
US10568625B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Staple cartridges and arrangements of staples and staple cavities therein
US11419606B2 (en) 2016-12-21 2022-08-23 Cilag Gmbh International Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems
US20180168625A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Surgical stapling instruments with smart staple cartridges
US11090048B2 (en) 2016-12-21 2021-08-17 Cilag Gmbh International Method for resetting a fuse of a surgical instrument shaft
US10973516B2 (en) 2016-12-21 2021-04-13 Ethicon Llc Surgical end effectors and adaptable firing members therefor
EP3558139A4 (en) 2016-12-21 2020-08-12 Nxthera, Inc. Vapor ablation systems and methods
US20180168615A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument
JP7010956B2 (en) 2016-12-21 2022-01-26 エシコン エルエルシー How to staple tissue
US10667809B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Staple cartridge and staple cartridge channel comprising windows defined therein
US20180168598A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Staple forming pocket arrangements comprising zoned forming surface grooves
US10758229B2 (en) 2016-12-21 2020-09-01 Ethicon Llc Surgical instrument comprising improved jaw control
US10675025B2 (en) 2016-12-21 2020-06-09 Ethicon Llc Shaft assembly comprising separately actuatable and retractable systems
US10568626B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Surgical instruments with jaw opening features for increasing a jaw opening distance
US10959727B2 (en) 2016-12-21 2021-03-30 Ethicon Llc Articulatable surgical end effector with asymmetric shaft arrangement
BR112019011947A2 (en) 2016-12-21 2019-10-29 Ethicon Llc surgical stapling systems
US10667810B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Closure members with cam surface arrangements for surgical instruments with separate and distinct closure and firing systems
US10863980B2 (en) 2016-12-28 2020-12-15 Edwards Lifesciences Corporation Suture fastener having spaced-apart layers
EP3565493A4 (en) 2017-01-06 2020-11-11 Nxthera, Inc. Transperineal vapor ablation systems and methods
US10743991B2 (en) * 2017-01-23 2020-08-18 Edwards Lifesciences Corporation Chordae tendineae adjustment
US11045627B2 (en) 2017-04-18 2021-06-29 Edwards Lifesciences Corporation Catheter system with linear actuation control mechanism
US10881399B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US11090046B2 (en) 2017-06-20 2021-08-17 Cilag Gmbh International Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument
US11653914B2 (en) 2017-06-20 2023-05-23 Cilag Gmbh International Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector
US10779820B2 (en) 2017-06-20 2020-09-22 Ethicon Llc Systems and methods for controlling motor speed according to user input for a surgical instrument
US10980537B2 (en) 2017-06-20 2021-04-20 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations
US10646220B2 (en) 2017-06-20 2020-05-12 Ethicon Llc Systems and methods for controlling displacement member velocity for a surgical instrument
US10307170B2 (en) 2017-06-20 2019-06-04 Ethicon Llc Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US10888321B2 (en) 2017-06-20 2021-01-12 Ethicon Llc Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument
US11382638B2 (en) 2017-06-20 2022-07-12 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance
US10881396B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Surgical instrument with variable duration trigger arrangement
USD879808S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
USD879809S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with changeable graphical user interface
US11517325B2 (en) 2017-06-20 2022-12-06 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval
US11071554B2 (en) 2017-06-20 2021-07-27 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements
USD890784S1 (en) 2017-06-20 2020-07-21 Ethicon Llc Display panel with changeable graphical user interface
US10813639B2 (en) 2017-06-20 2020-10-27 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions
US10624633B2 (en) 2017-06-20 2020-04-21 Ethicon Llc Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument
US11266405B2 (en) 2017-06-27 2022-03-08 Cilag Gmbh International Surgical anvil manufacturing methods
US20180368844A1 (en) 2017-06-27 2018-12-27 Ethicon Llc Staple forming pocket arrangements
US11324503B2 (en) 2017-06-27 2022-05-10 Cilag Gmbh International Surgical firing member arrangements
US10993716B2 (en) 2017-06-27 2021-05-04 Ethicon Llc Surgical anvil arrangements
US10856869B2 (en) 2017-06-27 2020-12-08 Ethicon Llc Surgical anvil arrangements
US10772629B2 (en) 2017-06-27 2020-09-15 Ethicon Llc Surgical anvil arrangements
US10903685B2 (en) 2017-06-28 2021-01-26 Ethicon Llc Surgical shaft assemblies with slip ring assemblies forming capacitive channels
EP4070740A1 (en) 2017-06-28 2022-10-12 Cilag GmbH International Surgical instrument comprising selectively actuatable rotatable couplers
US11564686B2 (en) 2017-06-28 2023-01-31 Cilag Gmbh International Surgical shaft assemblies with flexible interfaces
US10716614B2 (en) 2017-06-28 2020-07-21 Ethicon Llc Surgical shaft assemblies with slip ring assemblies with increased contact pressure
US11478242B2 (en) 2017-06-28 2022-10-25 Cilag Gmbh International Jaw retainer arrangement for retaining a pivotable surgical instrument jaw in pivotable retaining engagement with a second surgical instrument jaw
USD869655S1 (en) 2017-06-28 2019-12-10 Ethicon Llc Surgical fastener cartridge
US11246592B2 (en) 2017-06-28 2022-02-15 Cilag Gmbh International Surgical instrument comprising an articulation system lockable to a frame
US10765427B2 (en) 2017-06-28 2020-09-08 Ethicon Llc Method for articulating a surgical instrument
US11389161B2 (en) 2017-06-28 2022-07-19 Cilag Gmbh International Surgical instrument comprising selectively actuatable rotatable couplers
USD906355S1 (en) 2017-06-28 2020-12-29 Ethicon Llc Display screen or portion thereof with a graphical user interface for a surgical instrument
US11259805B2 (en) 2017-06-28 2022-03-01 Cilag Gmbh International Surgical instrument comprising firing member supports
US10398434B2 (en) * 2017-06-29 2019-09-03 Ethicon Llc Closed loop velocity control of closure member for robotic surgical instrument
US10932772B2 (en) 2017-06-29 2021-03-02 Ethicon Llc Methods for closed loop velocity control for robotic surgical instrument
US10898183B2 (en) 2017-06-29 2021-01-26 Ethicon Llc Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing
US11007022B2 (en) 2017-06-29 2021-05-18 Ethicon Llc Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US11304695B2 (en) 2017-08-03 2022-04-19 Cilag Gmbh International Surgical system shaft interconnection
US11471155B2 (en) 2017-08-03 2022-10-18 Cilag Gmbh International Surgical system bailout
USD907648S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
USD907647S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
US10765429B2 (en) 2017-09-29 2020-09-08 Ethicon Llc Systems and methods for providing alerts according to the operational state of a surgical instrument
US10729501B2 (en) 2017-09-29 2020-08-04 Ethicon Llc Systems and methods for language selection of a surgical instrument
US11399829B2 (en) 2017-09-29 2022-08-02 Cilag Gmbh International Systems and methods of initiating a power shutdown mode for a surgical instrument
USD917500S1 (en) 2017-09-29 2021-04-27 Ethicon Llc Display screen or portion thereof with graphical user interface
US10743872B2 (en) 2017-09-29 2020-08-18 Ethicon Llc System and methods for controlling a display of a surgical instrument
CN107647903A (en) * 2017-10-12 2018-02-02 熊宙芳 A kind of laparoscope punctures pull needle and traction method
US11090075B2 (en) 2017-10-30 2021-08-17 Cilag Gmbh International Articulation features for surgical end effector
US11134944B2 (en) 2017-10-30 2021-10-05 Cilag Gmbh International Surgical stapler knife motion controls
US10842490B2 (en) 2017-10-31 2020-11-24 Ethicon Llc Cartridge body design with force reduction based on firing completion
US10779903B2 (en) 2017-10-31 2020-09-22 Ethicon Llc Positive shaft rotation lock activated by jaw closure
US10835221B2 (en) 2017-11-02 2020-11-17 Valtech Cardio, Ltd. Implant-cinching devices and systems
US11135062B2 (en) 2017-11-20 2021-10-05 Valtech Cardio Ltd. Cinching of dilated heart muscle
US10779825B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments
US11197670B2 (en) 2017-12-15 2021-12-14 Cilag Gmbh International Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed
US10687813B2 (en) 2017-12-15 2020-06-23 Ethicon Llc Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments
US10743875B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member
US10743874B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Sealed adapters for use with electromechanical surgical instruments
US10828033B2 (en) 2017-12-15 2020-11-10 Ethicon Llc Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto
US10779826B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Methods of operating surgical end effectors
US10869666B2 (en) 2017-12-15 2020-12-22 Ethicon Llc Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument
US11071543B2 (en) 2017-12-15 2021-07-27 Cilag Gmbh International Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges
US11006955B2 (en) 2017-12-15 2021-05-18 Ethicon Llc End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments
US10966718B2 (en) 2017-12-15 2021-04-06 Ethicon Llc Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments
US11033267B2 (en) 2017-12-15 2021-06-15 Ethicon Llc Systems and methods of controlling a clamping member firing rate of a surgical instrument
US11045270B2 (en) 2017-12-19 2021-06-29 Cilag Gmbh International Robotic attachment comprising exterior drive actuator
US10835330B2 (en) 2017-12-19 2020-11-17 Ethicon Llc Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
US11020112B2 (en) 2017-12-19 2021-06-01 Ethicon Llc Surgical tools configured for interchangeable use with different controller interfaces
USD910847S1 (en) 2017-12-19 2021-02-16 Ethicon Llc Surgical instrument assembly
US10716565B2 (en) 2017-12-19 2020-07-21 Ethicon Llc Surgical instruments with dual articulation drivers
US10729509B2 (en) 2017-12-19 2020-08-04 Ethicon Llc Surgical instrument comprising closure and firing locking mechanism
US11129680B2 (en) 2017-12-21 2021-09-28 Cilag Gmbh International Surgical instrument comprising a projector
US11311290B2 (en) 2017-12-21 2022-04-26 Cilag Gmbh International Surgical instrument comprising an end effector dampener
US10682134B2 (en) 2017-12-21 2020-06-16 Ethicon Llc Continuous use self-propelled stapling instrument
US11076853B2 (en) 2017-12-21 2021-08-03 Cilag Gmbh International Systems and methods of displaying a knife position during transection for a surgical instrument
CA3086884A1 (en) 2018-01-24 2019-08-01 Valtech Cardio, Ltd. Contraction of an annuloplasty structure
EP4248904A3 (en) 2018-01-26 2023-11-29 Edwards Lifesciences Innovation (Israel) Ltd. Techniques for facilitating heart valve tethering and chord replacement
EP3773270A4 (en) * 2018-03-19 2022-02-23 Medi-Tate Ltd. Urethral implant delivery system and method
WO2019232432A1 (en) 2018-06-01 2019-12-05 Santa Anna Tech Llc Multi-stage vapor-based ablation treatment methods and vapor generation and delivery systems
US11134937B2 (en) 2018-07-02 2021-10-05 Edwards Lifesciences Corporation Suture clip
CA3106104A1 (en) 2018-07-12 2020-01-16 Valtech Cardio, Ltd. Annuloplasty systems and locking tools therefor
RU2698623C1 (en) * 2018-08-03 2019-08-28 Петр Витальевич Глыбочко Method of predicting a risk of complications of unipolar transurethral enucleation of benign prostatic hyperplasia
US11419610B2 (en) 2018-08-17 2022-08-23 Empress Medical, Inc. Device and method for passing tension member around tissue mass
CN112770680A (en) * 2018-08-17 2021-05-07 安普列斯医疗公司 Device and method for compression of tumors
US11324501B2 (en) 2018-08-20 2022-05-10 Cilag Gmbh International Surgical stapling devices with improved closure members
US11253256B2 (en) 2018-08-20 2022-02-22 Cilag Gmbh International Articulatable motor powered surgical instruments with dedicated articulation motor arrangements
US11083458B2 (en) 2018-08-20 2021-08-10 Cilag Gmbh International Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions
USD914878S1 (en) 2018-08-20 2021-03-30 Ethicon Llc Surgical instrument anvil
US10779821B2 (en) 2018-08-20 2020-09-22 Ethicon Llc Surgical stapler anvils with tissue stop features configured to avoid tissue pinch
US10912559B2 (en) 2018-08-20 2021-02-09 Ethicon Llc Reinforced deformable anvil tip for surgical stapler anvil
US11291440B2 (en) 2018-08-20 2022-04-05 Cilag Gmbh International Method for operating a powered articulatable surgical instrument
US10842492B2 (en) 2018-08-20 2020-11-24 Ethicon Llc Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system
US11039834B2 (en) 2018-08-20 2021-06-22 Cilag Gmbh International Surgical stapler anvils with staple directing protrusions and tissue stability features
US10856870B2 (en) 2018-08-20 2020-12-08 Ethicon Llc Switching arrangements for motor powered articulatable surgical instruments
US11207065B2 (en) 2018-08-20 2021-12-28 Cilag Gmbh International Method for fabricating surgical stapler anvils
US11045192B2 (en) 2018-08-20 2021-06-29 Cilag Gmbh International Fabricating techniques for surgical stapler anvils
US20210378784A1 (en) * 2018-11-07 2021-12-09 Neotract, Inc. System for delivery of a fiducial marker
US11504105B2 (en) 2019-01-25 2022-11-22 Rex Medical L.P. Vascular hole closure device
US11510766B2 (en) * 2019-02-14 2022-11-29 Uromedica, Inc. Method and apparatus for monitoring implantable device for urinary continence
US10957043B2 (en) * 2019-02-28 2021-03-23 Endosoftllc AI systems for detecting and sizing lesions
US11696761B2 (en) 2019-03-25 2023-07-11 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147551B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147553B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11172929B2 (en) 2019-03-25 2021-11-16 Cilag Gmbh International Articulation drive arrangements for surgical systems
US11471157B2 (en) 2019-04-30 2022-10-18 Cilag Gmbh International Articulation control mapping for a surgical instrument
US11426251B2 (en) 2019-04-30 2022-08-30 Cilag Gmbh International Articulation directional lights on a surgical instrument
US11452528B2 (en) 2019-04-30 2022-09-27 Cilag Gmbh International Articulation actuators for a surgical instrument
US11648009B2 (en) 2019-04-30 2023-05-16 Cilag Gmbh International Rotatable jaw tip for a surgical instrument
US11903581B2 (en) 2019-04-30 2024-02-20 Cilag Gmbh International Methods for stapling tissue using a surgical instrument
US11432816B2 (en) 2019-04-30 2022-09-06 Cilag Gmbh International Articulation pin for a surgical instrument
US11253254B2 (en) 2019-04-30 2022-02-22 Cilag Gmbh International Shaft rotation actuator on a surgical instrument
US11090080B2 (en) * 2019-05-15 2021-08-17 Indian Wells Medical, Inc. Steerable endoluminal punch with introducer
EP3979920A4 (en) * 2019-06-06 2023-07-05 Simplified Surgical Solutions, LLC System and method for paraurethral support restoration to treat stress incontinence
US11464601B2 (en) 2019-06-28 2022-10-11 Cilag Gmbh International Surgical instrument comprising an RFID system for tracking a movable component
US11298127B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Interational Surgical stapling system having a lockout mechanism for an incompatible cartridge
US11497492B2 (en) 2019-06-28 2022-11-15 Cilag Gmbh International Surgical instrument including an articulation lock
US11684434B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Surgical RFID assemblies for instrument operational setting control
US11298132B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Inlernational Staple cartridge including a honeycomb extension
US11376098B2 (en) 2019-06-28 2022-07-05 Cilag Gmbh International Surgical instrument system comprising an RFID system
US11771419B2 (en) 2019-06-28 2023-10-03 Cilag Gmbh International Packaging for a replaceable component of a surgical stapling system
US11259803B2 (en) 2019-06-28 2022-03-01 Cilag Gmbh International Surgical stapling system having an information encryption protocol
US11660163B2 (en) 2019-06-28 2023-05-30 Cilag Gmbh International Surgical system with RFID tags for updating motor assembly parameters
US11627959B2 (en) 2019-06-28 2023-04-18 Cilag Gmbh International Surgical instruments including manual and powered system lockouts
US11523822B2 (en) 2019-06-28 2022-12-13 Cilag Gmbh International Battery pack including a circuit interrupter
US11219455B2 (en) 2019-06-28 2022-01-11 Cilag Gmbh International Surgical instrument including a lockout key
US11224497B2 (en) 2019-06-28 2022-01-18 Cilag Gmbh International Surgical systems with multiple RFID tags
US11246678B2 (en) 2019-06-28 2022-02-15 Cilag Gmbh International Surgical stapling system having a frangible RFID tag
US11241235B2 (en) 2019-06-28 2022-02-08 Cilag Gmbh International Method of using multiple RFID chips with a surgical assembly
US11426167B2 (en) 2019-06-28 2022-08-30 Cilag Gmbh International Mechanisms for proper anvil attachment surgical stapling head assembly
US11638587B2 (en) 2019-06-28 2023-05-02 Cilag Gmbh International RFID identification systems for surgical instruments
US11051807B2 (en) 2019-06-28 2021-07-06 Cilag Gmbh International Packaging assembly including a particulate trap
US11399837B2 (en) 2019-06-28 2022-08-02 Cilag Gmbh International Mechanisms for motor control adjustments of a motorized surgical instrument
US11291451B2 (en) 2019-06-28 2022-04-05 Cilag Gmbh International Surgical instrument with battery compatibility verification functionality
US11553971B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Surgical RFID assemblies for display and communication
US11478241B2 (en) 2019-06-28 2022-10-25 Cilag Gmbh International Staple cartridge including projections
CN114929116A (en) * 2019-08-08 2022-08-19 透壁系统有限责任公司 Tissue crossing system and anchor for use therewith
AU2020375903A1 (en) 2019-10-29 2021-12-23 Edwards Lifesciences Innovation (Israel) Ltd. Annuloplasty and tissue anchor technologies
US11911499B2 (en) 2019-11-07 2024-02-27 Resurge Therapeutics, Inc. System and method for prostate treatment
US11291447B2 (en) 2019-12-19 2022-04-05 Cilag Gmbh International Stapling instrument comprising independent jaw closing and staple firing systems
US11446029B2 (en) 2019-12-19 2022-09-20 Cilag Gmbh International Staple cartridge comprising projections extending from a curved deck surface
US11576672B2 (en) 2019-12-19 2023-02-14 Cilag Gmbh International Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw
US11464512B2 (en) 2019-12-19 2022-10-11 Cilag Gmbh International Staple cartridge comprising a curved deck surface
US11559304B2 (en) 2019-12-19 2023-01-24 Cilag Gmbh International Surgical instrument comprising a rapid closure mechanism
US11234698B2 (en) 2019-12-19 2022-02-01 Cilag Gmbh International Stapling system comprising a clamp lockout and a firing lockout
US11844520B2 (en) 2019-12-19 2023-12-19 Cilag Gmbh International Staple cartridge comprising driver retention members
US11911032B2 (en) 2019-12-19 2024-02-27 Cilag Gmbh International Staple cartridge comprising a seating cam
US11607219B2 (en) 2019-12-19 2023-03-21 Cilag Gmbh International Staple cartridge comprising a detachable tissue cutting knife
US11529139B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Motor driven surgical instrument
US11304696B2 (en) 2019-12-19 2022-04-19 Cilag Gmbh International Surgical instrument comprising a powered articulation system
US11529137B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Staple cartridge comprising driver retention members
US11504122B2 (en) 2019-12-19 2022-11-22 Cilag Gmbh International Surgical instrument comprising a nested firing member
US11701111B2 (en) 2019-12-19 2023-07-18 Cilag Gmbh International Method for operating a surgical stapling instrument
WO2021168057A1 (en) 2020-02-21 2021-08-26 Neotract, Inc. Apparatus for preventing device deployment failure
AU2021251123A1 (en) * 2020-04-06 2022-10-20 Corbin Clinical Resources, Llc Transperineal prostate biopsy and treatment methods
USD976401S1 (en) 2020-06-02 2023-01-24 Cilag Gmbh International Staple cartridge
USD975278S1 (en) 2020-06-02 2023-01-10 Cilag Gmbh International Staple cartridge
USD975851S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD966512S1 (en) 2020-06-02 2022-10-11 Cilag Gmbh International Staple cartridge
USD967421S1 (en) 2020-06-02 2022-10-18 Cilag Gmbh International Staple cartridge
USD975850S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD974560S1 (en) 2020-06-02 2023-01-03 Cilag Gmbh International Staple cartridge
US11737748B2 (en) 2020-07-28 2023-08-29 Cilag Gmbh International Surgical instruments with double spherical articulation joints with pivotable links
DK3989844T3 (en) 2020-08-03 2023-10-30 Teleflex Life Sciences Ltd Handle and cartridge system for medical inventions
KR102170400B1 (en) * 2020-08-31 2020-10-27 정윤호 Prostate enlargement treatment device
US11534259B2 (en) 2020-10-29 2022-12-27 Cilag Gmbh International Surgical instrument comprising an articulation indicator
US11896217B2 (en) 2020-10-29 2024-02-13 Cilag Gmbh International Surgical instrument comprising an articulation lock
US11517390B2 (en) 2020-10-29 2022-12-06 Cilag Gmbh International Surgical instrument comprising a limited travel switch
US11779330B2 (en) 2020-10-29 2023-10-10 Cilag Gmbh International Surgical instrument comprising a jaw alignment system
USD980425S1 (en) 2020-10-29 2023-03-07 Cilag Gmbh International Surgical instrument assembly
US11844518B2 (en) 2020-10-29 2023-12-19 Cilag Gmbh International Method for operating a surgical instrument
USD1013170S1 (en) 2020-10-29 2024-01-30 Cilag Gmbh International Surgical instrument assembly
US11617577B2 (en) 2020-10-29 2023-04-04 Cilag Gmbh International Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable
US11717289B2 (en) 2020-10-29 2023-08-08 Cilag Gmbh International Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable
US11452526B2 (en) 2020-10-29 2022-09-27 Cilag Gmbh International Surgical instrument comprising a staged voltage regulation start-up system
US11627960B2 (en) 2020-12-02 2023-04-18 Cilag Gmbh International Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections
US11653920B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Powered surgical instruments with communication interfaces through sterile barrier
US11744581B2 (en) 2020-12-02 2023-09-05 Cilag Gmbh International Powered surgical instruments with multi-phase tissue treatment
US11678882B2 (en) 2020-12-02 2023-06-20 Cilag Gmbh International Surgical instruments with interactive features to remedy incidental sled movements
US11849943B2 (en) 2020-12-02 2023-12-26 Cilag Gmbh International Surgical instrument with cartridge release mechanisms
US11737751B2 (en) 2020-12-02 2023-08-29 Cilag Gmbh International Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings
US11653915B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Surgical instruments with sled location detection and adjustment features
US11890010B2 (en) 2020-12-02 2024-02-06 Cllag GmbH International Dual-sided reinforced reload for surgical instruments
CN112826548B (en) * 2021-01-06 2022-09-30 北科创新(深圳)科技有限公司 Incision expanding device applied to surgical operation
RU2752949C1 (en) * 2021-02-05 2021-08-11 Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Method for predicting risk of developing lymphogenous complications after radical prostatectomy with pelvic lymphadenectomy
US11812964B2 (en) 2021-02-26 2023-11-14 Cilag Gmbh International Staple cartridge comprising a power management circuit
US11751869B2 (en) 2021-02-26 2023-09-12 Cilag Gmbh International Monitoring of multiple sensors over time to detect moving characteristics of tissue
US11730473B2 (en) 2021-02-26 2023-08-22 Cilag Gmbh International Monitoring of manufacturing life-cycle
US11744583B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Distal communication array to tune frequency of RF systems
US11701113B2 (en) 2021-02-26 2023-07-18 Cilag Gmbh International Stapling instrument comprising a separate power antenna and a data transfer antenna
US11696757B2 (en) 2021-02-26 2023-07-11 Cilag Gmbh International Monitoring of internal systems to detect and track cartridge motion status
US11749877B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Stapling instrument comprising a signal antenna
US11723657B2 (en) 2021-02-26 2023-08-15 Cilag Gmbh International Adjustable communication based on available bandwidth and power capacity
US11793514B2 (en) 2021-02-26 2023-10-24 Cilag Gmbh International Staple cartridge comprising sensor array which may be embedded in cartridge body
US11529236B2 (en) 2021-03-04 2022-12-20 OTS Medical Ltd. Repair of shoulder-joint lesions
US11759202B2 (en) 2021-03-22 2023-09-19 Cilag Gmbh International Staple cartridge comprising an implantable layer
US11723658B2 (en) 2021-03-22 2023-08-15 Cilag Gmbh International Staple cartridge comprising a firing lockout
US11737749B2 (en) 2021-03-22 2023-08-29 Cilag Gmbh International Surgical stapling instrument comprising a retraction system
US11717291B2 (en) 2021-03-22 2023-08-08 Cilag Gmbh International Staple cartridge comprising staples configured to apply different tissue compression
US11826012B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Stapling instrument comprising a pulsed motor-driven firing rack
US11826042B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Surgical instrument comprising a firing drive including a selectable leverage mechanism
US11806011B2 (en) 2021-03-22 2023-11-07 Cilag Gmbh International Stapling instrument comprising tissue compression systems
US11793516B2 (en) 2021-03-24 2023-10-24 Cilag Gmbh International Surgical staple cartridge comprising longitudinal support beam
US11896218B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Method of using a powered stapling device
US11744603B2 (en) 2021-03-24 2023-09-05 Cilag Gmbh International Multi-axis pivot joints for surgical instruments and methods for manufacturing same
US11896219B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Mating features between drivers and underside of a cartridge deck
US11849945B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Rotary-driven surgical stapling assembly comprising eccentrically driven firing member
US11786239B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Surgical instrument articulation joint arrangements comprising multiple moving linkage features
US11903582B2 (en) 2021-03-24 2024-02-20 Cilag Gmbh International Leveraging surfaces for cartridge installation
US11857183B2 (en) 2021-03-24 2024-01-02 Cilag Gmbh International Stapling assembly components having metal substrates and plastic bodies
US11832816B2 (en) 2021-03-24 2023-12-05 Cilag Gmbh International Surgical stapling assembly comprising nonplanar staples and planar staples
US11849944B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Drivers for fastener cartridge assemblies having rotary drive screws
US11786243B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Firing members having flexible portions for adapting to a load during a surgical firing stroke
US11826047B2 (en) 2021-05-28 2023-11-28 Cilag Gmbh International Stapling instrument comprising jaw mounts
US11877745B2 (en) 2021-10-18 2024-01-23 Cilag Gmbh International Surgical stapling assembly having longitudinally-repeating staple leg clusters
US11602516B1 (en) 2022-01-29 2023-03-14 Resurge Therapeutics Inc. Treating benign prostatic hyperplasia
WO2024003851A1 (en) * 2022-06-30 2024-01-04 Proarc Medical Ltd. Urethral treatment apparatus and method

Citations (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3716058A (en) * 1970-07-17 1973-02-13 Atlanta Res Inst Barbed suture
US3875648A (en) * 1973-04-04 1975-04-08 Dennison Mfg Co Fastener attachment apparatus and method
US4493323A (en) * 1982-12-13 1985-01-15 University Of Iowa Research Foundation Suturing device and method for using same
US4513746A (en) * 1981-10-09 1985-04-30 United States Surgical Corp. Instrument for applying plastic-like surgical fastening devices
US4657461A (en) * 1984-10-26 1987-04-14 Smith Gareth J Anchoring bolt
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US4741330A (en) * 1983-05-19 1988-05-03 Hayhurst John O Method and apparatus for anchoring and manipulating cartilage
US4899743A (en) * 1987-12-15 1990-02-13 Mitek Surgical Products, Inc. Suture anchor installation tool
US4926860A (en) * 1988-02-05 1990-05-22 Flexmedics Corporation ARthroscopic instrumentation and method
US5002550A (en) * 1989-06-06 1991-03-26 Mitek Surgical Products, Inc. Suture anchor installation tool
US5100421A (en) * 1991-02-05 1992-03-31 Cyprus Endosurgical Tools, Inc. Christoudias curved needle suture assembly
US5123914A (en) * 1986-05-19 1992-06-23 Cook Incorporated Visceral anchor for visceral wall mobilization
US5192303A (en) * 1987-05-18 1993-03-09 Mitek Surgical Products, Inc. Suture anchor
US5203787A (en) * 1990-11-19 1993-04-20 Biomet, Inc. Suture retaining arrangement
US5217486A (en) * 1992-02-18 1993-06-08 Mitek Surgical Products, Inc. Suture anchor and installation tool
US5280460A (en) * 1990-05-21 1994-01-18 Eta S.A. Fabriques D'ebauches Gear mechanism especially for timepiece
US5330488A (en) * 1993-03-23 1994-07-19 Goldrath Milton H Verres needle suturing kit
US5417691A (en) * 1982-05-20 1995-05-23 Hayhurst; John O. Apparatus and method for manipulating and anchoring tissue
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5501690A (en) * 1994-09-02 1996-03-26 Ethicon Endo-Surgery Suturing device
US5507754A (en) * 1993-08-20 1996-04-16 United States Surgical Corporation Apparatus and method for applying and adjusting an anchoring device
US5522846A (en) * 1993-05-14 1996-06-04 Bonutti; Peter M. Suture anchor
US5536240A (en) * 1992-08-12 1996-07-16 Vidamed, Inc. Medical probe device and method
US5540704A (en) * 1992-09-04 1996-07-30 Laurus Medical Corporation Endoscopic suture system
US5593421A (en) * 1995-06-06 1997-01-14 Bauer; William Suture element delivery device and method
US5626614A (en) * 1995-12-22 1997-05-06 Applied Medical Resources Corporation T-anchor suturing device and method for using same
US5630824A (en) * 1994-06-01 1997-05-20 Innovasive Devices, Inc. Suture attachment device
US5718717A (en) * 1996-08-19 1998-02-17 Bonutti; Peter M. Suture anchor
US5733306A (en) * 1993-05-14 1998-03-31 Bonutti; Peter M. Method and apparatus for anchoring a suture
US5741276A (en) * 1996-03-28 1998-04-21 Innovative Surgical Instruments Apparatus for facilitating the performance of surgical procedures such as the placement of sutures, ligatures and the like
US5746753A (en) * 1996-05-13 1998-05-05 Boston Scientific Corporation Needle grasping apparatus
US5782862A (en) * 1996-07-01 1998-07-21 Bonutti; Peter M. Suture anchor inserter assembly and method
US5782864A (en) * 1997-04-03 1998-07-21 Mitek Surgical Products, Inc. Knotless suture system and method
US5861002A (en) * 1991-10-18 1999-01-19 Desai; Ashvin H. Endoscopic surgical instrument
US5868762A (en) * 1997-09-25 1999-02-09 Sub-Q, Inc. Percutaneous hemostatic suturing device and method
US5873891A (en) * 1994-12-14 1999-02-23 Influence Medical Technologies, Ltd. Staple and thread assembly particularly for use in power-driven staplers for medical suturing
US5899911A (en) * 1993-08-25 1999-05-04 Inlet Medical, Inc. Method of using needle-point suture passer to retract and reinforce ligaments
US5904696A (en) * 1994-01-13 1999-05-18 Ethicon, Inc. Spiral surgical tack
US5908428A (en) * 1997-05-27 1999-06-01 United States Surgical Corporation Stitching devices for heart valve replacement surgery
US5919202A (en) * 1989-12-05 1999-07-06 Yoon; Inbae Surgical instrument with jaws and movable internal needle and method for use thereof
US5919198A (en) * 1997-04-17 1999-07-06 Ethicon Endo-Surgery, Inc. Disposable cartridge with drivers
US5928252A (en) * 1997-01-21 1999-07-27 Regen Biologics, Inc. Device and method for driving a needle and meniscal repair
US6010514A (en) * 1998-03-17 2000-01-04 Burney; Bryan T. Suturing assembly and method of use
US6030393A (en) * 1998-09-15 2000-02-29 Corlew; Earvin L. Needle and procedure for relieving urinary incontinence
US6048351A (en) * 1992-09-04 2000-04-11 Scimed Life Systems, Inc. Transvaginal suturing system
US6053908A (en) * 1999-01-07 2000-04-25 Design Standards Corporation Ratchet assembly for surgical instrument
US6056772A (en) * 1993-02-04 2000-05-02 Bonutti; Peter M. Method and apparatus for positioning a suture anchor
US6056722A (en) * 1997-09-18 2000-05-02 Iowa-India Investments Company Limited Of Douglas Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use
US6068648A (en) * 1998-01-26 2000-05-30 Orthodyne, Inc. Tissue anchoring system and method
US6080167A (en) * 1998-04-28 2000-06-27 Lyell; Mark S. Anastomotic instrument
US6206895B1 (en) * 1999-07-13 2001-03-27 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6228096B1 (en) * 1999-03-31 2001-05-08 Sam R. Marchand Instrument and method for manipulating an operating member coupled to suture material while maintaining tension on the suture material
US6258124B1 (en) * 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US6398795B1 (en) * 2000-11-30 2002-06-04 Scimed Life Systems, Inc. Stapling and cutting in resectioning for full thickness resection devices
US6425900B1 (en) * 2000-10-19 2002-07-30 Ethicon Endo-Surgery Method for attaching hernia mesh
US6527794B1 (en) * 1999-08-10 2003-03-04 Ethicon, Inc. Self-locking suture anchor
US6530932B1 (en) * 2000-08-30 2003-03-11 Ethicon Endo-Surgery, Inc. Anastomosis device having improved tissue presentation
US6533796B1 (en) * 2000-10-11 2003-03-18 Lsi Solutions, Inc. Loader for surgical suturing instrument
US6547725B1 (en) * 1998-08-10 2003-04-15 Coroneo, Inc. Surgical suture and associated anchoring mechanism for tissue retraction
US6551328B2 (en) * 1997-11-03 2003-04-22 Symbiosis Corporation Surgical instrument for invagination and fundoplication
US6551333B2 (en) * 2000-10-19 2003-04-22 Ethicon Endo-Surgery, Inc. Method for attaching hernia mesh
US6565578B1 (en) * 1995-09-06 2003-05-20 Wilson-Cook Medical Inc. Channel mounted activating mechanism for an endoscopic ligator
US6572653B1 (en) * 2001-12-07 2003-06-03 Rush E. Simonson Vertebral implant adapted for posterior insertion
US6572626B1 (en) * 2000-10-19 2003-06-03 Ethicon Endo-Surgery, Inc. Surgical instrument having a fastener delivery mechanism
US6592609B1 (en) * 1999-08-09 2003-07-15 Bonutti 2003 Trust-A Method and apparatus for securing tissue
US6699263B2 (en) * 2002-04-05 2004-03-02 Cook Incorporated Sliding suture anchor
US6706047B2 (en) * 2000-02-15 2004-03-16 Eva Corporation Suture support assembly
US6709493B2 (en) * 2001-03-26 2004-03-23 Gore Enterprise Holdings, Inc. Device for reducing the presence of moisture within an enclosure containing a heat source
US20040078046A1 (en) * 2002-10-16 2004-04-22 Barzell Winston E. Suturing system and method
US6736854B2 (en) * 2002-05-10 2004-05-18 C. R. Bard, Inc. Prosthetic repair fabric with erosion resistant edge
US6736823B2 (en) * 2002-05-10 2004-05-18 C.R. Bard, Inc. Prosthetic repair fabric
US6740098B2 (en) * 1998-05-11 2004-05-25 Surgical Connections, Inc. Surgical stabilizer devices and methods
US20050055087A1 (en) * 2003-09-04 2005-03-10 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US20050065550A1 (en) * 2003-02-06 2005-03-24 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20050107811A1 (en) * 2002-06-13 2005-05-19 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025819A1 (en) * 2004-05-14 2006-02-02 Nobis Rudolph H T-type suture anchoring devices and methods of using same
US20060030884A1 (en) * 2002-03-14 2006-02-09 Yeung Jeffrey E Suture anchor and approximating device
US7011688B2 (en) * 2002-05-10 2006-03-14 C.R. Bard, Inc. Prosthetic repair fabric
US20060058817A1 (en) * 2002-06-13 2006-03-16 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7015253B2 (en) * 2001-07-10 2006-03-21 American Medical Systems, Inc. Regimen for treating prostate tissue and surgical kit for use in the regimen
US7048747B2 (en) * 1999-09-14 2006-05-23 Abbott Laboratories Device and method for performing end-to-side anastomosis
US7060077B2 (en) * 1992-09-04 2006-06-13 Boston Scientific Scimed, Inc. Suturing instruments and methods of use
US7226558B2 (en) * 2000-11-22 2007-06-05 Bard Peripheral Vascular, Inc. Method of making an expanded polytetrafluoroethylene structure
US7232448B2 (en) * 2004-06-17 2007-06-19 Ethicon, Inc. - Usa Minimally invasive stitching device
US7320701B2 (en) * 2003-06-02 2008-01-22 Linvatec Corporation Push-in suture anchor, insertion tool, and method for inserting a push-in suture anchor
US20080021445A1 (en) * 2004-10-13 2008-01-24 Medtronic, Inc. Transurethral needle ablation system
US7322974B2 (en) * 2004-08-10 2008-01-29 Medtronic, Inc. TUNA device with integrated saline reservoir
US20080045978A1 (en) * 2000-10-19 2008-02-21 Kuhns Jesse J Method For Delivering a Plurality of Fasteners
US7340300B2 (en) * 2003-04-25 2008-03-04 Medtronic, Inc. Neurostimulation delivery during transurethral prostate treatment
US20080119874A1 (en) * 2002-10-07 2008-05-22 Michael Merves Instrument handle for storing suture and needles

Family Cites Families (580)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734299A (en) 1956-02-14 Igudolph
US677076A (en) * 1897-12-17 1901-06-25 Gen Fire Extinguisher Co Valve.
US659422A (en) 1900-06-12 1900-10-09 George W Shidler Surgical instrument.
US789467A (en) 1903-06-12 1905-05-09 Stillman A West Method of tying knots.
US780392A (en) 1903-09-14 1905-01-17 Brown Straw Binder Company Straw-bundle tie.
US2360164A (en) 1943-12-23 1944-10-10 Edward A Swenson Clothespin
US2485531A (en) * 1948-01-13 1949-10-18 Dzus William Surgical toggle bolt
US2579192A (en) 1950-08-15 1951-12-18 George H Sciaroni Suturing instrument
US2697624A (en) 1951-11-03 1954-12-21 John A Thomas Portable knot tying device
US2646298A (en) 1952-07-15 1953-07-21 Joseph C Leary Method of knot tying
US2825592A (en) 1954-01-06 1958-03-04 Semple James Mckenzie Portable knot tying device for smooth filaments
US3326586A (en) 1965-07-09 1967-06-20 Robert M Frost Snell knot tying tool
US3470834A (en) 1968-03-08 1969-10-07 Dennison Mfg Co Fastener attaching device
US3541591A (en) 1968-04-26 1970-11-17 Henry J Hoegerman Method and apparatus for closing wounds
US3521918A (en) 1968-08-14 1970-07-28 Richard L Hammond Fishline knotting fixture and cutter
US3664345A (en) 1970-07-06 1972-05-23 Clyde Harwell Dabbs Surgical buttons
US3713680A (en) 1971-02-09 1973-01-30 S Pagano Knot typing device for barrel knots
US3756638A (en) 1972-02-22 1973-09-04 L Stockberger Knot tyer
US3886933A (en) * 1973-10-10 1975-06-03 Olympus Optical Co Ureteral catheter device
US3873140A (en) 1973-10-15 1975-03-25 Moodus Sports Products Fish hook holder and knot tying device
US3931667A (en) 1974-05-08 1976-01-13 Dennison Manufacturing Company Interlocking attachment device
US3976079A (en) 1974-08-01 1976-08-24 Samuels Peter B Securing devices for sutures
US4006747A (en) 1975-04-23 1977-02-08 Ethicon, Inc. Surgical method
JPS5836559B2 (en) 1975-12-22 1983-08-10 ソニー株式会社 4 Channel stereo adjustment
DE2601802C3 (en) 1976-01-20 1979-02-08 Richard Wolf Gmbh, 7134 Knittlingen Instruments for the treatment of urethral strictures
SU825094A1 (en) 1976-12-25 1981-04-30 Lovenetskij Petr S Dilator of prostate
US4164225A (en) * 1977-12-28 1979-08-14 Johnson & Lorenz, Inc. Surgical suturing instrument
US4235238A (en) 1978-05-11 1980-11-25 Olympus Optical Co., Ltd. Apparatus for suturing coeliac tissues
US4210148A (en) 1978-11-03 1980-07-01 Stivala Oscar G Retention suture system
DE2853289C2 (en) 1978-12-09 1980-12-18 B. Braun Melsungen Ag, 3508 Melsungen Button for surgical use
JPS5836559Y2 (en) 1979-05-26 1983-08-17 三菱鉛筆株式会社 Head and side-knock type shampoo pencil
JPS57188231A (en) 1981-05-14 1982-11-19 Olympus Optical Co Treating tool guide apparatus of endoscope
US4419094A (en) * 1981-06-08 1983-12-06 The Kendall Company Suprapubic catheter system
US4409974A (en) 1981-06-29 1983-10-18 Freedland Jeffrey A Bone-fixating surgical implant device
AU8679382A (en) 1981-08-10 1983-02-17 Ethicon Inc. Polyolefin surgical device
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US6656182B1 (en) 1982-05-20 2003-12-02 John O. Hayhurst Tissue manipulation
US4823794A (en) 1982-07-12 1989-04-25 Pierce William S Surgical pledget
US5385544A (en) 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US4621640A (en) 1984-01-09 1986-11-11 Mulhollan James S Mechanical needle carrier and method for its use
US4750492A (en) 1985-02-27 1988-06-14 Richards Medical Company Absorbable suture apparatus, method and installer
US4955913A (en) 1985-03-28 1990-09-11 Robinson Walter C Surgical tie
US4790809A (en) 1985-08-29 1988-12-13 Medical Engineering Corporation Ureteral stent
US4705040A (en) 1985-11-18 1987-11-10 Medi-Tech, Incorporated Percutaneous fixation of hollow organs
US4738255A (en) 1986-04-07 1988-04-19 Biotron Labs, Inc. Suture anchor system
US4893623A (en) 1986-12-09 1990-01-16 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
US4714281A (en) 1987-01-02 1987-12-22 Peck Richard M Device and method for tying a twisted clinch knot
US4935028A (en) 1987-01-12 1990-06-19 Drews Robert C Corneal rivet
US4744364A (en) 1987-02-17 1988-05-17 Intravascular Surgical Instruments, Inc. Device for sealing percutaneous puncture in a vessel
DK163713C (en) * 1987-09-02 1992-09-07 Ole Gyring Nieben DEVICE FOR THE POSITION OF A PARTICULAR CATHETTE IN A BODY
US4863439A (en) 1987-11-02 1989-09-05 S. Robert Kovac Surgical cannula
US4968315A (en) 1987-12-15 1990-11-06 Mitek Surgical Products, Inc. Suture anchor and suture anchor installation tool
US5053046A (en) 1988-08-22 1991-10-01 Woodrow W. Janese Dural sealing needle and method of use
US5159925A (en) 1988-09-09 1992-11-03 Gynelab, Inc. Cauterizing apparatus and method for laparoscopic cholecystostomy, gallbladder ablation and treatment of benign prostate hypertrophy
US4994066A (en) 1988-10-07 1991-02-19 Voss Gene A Prostatic stent
US5904679A (en) * 1989-01-18 1999-05-18 Applied Medical Resources Corporation Catheter with electrosurgical cutter
EP0471764B1 (en) * 1989-05-03 1996-07-03 ENTERPRISE MEDICAL TECHNOLOGIES, Inc. Instrument for intraluminally relieving stenosis
US5620461A (en) 1989-05-29 1997-04-15 Muijs Van De Moer; Wouter M. Sealing device
US4946468A (en) 1989-06-06 1990-08-07 Mitek Surgical Products, Inc. Suture anchor and suture anchor installation tool
US4955859A (en) 1989-07-07 1990-09-11 C. R. Bard, Inc. High-friction prostatic stent
RU2062121C1 (en) 1989-10-13 1996-06-20 Давыдов Владимир Александрович Dilating device
US5267960A (en) 1990-03-19 1993-12-07 Omnitron International Inc. Tissue engaging catheter for a radioactive source wire
EP0448857A1 (en) * 1990-03-27 1991-10-02 Jong-Khing Huang An apparatus of a spinning type of resectoscope for prostatectomy
US5019032A (en) 1990-04-03 1991-05-28 Robertson Jack R Refined suspension procedure with implement for treating female stress incontinence
US5080660A (en) * 1990-05-11 1992-01-14 Applied Urology, Inc. Electrosurgical electrode
US5078731A (en) 1990-06-05 1992-01-07 Hayhurst John O Suture clip
US6203565B1 (en) 1990-06-28 2001-03-20 Peter M. Bonutti Surgical devices assembled using heat bondable materials
US5163960A (en) 1990-06-28 1992-11-17 Bonutti Peter M Surgical devices assembled using heat bondable materials
US5269809A (en) 1990-07-02 1993-12-14 American Cyanamid Company Locking mechanism for use with a slotted suture anchor
US5236445A (en) 1990-07-02 1993-08-17 American Cyanamid Company Expandable bone anchor and method of anchoring a suture to a bone
US5041129A (en) 1990-07-02 1991-08-20 Acufex Microsurgical, Inc. Slotted suture anchor and method of anchoring a suture
US5653373A (en) 1990-09-17 1997-08-05 United States Surgical Corporation Arcuate apparatus for applying two-part surgical fasteners
US5372146A (en) 1990-11-06 1994-12-13 Branch; Thomas P. Method and apparatus for re-approximating tissue
DE9190181U1 (en) 1990-12-10 1993-07-29 Howmedica Inc
US5129912B2 (en) 1991-01-07 2000-01-11 Urohealth Systems Inc Device and method for applying suture
US5409453A (en) 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
DE4106823C1 (en) 1991-03-04 1992-06-25 Liebscher Kunststofftechnik, 8032 Graefelfing, De
US5405352A (en) 1991-04-09 1995-04-11 Weston; Peter V. Suture knot, method for its formation and use, and knot forming apparatus
US5217470A (en) 1991-04-29 1993-06-08 Weston Peter V Apparatuses and methods for formation and use of a slipknot as a surgical suture knot
US5258015A (en) 1991-05-03 1993-11-02 American Cyanamid Company Locking filament caps
US5127393A (en) * 1991-05-28 1992-07-07 Medilase, Inc. Flexible endoscope with rigid introducer
US5160339A (en) 1991-06-18 1992-11-03 Ethicon, Inc. Endoscopic suture clip
US5237984A (en) * 1991-06-24 1993-08-24 Xomed-Treace Inc. Sheath for endoscope
US5234454A (en) 1991-08-05 1993-08-10 Akron City Hospital Percutaneous intragastric balloon catheter and method for controlling body weight therewith
GB9118670D0 (en) 1991-08-30 1991-10-16 Mcnicholas Thomas A Surgical devices and uses thereof
US5269802A (en) 1991-09-10 1993-12-14 Garber Bruce B Prostatic stent
CA2078530A1 (en) 1991-09-23 1993-03-24 Jay Erlebacher Percutaneous arterial puncture seal device and insertion tool therefore
US7549424B2 (en) 1991-10-18 2009-06-23 Pro Surg, Inc. Method and apparatus for tissue treatment with laser and electromagnetic radiation
US5167614A (en) 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent
US5372600A (en) 1991-10-31 1994-12-13 Instent Inc. Stent delivery systems
US5411520A (en) 1991-11-08 1995-05-02 Kensey Nash Corporation Hemostatic vessel puncture closure system utilizing a plug located within the puncture tract spaced from the vessel, and method of use
DE69323779T2 (en) 1991-12-03 1999-09-30 Boston Scient Ireland Ltd Instrument for passing a sewing thread
MX9300607A (en) 1992-02-06 1993-10-01 American Med Syst APPARATUS AND METHOD FOR INTERSTITIAL TREATMENT.
US5171251A (en) 1992-03-02 1992-12-15 Ethicon, Inc. Surgical clip having hole therein and method of anchoring suture
US5300099A (en) 1992-03-06 1994-04-05 Urologix, Inc. Gamma matched, helical dipole microwave antenna
US5254126A (en) 1992-06-24 1993-10-19 Ethicon, Inc. Endoscopic suture punch
US5470308A (en) 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5667488A (en) 1992-08-12 1997-09-16 Vidamed, Inc. Transurethral needle ablation device and method for the treatment of the prostate
US5364408A (en) 1992-09-04 1994-11-15 Laurus Medical Corporation Endoscopic suture system
US5578044A (en) 1992-09-04 1996-11-26 Laurus Medical Corporation Endoscopic suture system
US5322501A (en) 1992-10-02 1994-06-21 Mahmud Durrani Ayaz Continent urethral stent for treating and preventing urethral stricture after surgery
US5368599A (en) 1992-10-08 1994-11-29 United States Surgical Corporation Surgical fastening apparatus with suture array
US5464416A (en) 1992-11-10 1995-11-07 Ethicon, Inc. Ligating clip
IL127978A0 (en) 1999-01-08 1999-11-30 Influence Med Tech Ltd Incontinence device
IL103737A (en) 1992-11-13 1997-02-18 Technion Res & Dev Foundation Stapler device particularly useful in medical suturing
US5972000A (en) 1992-11-13 1999-10-26 Influence Medical Technologies, Ltd. Non-linear anchor inserter device and bone anchors
US5370646A (en) 1992-11-16 1994-12-06 Reese; H. William Bone clamp and installation tool
US5380334A (en) 1993-02-17 1995-01-10 Smith & Nephew Dyonics, Inc. Soft tissue anchors and systems for implantation
US5334200A (en) 1993-03-02 1994-08-02 Lanny L. Johnson Suture knot making device and method for use
SE505436C2 (en) 1993-04-27 1997-08-25 Ams Medinvent Sa prostatic stent
US5282472A (en) * 1993-05-11 1994-02-01 Companion John A System and process for the detection, evaluation and treatment of prostate and urinary problems
US5845645A (en) 1993-05-14 1998-12-08 Bonutti; Peter M. Method of anchoring a suture
US5464426A (en) 1993-05-14 1995-11-07 Bonutti; Peter M. Method of closing discontinuity in tissue
US5716368A (en) 1993-06-02 1998-02-10 General Surgical Innovations, Inc. Knotmaker with curved elongate member used in tying a ligature
US5472446A (en) 1993-06-02 1995-12-05 De La Torre; Roger A. Surgical instrument for tying a knot in a length of suture at a remote location
US5505735A (en) 1993-06-10 1996-04-09 Mitek Surgical Products, Inc. Surgical anchor and method for using the same
DK76293D0 (en) 1993-06-25 1993-06-25 Brueel & Kjaer As displacement transducer
US5500000A (en) 1993-07-01 1996-03-19 United States Surgical Corporation Soft tissue repair system and method
US5921982A (en) 1993-07-30 1999-07-13 Lesh; Michael D. Systems and methods for ablating body tissue
US5499994A (en) * 1993-07-30 1996-03-19 American Medical Systems, Inc. Dilation device for the urethra
US5391182A (en) 1993-08-03 1995-02-21 Origin Medsystems, Inc. Apparatus and method for closing puncture wounds
US5354271A (en) 1993-08-05 1994-10-11 Voda Jan K Vascular sheath
CA2124651C (en) 1993-08-20 2004-09-28 David T. Green Apparatus and method for applying and adjusting an anchoring device
US5542594A (en) 1993-10-06 1996-08-06 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US5536273A (en) 1993-12-09 1996-07-16 Lehrer; Theodor Apparatus and method of extracorporeally applying and locking laparoscopic suture and loop ligatures
US5458612A (en) 1994-01-06 1995-10-17 Origin Medsystems, Inc. Prostatic ablation method and apparatus for perineal approach
US5690677A (en) 1994-02-17 1997-11-25 Arthrex, Inc. Method for installing a suture anchor through a cannulated tissue-shifting guide
CA2141911C (en) 1994-02-24 2002-04-23 Jude S. Sauer Surgical crimping device and method of use
US5441485A (en) 1994-02-24 1995-08-15 Peters; Michael J. Bladder catheter
IL108832A (en) 1994-03-03 1999-12-31 Medinol Ltd Urological stent and deployment device therefor
US5562688A (en) 1994-03-25 1996-10-08 Riza; Erol D. Apparatus facilitating suturing in laparoscopic surgery
US5531759A (en) 1994-04-29 1996-07-02 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5545178A (en) 1994-04-29 1996-08-13 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5470337A (en) 1994-05-17 1995-11-28 Moss; Gerald Surgical fastener
US5540701A (en) 1994-05-20 1996-07-30 Hugh Sharkey Passive fixation anastomosis method and device
US5672171A (en) 1994-06-30 1997-09-30 American Medical Systems, Inc. Apparatus and method for interstitial laser treatment
US5573540A (en) 1994-07-18 1996-11-12 Yoon; Inbae Apparatus and method for suturing an opening in anatomical tissue
US5545171A (en) 1994-09-22 1996-08-13 Vidamed, Inc. Anastomosis catheter
US5531763A (en) 1994-10-07 1996-07-02 United States Surgical Corporation Suture cinching apparatus
US5480406A (en) 1994-10-07 1996-01-02 United States Surgical Corporation Method of employing surgical suturing apparatus to tie knots
US5643321A (en) 1994-11-10 1997-07-01 Innovasive Devices Suture anchor assembly and methods
US5554162A (en) 1994-12-02 1996-09-10 Delange; Gregory S. Method and device for surgically joining luminal structures
US5665109A (en) 1994-12-29 1997-09-09 Yoon; Inbae Methods and apparatus for suturing tissue
US5550172A (en) 1995-02-07 1996-08-27 Ethicon, Inc. Utilization of biocompatible adhesive/sealant materials for securing surgical devices
RU2112571C1 (en) 1995-04-11 1998-06-10 Педдер Валерий Викторович Method for treatment of chronic prostatitis and device for its realization (variants)
US5591179A (en) 1995-04-19 1997-01-07 Applied Medical Resources Corporation Anastomosis suturing device and method
US6117161A (en) 1995-06-06 2000-09-12 Li Medical Tecnologies, Inc. Fastener and fastening method, particularly for fastening sutures to bone
US6132438A (en) * 1995-06-07 2000-10-17 Ep Technologies, Inc. Devices for installing stasis reducing means in body tissue
US6086608A (en) 1996-02-22 2000-07-11 Smith & Nephew, Inc. Suture collet
US5647836A (en) 1995-09-28 1997-07-15 Blake, Iii; Joseph W. Method and means for treating female urinary incontinence
US6428538B1 (en) 1995-10-20 2002-08-06 United States Surgical Corporation Apparatus and method for thermal treatment of body tissue
CA2187975C (en) 1995-10-20 2001-05-01 Lisa W. Heaton Surgical apparatus and method for marking tissue location
US5800445A (en) 1995-10-20 1998-09-01 United States Surgical Corporation Tissue tagging device
JPH09122134A (en) 1995-11-01 1997-05-13 Senko Ika Kogyo Kk Method for suturing aperture of trachea and device for suturing the same
US5690649A (en) 1995-12-05 1997-11-25 Li Medical Technologies, Inc. Anchor and anchor installation tool and method
US5725556A (en) 1995-12-15 1998-03-10 M & R Medical, Inc. Suture locking apparatus
US5810853A (en) 1996-01-16 1998-09-22 Yoon; Inbae Knotting element for use in suturing anatomical tissue and methods therefor
US5791022A (en) 1996-01-29 1998-08-11 Bohman; Lars Cord locking mechanism
US5697950A (en) 1996-02-07 1997-12-16 Linvatec Corporation Pre-loaded suture anchor
US5707394A (en) 1996-02-07 1998-01-13 Bristol-Myers Squibb Company Pre-loaded suture anchor with rigid extension
US5749889A (en) * 1996-02-13 1998-05-12 Imagyn Medical, Inc. Method and apparatus for performing biopsy
US6436107B1 (en) 1996-02-20 2002-08-20 Computer Motion, Inc. Method and apparatus for performing minimally invasive surgical procedures
US5830179A (en) * 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
US6702846B2 (en) * 1996-04-09 2004-03-09 Endocare, Inc. Urological stent therapy system and method
EP0893970B1 (en) 1996-04-19 2006-06-21 Applied Medical Resources Corporation Grasping clip applier
FR2750031B1 (en) 1996-06-19 1998-09-18 Martin Jean Jacques BONE ANCHORING DEVICE FOR SUTURE WIRE AND INSTRUMENT FOR THE IMPLEMENTATION OF THIS DEVICE
US5775328A (en) 1996-06-26 1998-07-07 Lowe; Robert I. Device for use in temporary insertion of a sensor within a patient's body
US5752963A (en) 1996-08-19 1998-05-19 Bristol-Myers Squibb Company Suture anchor driver
US5810848A (en) 1996-08-21 1998-09-22 Hayhurst; John O. Suturing system
US5830221A (en) 1996-09-20 1998-11-03 United States Surgical Corporation Coil fastener applier
US5948001A (en) 1996-10-03 1999-09-07 United States Surgical Corporation System for suture anchor placement
US5948000A (en) 1996-10-03 1999-09-07 United States Surgical Corporation System for suture anchor placement
US6053935A (en) 1996-11-08 2000-04-25 Boston Scientific Corporation Transvaginal anchor implantation device
US5814072A (en) 1996-11-15 1998-09-29 Bonutti; Peter M. Method and apparatus for use in anchoring a suture
US5948002A (en) 1996-11-15 1999-09-07 Bonutti; Peter M. Apparatus and method for use in positioning a suture anchor
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
CA2224366C (en) 1996-12-11 2006-10-31 Ethicon, Inc. Meniscal repair device
US5964732A (en) 1997-02-07 1999-10-12 Abbeymoor Medical, Inc. Urethral apparatus with position indicator and methods of use thereof
US5954057A (en) 1997-02-12 1999-09-21 Li Medical Technologies, Inc. Soft tissue suspension clip, clip assembly, emplacement tool and method
US6039686A (en) 1997-03-18 2000-03-21 Kovac; S. Robert System and a method for the long term cure of recurrent urinary female incontinence
US5846254A (en) 1997-04-08 1998-12-08 Ethicon Endo-Surgery, Inc. Surgical instrument for forming a knot
US5873877A (en) 1997-04-11 1999-02-23 Vidamed, Inc. Medical probe device with transparent distal extremity
US5964756A (en) 1997-04-11 1999-10-12 Vidamed, Inc. Transurethral needle ablation device with replaceable stylet cartridge
US6024751A (en) 1997-04-11 2000-02-15 Coherent Inc. Method and apparatus for transurethral resection of the prostate
US6156049A (en) 1997-04-11 2000-12-05 Coherent Inc. Method and apparatus for transurethral resection of the prostate
US6120539A (en) 1997-05-01 2000-09-19 C. R. Bard Inc. Prosthetic repair fabric
US5941439A (en) 1997-05-14 1999-08-24 Mitek Surgical Products, Inc. Applicator and method for deploying a surgical fastener in tissue
US6015428A (en) 1997-06-03 2000-01-18 Anthony C. Pagedas Integrally formed suture and suture lock
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
FR2765732B1 (en) 1997-07-04 1999-08-27 France Telecom VARIABLE PROPELLER ANTENNA
US5899921A (en) 1997-07-25 1999-05-04 Innovasive Devices, Inc. Connector device and method for surgically joining and securing flexible tissue repair members
US6159207A (en) 1997-07-31 2000-12-12 Yoon; Inbae Protected ablation method and apparatus
US6159234A (en) 1997-08-01 2000-12-12 Peter M. Bonutti Method and apparatus for securing a suture
US5971967A (en) 1997-08-19 1999-10-26 Abbeymoor Medical, Inc. Urethral device with anchoring system
US5954747A (en) 1997-11-20 1999-09-21 Clark; Ron Meniscus repair anchor system
US6280441B1 (en) 1997-12-15 2001-08-28 Sherwood Services Ag Apparatus and method for RF lesioning
US6626919B1 (en) 1997-12-29 2003-09-30 Lee L. Swanstrom Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall
US6295990B1 (en) * 1998-02-03 2001-10-02 Salient Interventional Systems, Inc. Methods and systems for treating ischemia
US5908447A (en) 1998-02-06 1999-06-01 Intermedics Inc. Breakaway structure for body implantable medical device
US6045551A (en) 1998-02-06 2000-04-04 Bonutti; Peter M. Bone suture
US5921986A (en) 1998-02-06 1999-07-13 Bonutti; Peter M. Bone suture
US6440127B2 (en) 1998-02-11 2002-08-27 Cosman Company, Inc. Method for performing intraurethral radio-frequency urethral enlargement
US6280460B1 (en) 1998-02-13 2001-08-28 Heartport, Inc. Devices and methods for performing vascular anastomosis
RU2128012C1 (en) 1998-03-11 1999-03-27 Оспанов Орал Базарбаевич Compression anastomosis apparatus
US5944739A (en) 1998-03-12 1999-08-31 Surgical Dynamics, Inc. Suture anchor installation system
US5931844A (en) 1998-03-31 1999-08-03 Smith & Nephew, Inc. Surgical drive tool
ATE308276T1 (en) * 1998-03-31 2005-11-15 Transvascular Inc TISSUE-PENETRATING CATHETER WITH TRANSDUCER FOR IMAGING AND ASSOCIATED METHODS OF APPLICATION
US6117133A (en) * 1998-04-03 2000-09-12 Zappala; Stephen M. Multiple-lumen sheath for a resectoscope
US5971447A (en) 1998-04-15 1999-10-26 Steck, Iii; William F Fisherman's knot tying device
US6143006A (en) 1998-04-18 2000-11-07 Chan; Kwan-Ho Apparatus and method for tying and tensioning knots
US6033413A (en) 1998-04-20 2000-03-07 Endocare, Inc. Stent delivery system
US6382214B1 (en) 1998-04-24 2002-05-07 American Medical Systems, Inc. Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
US6216703B1 (en) 1998-05-08 2001-04-17 Thermatrx, Inc. Therapeutic prostatic thermotherapy
AU737877B2 (en) 1998-05-21 2001-09-06 Christopher J. Walshe A tissue anchor system
US6599311B1 (en) 1998-06-05 2003-07-29 Broncus Technologies, Inc. Method and assembly for lung volume reduction
US6488691B1 (en) 1998-06-24 2002-12-03 Brendan J. Carroll Laparascopic incision closure device
US6261302B1 (en) * 1998-06-26 2001-07-17 Ethicon Endo-Surgery, Inc. Applier for implantable surgical marker
US6332889B1 (en) 1998-08-27 2001-12-25 Onux Medical, Inc. Surgical suturing instrument and method of use
US6200329B1 (en) 1998-08-31 2001-03-13 Smith & Nephew, Inc. Suture collet
US6093194A (en) 1998-09-14 2000-07-25 Endocare, Inc. Insertion device for stents and methods for use
JP2002526193A (en) 1998-09-18 2002-08-20 ユナイテッド ステイツ サージカル コーポレーション Intravascular fastener applicator
US6066160A (en) 1998-11-23 2000-05-23 Quickie Llc Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing
US6110183A (en) 1998-12-22 2000-08-29 Cook Incorporated Suture anchor device
JP3370300B2 (en) 1998-12-25 2003-01-27 メイラ株式会社 Transplant ligament fixation device
EP1016377B1 (en) 1998-12-30 2006-04-26 Ethicon Inc. Suture locking device
ATE543442T1 (en) * 1998-12-31 2012-02-15 Kensey Nash Corp TISSUE FASTENING DEVICES
US6896683B1 (en) 1999-01-25 2005-05-24 Applied Material Resources Corporation Surgical instrument with improved handle assembly
US8529588B2 (en) 1999-01-25 2013-09-10 Applied Medical Resources Corporation Multiple clip applier apparatus and method
US6306158B1 (en) 1999-03-02 2001-10-23 Edwin C. Bartlett Suture anchor and associated method of implantation
AU769458B2 (en) 1999-03-03 2004-01-29 Smith & Nephew, Inc. Methods, systems, and instruments for inserting prosthetic implants
US8137364B2 (en) 2003-09-11 2012-03-20 Abbott Laboratories Articulating suturing device and method
US6709465B2 (en) 1999-03-18 2004-03-23 Fossa Medical, Inc. Radially expanding ureteral device
US20050283189A1 (en) 1999-03-31 2005-12-22 Rosenblatt Peter L Systems and methods for soft tissue reconstruction
JP4657456B2 (en) 1999-04-09 2011-03-23 イバルブ・インコーポレーテッド Method and apparatus for heart valve repair
US20040044350A1 (en) 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US6206907B1 (en) * 1999-05-07 2001-03-27 Cardia, Inc. Occlusion device with stranded wire support arms
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6461355B2 (en) 1999-05-27 2002-10-08 Ams Research Corporation Insulated electrode and method of assembly
US6368346B1 (en) 1999-06-03 2002-04-09 American Medical Systems, Inc. Bioresorbable stent
US6235024B1 (en) 1999-06-21 2001-05-22 Hosheng Tu Catheters system having dual ablation capability
US6663639B1 (en) 1999-06-22 2003-12-16 Ndo Surgical, Inc. Methods and devices for tissue reconfiguration
US6506196B1 (en) 1999-06-22 2003-01-14 Ndo Surgical, Inc. Device and method for correction of a painful body defect
US6821285B2 (en) 1999-06-22 2004-11-23 Ndo Surgical, Inc. Tissue reconfiguration
US6835200B2 (en) 1999-06-22 2004-12-28 Ndo Surgical. Inc. Method and devices for tissue reconfiguration
US6494888B1 (en) 1999-06-22 2002-12-17 Ndo Surgical, Inc. Tissue reconfiguration
US7416554B2 (en) 2002-12-11 2008-08-26 Usgi Medical Inc Apparatus and methods for forming and securing gastrointestinal tissue folds
US7744613B2 (en) 1999-06-25 2010-06-29 Usgi Medical, Inc. Apparatus and methods for forming and securing gastrointestinal tissue folds
US20040122456A1 (en) 2002-12-11 2004-06-24 Saadat Vahid C. Methods and apparatus for gastric reduction
US6398796B2 (en) 1999-07-13 2002-06-04 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US7935108B2 (en) 1999-07-14 2011-05-03 Cardiofocus, Inc. Deflectable sheath catheters
US6290711B1 (en) 1999-08-13 2001-09-18 Innovasive Devices, Inc. Connector device and method for surgically joining and securing flexible tissue repair members
US6425919B1 (en) 1999-08-18 2002-07-30 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
DE69924373T2 (en) 1999-09-10 2005-09-15 Zimmer Technology, Inc., Chicago Binding element for wound healing
AU5598300A (en) * 1999-10-13 2001-04-23 Jeffrey E. Yeung Non-invasive and minimally invasive methods and devices for treating urinary incontinence or obstruction
US6626930B1 (en) 1999-10-21 2003-09-30 Edwards Lifesciences Corporation Minimally invasive mitral valve repair method and apparatus
US20030144570A1 (en) 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
US6641592B1 (en) 1999-11-19 2003-11-04 Lsi Solutions, Inc. System for wound closure
WO2001039671A1 (en) 1999-12-02 2001-06-07 Smith & Nephew, Inc. Wound closure devices and methods
US7887551B2 (en) 1999-12-02 2011-02-15 Smith & Nephew, Inc. Soft tissue attachment and repair
SE515932C2 (en) 1999-12-23 2001-10-29 Prostalund Operations Ab Method and apparatus for the treatment of prostate
US6635073B2 (en) 2000-05-03 2003-10-21 Peter M. Bonutti Method of securing body tissue
US6527702B2 (en) 2000-02-01 2003-03-04 Abbeymoor Medical, Inc. Urinary flow control device and method
AU2001236731A1 (en) 2000-02-10 2001-08-20 Harmonia Medical Technologies Inc. Transurethral volume reduction of the prostate (tuvor)
JP2004514462A (en) 2000-03-03 2004-05-20 シー・アール・バード・インク Tissue adhesion device for endoscope with multiple suction ports
US6402750B1 (en) 2000-04-04 2002-06-11 Spinlabs, Llc Devices and methods for the treatment of spinal disorders
US6682473B1 (en) 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US6908473B2 (en) 2000-04-14 2005-06-21 Jeffry B. Skiba Tissue anchoring devices, biological vessel suspending devices and systems and methods utilizing same
US7470228B2 (en) 2000-04-14 2008-12-30 Attenuex Technologies, Inc. Method of treating benign hypertrophy of the prostate
DE60031175D1 (en) 2000-06-12 2006-11-16 Jeffrey E Yeung REPAIR OF INTERMEDIATE WHEELS
EP1303218A1 (en) 2000-06-14 2003-04-23 Sterilis, Inc. Suturing method and apparatus
US6663589B1 (en) 2000-06-20 2003-12-16 Haim Halevy Catheter system
US6716252B2 (en) * 2000-06-30 2004-04-06 Wit Ip Corporation Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra
US6582453B1 (en) 2000-07-14 2003-06-24 Opus Medical, Inc. Method and apparatus for attaching connective tissues to bone using a suture anchoring device
US6660008B1 (en) 2001-06-07 2003-12-09 Opus Medical, Inc. Method and apparatus for attaching connective tissues to bone using a suture anchoring device
US6921361B2 (en) 2000-07-24 2005-07-26 Olympus Corporation Endoscopic instrument for forming an artificial valve
US7141038B2 (en) 2000-08-07 2006-11-28 Abbeymoor Medical, Inc. Endourethral device and method
AU2001288573A1 (en) 2000-08-31 2002-03-13 Abbeymoor Medical, Inc. Diagnostic urethral assembly and method
US6322112B1 (en) 2000-09-14 2001-11-27 Franklin R. Duncan Knot tying methods and apparatus
US6736828B1 (en) * 2000-09-29 2004-05-18 Scimed Life Systems, Inc. Method for performing endoluminal fundoplication and apparatus for use in the method
US6638275B1 (en) 2000-10-05 2003-10-28 Medironic, Inc. Bipolar ablation apparatus and method
US6616684B1 (en) 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
WO2002032321A1 (en) * 2000-10-19 2002-04-25 Yeung Jeffrey E Urethral muscle controlled micro-invasive sphincteric closure device
US6773438B1 (en) 2000-10-19 2004-08-10 Ethicon Endo-Surgery Surgical instrument having a rotary lockout mechanism
US6949064B2 (en) 2000-10-20 2005-09-27 Bard Brachytherapy, Inc. Brachytherapy seed deployment system
EP2056248A1 (en) 2000-10-25 2009-05-06 Thomson Financial Inc. Electronic commerce system
US6663633B1 (en) 2000-10-25 2003-12-16 Pierson, Iii Raymond H. Helical orthopedic fixation and reduction device, insertion system, and associated methods
JP4160386B2 (en) 2000-11-02 2008-10-01 スミス アンド ネフュー インコーポレーテッド Tissue repair occlusion device and tissue repair method
US6682555B2 (en) 2000-11-13 2004-01-27 Wit Ip Corporation Methods for treating the prostate and inhibiting obstruction of the prostatic urethra using biodegradable stents
US6821282B2 (en) 2000-11-27 2004-11-23 Scimed Life Systems, Inc. Full thickness resection device control handle
ATE483492T1 (en) 2001-01-23 2010-10-15 Abbeymoor Medical Inc ENDOURETHRAL DEVICE
US20020161382A1 (en) 2001-03-29 2002-10-31 Neisz Johann J. Implant inserted without bone anchors
US6500184B1 (en) 2001-01-31 2002-12-31 Yung C. Chan Suturing apparatus and method of suturing
US20040030217A1 (en) 2001-02-02 2004-02-12 Yeung Jeffrey E Urethral muscle controlled micro-invasive sphincteric closure device
US7083638B2 (en) 2001-02-12 2006-08-01 Arthrocare Corporation Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
US6802846B2 (en) 2001-02-12 2004-10-12 Ams Research Corporation Foreign body retrieval device and method
US6770076B2 (en) 2001-02-12 2004-08-03 Opus Medical, Inc. Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
BE1013974A3 (en) 2001-02-16 2003-01-14 Janssens Jacques Phillibert Device for taking a tissue language.
US6595911B2 (en) 2001-04-03 2003-07-22 Lovuolo Michael Method and device for anchor implantation and support of bodily structures
US6632235B2 (en) 2001-04-19 2003-10-14 Synthes (U.S.A.) Inflatable device and method for reducing fractures in bone and in treating the spine
US8202315B2 (en) 2001-04-24 2012-06-19 Mitralign, Inc. Catheter-based annuloplasty using ventricularly positioned catheter
US7282020B2 (en) 2001-04-24 2007-10-16 Microspherix Llc Deflectable implantation device and method of use
US7015004B2 (en) * 2001-11-23 2006-03-21 Syn X Pharma, Inc. Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
US7417175B2 (en) * 2001-05-09 2008-08-26 Taiho Pharmaceuticals Co., Ltd. Interstitial prostatism model animal
US6821291B2 (en) 2001-06-01 2004-11-23 Ams Research Corporation Retrievable stent and method of use thereof
US6926732B2 (en) 2001-06-01 2005-08-09 Ams Research Corporation Stent delivery device and method
EP1406545B1 (en) 2001-06-14 2015-10-28 Endoevolution, Llc Apparatus and method for surgical suturing with thread management
EP1404222B8 (en) 2001-06-22 2010-05-26 Abbeymoor Medical, Inc. Urethral profiling device
US7727248B2 (en) 2001-06-25 2010-06-01 Ethicon Endo-Surgery, Inc. Surgical clip
US20030040803A1 (en) 2001-08-23 2003-02-27 Rioux Robert F. Maintaining an open passageway through a body lumen
US7104949B2 (en) 2001-08-31 2006-09-12 Ams Research Corporation Surgical articles for placing an implant about a tubular tissue structure and methods
US6596013B2 (en) 2001-09-20 2003-07-22 Scimed Life Systems, Inc. Method and apparatus for treating septal defects
US6790223B2 (en) 2001-09-21 2004-09-14 Scimed Life Systems, Inc. Delivering a uretheral stent
US6767037B2 (en) 2001-09-27 2004-07-27 Depuy Mitek, Inc. Sliding and locking surgical knot
US6773436B2 (en) 2001-09-28 2004-08-10 Depuy Mitek, Inc. Absorbable bone anchor
US6770101B2 (en) * 2001-10-09 2004-08-03 Scimed Life Systems, Inc. Prostatic stent and delivery system
EP1434530A2 (en) 2001-10-12 2004-07-07 AMS Research Corporation Surgical instrument and method
ATE536198T1 (en) 2001-10-18 2011-12-15 Abbeymoor Medical Inc ENDOURETHRAL DEVICE
US20030078601A1 (en) 2001-10-22 2003-04-24 Oleg Shikhman Crimping and cutting device
US7867251B2 (en) 2001-11-08 2011-01-11 Smith & Nephew, Inc. Reattachment of tissue to base tissue
US20060167477A1 (en) * 2001-11-20 2006-07-27 Arcia Rovil P Device and method for performing end-to-side anastomosis
US20070198038A1 (en) 2001-12-03 2007-08-23 Cohen Adam L Microdevices for Tissue Approximation and Retention, Methods for Using, and Methods for Making
DE10159470B4 (en) 2001-12-04 2012-12-13 Ovesco Endoscopy Gmbh Surgical instrument with anchor device at the head end
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
US6855115B2 (en) 2002-01-22 2005-02-15 Cardiomems, Inc. Implantable wireless sensor for pressure measurement within the heart
US7402166B2 (en) 2002-02-15 2008-07-22 A&P Feigl Family Limited Partnership Devices and methods for positioning sutures
RU2221501C2 (en) 2002-02-28 2004-01-20 Оспанов Орал Базарбаевич Method for laparoscopic performance of compression anastomosis
US6824516B2 (en) 2002-03-11 2004-11-30 Medsci Technologies, Inc. System for examining, mapping, diagnosing, and treating diseases of the prostate
AU2003208226A1 (en) 2002-03-11 2003-09-22 Janusz B. Pawliszyn Micro-devices and analytical procedures for investigation of biological systems
US20030176883A1 (en) 2002-03-12 2003-09-18 Sauer Jude S Tissue manipulation apparatus and method of use
JP2003273005A (en) * 2002-03-18 2003-09-26 Ushio Inc Exposure system
CN100574728C (en) 2002-03-30 2009-12-30 无限整形外科有限公司 Replacement device and system
US7007698B2 (en) 2002-04-03 2006-03-07 Boston Scientific Corporation Body lumen closure
US7463934B2 (en) 2002-04-12 2008-12-09 Medtronic, Inc. Implantable medical device with captivation fixation
AU2003223672A1 (en) * 2002-04-17 2003-11-03 Tyco Healthcare Group Lp Method and apparatus for anastomosis including an expandable anchor
US6802838B2 (en) 2002-04-22 2004-10-12 Trimedyne, Inc. Devices and methods for directed, interstitial ablation of tissue
US6951565B2 (en) 2002-04-24 2005-10-04 Linvatec Biomaterials Ltd. Device for inserting surgical implants
US8105342B2 (en) 2002-05-08 2012-01-31 Apollo Endosurgery, Inc. Apparatus for ligating/suturing living tissues and system for resecting/suturing living tissues
US7112172B2 (en) 2002-05-17 2006-09-26 Tyco Healthcare Group Lp Endoscopic organ retraction system and method of using the same
CN100341589C (en) 2002-05-24 2007-10-10 血管技术国际股份公司 Compositions and methods for coating medical implants
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US8287555B2 (en) 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20050216078A1 (en) 2002-06-13 2005-09-29 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
AU2003245606B2 (en) 2002-06-19 2008-04-03 Covidien Lp Method and apparatus for anastomosis
US20050146070A1 (en) 2002-06-21 2005-07-07 Massachusetts General Hospital Meta lback or mesh crosslinking
US6715804B2 (en) 2002-07-05 2004-04-06 Daniel James Beers Fisherman's knot tier
EP1380319B1 (en) 2002-07-11 2006-03-01 Nucletron B.V. Urethral probe device
JP4373146B2 (en) * 2002-07-11 2009-11-25 オリンパス株式会社 Endoscopic suturing device
ES2397221T3 (en) 2002-07-23 2013-03-05 Covidien Ag IVS shutter instrument
US7041111B2 (en) 2002-08-02 2006-05-09 Boston Scientific Scimed, Inc. Placing sutures
AU2003250591B2 (en) 2002-08-23 2007-06-21 Pamarope Pty Limited Anchoring device and its implementation
US20040044364A1 (en) * 2002-08-29 2004-03-04 Devries Robert Tissue fasteners and related deployment systems and methods
US7083630B2 (en) * 2002-08-29 2006-08-01 Scimed Life Systems, Inc. Devices and methods for fastening tissue layers
US7369894B2 (en) 2002-09-06 2008-05-06 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
US7153849B2 (en) 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
DE60325634D1 (en) 2002-10-01 2009-02-12 Ample Medical Inc DEVICES AND SYSTEMS FOR FORMING A HEADLAP ANNULUS
US7794494B2 (en) * 2002-10-11 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices
US7105004B2 (en) 2002-10-21 2006-09-12 Start Llc One-hand locking and releasing handheld medical instrument
JP2006503651A (en) 2002-10-21 2006-02-02 ミトラリグン・インコーポレーテッド Method and apparatus for performing catheter-based annuloplasty surgery using plication
US6733536B1 (en) 2002-10-22 2004-05-11 Scimed Life Systems Male urethral stent device
US20090149871A9 (en) 2002-11-01 2009-06-11 Jonathan Kagan Devices and methods for treating morbid obesity
US7090690B2 (en) 2002-11-19 2006-08-15 Arthrocare Corporation Devices and methods for repairing soft tissue
US8562646B2 (en) * 2002-12-19 2013-10-22 Boston Scientific Scimed, Inc. Anchoring to soft tissue
US7096301B2 (en) 2003-01-13 2006-08-22 Texas Instruments Incorporated Communications interface for enabling extension of an internal common bus architecture (CBA)
US20040143343A1 (en) 2003-01-17 2004-07-22 Grocela Joseph A. Post-radical prostatectomy continence implant
US9333102B2 (en) 2003-02-24 2016-05-10 Allium Medical Solutions Ltd. Stent
CN2885311Y (en) 2006-01-18 2007-04-04 郑成福 Via urethra prostate therapeutic equipment using photodynamic therapy
US7220274B1 (en) 2003-03-21 2007-05-22 Quinn Stephen F Intravascular stent grafts and methods for deploying the same
US7131981B2 (en) 2003-03-25 2006-11-07 Angiodynamics, Inc. Device and method for converting a balloon catheter into a cutting balloon catheter
GB0307082D0 (en) 2003-03-27 2003-04-30 Gyne Ideas Ltd Drug delivery device and method
EP1615567B1 (en) 2003-04-16 2010-12-01 Tyco Healthcare Group LP Apparatus for radical prostatectomy anastomosis including an anchor for engaging a body vessel and deployable sutures
US20060041182A1 (en) 2003-04-16 2006-02-23 Forbes Zachary G Magnetically-controllable delivery system for therapeutic agents
US20040215181A1 (en) 2003-04-25 2004-10-28 Medtronic, Inc. Delivery of fluid during transurethral prostate treatment
US7238182B2 (en) * 2003-04-25 2007-07-03 Medtronic, Inc. Device and method for transurethral prostate treatment
US7862584B2 (en) 2003-05-07 2011-01-04 Anpa Medical, Inc. Suture lock
US20040230316A1 (en) 2003-05-12 2004-11-18 Iulian Cioanta Method for treating the prostate and inhibiting obstruction of the prostatic urethra using biodegradable stents
JP2004341127A (en) 2003-05-14 2004-12-02 Sharp Corp Method for manufacturing wiring substrate material, method for removing short circuit connection line of wiring substrate material, and wiring substrate material
CN1822794B (en) 2003-05-16 2010-05-26 C.R.巴德有限公司 Single intubation, multi-stitch endoscopic suturing system
JP4338440B2 (en) 2003-05-22 2009-10-07 Hoya株式会社 Magnetic guidance means guidance system for endoscope
CN1830163B (en) 2003-05-23 2011-11-09 讯宝科技公司 Method for calibrating target positioning system
JP4166632B2 (en) 2003-06-06 2008-10-15 オリンパス株式会社 Suture device
IL156945A0 (en) * 2003-07-15 2004-02-08 Itzhak Tavori Device and a method for orthopedic delivery of bone reconstruction medium
WO2005013855A2 (en) 2003-08-01 2005-02-17 Cook Urological, Incorporated Implant delivery device
EP1667584B1 (en) 2003-08-26 2008-12-10 Zimmer Spine, Inc. Access systems for minimally invasive surgery
US7766899B2 (en) 2003-09-17 2010-08-03 Prostalund Operations Ab Partial-length, indwelling prostatic catheter using coiled inflation tube as an anchor and methods of draining urine and flushing clots
US7303108B2 (en) 2003-09-29 2007-12-04 Ethicon Endo-Surgery, Inc. Surgical stapling instrument incorporating a multi-stroke firing mechanism with a flexible rack
US7556647B2 (en) * 2003-10-08 2009-07-07 Arbor Surgical Technologies, Inc. Attachment device and methods of using the same
CA2542089A1 (en) 2003-10-10 2005-04-21 Proximare, Inc. Patent foramen ovale (pfo) closure devices, delivery apparatus and related methods and systems
US7682374B2 (en) 2003-10-21 2010-03-23 Arthrocare Corporation Knotless suture lock and bone anchor implant method
US7437194B2 (en) 2003-10-31 2008-10-14 Medtronic, Inc. Stimulating the prostate gland
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
WO2005053517A1 (en) 2003-12-01 2005-06-16 Olympus Corporation Endoscope system
US7004965B2 (en) 2003-12-17 2006-02-28 Yosef Gross Implant and delivery tool therefor
US20050273138A1 (en) 2003-12-19 2005-12-08 Guided Delivery Systems, Inc. Devices and methods for anchoring tissue
US20050154401A1 (en) * 2004-01-08 2005-07-14 Scimed Life Systems, Inc. Suturing device for implantable device
US20050171522A1 (en) 2004-01-30 2005-08-04 Christopherson Mark A. Transurethral needle ablation system with needle position indicator
US20050192652A1 (en) * 2004-02-26 2005-09-01 Iulian Cioanta Thermal treatment systems with enhanced tissue penetration depth using adjustable treatment pressures and related methods
US20050203550A1 (en) 2004-03-11 2005-09-15 Laufer Michael D. Surgical fastener
US7255675B2 (en) * 2004-03-23 2007-08-14 Michael Gertner Devices and methods to treat a patient
JP4700384B2 (en) 2004-04-07 2011-06-15 オリンパス株式会社 Medical ligature suturing apparatus and medical ligature suturing system
JP4643328B2 (en) 2004-04-07 2011-03-02 オリンパス株式会社 Medical ligature suturing device
US7938847B2 (en) 2006-01-04 2011-05-10 Tornier, Inc. Ring cinch assembly to attach bone to tissue
EP2422751A3 (en) 2004-05-05 2013-01-02 Direct Flow Medical, Inc. Unstented heart valve with formed in place support structure
US7497854B2 (en) 2004-05-07 2009-03-03 Ethicon Endo-Surgery, Inc. Method and instrument for effecting anastomosis of respective tissues defining two body lumens
US7736374B2 (en) * 2004-05-07 2010-06-15 Usgi Medical, Inc. Tissue manipulation and securement system
US8057511B2 (en) 2004-05-07 2011-11-15 Usgi Medical, Inc. Apparatus and methods for positioning and securing anchors
US8444657B2 (en) 2004-05-07 2013-05-21 Usgi Medical, Inc. Apparatus and methods for rapid deployment of tissue anchors
US20050251159A1 (en) 2004-05-07 2005-11-10 Usgi Medical Inc. Methods and apparatus for grasping and cinching tissue anchors
US7334822B1 (en) 2004-05-20 2008-02-26 Hines Jr Robert S Bimini twist knot tying device
US7112186B2 (en) 2004-05-26 2006-09-26 Shah Tilak M Gastro-occlusive device
US7695503B1 (en) 2004-06-09 2010-04-13 Biomet Sports Medicine, Llc Method and apparatus for soft tissue attachment
US20050288694A1 (en) 2004-06-23 2005-12-29 Stepehen Solomon Adjustable percutaneous stomach lumen restriction device
SE0401708D0 (en) 2004-06-30 2004-06-30 Wallsten Medical Sa Balloon Catheter
US20060020276A1 (en) 2004-07-23 2006-01-26 Usgi Medical Inc. Apparatus and methods for achieving prolonged maintenance of gastrointestinal tissue folds
KR100551740B1 (en) 2004-07-26 2006-02-13 학교법인고려중앙학원 Bead for stitching and apparatus for stitching internal organ using the same
US20060026750A1 (en) 2004-08-03 2006-02-09 Rodney Ballance Superscrubber
US7435251B2 (en) 2004-08-31 2008-10-14 Green David T System for securing a suture
US20060079881A1 (en) 2004-10-13 2006-04-13 Christopherson Mark A Single-use transurethral needle ablation
US7335197B2 (en) 2004-10-13 2008-02-26 Medtronic, Inc. Transurethral needle ablation system with flexible catheter tip
IL164563A0 (en) 2004-10-13 2005-12-18 Protech Medical Technologies L Prostate treatment stent
US7261709B2 (en) 2004-10-13 2007-08-28 Medtronic, Inc. Transurethral needle ablation system with automatic needle retraction
US20060089646A1 (en) 2004-10-26 2006-04-27 Bonutti Peter M Devices and methods for stabilizing tissue and implants
US9463012B2 (en) 2004-10-26 2016-10-11 P Tech, Llc Apparatus for guiding and positioning an implant
US20060089636A1 (en) * 2004-10-27 2006-04-27 Christopherson Mark A Ultrasound visualization for transurethral needle ablation
US7905904B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8303604B2 (en) 2004-11-05 2012-11-06 Biomet Sports Medicine, Llc Soft tissue repair device and method
US8080021B2 (en) * 2005-01-11 2011-12-20 Boston Scientific Scimed, Inc. Multiple clip deployment magazine
US7536225B2 (en) * 2005-01-21 2009-05-19 Ams Research Corporation Endo-pelvic fascia penetrating heating systems and methods for incontinence treatment
US7914437B2 (en) 2005-02-04 2011-03-29 Ams Research Corporation Transobturator methods for installing sling to treat incontinence, and related devices
EP1855599B1 (en) 2005-02-07 2016-06-08 Ivy Sports Medicine, LLC. System for all-inside suture fixation for implant attachment and soft tissue repair
US20060189940A1 (en) * 2005-02-24 2006-08-24 Kirsch Andrew J Implant positioning system and method
US20060199996A1 (en) 2005-03-04 2006-09-07 Ricardo Caraballo Sling for supporting and occluding a tissue and method of using the same
US7569059B2 (en) 2005-04-20 2009-08-04 Arthroscopic Innovations Llc Method and apparatus for surgical repair
US7608108B2 (en) 2005-04-29 2009-10-27 Jmea Corporation Tissue repair system
US7935140B2 (en) 2005-05-13 2011-05-03 Merit Medical Systems, Inc. Delivery device with anchoring features and associated method
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US8394113B2 (en) 2005-05-20 2013-03-12 Neotract, Inc. Coiled anchor device
US9149266B2 (en) 2005-05-20 2015-10-06 Neotract, Inc. Deforming anchor device
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US9364212B2 (en) 2005-05-20 2016-06-14 Neotract, Inc. Suture anchoring devices and methods for use
US8628542B2 (en) 2005-05-20 2014-01-14 Neotract, Inc. Median lobe destruction apparatus and method
US8157815B2 (en) 2005-05-20 2012-04-17 Neotract, Inc. Integrated handle assembly for anchor delivery system
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8834492B2 (en) 2005-05-20 2014-09-16 Neotract, Inc. Continuous indentation lateral lobe apparatus and method
US8333776B2 (en) 2005-05-20 2012-12-18 Neotract, Inc. Anchor delivery system
US20130296889A1 (en) 2005-05-20 2013-11-07 Neotract, Inc. Anchor delivery system
US8425535B2 (en) 2005-05-20 2013-04-23 Neotract, Inc. Multi-actuating trigger anchor delivery system
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8491606B2 (en) 2005-05-20 2013-07-23 Neotract, Inc. Median lobe retraction apparatus and method
US7909836B2 (en) 2005-05-20 2011-03-22 Neotract, Inc. Multi-actuating trigger anchor delivery system
US9504461B2 (en) 2005-05-20 2016-11-29 Neotract, Inc. Anchor delivery system
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8529584B2 (en) 2005-05-20 2013-09-10 Neotract, Inc. Median lobe band implant apparatus and method
US20060271032A1 (en) 2005-05-26 2006-11-30 Chin Albert K Ablation instruments and methods for performing abalation
US8114070B2 (en) 2005-06-24 2012-02-14 Angiodynamics, Inc. Methods and systems for treating BPH using electroporation
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
US7588583B2 (en) 2005-09-14 2009-09-15 Rhaphis Medical, Inc. Suturing device, system and method
US20070073342A1 (en) 2005-09-27 2007-03-29 Innovative Spinal Technologies Annular access device using t-anchors
US8758375B2 (en) 2005-09-28 2014-06-24 Olympus Medical Systems Corp Method for suturing perforation
US20070123988A1 (en) 2005-10-28 2007-05-31 Halkey-Roberts Corporation Tapered anchor for tendon graft
EP2243507A1 (en) 2005-10-29 2010-10-27 PNN Medical SA Stent with anchoring portion
US20080065120A1 (en) 2005-10-31 2008-03-13 Zannis Anthony D Surgical instrument, kit and method for creating mattress-type stitches
US20070112385A1 (en) 2005-11-15 2007-05-17 Conlon Sean P Expandable suture anchor
US20070112423A1 (en) 2005-11-16 2007-05-17 Chu Jack F Devices and methods for treatment of venous valve insufficiency
WO2007064906A2 (en) 2005-12-01 2007-06-07 Ndo Surgical, Inc. Devices and methods for endoluminal gastric restriction and tissue manipulation
US20070179496A1 (en) 2006-01-31 2007-08-02 Medtronic, Inc. Flexible catheter for ablation therapy
US20070179491A1 (en) 2006-01-31 2007-08-02 Medtronic, Inc. Sensing needle for ablation therapy
US8521257B2 (en) 2006-03-14 2013-08-27 The Johns Hopkins University Apparatus for insertion of a medical device within a body during a medical imaging process
US8876810B2 (en) 2006-03-20 2014-11-04 Biolitec Pharma Marketing Ltd Benign prostatic hyperplasia treatment method and device
EP1996084A1 (en) 2006-03-22 2008-12-03 Sapphire Medical, Inc. Suture passer devices and uses thereof
DK2006389T3 (en) 2006-04-13 2017-08-28 Nippon Suisan Kaisha Ltd Process for preparing concentrated polyunsaturated fatty acid oil
US7862582B2 (en) 2006-05-02 2011-01-04 Ethicon Endo-Surgery, Inc. Suture management
EP2019648A4 (en) 2006-05-19 2017-06-07 AMS Research Corporation Method and articles for treatment of stress urinary incontinence
CA2654294C (en) 2006-06-22 2016-09-20 Ams Research Corporation Adjustable tension incontinence sling assemblies
US8870916B2 (en) 2006-07-07 2014-10-28 USGI Medical, Inc Low profile tissue anchors, tissue anchor systems, and methods for their delivery and use
US9788825B2 (en) 2006-08-04 2017-10-17 Depuy Mitek, Llc Suture anchor with relief mechanism
US9750492B2 (en) 2006-08-04 2017-09-05 Depuy Mitek, Llc Suture anchor system with tension relief mechanism
US20080058710A1 (en) 2006-08-15 2008-03-06 Wilk Peter J Surgical kit, closure device, and associated method
US7862542B1 (en) 2006-09-11 2011-01-04 Harmon Sr James V Flaccid tubular membrane and insertion appliance for surgical intubation and method
JP2010505543A (en) 2006-10-03 2010-02-25 アルレ メディカル,インコーポレイテッド Minimally invasive tissue support
EP2076183A4 (en) 2006-10-04 2009-09-16 Ndo Surgical Inc Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery
US7674275B2 (en) 2006-10-05 2010-03-09 Ethicon Endo-Surgery, Inc. Suture anchor
FR2906995B1 (en) 2006-10-11 2009-04-17 Cie Euro Etude Rech Paroscopie MULTI-NEEDLE SURGICAL HANDWOOD FOR HOLLOW MEMBER AND CORRESPONDING SYSTEM
US8702729B2 (en) 2006-10-13 2014-04-22 Boston Scientific Scimed, Inc. Placing multiple sutures
US20080154378A1 (en) 2006-12-22 2008-06-26 Warsaw Orthopedic, Inc. Bone implant having engineered surfaces
US8167830B2 (en) 2006-12-26 2012-05-01 Noriega Gerardo V Methods and systems for low frequency mechanical treatment of the prostate
WO2008086195A1 (en) 2007-01-05 2008-07-17 Kim Daniel H Apparatus and method for prostatic tissue removal
US8617185B2 (en) 2007-02-13 2013-12-31 P Tech, Llc. Fixation device
US7896871B2 (en) 2007-02-22 2011-03-01 Medtronic, Inc. Impedance computation for ablation therapy
US8128657B2 (en) 2007-02-27 2012-03-06 Olympus Medical Systems Corp. Suture instrument
EP2129301A4 (en) 2007-03-13 2015-03-25 Peter S Harris Methods and devices for reducing gastric volume
US20080228202A1 (en) 2007-03-16 2008-09-18 Ethicon Endo-Surgery, Inc. Endoscopic tissue approximation system
US8409270B2 (en) 2007-04-16 2013-04-02 Boston Scientific Scimed, Inc. Radiopaque compositions, stents and methods of preparation
WO2008132735A1 (en) 2007-04-25 2008-11-06 Mediflow Medical Solutions Ltd. A urethral implant and method
US8945114B2 (en) 2007-04-26 2015-02-03 Medtronic, Inc. Fluid sensor for ablation therapy
US8814856B2 (en) 2007-04-30 2014-08-26 Medtronic, Inc. Extension and retraction mechanism for a hand-held device
US8603187B2 (en) 2007-05-07 2013-12-10 Medi-Tate Device for dilating the urethra of the body of a patient and device for removing prostate tissue
WO2008142677A2 (en) 2007-05-18 2008-11-27 Prostaplant, Ltd. Prostate implant and methods for insertion and extraction thereof
US20100130815A1 (en) 2007-05-18 2010-05-27 Prostaplant Ltd. Intraurethral and extraurethral apparatus
DE202007008378U1 (en) 2007-06-15 2007-08-23 Ceramoptec Gmbh Urological diode laser systems with glass fiber application system
US7658311B2 (en) 2007-06-22 2010-02-09 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with a geared return mechanism
US8758366B2 (en) 2007-07-09 2014-06-24 Neotract, Inc. Multi-actuating trigger anchor delivery system
WO2009036471A1 (en) 2007-09-14 2009-03-19 Lazure Technologies, Llc Prostate cancer ablation
JP5315664B2 (en) 2007-10-29 2013-10-16 沖電気工業株式会社 POSITION EXPRESSION DETECTING DEVICE, PROGRAM, AND STORAGE MEDIUM
US8496684B2 (en) 2007-10-31 2013-07-30 Ethicon Endo-Surgery, Inc. Method for deploying a device for gastric volume reduction
US20090112234A1 (en) 2007-10-31 2009-04-30 Lawrence Crainich Reloadable laparoscopic fastener deploying device for use in a gastric volume reduction procedure
US20090118762A1 (en) 2007-10-31 2009-05-07 Lawrence Crainch Disposable cartridge for use in a gastric volume reduction procedure
WO2009072131A2 (en) 2007-12-05 2009-06-11 Aquaduct Ltd - Fortis Prostatic capsulotomy for treatment of conditions
US8353902B2 (en) 2008-01-31 2013-01-15 Vivant Medical, Inc. Articulating ablation device and method
US20100286106A1 (en) 2008-03-10 2010-11-11 Yigal Gat Methods and apparatus for treating the prostate
US8926494B1 (en) 2008-03-26 2015-01-06 Uromedica, Inc. Method and apparatus for placement of implantable device adjacent a body lumen
US8603123B2 (en) 2008-04-28 2013-12-10 Urotech, Inc. Benign prostatic hyperplasia surgical system featuring mechanical coring probe with live aspiration
US8361112B2 (en) 2008-06-27 2013-01-29 Ethicon Endo-Surgery, Inc. Surgical suture arrangement
US20100023022A1 (en) 2008-07-25 2010-01-28 Zeiner Mark S Reloadable laparoscopic fastener deploying device with disposable cartridge use in a gastric volume reduction procedure
US20100023026A1 (en) 2008-07-25 2010-01-28 Zeiner Mark S Reloadable laparoscopic fastener deploying device with disposable cartridge for use in a gastric volume reduction procedure
US20100023025A1 (en) 2008-07-25 2010-01-28 Zeiner Mark S Reloadable laparoscopic fastener deploying device with disposable cartridge for use in a gastric volume reduction procedure
US20100023024A1 (en) 2008-07-25 2010-01-28 Zeiner Mark S Reloadable laparoscopic fastener deploying device with disposable cartridge for use in a gastric volume reduction procedure
WO2010014825A1 (en) 2008-07-30 2010-02-04 Neotract, Inc. Slotted anchor device
WO2010014821A2 (en) 2008-07-30 2010-02-04 Neotract, Inc. Anchor delivery system with replaceable cartridge
US9211155B2 (en) 2008-08-20 2015-12-15 Prostacare Pty Ltd. Non-thermal ablation system for treating BPH and other growths
US8777990B2 (en) 2008-09-08 2014-07-15 Howmedica Osteonics Corp. Knotless suture anchor for soft tissue repair and method of use
US8480686B2 (en) 2008-09-25 2013-07-09 Ethicon Endo-Surgery, Inc. Methods and devices for delivering and applying suture anchors
US9089320B2 (en) 2008-09-25 2015-07-28 Ethicon Endo-Surgery, Inc. Methods and devices for delivering and applying multiple suture anchors
US20110196393A1 (en) 2008-10-20 2011-08-11 Keren Medical Ltd. Urethral anastomosis device and method of using the same
JP2012508069A (en) 2008-11-06 2012-04-05 エヌエックスセラ インコーポレイテッド System and method for treatment of benign prostatic hyperplasia
HUE037785T2 (en) 2008-11-06 2018-09-28 Nxthera Inc Systems and methods for treatment of prostatic tissue
EP2352452A4 (en) 2008-11-06 2012-07-18 Nxthera Inc Systems and methods for treatment of prostatic tissue
CA2747971C (en) 2008-12-22 2020-05-26 Medi-Tate Ltd. Radial cutter implant
US8388611B2 (en) 2009-01-14 2013-03-05 Nxthera, Inc. Systems and methods for treatment of prostatic tissue
JP2012515603A (en) 2009-01-27 2012-07-12 サイレンシード リミテッド Implant delivery methods and systems
EP2408506B1 (en) 2009-03-20 2020-09-16 Proarc Medical Ltd. Devices for urethral treatment
US20100298948A1 (en) 2009-04-27 2010-11-25 Michael Hoey Systems and Methods for Prostate Treatment
US9833277B2 (en) 2009-04-27 2017-12-05 Nxthera, Inc. Systems and methods for prostate treatment
US8236011B2 (en) 2009-10-06 2012-08-07 Ethicon Endo-Surgery, Inc. Method for deploying fasteners for use in a gastric volume reduction procedure
US8734469B2 (en) 2009-10-13 2014-05-27 Covidien Lp Suture clip applier
WO2014145381A1 (en) 2013-03-15 2014-09-18 Ceterix Orthopaedics, Inc. Suture passer devices and methods
SI2512581T1 (en) 2009-12-17 2021-09-30 Taris Biomedical Llc Implantable device with intravesical tolerability
US20110202052A1 (en) 2010-02-12 2011-08-18 Daniel Gelbart System for treating benign prostatic hyperplasia
US8683895B2 (en) 2010-02-23 2014-04-01 Kensey Nash Corporation Single revolution snap action drive for surgical fasteners
US20110218387A1 (en) 2010-03-05 2011-09-08 Neotract, Inc. Anchors for use in medical applications
BR112012022132A2 (en) 2010-03-25 2016-10-25 Nxthera Inc steam therapy system
US8419767B2 (en) 2010-05-04 2013-04-16 Mustafa H. Al-Qbandi Steerable atrial septal occluder implantation device with flexible neck
JP2013532016A (en) 2010-06-09 2013-08-15 シー・アール・バード・インコーポレーテッド Instrument for delivering a transfascial suture, transfascial suture assembly, and transfascial suture method
WO2011163634A1 (en) 2010-06-25 2011-12-29 Suturenetics, Inc. Endoscopic suturing device, system and method
US20120059387A1 (en) 2010-09-03 2012-03-08 Schanz Ii, Llc Delivery system and urethra stent for enlarged prostates and method
WO2012075112A1 (en) 2010-12-01 2012-06-07 Enable Urology, Llc Method and apparatus for remodeling/profiling a tissue lumen, particularly in the urethral lumen in the prostate gland
CZ303056B6 (en) 2010-12-14 2012-03-14 Mikrobiologický ústav AV CR, v.v.i. Surface modification method for preconcentration of phosphorylated peptides for desorption-ionization techniques of mass spectrometry
CZ303676B6 (en) 2010-12-16 2013-02-27 Lasák@Stanislav Prostatic implant assembly
JP2014512867A (en) 2011-02-09 2014-05-29 シー・アール・バード・インコーポレーテッド T-fastener suture feed system
US10035005B2 (en) 2011-03-17 2018-07-31 Proarc Medical Ltd. Devices for urethral treatment
US9161749B2 (en) 2011-04-14 2015-10-20 Neotract, Inc. Method and apparatus for treating sexual dysfunction
US8465551B1 (en) 2011-07-09 2013-06-18 Bandula Wijay Temporary prostatic stent for benign prostatic hyperplasia
WO2013096855A1 (en) 2011-12-23 2013-06-27 Arthrex, Inc. Drive system for tissue repair
KR101358119B1 (en) 2012-01-31 2014-02-07 삼성중공업 주식회사 Driving apparatus of variable pitch propeller and blade pitch angle control method and the ship having the same
US20150157309A1 (en) 2012-02-28 2015-06-11 Scott & White Healthcare Devices, apparatuses, and methods for tissue suspension
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
WO2013181397A1 (en) 2012-05-30 2013-12-05 Vascular Access Technologies, Inc. Transvascular access device and method
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
WO2014153219A1 (en) 2013-03-14 2014-09-25 Perryman Laura Tyler Devices and methods for treating urological disorders
US8808363B2 (en) 2012-08-31 2014-08-19 Cormatrix Cardiovascular, Inc. Vascular prosthesis
WO2014046939A1 (en) 2012-09-21 2014-03-27 Boston Scientific Neuromodulation Corporation Tissue fixation delivery apparatus
US9229553B2 (en) 2012-11-30 2016-01-05 3M Innovative Properties Company Mesh patterns for touch sensor electrodes
US20160000455A1 (en) 2013-03-14 2016-01-07 Proarc Medical Ltd. Methods and devices for urethral treatment
US20160038087A1 (en) 2013-03-15 2016-02-11 William L. Hunter Stent monitoring assembly and method of use thereof
EP2982321A4 (en) 2013-04-01 2016-12-07 Terumo Corp Puncture device
CA2908421C (en) 2013-04-04 2019-02-26 The Arizona Board Of Regents On Behalf Of The University Of Arizona Materials, systems, devices, and methods for endoluminal electropolymeric paving and sealing
US10463495B2 (en) 2013-06-12 2019-11-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Encircling implant delivery systems and methods
CA2935096C (en) 2013-12-30 2022-01-11 Medi-Tate Ltd. An incising implant for the prostatic urethra
DK3096711T3 (en) 2014-01-26 2021-05-25 Butterfly Medical Ltd DILATION DEVICE FOR PROSTATIC URINE PIPE
US20150257908A1 (en) 2014-03-14 2015-09-17 The Board Of Trustees Of The Leland Stanford Junior University Indwelling body lumen expander
US10231718B2 (en) 2014-05-23 2019-03-19 Boston Scientific Scimed, Inc. Tissue extraction devices and related methods
WO2016134166A1 (en) 2015-02-20 2016-08-25 Scaffold Medical Ag Urethral patency implant
FI3328317T3 (en) 2015-07-29 2023-01-13 Retracting or/and supporting periurethral tissue
EP3167845A1 (en) 2015-11-12 2017-05-17 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin An implantable biocompatible expander suitable for treatment of constrictions of body lumen
WO2017112856A1 (en) 2015-12-22 2017-06-29 Prodeon, Inc. System and method for increasing a cross-sectional area of a body lumen
CN105919695A (en) 2016-05-18 2016-09-07 武汉奥绿新生物科技有限公司 Anchor for lifting prostate tissue
US20210378784A1 (en) 2018-11-07 2021-12-09 Neotract, Inc. System for delivery of a fiducial marker

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3716058A (en) * 1970-07-17 1973-02-13 Atlanta Res Inst Barbed suture
US3875648A (en) * 1973-04-04 1975-04-08 Dennison Mfg Co Fastener attachment apparatus and method
US4513746A (en) * 1981-10-09 1985-04-30 United States Surgical Corp. Instrument for applying plastic-like surgical fastening devices
US5417691A (en) * 1982-05-20 1995-05-23 Hayhurst; John O. Apparatus and method for manipulating and anchoring tissue
US4493323A (en) * 1982-12-13 1985-01-15 University Of Iowa Research Foundation Suturing device and method for using same
US4741330A (en) * 1983-05-19 1988-05-03 Hayhurst John O Method and apparatus for anchoring and manipulating cartilage
US4657461A (en) * 1984-10-26 1987-04-14 Smith Gareth J Anchoring bolt
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US5123914A (en) * 1986-05-19 1992-06-23 Cook Incorporated Visceral anchor for visceral wall mobilization
US5725557A (en) * 1987-05-18 1998-03-10 Mitek Surgical Products, Inc. Suture anchor
US5192303A (en) * 1987-05-18 1993-03-09 Mitek Surgical Products, Inc. Suture anchor
US4899743A (en) * 1987-12-15 1990-02-13 Mitek Surgical Products, Inc. Suture anchor installation tool
US4926860A (en) * 1988-02-05 1990-05-22 Flexmedics Corporation ARthroscopic instrumentation and method
US5002550A (en) * 1989-06-06 1991-03-26 Mitek Surgical Products, Inc. Suture anchor installation tool
US5919202A (en) * 1989-12-05 1999-07-06 Yoon; Inbae Surgical instrument with jaws and movable internal needle and method for use thereof
US5280460A (en) * 1990-05-21 1994-01-18 Eta S.A. Fabriques D'ebauches Gear mechanism especially for timepiece
US5203787A (en) * 1990-11-19 1993-04-20 Biomet, Inc. Suture retaining arrangement
US5100421A (en) * 1991-02-05 1992-03-31 Cyprus Endosurgical Tools, Inc. Christoudias curved needle suture assembly
US5861002A (en) * 1991-10-18 1999-01-19 Desai; Ashvin H. Endoscopic surgical instrument
US5217486A (en) * 1992-02-18 1993-06-08 Mitek Surgical Products, Inc. Suture anchor and installation tool
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5536240A (en) * 1992-08-12 1996-07-16 Vidamed, Inc. Medical probe device and method
US5749846A (en) * 1992-08-12 1998-05-12 Vidamed, Inc. Medical probe device with optical viewing capability
US6048351A (en) * 1992-09-04 2000-04-11 Scimed Life Systems, Inc. Transvaginal suturing system
US5540704A (en) * 1992-09-04 1996-07-30 Laurus Medical Corporation Endoscopic suture system
US7060077B2 (en) * 1992-09-04 2006-06-13 Boston Scientific Scimed, Inc. Suturing instruments and methods of use
US6056772A (en) * 1993-02-04 2000-05-02 Bonutti; Peter M. Method and apparatus for positioning a suture anchor
US5330488A (en) * 1993-03-23 1994-07-19 Goldrath Milton H Verres needle suturing kit
US5733306A (en) * 1993-05-14 1998-03-31 Bonutti; Peter M. Method and apparatus for anchoring a suture
US5522846A (en) * 1993-05-14 1996-06-04 Bonutti; Peter M. Suture anchor
US5507754A (en) * 1993-08-20 1996-04-16 United States Surgical Corporation Apparatus and method for applying and adjusting an anchoring device
US5899911A (en) * 1993-08-25 1999-05-04 Inlet Medical, Inc. Method of using needle-point suture passer to retract and reinforce ligaments
US6036701A (en) * 1994-01-13 2000-03-14 Ethicon, Inc. Spiral surgical tack
US5904696A (en) * 1994-01-13 1999-05-18 Ethicon, Inc. Spiral surgical tack
US5630824A (en) * 1994-06-01 1997-05-20 Innovasive Devices, Inc. Suture attachment device
US5501690A (en) * 1994-09-02 1996-03-26 Ethicon Endo-Surgery Suturing device
US5873891A (en) * 1994-12-14 1999-02-23 Influence Medical Technologies, Ltd. Staple and thread assembly particularly for use in power-driven staplers for medical suturing
US5593421A (en) * 1995-06-06 1997-01-14 Bauer; William Suture element delivery device and method
US6565578B1 (en) * 1995-09-06 2003-05-20 Wilson-Cook Medical Inc. Channel mounted activating mechanism for an endoscopic ligator
US5626614A (en) * 1995-12-22 1997-05-06 Applied Medical Resources Corporation T-anchor suturing device and method for using same
US5741276A (en) * 1996-03-28 1998-04-21 Innovative Surgical Instruments Apparatus for facilitating the performance of surgical procedures such as the placement of sutures, ligatures and the like
US5746753A (en) * 1996-05-13 1998-05-05 Boston Scientific Corporation Needle grasping apparatus
US5897574A (en) * 1996-07-01 1999-04-27 Bonutti; Peter M. Suture anchor inserter assembly and method
US5782862A (en) * 1996-07-01 1998-07-21 Bonutti; Peter M. Suture anchor inserter assembly and method
US5718717A (en) * 1996-08-19 1998-02-17 Bonutti; Peter M. Suture anchor
US5928252A (en) * 1997-01-21 1999-07-27 Regen Biologics, Inc. Device and method for driving a needle and meniscal repair
US5782864A (en) * 1997-04-03 1998-07-21 Mitek Surgical Products, Inc. Knotless suture system and method
US5919198A (en) * 1997-04-17 1999-07-06 Ethicon Endo-Surgery, Inc. Disposable cartridge with drivers
US5908428A (en) * 1997-05-27 1999-06-01 United States Surgical Corporation Stitching devices for heart valve replacement surgery
US6056722A (en) * 1997-09-18 2000-05-02 Iowa-India Investments Company Limited Of Douglas Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use
US5868762A (en) * 1997-09-25 1999-02-09 Sub-Q, Inc. Percutaneous hemostatic suturing device and method
US6551328B2 (en) * 1997-11-03 2003-04-22 Symbiosis Corporation Surgical instrument for invagination and fundoplication
US6068648A (en) * 1998-01-26 2000-05-30 Orthodyne, Inc. Tissue anchoring system and method
US6010514A (en) * 1998-03-17 2000-01-04 Burney; Bryan T. Suturing assembly and method of use
US6080167A (en) * 1998-04-28 2000-06-27 Lyell; Mark S. Anastomotic instrument
US6740098B2 (en) * 1998-05-11 2004-05-25 Surgical Connections, Inc. Surgical stabilizer devices and methods
US6547725B1 (en) * 1998-08-10 2003-04-15 Coroneo, Inc. Surgical suture and associated anchoring mechanism for tissue retraction
US6030393A (en) * 1998-09-15 2000-02-29 Corlew; Earvin L. Needle and procedure for relieving urinary incontinence
US6053908A (en) * 1999-01-07 2000-04-25 Design Standards Corporation Ratchet assembly for surgical instrument
US6228096B1 (en) * 1999-03-31 2001-05-08 Sam R. Marchand Instrument and method for manipulating an operating member coupled to suture material while maintaining tension on the suture material
US6258124B1 (en) * 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US6206895B1 (en) * 1999-07-13 2001-03-27 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6730112B2 (en) * 1999-07-13 2004-05-04 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6592609B1 (en) * 1999-08-09 2003-07-15 Bonutti 2003 Trust-A Method and apparatus for securing tissue
US6527794B1 (en) * 1999-08-10 2003-03-04 Ethicon, Inc. Self-locking suture anchor
US7048747B2 (en) * 1999-09-14 2006-05-23 Abbott Laboratories Device and method for performing end-to-side anastomosis
US6706047B2 (en) * 2000-02-15 2004-03-16 Eva Corporation Suture support assembly
US6530932B1 (en) * 2000-08-30 2003-03-11 Ethicon Endo-Surgery, Inc. Anastomosis device having improved tissue presentation
US6533796B1 (en) * 2000-10-11 2003-03-18 Lsi Solutions, Inc. Loader for surgical suturing instrument
US6572626B1 (en) * 2000-10-19 2003-06-03 Ethicon Endo-Surgery, Inc. Surgical instrument having a fastener delivery mechanism
US20080045978A1 (en) * 2000-10-19 2008-02-21 Kuhns Jesse J Method For Delivering a Plurality of Fasteners
US6551333B2 (en) * 2000-10-19 2003-04-22 Ethicon Endo-Surgery, Inc. Method for attaching hernia mesh
US6425900B1 (en) * 2000-10-19 2002-07-30 Ethicon Endo-Surgery Method for attaching hernia mesh
US7226558B2 (en) * 2000-11-22 2007-06-05 Bard Peripheral Vascular, Inc. Method of making an expanded polytetrafluoroethylene structure
US6398795B1 (en) * 2000-11-30 2002-06-04 Scimed Life Systems, Inc. Stapling and cutting in resectioning for full thickness resection devices
US6709493B2 (en) * 2001-03-26 2004-03-23 Gore Enterprise Holdings, Inc. Device for reducing the presence of moisture within an enclosure containing a heat source
US7015253B2 (en) * 2001-07-10 2006-03-21 American Medical Systems, Inc. Regimen for treating prostate tissue and surgical kit for use in the regimen
US6572653B1 (en) * 2001-12-07 2003-06-03 Rush E. Simonson Vertebral implant adapted for posterior insertion
US20060030884A1 (en) * 2002-03-14 2006-02-09 Yeung Jeffrey E Suture anchor and approximating device
US6699263B2 (en) * 2002-04-05 2004-03-02 Cook Incorporated Sliding suture anchor
US6736823B2 (en) * 2002-05-10 2004-05-18 C.R. Bard, Inc. Prosthetic repair fabric
US7011688B2 (en) * 2002-05-10 2006-03-14 C.R. Bard, Inc. Prosthetic repair fabric
US6736854B2 (en) * 2002-05-10 2004-05-18 C. R. Bard, Inc. Prosthetic repair fabric with erosion resistant edge
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20050107812A1 (en) * 2002-06-13 2005-05-19 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060058817A1 (en) * 2002-06-13 2006-03-16 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20050107811A1 (en) * 2002-06-13 2005-05-19 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20080119874A1 (en) * 2002-10-07 2008-05-22 Michael Merves Instrument handle for storing suture and needles
US20040078046A1 (en) * 2002-10-16 2004-04-22 Barzell Winston E. Suturing system and method
US20050065550A1 (en) * 2003-02-06 2005-03-24 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7340300B2 (en) * 2003-04-25 2008-03-04 Medtronic, Inc. Neurostimulation delivery during transurethral prostate treatment
US7320701B2 (en) * 2003-06-02 2008-01-22 Linvatec Corporation Push-in suture anchor, insertion tool, and method for inserting a push-in suture anchor
US20050055087A1 (en) * 2003-09-04 2005-03-10 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025819A1 (en) * 2004-05-14 2006-02-02 Nobis Rudolph H T-type suture anchoring devices and methods of using same
US7232448B2 (en) * 2004-06-17 2007-06-19 Ethicon, Inc. - Usa Minimally invasive stitching device
US7322974B2 (en) * 2004-08-10 2008-01-29 Medtronic, Inc. TUNA device with integrated saline reservoir
US20080021445A1 (en) * 2004-10-13 2008-01-24 Medtronic, Inc. Transurethral needle ablation system

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11504149B2 (en) 2005-05-20 2022-11-22 Teleflex Life Sciences Limited Median lobe destruction apparatus and method
US10537354B2 (en) 2006-12-22 2020-01-21 The Spectranetics Corporation Retractable separating systems and methods
US9808275B2 (en) 2006-12-22 2017-11-07 The Spectranetics Corporation Retractable separating systems and methods
US9289226B2 (en) 2006-12-22 2016-03-22 The Spectranetics Corporation Retractable separating systems and methods
US8961551B2 (en) 2006-12-22 2015-02-24 The Spectranetics Corporation Retractable separating systems and methods
US10869687B2 (en) 2006-12-22 2020-12-22 Spectranetics Llc Tissue separating systems and methods
US9801650B2 (en) 2006-12-22 2017-10-31 The Spectranetics Corporation Tissue separating systems and methods
US9028520B2 (en) 2006-12-22 2015-05-12 The Spectranetics Corporation Tissue separating systems and methods
US20170151428A1 (en) * 2009-04-07 2017-06-01 Boston Scientific Neuromodulation Corporation Anchoring units for implantable electrical stimulation systems and methods of making and using
US20150250998A1 (en) * 2009-04-07 2015-09-10 Boston Scientific Neuromodulation Corporation Anchoring units for implantable electrical stimulation systems and methods of making and using
US9610435B2 (en) * 2009-04-07 2017-04-04 Boston Scientific Neuromodulation Corporation Anchoring units for implantable electrical stimulation systems and methods of making and using
US9413896B2 (en) 2012-09-14 2016-08-09 The Spectranetics Corporation Tissue slitting methods and systems
US9949753B2 (en) 2012-09-14 2018-04-24 The Spectranetics Corporation Tissue slitting methods and systems
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US9724122B2 (en) 2012-09-14 2017-08-08 The Spectranetics Corporation Expandable lead jacket
US9763692B2 (en) 2012-09-14 2017-09-19 The Spectranetics Corporation Tissue slitting methods and systems
US11596435B2 (en) 2012-09-14 2023-03-07 Specrtranetics Llc Tissue slitting methods and systems
US10531891B2 (en) 2012-09-14 2020-01-14 The Spectranetics Corporation Tissue slitting methods and systems
US10485613B2 (en) 2013-03-13 2019-11-26 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US10265520B2 (en) 2013-03-13 2019-04-23 The Spetranetics Corporation Alarm for lead insulation abnormality
US9925371B2 (en) 2013-03-13 2018-03-27 The Spectranetics Corporation Alarm for lead insulation abnormality
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9937005B2 (en) 2013-03-13 2018-04-10 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9291663B2 (en) 2013-03-13 2016-03-22 The Spectranetics Corporation Alarm for lead insulation abnormality
US10799293B2 (en) 2013-03-13 2020-10-13 The Spectranetics Corporation Laser ablation catheter
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US11850140B2 (en) 2013-03-14 2023-12-26 Teleflex Life Sciences Limited Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10448999B2 (en) 2013-03-15 2019-10-22 The Spectranetics Corporation Surgical instrument for removing an implanted object
US10052129B2 (en) 2013-03-15 2018-08-21 The Spectranetics Corporation Medical device for removing an implanted object
US10314615B2 (en) 2013-03-15 2019-06-11 The Spectranetics Corporation Medical device for removing an implanted object
US9918737B2 (en) 2013-03-15 2018-03-20 The Spectranetics Corporation Medical device for removing an implanted object
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device
US10136913B2 (en) 2013-03-15 2018-11-27 The Spectranetics Corporation Multiple configuration surgical cutting device
US10842532B2 (en) 2013-03-15 2020-11-24 Spectranetics Llc Medical device for removing an implanted object
US10849603B2 (en) 2013-03-15 2020-12-01 Spectranetics Llc Surgical instrument for removing an implanted object
US9603618B2 (en) 2013-03-15 2017-03-28 The Spectranetics Corporation Medical device for removing an implanted object
US10524817B2 (en) 2013-03-15 2020-01-07 The Spectranetics Corporation Surgical instrument including an inwardly deflecting cutting tip for removing an implanted object
US9925366B2 (en) 2013-03-15 2018-03-27 The Spectranetics Corporation Surgical instrument for removing an implanted object
US9980743B2 (en) 2013-03-15 2018-05-29 The Spectranetics Corporation Medical device for removing an implanted object using laser cut hypotubes
US11160579B2 (en) 2013-03-15 2021-11-02 Spectranetics Llc Multiple configuration surgical cutting device
US10219819B2 (en) 2013-03-15 2019-03-05 The Spectranetics Corporation Retractable blade for lead removal device
US9956399B2 (en) 2013-03-15 2018-05-01 The Spectranetics Corporation Medical device for removing an implanted object
US10405924B2 (en) 2014-05-30 2019-09-10 The Spectranetics Corporation System and method of ablative cutting and vacuum aspiration through primary orifice and auxiliary side port
USD819204S1 (en) 2015-02-20 2018-05-29 The Spectranetics Corporation Medical device handle
USD765243S1 (en) 2015-02-20 2016-08-30 The Spectranetics Corporation Medical device handle
USD806245S1 (en) 2015-02-20 2017-12-26 The Spectranetics Corporation Medical device handle
USD770616S1 (en) 2015-02-20 2016-11-01 The Spectranetics Corporation Medical device handle
USD854682S1 (en) 2015-02-20 2019-07-23 The Spectranetics Corporation Medical device handle
US20200022692A1 (en) * 2017-12-23 2020-01-23 Neotract, Inc. Expandable tissue engagement apparatus and method
US11672520B2 (en) * 2017-12-23 2023-06-13 Teleflex Life Sciences Limited Expandable tissue engagement apparatus and method
US11925380B2 (en) 2020-11-17 2024-03-12 Spectranetics Llc Distal end supported tissue slitting apparatus
US11925334B2 (en) 2020-11-30 2024-03-12 Spectranetics Llc Surgical instrument for removing an implanted object

Also Published As

Publication number Publication date
EP1887976B8 (en) 2022-03-02
US20180353169A1 (en) 2018-12-13
US20130325143A1 (en) 2013-12-05
US20190282225A1 (en) 2019-09-19
US11090036B2 (en) 2021-08-17
US11471148B2 (en) 2022-10-18
US20090060977A1 (en) 2009-03-05
US8663243B2 (en) 2014-03-04
US8715239B2 (en) 2014-05-06
WO2006127431A3 (en) 2009-05-07
US20080039889A1 (en) 2008-02-14
EP1887976A4 (en) 2012-10-31
EP1887976B1 (en) 2022-01-26
US20060276871A1 (en) 2006-12-07
WO2006127431A2 (en) 2006-11-30
US20210378659A1 (en) 2021-12-09
US20230293166A1 (en) 2023-09-21
US10575844B2 (en) 2020-03-03
US20150127050A1 (en) 2015-05-07
US7914542B2 (en) 2011-03-29
US20090192439A1 (en) 2009-07-30
US8734468B2 (en) 2014-05-27
US20200187931A1 (en) 2020-06-18
EP1887976A2 (en) 2008-02-20
US20090018523A1 (en) 2009-01-15
US8343187B2 (en) 2013-01-01
US8900252B2 (en) 2014-12-02
US20110190758A1 (en) 2011-08-04
US7758594B2 (en) 2010-07-20
US10105132B2 (en) 2018-10-23

Similar Documents

Publication Publication Date Title
US11471148B2 (en) Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10492792B2 (en) Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US10945719B2 (en) Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: NEOTRACT, INC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CATANESE, JOSEPH, III;LAMSON, THEODORE C;VIDAL, CLAUDE;AND OTHERS;SIGNING DATES FROM 20050706 TO 20050721;REEL/FRAME:032212/0047

Owner name: NEOTRACT, INC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNORS:CATANESE, JOSEPH, III;LAMSON, THEODORE C;VIDAL, CLAUDE;AND OTHERS;SIGNING DATES FROM 20050706 TO 20050721;REEL/FRAME:032264/0028

AS Assignment

Owner name: PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.

Free format text: SHORT-FORM PATENT SECURITY AGREEMENT;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:032525/0104

Effective date: 20140324

Owner name: CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.

Free format text: SHORT-FORM PATENT SECURITY AGREEMENT;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:032525/0104

Effective date: 20140324

Owner name: CAPITAL ROYALTY PARTNERS II L.P., TEXAS

Free format text: SHORT-FORM PATENT SECURITY AGREEMENT;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:032525/0104

Effective date: 20140324

FPAY Fee payment

Year of fee payment: 4

SULP Surcharge for late payment
AS Assignment

Owner name: EXPLORAMED NC2, INC., CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 032212 FRAME: 0047. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNORS:LAMSON, THEODORE CHARLES;MAKOWER, JOSHUA;CATANESE, JOSEPH, III;AND OTHERS;SIGNING DATES FROM 20050706 TO 20050721;REEL/FRAME:042466/0075

Owner name: NEOTRACT, INC., CALIFORNIA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA PREVIOUSLY RECORDED AT REEL: 032264 FRAME: 0028. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME;ASSIGNOR:EXPLORAMED NC2, INC.;REEL/FRAME:042466/0092

Effective date: 20060227

AS Assignment

Owner name: NEOTRACT, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNORS:CAPITAL ROYALTY PARTNERS II L.P.;CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.;PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.;REEL/FRAME:044114/0608

Effective date: 20171002

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.)

AS Assignment

Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT

Free format text: SECURITY INTEREST;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:050619/0780

Effective date: 20190925

Owner name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT, ILLINOIS

Free format text: SECURITY INTEREST;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:050619/0780

Effective date: 20190925

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

AS Assignment

Owner name: TELEFLEX LIFE SCIENCES LIMITED, MALTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:058592/0907

Effective date: 20211210

AS Assignment

Owner name: TELEFLEX LIFE SCIENCES LIMITED, MALTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEOTRACT, INC.;REEL/FRAME:058917/0381

Effective date: 20211210

AS Assignment

Owner name: TELEFLEX LIFE SCIENCES LLC, DELAWARE

Free format text: MERGER;ASSIGNOR:TELEFLEX LIFE SCIENCES III LLC;REEL/FRAME:066305/0802

Effective date: 20231212

Owner name: TELEFLEX LIFE SCIENCES III LLC, DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TELEFLEX LIFE SCIENCES LIMITED;REEL/FRAME:066305/0073

Effective date: 20231211